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Human Tissue Plasminogen Activator
Abstract
Tissue plasminogen activator (tPA) has long been considered "the flagship product" of the biotechnology
industry. This protein is a popular treatment for heart attacks, coronary heart disease, and stroke.
Genentech has held a patent for the development of tPA-producing cells and sold it for approximately
$2,000 per 100-mg dose. Within the next few years this patent will expire and the opportunity will exist to
produce a generic form of tPA at a fraction of the cost. This design report describes a plant that can
manufacture this recombinant protein without spending $500 MM on research and development costs.
A cheap, generic form of tPA can acquire a large share of the current $300 MM tPA market. The FDA has
recently prohibited the sale Abbott Laboratories' thrombolytic drug, urokinase. The only other thrombolytic
medication available is streptokinase (SK); while it is much cheaper, SK causes more severe side effects
and is somewhat less effective than tPA. It is therefore likely that the market for a generic tPA will expand
as the price decreases. For this reason we have designed our plant to produce approximately 80 kg per
year. Plant calculations were completed by hand and with the use of the SuperPro Designer program (for
the Separation Section). Costing was completed using the economic spreadsheet created by Holger
Nickisch. Purchase costs were obtained as company quotes or estimates from the design consultants.
Our pharmaceutical plant has an investor's rate of return of 59.7% based on a total capital investment of
$104 MM. Given the profitability of this process we highly recommend construction of this plant.
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April 18, 2000
Prof. Scott Diamond
Dr. Arnold Kivnick
Department of Chemical Engineering
University of Pennsylvania
Philadelphia, P A, 19104

Dear Prof. Diamond and Dr. Kivnick,
Enclosed in this report is the completed design and economic analysis of the proposed
human tissue plasminogen activator plant. The plant is designed to be implemented in
the U.S. Northeast and will have a capacity to produce 80 kg oftPA per year or 1.28 MM
doses per year.

The optimum plant design has 2 individual fermentation and separation trains. The
fermentation trains grow the cells that produce our product in a scale-up process
consisting of three different size vessels: 40 L, 400 L and the maximum 5000 L. The
product is sent to a separation train, which purifies and sterilizes the protein for medical
use. The plant also contains a reverse osmosis water purification system that is designed
to produce all of the pure, pharmaceutical quality water used to make all of the process
liquids and clean out the unit operations during sterilization.

An economic analysis of the plant was performed based on the design data using the

spreadsheet provided by Holger Nickisch. The plant described within the report has an
JRR of59.7% based on a $117 MM initial capital investment. The optimum selling price
of the product tP A was determined using market share information provided by Prof.
Diamond to be $500.00 per dose. The group highly recommends construction of the
plant.

Sincerely,
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ABSTRACT
Tissue plasminogen activator (tPA) has long been considered "the flagship
product" of the biotechnology industry. This protein is a popular treatment for heart
attacks, coronary heart disease, and stroke. Genentech has held a patent for the
development of tPA-producing cells and sold it for approximately $2,000 per 100-mg
dose. Within the next few years this patent will expire and the opportunity will exist to
produce a generic fonn oftPA at a fraction of the cost. This design report describes a
plant that can manufacture this recombinant protein without spending $500 MM on
research and development costs.
A cheap, generic fonn of tP A can acquire a large share of the current $300 MM
tPA market. The FDA has recently prohibited the sale Abbott Laboratories' thrombolytic
drug, urokinase. The only other tru-ombolytic medication available is streptokinase (SK);
while it is much cheaper, SK causes more severe side effects and is somewhat less
effective than tP A. It is therefore likely that the market for a generic tP A will expand as
the price decreases. For this reason we have designed our plant to produce approximately
80 kg per year. Plant calculations were completed by hand and with the use of the
SuperPro Designer program (for the Separation Section). Costing was completed using
the economic spreadsheet created by Rolger Nickisch. Purchase costs were obtained as
company quotes or estimates from the design consultants. Our phannaceutical plant has
an investor's rate of return of59.7% based on a total capital investment of$104 MM.
Given the profitability of this process we highly recommend construction of this plant.
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Introduction

Impetus for the Project
The emergence of the biotechnology industry has created an explosion of new
products in the healthcare industry. In 1986 tissue plasminogen activator (tPA) was
approved by the FDA for the treatment of acute myocardial infarction and was the first
recombinant, therapeutic protein to be produced in mammalian cells. Since that time
biotechnology and phannaceutical companies have attempted to beat competitors to the
market with newly invented medications. In the next few years the patent ofthis popular
"clot-busting" drug will be expiring, and competitors will be able to enter the market and
create low-cost generic tP A. This report describes a process for the production of such a
drug. A cheaper version oftPA can compete with expensive fonns such as Genentech's
Activase™ and at the same time compete for market share owned by low-cost
alternatives like streptokinase. Reduced healthcare reimbursements to U.S. hospitals and
growing scrutiny over excessive drug prices will create a market for generic tP A in the
U.S., and the prospect of a safer alternative to streptokinase and urokinase in foreign
markets can potentially make it extremely profitable.

Applications
The function of tP A in the human body is to activate plasminogen. This helps the
body clear arterial blockage, which is a major cause of heart disease. Cholesterol
buildup in arteries is exacerbated by fibrin fonnations that surround the blockage.
Shrinking arterial diameters puts undue strain on the heart, leading to a variety of health
problems. Active plasminogen releases plasmin, an enzyme that dissolves these fibrin
fonnations, which hold the clot in place. This in tum can reduce blood pressure and
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relieve cardiac stress in individuals with heart disease. The role of tP A in plasminogen
activation makes it an extremely effective medication for patients suffering from acute
myocardial infarction or cardiac arrest. More recently tP A has been approved for the
treatment of deep vein thrombosis, pulmonary embolism, and stroke.

Production
Production of recombinant tPA has been docwnented in both bacterial and
mammalian cells. The use of Escherichia coli (bacterial host cell) produces small
amounts of protein and makes the separation process much more complicated. Our
process utilizes mammalian Chinese Hamster Ovary (CHO) cells, which are commonly
used for genetic engineering production and research.
The DNA sequence from which tP A is produced is cloned from human melanoma
cells. This sequence is then inserted into the genome of the CHO cells, and the highest
producing strains of these tP A-CHO cells are selected and used for our process. The
selected tP A-CHO cells are grown in a train of three fermentors, and after twenty days of
growth in the three reactors the cell broth is harvested and sent to the Separation Train.
During fermentation tP A is produced by the CHO cells and secreted into the liquid media
solution. Serum-free media is used because it contains no growth proteins that would
interfere with the purification process.

Purification
Purification of biologically active molecules can be very difficult and costly. The
Separation section is usually the most expensive part of pharmaceutical processes; this
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holds true for our plant as well. The purification of our recombinant tP A exploits
differences in density, protein size, and chemical affinity. The heart of the Separation
trains is the Affinity Chromatography column, in which our protein is isolated from the
thousands of proteins present in the harvest media. At the end, steps are taken to ensure
the safety of therapeutic use in humans. Endotoxins that may be present in the solution
are removed and the solution is sterilized in a 0.2 ).lm filter. The final product is then
bottled in the correct dosage and lyophilized, creating a stable drug that can be shipped to
hospitals and stored indefinitely.

Protein Chemistry
Proteins are chemicals in the body that interact with one another to send messages
and complete complex enzymatic reactions. In order to retain their activity (functional
ability) they must be treated with care under "gentle" conditions. Proteins lose activity at
temperatures above freezing; for this reason the entire Separation section of our process
is kept at 4°C by a refrigeration system. Any sudden change in environment can also
damage the tP A, so our process is designed to minimize abrupt chemical changes.
The size of tP A is about 66,000 daltons (one dalton

=

g/mol), the mature full

length protein is made up of 562 amino acids. In high concentrations tP A can form
aggregates which are difficult to separate and can be considered inactive protein. To
circumvent this problem arginine is added to the tP A solution at a concentration of 2M.
The product stream in our process has a 2M arginine concentration during most steps.
Our recombinant tP A exactly resembles the protein produced in human melanoma cells
and its ability to activate plasminogen has been demonstrated as well.
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Flowsheet Preparation
The production method of tP A is straight forward and similar to any other
fermentation process in the pharmaceutical industry (i .e. penicillin). The main difficulty
lies in the creation of a batch schedule that provides for the completion of 50 batch-runs
each year. The separation oftPA centers around affinity chromatography, for which the
tP A containing solution must be adequately prepared. Various forms of filtration were
investigated including micro filtration, tangential flow ultrafiltration, and gel filtration.
Once the unit operations were chosen they were organized and scheduled to provide for
two-week batches. In addition to the Fermentation and Separation Trains, a reverse
osmosis water purification system is required to provide the sterile water that is needed
throughout our plant. The final, detailed process is presented in the following sections.
All design considerations relevant to a batch-wise, pharmaceutical process have been
taken into account, including scheduling, sterilization, and sanitization requirements.
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Development of CHO Cell Line
Before designing the human tissue plasminogen activator (tPA) process plant, a
Chinese Hamster Ovary (CHO) cell line that secretes the product protein must be
developed in the research and development laboratory. The cell line development
process is estimated to take one year based on a suggestion by Prof. Diamond. The
strategy for synthesizing tP A from CHO cells is a combination of transfecting the DNA
sequence that produces tP A into the CHO cells and amplifying the gene into multiple
plasmids. The Bowes melanoma cell line, which naturally produces tP A, is used to
isolate the desired DNA sequence. PCR (polymerase chain reaction) is then used to
make numerous copies of the tPA sequence that is}009 bases long. Two specifically
designed primers are applied to isolate the tPA gene. The primers are a sequence of
nucleotides that form base pairs with the complementary sequences located near the
beginning and the end of the desired gene. The primers ensure that only the tP A gene is
amplified during the PCR. The sequence can be checked using restriction enzymes to
break it down into smaller segments and measure them using the technique of gel
electrophoresis.
The amplified sequence is inserted into a DHFR expression vector with the
EcoRY blunt cut restriction enzyme. The vector is placed in a neo-tPA plasmid and
transfected into the CHO cells. Those cells that take up the plasmid will produce
multiple copies of the gene as they grow and divide. The presence of the gene in the cell
will result in the production of tPA. In order to only select the cell culture strains that
largely amplify the gene, the cells are exposed to a cytotoxic drug that will kill any cells
that possess the DHFR vector. The tPA gene is located within the DHFR vector, so the
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desired cultures die most readily in the presence of the drug. The cells that exhibit the

most "favorable" response to the drug are grown up in large volumes and frozen at -70 D e
to create a cell stock. This cell stock will be used to begin every subsequent batch to
enslffe /hal each cuh'lffe..-Ofoo'uces //lrge /l/7701U7/S o//FA.

The eHO cellline that is usedin our process is estimated to produce 50pg oftPA
per cell per day. Cell growth environments and the storage conditions of the cell line can
alter the production rate of the cells, therefore the value used is a slight under estimation
of the possible production levels of the cells. In addition to external factors, internal
ce\\uhr mutat\ons can effect the tota\ "Qrocluct1on of tV A.. 1n an,:! 'E,l'Jen culture. Mutat\ons
result 1n the "Qrocluct\on of cllfterent, 1nactlve "Qrotelns, or cause the cell to cease
"Qroo.uchon 01 t'P A.. a\together. 'The research laboratory conhnuous\)1 tests the lntegnt':! the
CHO cell line for its ability to produce tPA for the life of the process.

Raw Materials
Fermentation Materials
The raw materials for the process include 100% sterile water, powdered media,
compressed air, and CO 2 . The sterile water is produced in the plant with a reverse
osmosis water purification system from water that is purchased from the municipal
source in the area. The sterile water is mixed with HyQ PF-CHO duel powder media (see
Appendix C, page 272) to generate the liquid media that makes up the growth medium
for the CHO cells in the bioreactors. The Hyclone media is serum free but contains all of
the nutrients, salts and amino acids necessary for cell growth. A serum free media was
chosen because the presence of serum in the growth media interferes with the
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recombinant protein purification by introducing other proteins to the product stream.
Under the advice of Neil Collins from Hyclone Media Company, the media does not need
to be supplemented with any additional proteins such as glutamine. The formulation for
this media is not yet available due to patent protection but Mr. Collins verified the
presence of important components such as insulin, growth factors and transferrin.
The media also contains a sodium bicarbonate buffer to maintain a pH of7.3.
The pH is adjusted by the continuous flow of CO2 into the fermentors. A pH control
measures the internal conditions of the fermentor and adjusts the flow of C02 accordingly
to change the pH. The CO 2 is a part of the air stream that is pumped into the bioreactor
to provide the oxygen needed for the cells' metabolism. The CHO cells require 0.06 to
0.2

* 10- 12 mol 02/hr * cell (Shuler pA55) .

The compressed air and CO 2 are purchased in

tanks from BOC gases (see Appendix C, page 275). In order to prevent any disturbance
in the inlet stream, all of tanks for a given batch are hooked up to the fermentor and
opened at the same time to maintain a constant pressure and flow rate for the life of the
batch.

Arginine
Arginine Hydrochloride is used throughout the Separation process to prevent the
aggregation of tP A in concentrated solutions. It is first added to the product solution in
UF 1 Tank before concentration in UF 1. The concentration is only brought to 1M here in
order to reduce the waste of arginine (the majority would be immediately discarded in
UFI filtrate). Prof. Diamond advised us that a 1M concentration would be enough for the
short period of time between UFI and UF2 Tank. The 200 L volume in UF2 Tank is then
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increased to 2M arginine. The final input of arginine comes in the elution of Affinity
Column. As tPA is eluted, the concentration of the protein gets quite high in the elution
buffer. The glycine based buffer is made to a concentration of 2AM arginine which
results in a final product concentration of 2M in each dissolved dose. Endotoxin-free
arginine can be purchased in bulk from Sigma-Aldrich at a price of $119/kg; we will
require about 74,500 kg each year (see Appendix D, pages 283 and 290) .

Glycine
Glycine, or aminoacetic acid is the simplest amino acid and is an important
ingredient in the Elution buffer for our Affinity Column. We follow Reagan et al. in
using 0.5M glycine in our tPA elution. We will be using endotoxin-free glycine to ensure
the quality of our final product. Glycine can be purchased in bulk by Sigma-Aldrich at
$43/kg and our yearly needs are about 770 kg (see Appendix D, pages 283 and 290).

Sucrose
The final packaging requirements of lyophilized tPA contain a small amount of
sucrose. This biotechnology grade sucrose will be added into the product solution in ER
Tank. It is added before ER Column to ensure that any endotoxins introduced will be
removed the ER Column. Approximately 3 kg/yr are required and this can be bought for
$29 from Sigma-Aldrich (see Appendix D, pages 283 and 290).
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PBS
Phosphate buffer solution, or PBS, is the liquid medium for the Equilibration
buffer used in the Affinity Column. About 117,000 L of PBS will be used in our process
each year. This can be bought in bulk for approximately $0.80/L from Sigma-Aldrich
(see Appendix D, pages 283 and 290).

NaOH

Sodium hydroxide, or NaOH is used to adjust the pH in ER Tank after elution in
the acidic buffer, and it also acts as a cleaning agent for ER Column and Centrifuge. The
yearly requirements are 550 kg and this can be bought in bulk form Sigma-Aldrich for
$17.50Ikg (see Appendix D, pages 283 and 290).

NaCI

Sodium chloride, or NaCI is present in the Affinity Column Equilibration buffer
in a concentration of 0.65M. This adds up to yearly requirements of about 4500 kg.
Biotechnology grade NaCI can be purchased in bulk from Sigma-Aldrich at $18/kg (see
Appendix D, pages 283 and 290).

Fermentation Process
The fermentation section of the tP A production is a batch process that consists of
a scale-up series of 3 individual stainless steel fermentors ranging in size from 40 Liters
to 5000 Liters. Each fermentor operates under the same growing conditions: a
temperature of 37°C, a pressure of 14.7 psi, and a pH of7.3. The vessels contain a 6
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blade standard Marine impel lor located in the center to mix the contents and disperse the
air stream sparged through the bottom. The function of these fennentors is to provide an
optimal environment for growth of a CHO cell line that excretes the product tPA protein.
The fennentors are filled with media that is produced in a blending tank T-l (see
specification page 100. Before the media can enter any of the bioreactors, it is heated to
37°C and extensively filtered. Due to varying batch lengths for the three different
fennentors, the media is held in the tank for up to 7 days at 4 °C before it is needed to fill
a bioreactor. The cold temperature preserves the quality of the media and prevents the
growth of any bacteria. The media is sent through filters F-l and F-2 (see specification
pages 108 and 109) before it is heated to growth temperature. The filters are used to
remove 99.9% of the contaminants and to sterilize the media. The purpose ofF-l is to
protect the 0.2 micron F-2 from getting clogged too quickly.
The media is pumped through the filters with peristaltic pumps that maintain a
flow rate of2 gal/min and increase the pressure from 14.7 psi up to 29.7 psi. The media
is finally pumped through a shell and tube heat exchanger that is designed to heat the
media up to 37°C using a small temperature gradient that will not damage the organic
material in the media. A wann water stream heats the media as it enters the shell side of
HX-l (see specification page 99) at a temperature of 55°C and leaves at 48

0c.

The

wann water stream is a recycle stream made up of city water that is heated using a steam
sparger. The wann media is finally pumped into the fennentors to provide the essential
liquid environment for CHO cell growth.
The fennentors are all outfitted with a complete computer control system as well
as individual unit operation control units. The internal environment of the bioreactors is
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maintained with the aid ofa conventional heating jacket on BR-I and BR-2 (see
specification pages 96 and 97) and a 4-inch half-pipe heating jacket surrounding BR-3
(see specification page 98). All the fermentors are also covered in 2 inches of fiberglass
insulation to increase the efficiency of the heating jackets. The pH is regulated by a pH
control that adjusts a valve on the inlet stream of CO 2. The amount of C02 flowing into
the reactor can change the pH of the cell broth (see Dynamic Controls page 44). Finally
the reactor is fed with a constant flow of compressed air, supplemented with CO2 . The
gases are supplied to the vessel by tanks that are attached to a sparger located at the base
of the fermentor.
In the designed process the CHO cells are grown up for a total of 20 days in the
three fermentors . The size of the fermentor influences the length of the cell culture batch.
BR-I only takes 5 days to achieve the desired cell density, while BR-2 takes 7 days to
grow and BR-3 takes 8 days to achieve maximum growth. The batch schedule for each
fermentor is designed to allow enough time to run 50 batches per year. BR-3 runs
continuously through out the year in order to fit in 25-2 week batches in one year, but the
smaller fermentors have some down time in between batches (see the complete schedule
on page 171). The schedule is also designed to fit in an extra fermentation train for
possible future expansion of the plant.

Separation Trains
The Separation trains accomplish the difficult task of purifying tP A from the
complex mixture of biochemicals present in the harvest media. Throughout the life cycle
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cells produce thousands of proteins of different size, structure, and chemical activity.
Each of these differences must be exploited in order to obtain a pure, stable product.
Throughout the Separation process the product solution must be kept as cold as
possible to prevent loss of protein activity. High temperatures (room temperature is
considered high for proteins) cause proteins to degrade and denature, basically changing
the conformation that is essential for correct function. For this reason an air-conditioning
system keeps the temperature of the entire Separation section at a temperature of 4°C .
Because there are two Bioreactor production lines running, the separation train
will be split to two trains at the outlet ofUF2. In effect, there will be two identical units
for each of the following: Affinity Tank, Affinity SkidJPump, Affinity Column, ER
Tank, ER SkidJPump, ER Column, MF Tank, MF Pump, MF, FD Tank, Bottler, and
Freeze Dryer. Once the train has been split it is unwise to reintroduce the separated
batches because cross contamination could possibly occur, resulting in a loss of both
batches.
The Separation Train begins with the draining of BR3. The cell broth is sent
directly to Centrifuge (see specification page 119) for clarification unless the machine is
down. If more time is needed the cell broth can be stored in Holdup Tank (see
specification page 112) until the Centrifuge is ready. The broth is processed at a rate of
400 LIhr and the resulting cell waste is sent to the EarthCare Company for disposal.
Given a cell production rate of 50 pglcelllday, an average cell density in BR-3 of 2 MM
cells/mL, a volume of 4000 L and a production time of 6 days, the amount of tPA
produced in BR-3 is estimated at 2.4 kg, and this number is reduced by 10% to yield 2.16
kg to account for variability in the cells' ability to produce the recombinant protein. We
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assume that another 5% is lost with the cells during clarification in the Centrifuge. After
this step the harvest media is sent to UF 1 Tank (see specification page 113). The total
process time for Centrifuge is about 12 hours.
The harvest media is then stored overnight and mixed with 850 kg of arginine in
UF 1 Tank. AIM concentration is needed at this time to prevent aggregation of the tP A
when it is concentrated. This concludes Day 1 of the separation. Day 2 consists of
ultrafiltration in UFI (see specification page 125) and UF2 (see specification page 126).
Water and other dissolved solids pass through the UFI membrane and a concentrated tPA
solution is collected in the retentate. The 3500 L of harvest media can be processed in
UFI in just over 6 hrs, and the resulting volume is 200 L.
More arginine is added in UF2 Tank to again prevent aggregation. The solution
must then be cleaned before application to the chromatography column because
microscopic solids may still remain in solution and these particles can damage the
chromatographic resins. The first method of pretreatment that we investigated was gel
filtration. This chromatography operation is accomplished by applying a given volume
of solution to a column and continually supplying sterile process water afterward.
Particles of different sizes have different residence times, so one can collect a sample
with a specific residence time that will contain the desired product. The downside of this
operation is that the large volume of sterile water used causes drastic dilution of the
sample, which is extremely undesirable in our purification process.
The method we eventually chose was ultrafiltration with a larger pore size. The
500 kDa pores ofUF2 allow tPA to pass through while removing larger debris. The
process requires no additional water so dilution does not occur. The 200 L volume can
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be ultrafiltered in less than one hour, and it is assumed that 5% of the tPA will not be
recovered, leaving 1.89 kg. (For a more complete description of ultrafiltration theory see

Unit Descriptions page 78).
The tPA is then purified in four cycles in the Affinity Column (see specification
page 128). tPA binds to the anti-tPA antibody which is bound to the Affinity Resin (see
specification page 129). The protein is then "released" during elution and sent to ER
Tank. Dividing the Affinity Column processing into four cycles allows us to cut the resin
requirements from about 180 L to approximately 45 L, which cuts our yearly capital costs
drastically. Two cycles can be performed each day, so the final elution cycle takes place
on Day 4. It is assumed that 15% of the tPA will be lost in this step leaving over 1.6 kg
to be recovered. (For a more complete description ofaffinity chromatography theory see

Unit Descriptions page 82).
After elution from Affinity Column the solution needs to be neutralized with
addition of 1M NaOH to protect the tP A. The final product must also contain a certain
amount of sucrose (see Prof. Diamond email page 289). These materials are added to the
solution in ER Tank (see specification page 116) before processing in ER Column.
The next step in the separation process is the removal of endotoxins, which are
chemicals derived from bacteria that cannot be injected into humans. The first removal
technique I investigated was anion exchange based on advice given by a representative at
Arnersham Pharmacia Biotech. The process required a gel filtration step, followed by an
adjustment to an acidic pH before application to an anion exchange column. About 98%
of the endotoxins would bind to an anion exchange column (Harrison 1994), which is
probably enough for our purposes. I was unsatisfied with this process because it was
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very costly (requiring many of Amersham's more expensive products) and forced us to
subject our protein to harsh conditions (low pH and ion exchange elution).
My search over the internet then led me to an affinity resin made by Sterogene.
The Acticlean Etox resin removes virtually all of the endotoxins in a sample. While it is
somewhat expensive, the resin can be reused, can be run at a neutral pH, and will bind to
practically none of our protein. The representative said that the resin was ideal for
removal of small amounts of endotoxins, while anion exchange is more commonly used
for removal of high endotoxin concentration. The ER Column (see specification page
130) simply involves the application of our product solution to ER Resin (see
specification page 131). The endotoxin free tPA solution can be collected directly from
the column and prepared for lyophilization in MF Tanle The solution will be completely
collected on Day 6. The tPA losses are conservatively estimated at 5% in the ER
Column, leaving about 1.6 kg to be purified. (For further information on endotoxin

removal see Unit Descriptions page 84).
The solution volume is then increased to 400 L with addition ofWF1 in MF Tank
in order to set the correct packaging concentrations. The contents are then sterilized by
filtration through a 0.2 f.lm filter, MF (see specification page 127). This filtration will be
complete in less than one hour and the filtrate will be collected in FD Tank (see
specification page 118). tPA losses in the MF are estimated at 1%, though the filter will
be replaced each batch.
FD Tank will store our final product solution overnight before the bottling and
freeze drying cycles begin. On Day 7 the first of five bottling/freeze drying cycles will
begin. A UV spectrophotometer is used to measure the protein concentration, and this
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concentration is used to calculate the volume to be loaded into each vial. The Bottler (see
specification page 132) uses this information and charges approximately 3200 100-mL
vials with the tPA solution and loads them onto trays in the Freeze Dryer. The charging
and loading wiB take a total of 2 hours based on comments from a representative of the
Cozzoli Machine Company.
Finally, the Freeze Dryer (see specification page 133) forms a solid tPA powder
in sterile vials and seals the stoppers. The drying time for each cycle is estimated as 24
hours, which is a conservative estimate, though we cannot be certain without
experimentation. Given five cycles and allowing for over five hours of cleaning time
between each cycle the Separation batch will be complete on Day 12. This is weB within
the limits of 14 days per batch. In fact, the two Separation trains can handle 75 batches
per year (three fermentation trains) ifthere is enough demand. Approximately 1.6 kg of
tP A should be present after lyophilization, and this is enough tP A for 16,000 doses. Our
yearly production is then estimated at 1.28 MM doses.

Water Purification System
City water from stream WI 01 is brought into the water purification system
through pump PW-1 (see specification page 135). This water contains small organic
molecules, salts, and various types of bacteria, so it must be purified to meet purified
water standards.
The water stream WI 02 is pumped through filter FW-l (see specification page
136) to separate any particles that are larger than 10

~m.

FW-l is a tangential flow filter,

which has the advantage over the dead-end filter such that it can generate higher
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permeate flow. The purpose of FW-1 is not only to separate unwanted particles, but also
to protect the membrane of the reverse osmosis system downstream from damaging large
particles. Since FW-1 is exposed to many particles and unwanted species, it is easily
contaminated, so we will replace it before starting each batch. After FW-1, city water will
be pumped through FW-2 (see specification page 138), which is used to remove chlorine
and organic molecules. Chlorine must be removed from city water at this point since it is
quite erosive to the cation resin in water softener as well as the reverse osmosis
membrane and 0.2 )..lm filter downstream. Organic molecules can also damage the
reverse osmosis system membrane. After FW-2, city water is pumped directly to FW-3
(see specification page 139) using pump PW-3 (see specification page 140). Filter FW-3
is present to remove ions from the city water. For this particular softener, the Polystyrene
Sulfonate cation is chosen because it binds to positive ions like magnesium and calcium,
which are abundant in impure water.
At this point, large particles, chlorine, organic molecules, and positive ions have
already been separated from the city water stream. Water in stream W1 08 will now enter
RO-1 (see specification page 142), which is considered the most important piece of
equipment in the water purification process. The reverse osmosis system RO-1 is a high
pressure unit that allows only water to flow through its semi-permeable membrane. The
membrane is able to filter out any remaining ions, small particulates, organic molecules
or bacteria. Purified water RO-l is then transferred to the storage tank TW-1 (see
specification page 143) so that it can be allocated for various uses during the process.
During the time that the purified water sits in TW-1, some extremely small organic
particles and ions may be settle at the bottom and form larger particles - becoming a
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source for bacterial contamination. To prevent this from happening, water is circulated
through UV - I (see specifications page 145), which is capable of breaking down the
forming particles and killing any bacteria that may be left in the water. When the water is
needed in the fermentation or separation processes, purified water is flows through pump
\

PW-5 (see specification page 146) into filter FW-4 (see specification page 147), which
wi 11 act as the last line of protection to trap any minute particulates from contaminating
the final purified water. Like the 10 Ilm filter, the 0.2 )..tm microfilter will be replaced
after each batch.
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Control Considerations
The calculations for this process were performed assuming steady-state plant
condi tions. However, the steady-state analysis is not an adequate representation of the
plant design feasibility. The tissue plasminogen activator (tPA) production process is a
batch process with a batch length of2 weeks. The plant runs 50 batches a year in two
separate fermentation trains. The plant must have a reasonable control structure to
regulate the cell growth environments and the process recycle streams. The total yearly
production oftPA is only 80 kg/year, therefore the control scheme is important to prevent
any disturbances that could kill a batch of cells and significantly reduce the yearly
production.
The control scheme designed for the tP A process is based on the suggestions
made by Professor William Luyban from Lehigh University. Dr Lyban's nine basic rules
of plant-wide control could not be applied to the tPA process because of the batch mode
of operation. However, he was able to provide assistance in the design of controls over
individual unit operations. The final control scheme was a result of a meeting with Dr.
Lyban and Dr. Warren Seider in which he offered suggestions for an optimal structure.

Control Objectives
The principle objectives for the control system of a pharmaceutical process that
uses cells to produce a product are the preservation of 100% sterile quality through out
the entire production line and the maintenance of the growing environment of
temperature 37°C and pH of 7.3. The principle constraint for the process is the
sensitivity of the Chinese Hamster Ovary (CHO) cell line. A CHO cell cannot withstand
a temperature change of more that ± 2°C or a pH change of more than ± 0.2 units. In
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addition to growing conditions, a control system is put in place to regulate the flow rates
of steam that is sparged into recycle streams, as well as streams that are used to fill
vessels to very specific volumes. The control scheme expresses these specifications
using controllers that are designated for the important design considerations.

Control of Individual Unit Operations
Control of pH in Fermentors
The fermentors are filled with a media that contains a sodium bicarbonate buffer
that is sensitive to CO 2 . Each vessel is equipped with a pH meter located within the cell
broth liquid. The optimum pH for the cell culture is 7.3 with a tolerance of± 0.2 units. If
a change in the pH is detected, the pH meter will send a signal to adjust the valve
attached to the CO2 stream. In order to stabilize the pH to the optimum value, the C02
forms a chemical reaction with the Sodium Bicarbonate buffer in the media. The Sodium
bicarbonate ions and CO2 produce the following chemical reaction:

When the cell broth solution becomes basic, more C02 is pumped into the cell broth in
order to drive the reaction in the reverse direction to produce more H+ ions in the
solution. The reverse process occurs if the pH becomes too acidic; the C02 flow rate is
reduced and the reaction moves to the right in order reduce the number of H+ ions in the
liquid.

Level Controls
All of the tanks and fermentors are equipped with level controls on the inlet flows
to ensure the exact volume of water or media is added to the unit. In order to preserve the
sterile quality of the water and the media the fluid cannot be handled manually and must
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be pumped into the vessels through sanitary piping that is rinsed and sterilized after each
use. The level control will measure the volume of water or media in the tank and adjust
a valve located on the inlet flow stream. The liquid volumes must be measured with
precision for two important reasons: maintain the proper ratio of media to water and
provide enough void space in the fermentors. In order to provide enough room for
mixing and air circulation, the three fermentors are only filled with 90% of their capacity
with cell broth. Additionally, the media is purchased in sterile packages with a pre
measured volume equaling the amount for one batch; hence the volume of water in the
tank must correspond to the volume of media added to the tank.

Temperature and Pressure Controls
There are two steam spargers used to increase the temperature of warm water
streams for use in a heating jacket and a heat exchanger. Due to the sensitivity of the
organic media and the CHO cells, the temperature gradients of the heating streams must
be very small. The 130°C steam produced in the plant is too hot to be used as the
heating media in the heat exchanger or the half-pipe heating jacket around the 5000L
fermentor. As an alternative, steam is sparged into a water stream to produce
temperatures of 55°C and 38 °C for the Heat Exchanger and Heating Jacket respectively.
A temperature control is placed on the outlet stream of the sparger for the heating jacket
to ensure that the water flowing around the fermentor is an unvarying temperature of 38

0c.

The temperature control on the heat exchanger sparger measures the temperature of

the media outlet stream to adjust the valve on the steam pipeline. Any deviance from the
setpoint will send a signal to adjust the appropriate valve on each stream.
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The volume of steam sparged into the water stream is extremely small in
comparison to the volumetric flow of the water, but over time the volume would build in
the closed loop system. Since the streams never come into contact with the cells or the
cell media, unsterile recycle streams can be used for this process. In addition, recycle
streams cut down on the utility requirement for the plant. Pressure controls are placed on
the streams in to purge off the additional volume added by the steam. The pressure
control sends a signal to adjust a valve placed on the purge stream. The flow rate of the
purge stream is very small but it is necessary to maintain a steady flow through the units.
The flow rate of the heating jacket water stream is regulated with a temperature
control that measures the temperature of the cell broth in 5000 L fermentor. The interior
environment of the fermentor must be maintained at a temperature of 37°C. If the cell
broth fluctuates from this temperature, the flow of 38°C water in the jacket is increased
or decreased stabilize the internal environment of the vessel.

Ratio Flow Control
Only one control unit is needed in the separation and purification section of the
tPA process. A ratio flow control is used to specify the % volume of one holding tank
that is recovered in another holding tank, after it has been passed through an ultra filter.
The ultra filter reduces the volume of a liquid flow by removing most of the water in the
stream. The retentate is recycled through the filter to remove as much water as possible.
The tpa product remains in the retentate flowing off the top of the filter and is collected in
the ultra filter 2 holding tank . A meter that sends a signal to a flow controller, attached to
the retentate stream, measures the ratio of the retentate flow rate and the water removal
flow rate. The flow controller adjusts the valve on the retentate stream so that the flow is
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equal to 0.06 times the flow the water removal. The function of this control system is to
remove 94% of the liquid entering the ultra filter and forming a concentrated retentate
flow stream containing all of the tP A product.
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TABLE 4: UTILITY COSTS FOR PROCESS UNITS

Equipment

Total # of Units
(in Plant)

Utility

Usage
(per year)

BR-1
BR-2
BR-3
T-1
RFU
P1
P2
P3
P4
P5
P6
P7
Centirfuge
Refrigerator
Sep-Pumps
Sep-Tank Impellors
Bottler
Freeze Dryers
WP-1
WP-2
WP-3
WP-4
WP-5
WP-6
WP-7
UV-1
RO SYSTEM
Total

2
2
2
2
2
2
2
2
2
2
2
2

Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity
Electricity

17718
59060
177180
118120
126720
2952
2952
2952
2952
2952
2952
23620
9000
87600
1461.37
383900
8176
336530
399
260.98
870
130.5
348
435
2610
168
8948
1380966.85

Boiler
Total

Natural Gas

1053.6
1053.6

Water Production
Total

City Water

3000000
3000000

Total Yearly Cost =

$95,000.00

2
2
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Total Cost per year
1 kW*hr =$ 0.04
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr
kW*hr

$1,417.44
$4,724.80
$14,174.40
$9,449.60
$10,137.60
$236.16
$236.16
$236.16
$236.16
$236 .16
$236 .16
$1,889.60
$360 .00
$3,504.00
$58.45
$15,356.00
$654.08
$26,922.40
$15 .96
$10.44
$34.80
$5.22
$13.92
$17.40
$104.40
$6 .72
$357 .92
$90,632.11

MMBTU
MMBTU

$2,739.36
$2,739.36

L
L ·

$1,500.00
$1,500.00

Energy Balances

Generic ,PA

Utili.ty Sunlnlary
Electricity
The electricity for the plant comes from the local power plant. The electricity is
used primarily to drive the pump motors, the motors for the impellors, and the
refrigerators to cool the tanks and the separation room. The tank impellors and the freeze
dyers account for half of the electricity usage in the plant. The high energy costs for
these pieces of equipment are caused by the large amount of energy needed to run a
condenser in the freeze dyer at -55°C and the energy needed to rotate large impellors at
high rpms in a viscous solution. All of the pump motors are run on electricity but the
yearly requirement is so small is it negligible. The electricity is purchased at a price of
$0.04 per kW*hr (Seider p. 376).

City Water
Water is purchased from a local water supply and sterilized in house to meet the
standards required for a bioprocess production line. The HX-l and the heating jacket on
5000L fermentor are the only two unit operations that use impure water. The remainder
of the water used in the plant is sterilized in a reverse osmosis purification system.
Approximately 3,000,000 liters of water are purified each year for use in the process
streams. These large volumes of purified water are needed to make the liquid media for
cell growth, make up the basis of the elution buffers for the separation processed, and
rinse all of the process units to remove debris before they are steam sterilized. Due to the
location of the plant, the water is available at a relatively moderate temperature of 20°C.
The water is purchased at a cost of $0.0005 per gal (Seider p.376).
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Steam
Low-pressure steam is used through out the plant as a sterilization medium and
source of energy to heat water streams that supply feed for the HX-l and the wann waterheating jacket around BR-l. Because the steam is used to sterilize the process
equipment, it must be made from the sterile water produced in the plant. A boiler heats
up the water to a temperature of 130°C and a pressure of 39.16 psi. The boiler uses
natural gas as fuel to produce 500 L steam per hour. The natural gas contains 92.6%

C~

and can be purchased at a price of$2.60 per MMBTU of heating value. (Seider p. 376)

Figure 6: Percentages of Total Utility Costs
, 2%
Natural Gas

3%

City Water

/

(
95%
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TABLE 5: Major Equipment Specifications
Summary of Major Equipment
Important Specifications
Capacity: 40 L
Uptime per batch: 7 days
Quantity required : 2
Purchase Cost: $85,000
BR-2
Capacity: 400 L
1400 L Fermentor
Uptime per batch : 10 days
Quantity required : 2
Purchase Cost:$125,OOO
BR-3
5000 L Fermentor
Capacity: 5000 L
Uptime per batch : 14 days
Quantity required:2
Purchase Cost: $252,000
Throughput rate400 Llhr
Centrifuge
Separates CHO cells from
media
Uptime per batch :-12 hr ,"
Quantity required : 1
Purchase Cost: $355,000
IAffinity
Bed volume: 58 L
Purify tPA with using antiColumn &
PA antibody
Resin: CNBr-activated Sepharose FF
Skid/Pump
Superficial velocity: 100 cm/hr
Uptime per batch:48 hr
Quantity required:2
Purchase Cost: $200,000
Bed volume:8.2 L
ER Column & Remove endotoxins from
Skid/Pump
PA solution
Resin: Acticlean Etox
Superficial velocity: 100 cm/hr
Uptime per batch : 36 hr
Quantity required: 2
Purchase Cost: $1 06,190
Bottler
Bottling/Loading time: 2 hr
Load tPA-solution into vials
Electrical requirements: 1.5 hp
~nd load Freeze Dryer
rays
Uptime per batch : 146 hrs
Quantity required :2
Purchase Cost: $865,000
Freeze Dryer Lyophilize tPA solution in
Capacity in vials : 3500
1OO-mL vials
Condenser capacity:200 L water in 24 hrs
Electrical requirements: 46,,1 kW max
Uptime per batch : 146 hrs
Quantity required:2
Purchase Cost: $640,000
I
B-1
Capacity: 500 Llhr
Create steam for
sterilization and spargers
Quantity required: 1
Pu rchase Cost: $112,000
RO-1
Reverse osmosis system
Volume of water per year: 3,000,000 L
Quantity required: 1
Purchase Cost: $7,500
Name
BR-1

Description
140 L Fermentor
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Fermentors
The Chinese Hamster Ovary (CHO) cell line, which is genetically altered to
excrete the tissue plasminogen activator (tPA) product protein, is grown up in batches
through a scale-up process containing a series of three fermentors of varying sizes. A
small culture of cells is grown in a 40L bioreactor until a cell density of approximately
3.0 *10 6 cells/mL is reached. The cells from the 40L fermentor are transferred to the
400L where new media is added and the cells are allowed to grow up to the same density
in the larger bioreactor. The final growth and production stage occurs in the 5000L
fermentor after it has been inoculated with the cell broth from the 400L fermentor. A
scale up process of this magnitude is required in order to produce enough cells to
inoculate the largest fermentor with a cell density of 0.25 * 10 6 cells/mL. Other options
were investigated, but was determined unreasonable and not cost efficient. Two such
options that were explored were initially growing up large volumes of cells and freezing
them, or growing up cells in a laboratory, but it was concluded that a laboratory would
not have the capacity to produce enough cellular mass to inoculate the 5000 L fermentors

50 times a year.

40 Liter Fermentor BR-l
The function of BR-l is to grow a culture CHO cells up to a density of 3 * 10

6

cells/mL to be used to inoculate BR-2. The fermentor operates at an optimum growth
temperature of37 °C and a pressure of 14.7 psi. The fermentor temperature must be
regulated with a conventional heating jacket to sustain an internal temperature of 37°C.
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The interior environment of the ferrnentor must remain constant because the CHO cell
line is extremely sensitive to any changes. A temperature variance of ± 2°C can kill an
entire cell culture.
In addition to the temperature and pressure, the pH of the cell broth is maintained
at 7.3. A continuous flow of compressed air and CO 2 are pumped into the vessel through
a sparger on the bottom of the tank. This stream of air supplies the oxygen for cellular
metabolic consumption and carbon dioxide needed to regulate the pH. The ferrnentors
are all filled with a complete CHO media that is designed to provide all the essential
nutrients and proteins for CHO cell growth. The media also contains a sodium
bicarbonate buffer that functions to maintain the pH at 7.3. The pH is adjusted by the
percent concentration of CO 2 in the air stream pumped through the bottom (see Dynamic
Control page 44). The average flow of CO 2 is 5% of the inlet air stream, but a pH control
unit continuously measures the pH inside of the tank and adjusts the CO 2 flow
accordingly (Goswani p. 633). The compressed air and the CO2 are supplied to the
ferrnentor from tanks purchased from BOC gases. BR-l requires approximately 0.03
tanks of compressed air and 0.001 tanks of CO 2 per batch (see calculation page 244).
These growth conditions are deemed optimal by the Bioprocess Engineering book by
Schuler and Kargi
The ferrnentor is manufactured and designed by New Brunswick Scientific for the
growth of animal cells. This ferrnentor is a BIOFLO 5000 Ferrnentor with a total volume
of 40 L (see appendix page 225). In order to preserve an absolute sterile environment for
the cells to grow, each vessel is made of 316 Stainless Steel with sanitary piping and
couplings. A six blade standard marine impeller installed in the center of each bioreactor
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disperses the air stream and mixes the cell culture. The agitation speed of the culture is
only 30 rpm due to the sensitivity of CHO cells and the very low shear level the cells can
endure (Shuler p.451). The agitator is run by an electric motor that requires l.5 hp of
energy utility. The reactors are sterilized in place by a process of flushing with water to
remove any excess solid waste and automatically steam sterilized at 130 DC for
approximately 3-4 hours. The reactor must reach a temperature of 130 DC and remain at
that temperature for an extended period of time in order to kill or denature anything that
remains inside the growing environment.
Attached to the fermentor is a ML-6l 00 controller system is that is capable of
operating up to six process loops (see appendix page 229). The system also controls the
sterilization and internal environment preservation. The menu-driven system is designed
for simple control and minimal operator labor hours. The computer control system can
be programmed to run a batch for any given amount of time. A vessel view window is
installed into the wall of the fermentor in order to allow an operator monitor the process
inside. The cell growth rate and the quality of the automatic sterilization are observed
repeatedly through out the life of the batch. If a vessel is not completely clean after the
water flush it must be manually scrubbed before steam sterilization.
The batch length for the BR-l is 7 days. The batch schedule for the fermentor is
the following:
0.5
5
0.5
1

Days Fill and Inoculate
Days of Cell Growth
Days Harvest
Day to Clean and Sterilize

The times allotted for each of these processes are slightly over estimated to ensure
enough time, in the event of a disturbance in the system, to provide enough time for the
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next fennentor in the process train to be prepared to receive the cell broth. The tPA
production plant contains a total of2, BR-l fennentors; one for each of the two
fennentation trains. The quoted price from Ted Shields of New Brunswick Scientific for
one unit with a complete control system is $85,000. (see specification page 96 and

appendix page 225)

400 Liter Fermentor BR-2
The function of BR-2 is to grow a culture CHO cells up to a density of 3 * 10

6

cells/mL to be used to inoculate the 5000 Liter Fennentor BR-3. The bioreactor is

initially inoculated with a density of 0.25

* 106 cells/mL from the cell broth of the 40 L

fennentor BR-l. The fennentor operates at an optimum growth temperature of37 DC and
a pressure of 14.7 psi. The fennentor temperature must be regulated with a conventional
heating jacket to sustain the 37 DC internal temperature.
In addition to the temperature and pressure, the pH of the cell broth is maintained
at 7.3. A continuous flow of compressed air and C02 are pumped into the vessel through
a sparger on the bottom of the tank. This stream of air supplies the oxygen for cellular
metabolic consumption and carbon dioxide needed to regulate the pH. The fennentor is
filled with a complete CHO media that is designed to provide all the essential nutrients
and proteins for CHO cell growth. The media also contains a sodium bicarbonate buffer
to maintain the pH at 7.3. The pH is adjusted by the percent concentration of CO 2 in the
air stream pumped through the bottom. The average flow of CO 2 is 5% of the inlet air
stream, but a pH control unit continuously measures the pH inside of the tank and adjusts
the C02 flow accordingly (see Dynamic Control page 44). The compressed air and the
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CO 2 are supplied to the fennentor from tanks purchased from BOC gases. BR-2 requires
approximately 0.35 tanks of compressed air and 0.1 tanks of CO 2 per batch(see
calculations page 242). These growth conditions are deemed optimal by the Bioprocess
Engineering book by Schuler and Kargi
The fennentor is manufactured and designed by New Brunswick Scientific for the
growth of animal cells. A fennentor this size is custom ordered and designed for the
specific purpose of growing animal cells. New Brunswick Scientific provides the
engineering support to aid in the design of a reactor a large as 400L (see appendix page
231). In order to preserve an absolute sterile environment for the cells to grow, each
vessel is made of 316 Stainless Steel with sanitary piping and couplings. A six blade
standard marine impeller installed in the center of each bioreactor disperses the air stream
and mixes the cell culture. The agitation speed of the culture is only 30 rpm due to the
sensitivity of CRO cells and the very low shear level the cells can endure (Shuler p. 451).
The agitator is run by an electric motor that requires 5 hp of energy utility. The reactors
are sterilized in place by a process of flushing with water to remove any excess solid
waste and automatically steam sterilized at 130°C for approximately 3-4 hours. The
reactor must reach a temperature of 130 °C and remain at that temperature for a period of
time in order to kill or denature anything that remains inside the growing environment.
Attached to the fennentor is a ML-61 00 controller system is that is capable of
operating up to sixteen process loops controls (see appendix page 229). The system also
controls the sterilization and internal environment preservation. The menu-driven system
is designed for simple control and minimal operator labor hours. The computer control
system can be programmed to run a batch for any amount of time. A vessel view window
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is installed into the wall of the fennentor in order to allow an operator monitor the
process inside. The cell growth rate and the quality of the automatic sterilization are
observed repeatedly through out the life of the batch. If a vessel is not completely clean
after the water flush it must be manually scrubbed before steam sterilization.
The batch length ofBR-2 is 9.5 days. The batch schedule for the fennentor is the
following:
Days Fill and Inoculate
7 Days of Cell Growth
0.5 Days Harvest
1 Day to Sterilize
The times allotted for each of these processes are over estimated to ensure enough time,
in the event of a disturbance in the system, to provide enough time for the next fennentor
in the process train to be prepared to receive the cell broth. The tP A production plant
contains a total 2, BR-2 fennentors, one for each of the two trains. The quoted price from
Ted Shields of New Brunswick Scientific for one unit with a complete control system is

$125,000. (see specification page 97 and appendix page 231)

5000 Liter Fermentor BR-3
The function of the BR-3 is to grow a culture CHO cells up to a density of 3

* 106

cells/mL and provide an environment for optimum tP A production. The fennentor
operates at an optimum growth temperature of 37°C and a pressure of 14.7 psi. A 4-inch
half-pipe heating jacket located around the outside of the vessel and covered in a 2-inch
layer of fiberglass insulation is used to maintain the internal temperature at 37°C. The
tubing is filled with flowing wann water at an average flow rate range of 0.09-0.2 kg/sec
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(see calculations page 233). The range of flow rates is calculated using various
environmental conditions. A recycled water stream is heated with sparged steam to
maintain a temperature of 38°C is circulated through the jacket. Ted Shields of New
Brunswick Scientific suggested a half pipe jacket over a dimple jacket because a dimple
jacket is more likely to corrode under to operating conditions.
In addition to the temperature and pressure, the pH of the cell broth is maintained
at 7.3. A continuous flow of compressed air and CO 2 are pumped into the vessel through
a sparger on the bottom of the tank. This stream of air supplies the oxygen for cellular
metabolic consumption and carbon dioxide needed to regulate the pH . The fermentors
are all filled with a complete CHO media that is designed to provide all the essential
nutrients and proteins for CHO cell growth. The media also contains a sodium
bicarbonate buffer to maintain the pH at 7.3. The pH is adjusted by the percent
concentration of CO 2 in the air stream pumped through the bottom. The average flow of
CO 2 is 5% of the inlet air stream, but a pH control unit continuously measures the pH
inside of the tank and adjusts the CO 2 flow accordingly. The compressed air and the CO2
are supplied to the fermentor from tanks purchased from BOC gases. BR-3 requires
approximately 7 tanks of compressed air and 0.3 tanks of CO 2 per batch (see calculations
page 240). These growth conditions are deemed optimal by the Bioprocess Engineering
book by Schuler and Kargi
The fermentor is manufactured and designed by New Brunswick Scientific for the
growth of animal cells. A fermentor this size is custom ordered and designed for the
specific purpose of culturing animal cells. New Brunswick Scientific provides the
engineering support to aid in the design of a reactor a large as 5000L (see appendix page
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231). In order to preserve an absolute sterile environment for the cells to grow, each
vessel is made of 316 Stainless Steel with sanitary piping and couplings. A six blade
standard marine impeller installed in the center of each bioreactor disperses the air stream
and mixes the cell culture. The agitation speed of the culture is only 30 rpm due to the
sensitivity of CHO cells and the very low shear level the cells can endure. The agitator is
run by an electric motor that requires 10 hp of energy utility. The reactors are sterilized
in place by a process of flushing with water to remove any excess solid waste and
automatically steam sterilized at 130°C for approximately 5 hours. The reactor must
reach a temperature of 130 °C and remain at that temperature for an extended period of
time in order to kill or denature anything that remains inside the growing environment.
Attached to the fennentor is a ML-61 00 controller system is that is capable of
operating up to sixteen process loops (see appendix page 229). The system also controls
the sterilization and internal environment preservation. The menu-driven system is
designed for simple control and minimal operator labor hours. The computer control
system can be programmed to run a batch for any amount of time. A vessel view window
is installed into the wall of the fennentor in order to allow an operator monitor the
process inside. The cell growth rate and the quality of the automatic sterilization are
observed repeatedly through out the life of the batch. If a vessel is not completely clean
after the water flush it must be manually scrubbed before steam sterilization.
The batch length ofBR-3 is 14 days. The batch schedule for the fennentor is the
following:
2 Days Fill and Inoculate
8 Days of Cell Growth (and lag time)
1 Day Harvest
3 Days to Sterilize
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The times allotted for each of these processes are over estimated to ensure enough time
for adequate cell growth and production and provide enough time to stagger 50 batched
between 2 fermentor trains in the course of one year. The tPA production plant contains
a total 2, BR-3 fennentors, one for each of the two trains. The quoted price from Ted
Shields of New Brunswick Scientific for one unit with a complete control system is
$250,000. (see specification page 98 and appendix page 231)

Heat Exchanger (HX-l)
HX-l is a shell and tube heat exchanger, which heats the complete media from 4
°C to the optimal cell growth temperature of 37°C. It is 4 ft. long with 1 tube pass and
one shell pass. The unit had 18 tubes with a nominal outside diameter of 0.75 in. and a
1.25 in. square pitch. The shell has a 6.6 in. inner diameter. The heat duty for this heat
exchanger is 6.100 * 104 BTUIhr, with an overall heat transfer coefficient of 70
BTUIF*ft2*hr. Based on these calculations, the heat transfer area of this heat exchanger
is 12 ft2 (see calculations page 245).
The media is passed through the tube side at a flow rate of 2 gaVmin counter
currently to a wann water stream flowing at an approximate flow rate of9.7 gal/min (see
calculations p 245) that enters the heat exchanger at a temperature of 55°C and exits the
unit at 48 °C. The warm water stream cannot enter HX-l at a temperature greater than 55
°C because the organic materials in the media will be damaged . The wann water stream
is made up of a recycled flow of city water that is temperature controlled with a steam
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sparger. The additional water accumulated in the stream from the addition of steam is
regulated by a pressure control and purged off to the waste treatment facility.
The HX-I is made from 316 Stainless Steel with sanitary piping and couplings to
ensure sterile conditions. After each batch the unit if flushed out with water twice its
volume and steam sterilized in place with 130 DC steam for 2 hours. The tPA production
plant contains a total 2, Heat Exchangers, one for each of the two fermentation trains.
The total purchase cost of one exchanger is estimated using cost table in the Process
Design book by Dr. Warren Seider to be $6500.00. (see specification page 99 and

appendix page 245)

Blending Tank (T-l)
The media blending tank is used to combine the duel powder HyQ PF-CHO
media with 4500 L of sterile water in order to produce the complete media for use in BR
1, BR-2, and BR-3. The tank is first filled with 90% of the total volume of water desired.
While the water is gently stirred at 50-60 rpm, the powder media is added and mixed
until it is dissolved. The agitation motor that drives the impellor requires 10 hp and uses
59000 kW*hr per year energy (see calculations page 255). The water must stay at room
temperature, 20 DC while the powder is mixed into the water in order to ensure complete
dissolution. The volume is then brought up to 100% and the media is cooled to a
temperature of 4 DC. Due to staggered scheduling of each batch, the three fermentors are
filled at different times over the course of 7 days. The media remains in the tank at 4 DC
until it is needed in the fermentors. As suggested by Dr. Kivnick the T -1 is equipped
with a refrigeration unit and a jacket of copper tubing that is filled with flowing
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refrigerant (freon) in order to cool the liquid inside the tank. The outside of the tank is
covered with a 2 in. layer of fiberglass insulation to decrease the refrigeration
requirements. The refrigerator requires 65000 kW*hr per year to cool the liquid.
The media is prepared 2 days before its first scheduled use in order to allow
adequate time for quality testing of the mixed media. A sample of media extracted and
used to grow up a cell culture in the quality assurance laboratory. The results of the
culture are analyzed for the presence contamination and the average cellular growth rate
for the batch of media. The tank is manufactured using pharmaceutical standards of
materials and sterile qUality. The tank and internal impeller are made from 316 stainless
steel and the piping associated with the vessel is of sanitary grade. The unit is designed
to be steam sterilize in place after each batch. The blending tank is flushed out with
water twice its volume to remove any lingering debris and steam sterilized at 130°C for
3-4 hours. A sight glass is installed on the top of the tank so operators can view the
process inside and watch for any build up of material on the walls and impellor inside the
vessel that would have to be manually washed before steam sterilization.
The tP A production plant contains a total 2, T -1 tanks, one for each of the two
fermentation trains. Walker Stainless Steel Equipment approximates the cost of this
blending tank at $28,658.00 (see appendix page 250). Under the advice of Dr. Kivnick,
an additional $2,000 is added to the purchase cost for the copper tubing that makes up the
cooling jacket and the insulation. The small refrigerator attached to the tank is quoted at
$20,000 and 8 tons of refrigerant is purchased at a price 0[$250.00Iton to provide the
fuel for the refrigerator. (see specification page 100 and appendix page 250)
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PUlnps

Filter Pump P-l and P-2
Filter Pumps P-1 and P-2 increases the pressure of the 2 gal/min liquid media
stream from 14.7 psi up to 29.7 psi and sustains the volumetric flow rate. P-1 controls
the steam leaving T-1 and pushes the 4 °C stream through a 2 !lm filter F-l. P-2
increases the pressure of the same stream to overcome the pressure drop from F-1 and
push the stream through the next filter F-2. The pumps are Randolph Austin Series 610
vari-flow speed control peristaltic pumps that are equipped to handle a pharmaceutical
grade product streams and maintain their sterile quality (see appendix page 256). The
pumps are made out of stainless steel, which is sterilized in place by flushing water
through the pump until all residues are removed and steam sterilized at 130°C for 30
min. The power requirement for this peristaltic pump is specified by Randolph Austin
Company at 0.25 hp. There are a total of four filter pumps in the tP A production plan,
two for each of the two fermentation trains. The cost of one pump is listed as $1595.00.
(see specification page 101 and appendix page 253)

Heat Exchanger Pump P-3
Heat Exchanger Pump P-3 increases the pressure of the 2 gal/min liquid media
stream leaving F-2 at 14.7 psi to 29.7 psi and sustains the volumetric flow rate. The
pressure increase of the stream is used to flow the 4°C stream through HX-l. The pump
is a Randolph Austin Series 610 vari-flow speed control peristaltic pump that is equipped
to handle a pharmaceutical grade product stream and maintain its sterile quality (see
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appendix page 256). The pump is made out of stainless steel, which is sterilized in place
by flushing water through the pump until all residues are removed and steam sterilized at
130°C for 30 min. The power requirement for this peristaltic pump is specified by
Randolph Austin Company at 0.25 hp. There are a total of2 Heat Exchanger pumps (P
3) in the tP A production plan, one for each of the two fermentation trains. The cost of
one pump is listed as $1595.00. (see specification page 103 and appendix page 253)

Cell Broth Pumps P-4 and P-5
The Cell Broth pumps function to move the cell broth from one fermentor to the
next one in the process train. The streams flow at a volumetric flow rate of2 gal/min at
38°C and a pressure of29.7 psi. P-4 moves the cell broth from the BR-I to BR-2 and P-5
moves the cell broth from BR-2 to the last unit of the train, BR-3. The pump increases
the pressure of the stream from 14.7 psi to 29.7 psi to over come any pressure drop that
occurs over the piping between the bioreactors. The pumps are Randolph Austin Series
610 vari-flow speed control peristaltic pumps that are equipped to handle a
pharmaceutical grade product stream and maintain its sterile quality (see appendix page
256). The pump is made out of stainless steel, which is sterilized in place by flushing
water through the pump unttl all residues are removed and steam sterilized at 130°C for
30 min. The power requirement for these peristaltic pumps is specified by Randolph
Austin Company at 0.25 hp for each. There are a total of four cell broth pumps in the
tP A production plan, two for each of the two fermentation trains. The cost of one pump
is listed as $1595.00. (see specification page 104 and appendix page 253)
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Heating Jacket Water Pump P-6
The function ofthe Heating Jacket Water Pump P-6 is to flow water through the
half-pipe heating jacket that surrounds BR-3. The water is used to maintain an internal
fermentor temperature of37 °C. The flow rate of water is dependent upon the heat loss
from the reactor to the environment. The flow rates are calculated to range from 0.2
kglhr to 0.09 kg/hr for different environmental conditions (see calculations page 233).
The pump also increases the pressure ofthe stream from 14.7 psi to 29.7 psi in order to
overcome the pressure drop that occurs along the tubing. The pump is a Randolph Austin
Series 610 vari-flow speed control peristahic pump that is equipped to handle a
pharmaceutical grade product stream and maintain its sterile quality (see appendix page
256). The pump is made out of stainless steel, which is sterilized in place by flushing
water through the pump until all residues are removed and steam sterilized at 130°C for
30 min. The power requirement for this peristaltic pump is specified by Randolph Austin
Company at 0.25 hp. There are a total of two heating jacket water pumps in the tP A
production plan, one for each of the two fermentation trains. The cost of one pump is
listed as $1595.00. (see specification page 106 and appendix page 253)

Heat Exchanger Water Pump P-7
The function of the Heat Exchanger Water Pump is to flow warm water through
the shell side ofHX-I. The water is used to heat up a stream of media from 4 °C to 38
°C. The calculated flow rate of water of the water is approximately 9.6 gal/min (see
calculations page 245). The pump also increases the pressure ofthe stream from 14.7 psi
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to 29.7 psi in order to overcome the pressure drop that occurs over the heat exchanger
and piping. The pump is a Corcoran Model 3000D-HDl centrifugal pump that is
equipped for small flow rates (see appendix page 260). The pump is made out of carbon
steel and has a power requirement of2.0 hp. There are a total of two heat exchanger
water pumps in the tP A production plan, one for each of the two fermentation trains.
The cost of one pump is listed as $3250.00. (see specification page 107 and appendix
page 253)

FILTERS
Fermentor Air Filters (F-3, F-4, F-5, F-6 F-7, and F-8)
The air filters attached to the air inlet streams and the air purge streams of the 6
bioreactors function to sterilize the air that is fed to the cell culture and purify the exhaust
air from the fermentors of any biomaterial before it is released to the environment. The
Osmonics Memtrex-FE Filters are dead-end filters that are made from PTFE membrane
with an absolute filtration rating of 0.2 flm. The filters are designed to handle inlet flows
up to 15 cc/min per 10 inches of filtration area. Each cartridge is 2.75 inches in diameter
and 10 inches in length. Multiple cartridges can be placed in a row to handle larger flow
rates, but only one lOin cartridge is needed to handle the air flows for the process that
range from 0.03-0.35 kg/hr for the three different size fermentors. The pressure drop over
the filter is calculated by the equations provided by Osmonics to be than one bar for each
of the filters because of the small volumetric flow rate and working pressure of29.7 psi.
(see appendix page 267).
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The air filters are replaced approximately every 3rd batch, but the outlet flows are
still monitored by operators by gages on the pipes, in case a filter must be replaced before
the end of the third batch. In between batches, the filters are flushed with water and
sterilized with 130°C steam for 30 min. There are a total of 12 air filters in the tP A
production plan, six for each of the two fennentation trains. The cost of each filter is
quoted by Osmonics to be $44.00 per filter. Installation costs and piping are factored in
to the overall construction cost of the plant in the economics flow sheet. (see
specification page 110 and appendix page 267)

Media Filter- 2 Jlm (F-1)
The media filter F -1 function to sterilize the prepared media in the blending tank,
before it is pumped into the fennentors. The 2 !lm filter is used primarily to protect the
0.2 !lm filter F-2 from clogging to easily. The Osmonics Flotrex-AP Filters are dead-end

filters that are made from polypropylene fiber media with an absolute filtration rating of 2
!lm (see appendix page 263). Each cartridge is 2.75 inches in diameter and 10 inches in

length with effective filtration area of5.2 ft2. The filter operates with a flow of2 gaVmin
at a temperature of 4°C and a pressure of29.7 psi. The pressure drop calculated using
the equations provided by Osmonics is extremely small; therefore an estimated pressure
drop of 15 psi was used for all design calculations.
F-l is replaced every batch, but the outlet flows are still monitored by operators
through the aid of gages on the pipes, in case a filter must be replaced before the end of
the batch. During the course of one batch the filter is used three times: once to fill each of
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the three fennentors. The filter is sterilized during down time between each media load
with sterile water that is flushed through the filter to remove any debris and steam
sterilized at 130°C for 30 min. There are a total of 2, F -2 filters in the tP A production
plan, one for each of the two fennentation trains. The cost of each filter is quoted by
Osmonics to be $32.00 per filter. Installation costs and piping are factored in to the
overall construction cost of the plant in the economics flow sheet. (see specification page

108 and appendix page 263)

Media Filter- 0.2

~m

(F -2)

The media filter F-2 function to sterilize the prepared media in the blending tank,
before it is pumped into the fennentors. The 0.2 f!m filter removes 99.9% of all
contaminants found in the media. The Osmonics Memtrex-FE Filters are dead-end filters
that are made from PTFE membrane with an absolute filtration rating of 0.2 f!m. Each
cartridge is 2.75 inches in diameter and 10 inches in length that can handle a maximum
flow of 15 cc/min. The filter operates with a flow of 2 gal/min at temperature of 4 °C
and a pressure of 29.7 psi. The pressure drop calculated using the equations provided by
Osmonics is extremely small; therefore an estimated pressure drop of 15 psi was used for
all design calculations (see appendix page 267).
F-2 is replaced every batch, but the outlet flows are monitored by operators by
gages on the pipes, in case a filter must be replaced before the end of the batch. During
the course of one batch the filter is used three times: once to fill each of the three
fennentors. F-2 is sterilized in down time between each media load with sterile water
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that is flushed through the filter to remove any debris and steam sterilized at 130 °e for
30 min. There are a total of2 media filters in the tPA production plan, one for each of the
two fermentation trains. The cost of each filter is quoted by Osmonics to be $44.00 per
filter. Installation costs and piping are factored in to the overall construction cost of the
plant in the economics flow sheet. (see specification page i09 and appendix page 267)

Boiler
A small single boiler generates all ofthe plant's sterile steam. The steam is used
to sterilize all process equipment and piping, as well as a source of energy to increase the
temperature of four water streams. The boiler produces approximately 500 lblhr of39.16
absolute pressure, 130 °e steam. The water used to make the steam enters the boiler
from an in-house water purification system and is pumped in at 20 °e. The fuel for the
boiler, 54.54 lblhr of natural gas, which is 94.2% methane, is fed to the boiler. The
heating values of the natural gas stream are 23,000 BTU/lb.
The boiler efficiency is predicted to be 85%. The plant sterilization requirement
and the sparged streams are small compared to the capacity of the boiler, but an over
estimate was assumed in order to account for an increased load on the system and
provided enough capacity if the plant was expanded. The boiler is equipped with sanitary
piping and stainless steel components in order to maintain the highest levels of sterility.
Boiler controls include a feed-water flow control, fuel flow control, and the emission
monitoring equipment. The Icarus Process Evaluator and Aspen Steady State Simulator
aided in the boiler design. The approximate cost quoted by the IPE program for a boiler
of this size is $112,000. (see specification page ili and appendix page 279)
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Blending Tanks
Blending tanks are used throughout the Separation section to ease batch
scheduling and adjust the chemical composition of our product solution. The Separation
section, including all blending tanks, is held at 4°C. Low temperatures prevent loss of
protein activity over time, a primary concern during storage. Solutions are constantly
being agitated during storage or blending. Electrical requirements were calculated
assuming constant agitation over 7,920 hrs/year (large overestimate) and power needs of
7 hp for 300-500 L tanks and 10 hp for 4000-5000 L tanks. Yearly impeller electrical
needs for Holdup and UFl Tanks are 59,000 kW*hr. The remaining smaller tanks each
required 29,500 kW*hr/year (see appendix page 362). All tanks are cleaned-in-place
(CIP) after each use by flushing with two tank volumes of sterile water and sterilized-in
place (SIP) with steam for 30 minutes. Tanks are made with 316 Stainless steel and
pricing was completed with information from Walker Stainless Equipment. (see appendix
page 250)

Holdup Tank
The function of this blending tank is to provide storage space for our product after
removal from BRI. The capacity of this tank is 5000 L, but its use will only be necessary
if the Centrifuge is being repaired. The cost of Holdup Tank is estimated at $19,000
based on information provided by Walker Stainless Equipment. (see specification page
112 and appendix page 250)
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UFI Tank
The function of this tank is to blend arginine to 1M (-850 kg) in the product
stream taken from the Centrifuge. tP A will be concentrated in the next step, so protein
aggregation will be a concern; the arginine is added to prevent this aggregation. The
product solution is then stored overnight until it is pumped to UFI the next morning.
UF.! Tank also acts as a holding tank for the retentate recycled from UFI during the first
ultra filtration step. Its capacity is 4000 L, and its cost was quoted at $17,000 by Walker
Stainless Equipment. (see specification page 113 and appendix page 250)

UF2 Tank
The function of this 300 L tank is to blend arginine to 2M (-67 kg) in the
retentate collected from UFt. All of the retentate from UF2 is recycled to UF2 Tank
during the second ultra filtration step. The cost ofUF2 Tank was quoted at $9,000 by
Walker Stainless Equipment. (see specification page 114 and appendix page 250)

Affinity Tank
The function of this tank is to store UF2 filtrate at 4°C before it is applied to
Affinity Column. One quarter of its initial contents (-80 L) will be applied to Affinity
Column in each of four cycles. The cost of this 400 L capacity tank is estimated at
$10,000 based on infonnation provided by Walker Stainless Equipment. (see
specification page 115 and appendix page 250)
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ER Tank
The function of this 400 L tank is to store the elution from Affinity Column at
4°C, increase its contents' pH by addition of 1M NaOH, and add the required amount of
sucrose. Sucrose will also be added in this tank so any endotoxins introduced with it will
be removed in the ER Column. Approximately 80 mL of 1M NaOH is added to ER Tank
after each Affinity Column elution is collected. This is sufficient to neutralize the
solution (see appendix page 345). Sucrose is then added in the amount of 0.03 kg. After
water-for-injection (WFI) is added to MF Tank the concentration of sucrose will be 0.2
rnM and the salt concentration will be well within the injection standards given by Prof.

Diamond (see appendix page 289). Its cost is estimated at $10,000. (see specification
page 116 and appendix page 250)

MFTank
Final preparation of the product solution takes place in MF Tank. WFI is added
to increase the volume to 400 L. This sets the volume loaded into each 100 mL vial at
approximately 25 mL. The capacity ofthis tank is 500 L and its cost is estimated at
$11,000. (see specification page 117 and appendix page 250)

FDTank
The function of this tank is to store and agitate the MF filtrate at a temperature of
4°C until it is bottled (about 6 days). A small sample ofFD Tank contents is taken to the
control laboratory to determine the tP A concentration, which is required to set the amount
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of solution that will be loaded in each 100-mL vial. The absorbance of light at 260 nm
provides us with the protein concentration in our solution (the tryptophan in the protein
absorbs light at this wavelength). The volume of solution per vial is such that 100 mg of
tPA will be present after lyophilization (freeze drying). Bottling and freeze drying occur
in five cycles, requiring one-fifth of the initial FD Tank (~80 L) contents to be transferred
out every 26 hrs. FD Tank capacity is 500 L and its price is estimated at $11,000. (see
specification page 118 and appendix page 250)

Centrifuge
The Centrifuge is used to remove the CHO cells from the media harvested from
BR1. tP A is secreted from the cells after it is produced, so we can separate the intact
cells while losing minimal protein. I assumed that 5% of the tP A present in the harvest
media was lost during centrifugation, a large estimate. For the removal of mammalian
cells, the CSC 4 Clarifier by Westfalia Separator has a capacity of 400-500 LIhr. A built
in control system measures the turbidity of the clarified liquid and ejects solids when
necessary. Cleaning and sterilization are accomplished by washing with NaOH for 30
minutes and SIP for 30 minutes at 130°C. Given that processing time is less than 10 hrs,
one centrifuge is capable of handling batches from both Bioreactor trains. Even if three
5000 L Bioreactor trains were present there would be sufficient downtime for regular
maintenance of the centrifuge. The Westfalia representative assured me that the clarifier
is extremely reliable and breakdowns are rare. Power requirements are 9,000
kW*hr/year. The price of the CSC 4 Clarifier with controls, CIP, SIP, and a three
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charmel centripetal pump was quoted as $355,000. (see specification page 119 and
appendix page 296)

Pumps
Since our product is produced batch-wise in relatively small volumes, peristaltic
pumps are sufficient for us to use throughout our process. Maximum flow rates and an
efficiency of 80% were used in calculating the power requirements and costs for each
pump. All pumps operate at 4°C within the air-conditioned Separation section. (see
appendix page 362)

UFIPump
UFl Pump is required to increase the pressure of stream P-6 solution to 40 psi
before it is ultra filtered in UFl. The Series 750-362 Vari-flow pump from Randolph
Austin Company can bring 830 LIhr of solution up to 40 psi from a 14.7 psi tank.
Electrical requirements for this operations were calculated as 390 kW*hr/year. The price
for this pump was quoted by a Randolph Austin representative as $2,656. (see
specification page 120 and appendix page 256)

UF2 Pump
UF2 Pump increases the pressure of stream P-ll from 14.7 psi to 40 psi at a flow
rate of 1350 Uhr. Again, the Series 750-362 Vari-flow pump from Randolph Austin
Company will be used. Electrical requirements are 625 kW*hr/year, though it should be
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much less given that the pump is used for less than an hour each batch. The price for
UF2 Pump is also $2,656. (see specification page 121 and appendix page 256)

MFPump
MF Pump produces a pressure of34.7 psi in stream P-30, the inlet stream to MF.
The pressure drop across MF is assumed to be 20 psi, though it is certainly much lower
than that value. Increasing the pressure ofMF Tank contents from 14.7 psi to 34.7 psi at
a flow rate of 1135.6 LIhr can be accomplished by the Series 750-362 Vari-flow pump
from Randolph Austin Company. Electrical requirements for a year of use are 425
kW*hr. The price is again $2,656. (see specification page 122 and appendix page 256)

Affinity Skid/Pump
The Affinity SkidlPump increases the pressure at the inlet of the Affinity Column.
Its computer controls the volumes of the Load, Equilibration, Elution, and Wash steps
(see Affinity Column description page 82). Given a superficial velocity of 100 cmlhr, the
volumetric flow rate applied to this column is 135 LIhr. The pressure drop across the bed
was calculated as 1.2 psi using the Ergun equation. This number was increased to 10 psi
in determining the 25 kW*hr of electricity required each year to run the pump. Due to
the fact that items such as this are custom-made by Amersham Pharmacia Biotech, the
representative was unable to quote an accurate price. Prof. Diamond recommended
$100,000, which includes all of the pumping, computer, and control equipment. (see
specification page 123 and appendix page 256)
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ER Skid/Pump
The ER Skid/Pump controls flow through the ER Column and increases the inlet
pressure to make up for the pressure drop across the packed bed. Product, Cleaning, and
Regeneration solutions are applied to the column at 100 cmlhr or 11 LIhr (see ER
Column description page 84). The pressure drop across the bed is 1.9 psi as calculated by
the Ergun equation. Again, the value was increased to 10 psi in detennining the yearly
electrical requirements of2 kW*hr. Amersham Pharmacia Biotech could not provide a
quote for ER SkidlPump, so Prof. Diamond's recommendation of$100,000 will be used
again. (see specification page 124 and appendix page 256)

Tangential Flow Filtration
Tangential flow filtration involves the flow of a feed stream through a hollow
fiber filter in order to concentrate a product or remove solids from a stream. It is ideal for
use in the separation of small biological molecules and organisms.

78

Unit Descriptions

Generic tPA

Cross Flow Membrane Filb"ation

'Virus

ti

W~er

.....

Fiber

•



Starch

~~

Protein

~

•

Sug~

Alcohol

Metal Hydroxides

Membrane

Figure: 6

Ultra filters are used early in the process to concentrate the tPA solution after
centrifugation. Following the first ultrafilter, a second is used to "clean up" the solution
before the chromatography steps.
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The product stream flows along the filter, and osmotic pressure is used to push water or
dissolved solids through the filter. Proteins will either be rejected by the membrane or
flow through it, depending on the filter's specified Molecular Weight Cut-Off (MWCO).
If the protein's size is larger than the MWCO it remains in the retentate; if the MWCO is
larger than the protein it will flow through as penneate. (see appendix page 303)

UFI
UFI is used to concentrate tPA from the Centrifuge supernatant. UFl Tank
contains approximately 2 kg oftPA in about 3500 L ofliquid media. This volume will be
reduced to about 250 L. The MWCO ofthe Koch Membrane HF 14-43-PM50 is 50 kDa
(a Dalton is equivalent to one gram per mole and is commonly used in the description of
protein sizes). The molecular weight oftPA is 66 kDa, which causes it to be rejected
from the membrane remain in the retentate. The filtrate flux is specified for the PM50 as
550 LIhr; given this flow rate and starting volume, 33 LIhr (or 6% of 550 LIhr) needs to
be taken off as product retentate. The remaining retentate is recycled back to UFl Tank
as shown in Figure 8 on page 81. A ratio-flow controller is used to control the product
retentate flow in stream P-8. An inlet pressure of 40 psi is required, and the pressure
drop was quoted as 10 psi. f'he membrane is made ofpolysulfone and has an area of 14
ftl. The Koch Membrane representative assured me that fouling would not be a problem
and that the PM50 filter would last for at least a year.

The amount of tP A lost to

denaturing is assumed to be only 2%. This is a conservative estimate given that the pores
are designed to prevent clogging and aggregation at the openings. Cleaning is
accomplished by recirculation through the membrane of 10 gal diluted surfactant
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solution, priced at $75 per concentrated bottle. The pump and blending tanks are priced
separately, and the PM50 cartridge costs $785. Piping and equipment setup costs are
factored in during our economic analysis. (see specification page 125 and appendix page
303)

UF2
UF2 removes larger components that were not separated in the Centrifuge. The
MWCO of the Koch Membrane HF 14-43-PM500 is 500 kDa and will remove larger
proteins and cell debris that can potentially foul the resin in Affinity Column or ER
Column. tPA flows through the membrane and is collected along with the entire volume
ofUF2 Tank as filtrate. The inlet pressure is 40 psi and there is a pressure drop of 10 psi
across the membrane. The filtrate flux is specified as 880 Llhr over the 14 ft2
polysulfone filter, and all of the retentate is recycled to UF2 Tank. Cleaning is again
done be recirculating the surfactant fluid through the membrane. Because the tP A flows
through the

mem~rane

I increased the tP A loss to 5%, though the Koch representative

stated that minimal protein would get caught. The price of the PM500 cartridge was
quoted at $950 and it will be replaced yearly. (see specification page 126 and appendix
page 303)

MF (Microfiitration)
MF performs a final sterilization of the product stream before it is bottled and
freeze dried. The 9 ft2 PTEF membrane has a pore size of 0.2 microns. Unlike the UF1
and UF2 above, MF is a dead-end filter, where all of the fluid passes through the
membrane and is collected as filtrate. The pressure drop over MF is generously assumed
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to be 20 psi, and the maximum flow rate is 1140 Llhr. Filter cartridges will be replaced
after each batch and they are quoted at $44 each by Osmonics. (see specification page

127 and appendix page 267)

Affinity Column and Resin
Affinity Column is the most important separation unit in our process. It utilizes
affinity chromatography to select for tP A. Affinity chromatography involves the binding
of a protein or other biologically active molecule to a resin or other biologically active
molecule. This process utilizes the binding of a monoclonal antibody to tP A. A
monoclonal antibody simply means that will only bind with our protein. The anti-tP A
antibody is bound to the Affinity resin where it remains indefinitely. A protein solution
is loaded onto the column and as it flows through, the active protein (tPA in our case)
binds to the antibody that is attached to the resin. After the Loading is complete, the
column is washed,or equilibrated with Equilibration buffer. Finally, the column is eluted.
Elution takes place in a high salt or acidic solution; these conditions cause the protein to
break its bond with the antibody. The Elution only contains the active protein and any
salts or amino acids present in the Elution buffer. The column is then washed with
Equilibration buffer and can be reused (the antibody remains attached to the resin
throughout the process).
Our 58 L 316 Stainless steel column is completely filled with CNBr-activated
Sepharose 4 Fast Flow resin. The resin is made up of agarose beads with an average
diameter of90 microns, and our anti-tPA antibody forms a bond with the CNBr that is
attached to the resin. The contents of Affinity Tank are run through the Affinity Column
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in four cycles. After the first Load is applied to Affinity Column (through the Affinity
SkidlPump), 2.5 bed volumes of Equilibration buffer is applied to the column (a bed
volume is the volume of resin in the column, or 58 L). 1.3 bed volumes of Elution buffer
then flows through the column, and this tP A-containing solution is collected and sent to
ER Tank. The column is then washed with 5 bed volumes of Equilibration buffer and
cycle repeats itself three more times until the entire batch has been eluted. After each
batch the resin will be stored in 20% ethanol.
Amersham Pharmacia Biotech recommends flow through the column at 100
cmlhr superficial velocity or 135 LIhr in our 70 cm diameter column (15 cm height). The
pressure drop across the packed bed was calculated at 1.2 psi using the Ergun equation.
The buffer solutions used were the same as those used by Reagan et al. Equilibration
buffer contains is 0.65M NaCl in PBS at a pH of 6.8, and an acidic elution buffer is used,
which contains 0.5M glycine and 204M arginine at a pH of 2.85. In calculating the resin
requirements I used the value of 12.3 mg antibody/mL resin from Reagan et al. I
assumed that only 85% of the resin would be utilized and then provided enough resin to
bind all of the protein applied to the column (0.5 kg per cycle). Even with the increased
amount of resin I am assuming a loss of 15% of the tPA applied to the column based on
the recommendations by Prof. Diamond.
Bioprocess Stainless steel chromatography columns are custom-made by
Amersham Pharmacia Biotech, so we are using Prof. Diamond's recommendation of
$100,000. The anti-tP A antibody will be produced in our facility, but no data is available
on its production so Prof. Diamond advised us to use an estimate of$2,000Ig antibody.
We require 710 grams each the column so we accounted for 750 grams of antibody in our
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economic evaluation. The Sepharose resin can be bought in bulk from Amersham
Pharmacia Biotech at $2,81 OIL. Both the resin and antibody will need to be replaced
each year. (see specification page 128 and appendix page 314)

ER Column and Resin
The ER Column is used to remove endotoxins from the tP A solution. Endotoxins,
or pyrogens, are biochemicals that come from the cell wall of bacteria. If an endotoxin
containing solution is injected into a human, it will cause a feverish reaction and make
the person feel sick. Our process does not utilize bacteria in any way, but endotoxins will
still be present in low, but significant amounts. Endotoxins may enter our process in the
chemicals or materials we use, such as the media, PBS, sucrose, or NaCI (other chemicals
are bought endotoxin free). Endotoxins cannot be removed or "killed" with steam
sterilization, so they may remain on equipment even after a SIP cleaning. NaOH
application can remove pyrogens, but this would destroy our protein.
For the removal of endotoxins in our process we will use the Actic1ean Etox resin
from Sterogene. This resin binds endotoxins while allowing a protein to flow through
unaffected. The binding capacity of this resin ranges from 200 EU(endotoxin units)/mL
resin to 20000 EU/mL resin. Prof. Diamond advised us to assume our product solution
had 5 EU/mL. Our final endotoxin level must be below the detectable level of 0.05
EU/mL. Given these specifications, 8.2 L of the Actic1ean Etox resin will suffice in
rendering our product safe for injection. The 200/500 Bioprocess glass column from
Amersham Pharmacia Biotech can hold 8.2 L of resin and provides a large bed height to
increase contact time. The bed height is 26 cm (column height is 50 cm) and the column
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diameter is 20 cm. Flow through the column takes place at a neutral pH and 100 cmlhr
(11 LIhr). I am assuming a 5% loss oftPA, though Sterogene references experiments
where 99% of the protein is recovered. After our product solution is loaded and
collected, the resin needs to be washed with 1M NaOH for two hours. The resin is then
regenerated with WFI and stored at a neutral pH of 7.0. Amersham Pharmacia Biotech
quoted the column at $6,190, and the resin was quoted at a bulk price of$4,320/L by
Sterogene. The resin is replaced each year, and costing is completed assuming a
purchase of 10Llyear. (see specification page 130 and appendp. page 329)

Bottler
The bottler loads a designated amount of the final tPA solution in 100 mL vials,
stoppers them, and loads them into the freeze dryer. The Cozzoli Machine Company
provides machines that interact with one another to complete these tasks. The VR 840S
can load approximately 3200 100-mL vials with 25 mL of fluid in about an hour. A
concentration meter is required to set the amount oftPA solution that will be loaded in
each vial. The BT15 Tray Loader can load these vials into the freeze dryer in one hour,
and the A W160 Automatic Washer can clean and sterilize the VR 840S and BT15 after
each cycle. The freeze dryer needs to be loaded and unloaded five times per batch, so the
total uptime for the Bottler is about 146 hrs, though it is idle for most ofthat time. Each
machine requires 0.5 hp, and the total yearly electrical requirements are 8,200 kW*hr.
The total cost quoted by Cozzoli Machine Company is $1,265,000. (see specification
page 132 and appendix page 346)
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Freeze Dryer
The freeze dryer removes WFI from the final tP A solution, creating a stable solid
product. The final product is lyophilized (freeze dried) because it can remain active
indefinitely; the solid simply needs to be redissolved inWFI. The exact time it takes to
lyophilize a protein can only be determined experimentally. Since we are unable to
perform these tests we will be assuming a drying time of 24 hrs. The condenser capacity
of the Virtis Benchmark 6000 SQ Stoppering Lyophilizer is 220 L of water in 24 hours.
Each cycle will only contain about 80 L of solution, making our estimate of 24 hrs very
reasonable. The freeze dryer first freezes the solution in a vacuum, causing the solid
solution to sublimate (water vapor can escape the partially stoppered vials). After this
primary drying is complete, the remaining water molecules are removed by slowly
introducing heat. This must be done gradually because any extreme temperature changes
can cause the protein to lose activity. All heating and cooling is done by way of a silicon
fluid. The silicon heat transfer medium flows through the baffled trays and back to the
condenser, where it is again heated or cooled and returns to the vials. I chose the SQ
(square) version as opposed to the Plus (circular) on a recommendation from the Virtis
representative. He claimed there is a theory that a square lyophilizer is better for freeze
drying (it is also $100,000 more expensive). The freeze dryer requires 6 gaVmin of
cooling water, and the maximum power requirement is 46.1 kW, quoted in a phone
conversation with a Virtis representative. The equipment uptime for each batch is about
146 hours. The yearly electrical usage is 340,000 kW*hr. Virtis quoted the Benchmark
6000 SQ, SIP and CIP capable with full controls at S640,000. The fina1 rate of
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production of tP A is about 1.6 kglbatch or 16,000 doses. (see specification page 133 and
appendix page 350)

Refrigerator
A refrigerator or air-conditioning system is required to keep the Separation trains
at.4°C year-round. Prof. Diamond helped up estimate the total area of the Separation
sections as 4,000 ft2. Rich Metallo at Baltimore AirCoil provided "rules of thumb" for
the air-conditioning requirements. It is assumed that 1.25 tons of refrigerant are required
per 300 ft2 of space to be cooled. The power requirement for one ton of refrigerant is 1
kW, but a load factor of 0.6 is included in the calculation to account for the fact that
outside temperature varies throughout the year (not as much cooling is necessary during
the winter). Given these estimates, 17 tons of refrigerant are required for the Separation
refrigeration, and the cost of refrigerant is $250/ton. The yearly electrical consumption
ofthis system is 87,600 kW*hr. Prof. Diamond recommended we estimate the purchase
cost of such a refrigeration system as $10,000. (see specification page J34 )

Initial Pump (PW-1)
City water from stream WI 0 1 is brought into the water purification system
through pump PW-1. PW-I increases the pressure of stream WIOI from 14.7 psi to 34.7
psi in order to compensate the pressure drop in filter FW-1. PW-1 is a peristaltic pump
that is constructed from 316 stainless steel and has speed and flow controls. The pump is
capable of producing a flow rate of 35 lit/min at 25°C. According to the data in the
Randolph Austin Company website, the power requirement is 1 hp. The actual cost of the
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pump is $5,250 quoted from Mr. Mike Milson, a representative from Randolph Austin
Company. (see specification page 135 and appendix page 387)

10 gm MicrofiIter (FW-1)
The purpose ofFW-l is to remove large particles from original city water of
stream WI 01 before it enters the water purification process. The city water is brought
into the process at 25°C and will flow through FW-1, which will remove dissolved
particles larger than 10 j..!m. The flow rate of water and the pressure drop across the filter
are 18 Llmin, and 10 psi, respectively. The membranes are constructed from high-purity
polypropylene, which is an FDA-acceptable material as are all other parts ofthe filter.
The FW-1 cartridge will be replaced after each batch to ensure the sterilization. The
actual cost of the filter is $44 per cartridge according to Mr. James Lewis, the application
engineer at Osmonics. (see specification page 136 and appendix page 389)

Carbon Filter Pump (PW-2)
The function of pump PW-2 is to increase the pressure in stream WI03 from 14.7
psi to 26.7 psi in order to compensate the pressure drop in filter FW-2. PW-2 is a
peristaltic pump constructed from 316 stainless steel with speed and flow control. The
pump is capable ofproducing the flow rate of 18 Llmin at 25°C. According to the data in
the Randolph Austin Company's website, the power requirement is 0.25 hp. The actual
cost ofthe pump is $2,656 quoted from Mr. Mike Milson, a representative at Randolph
Austin Company. (see specification page 137 and appendix page 387)
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Carbon Filter (FW-2)
The function of filter (FW -2) is to remove chlorine and organic molecules from
stream WI 04 since chlorine can degrade the membranes of the reverse osmosis system
(RO-I) and filter (FW-4). The filter can produce 76 Llmin (20 gal/min) at 25°C, and is
able to work at a maximum temperature of 50 °c. The maximum pressure drop across the
filter is 12 psi recommended by the manufacturer, Ameriwater Company. The carbon
filter utilizes 1000 lbs of bituminous coal as the absorbent. In addition, the manufacturer
is also recommends a minimum contact time of 5.3 min based on a bed density of28
Ib/ft3. The actual cost of the filter according to Ms. Diane Dolan, a sale manager at
Ameriwater Company, is $1515. (see specification page 138 and appendix page 389)

Water Softener Pump (PW-3)
After FW-2, water in stream WI05 will proceed directly to pump PW-3, which
will increase pressure in stream W105 from 14.7 psi to 24.7 psi to compensate the
pressure drop in filter FW-3. PW-3 is a peristaltic pump is constructed from 316 stainless
steel with speed and flow controls. The pump is capable of producing the flow rate of 76
Llmin of water at 25°C. According to the data in the Randolph Austin Company's
website, the power requirement is 1 hp. The actual cost of the pump is $5,250 quoted
from Mr. Mike Milson, a representative Randolph Austin Company. (see specification
page 140 and appendix page 387)

Water Softener (FW-3)
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The water softener (FW-3) is used to remove the cations such a calcium and
magnesium salts from the city water. Stream W106 flows through the FW-3 at a rate of
76 Llmin, with a pressure drop of 10 psi. The inner shell ofFW-3 is constructed from
polyethylene, while the outer surface is made from fiberglass to provide strength of up to
150 psi. The amount of resin required is approximately 7 ft3, according to from Ms.
Diane Dolan, the sale manager at Ameriwater Company. The resin used for this particular
softener is polystyrene sulfonate cation, which can operate at a maximum temperature of
140°C and has a standard flow rate of 4 gall(min ft3). The life of the resin is 10 years,
while the price is $60/ft 3 , according to Mr. Dally, a representative ofSybron Chemical,
Inc, the manufacturer of the resin. Ms. Diane Dolan quotes the total cost of the FW-3
including resin at $4537. (see specification page 139 and appendix page 377)

Reverse Osmosis Pump (PW-7)
The water from stream WI07 is drawn into the reverse osmosis system through
the reverse osmosis pump (PW-7). PW-7 increases the pressure of stream WI07 from
14.7 psi to 34.7 psi in order to compensate the pressure drop in reverse osmosis system.
PW-7 is a Randolph Austin Mode1880 Vari-Flow peristaltic pump that is constructed
from 316 stainless steel with speed and flow controls. The pump produces a flow rate of
76 Llmin at 25°C, and has a power requirement of 1 hp. The purchase cost of the pump
is $5250 quoted by Mr. Mike Milson, a representative from Randolph Austin Company.
(see specification page 141 and appendix page 387)

Reverse Osmosis System (RO-I)
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The reverse osmosis system RO-I is a high-pressure membrane filter that is used
to separate low molecular weight molecules out of the feed stream. Sa salts, bacteria, and
other organic molecules are removed from the water stream WI08 that enters RO-I
system at 25°C, The water is produced at a rate of 13800 gal/day. The reverse osmosis
system is capable of working in the pH range from 4-11 and a temperature range of 1-45
0C, The pressure drop across the system is 20 psi. In addition, the system is also

equipped with a 1.5 hp pump and a 5 Jlm filter - to facilitate the flow within the system
and to protect it form large particles that could damage the membrane. RO-l is
constructed from thin film composite. In the model we are using, there are 6 membranes
that are each 4 x 40 inches. The electricity requirements of the system are 220 V, and 7.5
maximum Amps. The total power requirements per year for the system is 4474 kW*hr.
According to Ms. Diane Dolan, the sales manager at Ameriwater Company the purchase
cost is approximately $22500. (see specification page 142 and appendix page 374)

Storage Tank (TW-l)
Water from RO-I is stored in the Storage tank (TW-I) for future use in the 2
process trains. The horizontal tank is constructed from 4000 polyethylene, and has the
capacity of 50000 L The purchase cost for TW -1 is approximately $3554 as quoted by
Ms. Diane Dolan, the sales manager at Ameriwater. Note that this price does not include
freight. (see specification page 143)

Ultraviolet Light System Pump (PW-4)

Unit Descriptions
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The function of ultraviolet light system pump PW -4 is to increase the pressure in
stream W 11 0 from 14.7 psi to 19.7 psi in order to compensate the pressure drop in UV-1.
PW-4 is a Randolph Austin Model 780 Vari-flow peristaltic pump that is constructed
from 316 stainless steel and has speed and flow controls. The pump is capable of
producing a flow rate of23 Llmin (6 gal/min) at 25°C and has a power requirement of
0.25 hp. The purchase cost of the pump is $2656 as quoted by Mr. Mike Milson, the
salesperson at Randolph Austin. (see specification page 144 and appendix page 387)

Ultraviolet Light System (UV-1)
In order to prevent contamination of any of the process trains, the water in TW-1
is recirculated through an ultraviolet light system that continuously purifies the water.
Water from stream WIll enters the purifier and flows into the annular space between the
quartz sleeve and the outside chamber wall. Within the chamber, water is exposed to
intense germicidal UV radiation. UV-l can produce 23 Llmin (6 gal/min) of purified
water with a pressure drop at this flow rate of 5 psi. The Atlantic Ultraviolet Corporation
recommends that the maximum operating pressure of the lamp should not exceed 100 psi.
The power consumption ofthe UV lamp is 21 W. It also has the effective life of
10000 hours, and maximum rated output at 254 nanometers. The purchase cost of UV-l
as quoted by Ms. Diane Dolan of Ameriwater Company is $1567. (see specification page
145 and appendix page 384)

0.2 gm Microfilter Pump (PW-5)

92

Generic tPA

Unit Descriptions

The function of 0.2 !lm micro filter pump PW-5 is to increase the pressure in
stream WI 13 from 14.7 psi to 24.7 psi in order to compensate the pressure drop in FW-4.
PW-5 is a Randolph Austin model 780 Vari flow peristaltic pump is constructed from
316 stainless steel with speed and flow controls. The pump is capable of producing 30
Llmin (8 gal/min) flow rate at 25°C and has a power requirement of 0.25 hp. The
purchase cost ofthe pump is $2656 as quoted by Mr. Mike Milson, the salesperson of
Randolph Austin Company. (see specification page 147 and appendix page 387)

0.2

fJ,m

MicrofiIter (FW-4)

The 0.2 jlm Microfilter FW-4 is used to remove particles that may be left in water
of stream Wl14 before it enters the fermentors. Water in storage tank can settle out
particles and ions that must be removed before it enters the process. Therefore, FW-4 acts
as the last line of protection to ensure that the water produced is uncontaminated. The
size ofthe filter pore is 0.2 jlm. The flow rate through the filter is 18 Llmin (5 gal/min)
and the pressure drop is 10 psi. The filter is constructed from high-purity polypropylene.
The filter will be replaced after every batch and costs $44 per filter cartridge. (see
specification page 147 and appendix page 389)

Final Pump (PW-6)
After FW-4, purified water in stream Wl15 will flow through final pump (PW-6)
to increase the pressure from 14.7 psi to 34.7 psi in order to compensate the pressure drop
along the pipe. PW-6 is a Randolph Austin Model 880 Vari flow peristaltic pump that is
constructed from 316 stainless steel with speed and flow controls. The pump is capable of

Generic tPA

Unit Descriptions

producing a flow rate of 18 Llmin (5 gal/min) flow rate at 25°C and has a power
requirement of 1 hp. The purchase cost of the pump is $5250 as quoted by Mr. Mike
Milson, the salesperson at Randolph Austin. (see specification page 148 and appendix

page 387)
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40L FERMENTOR (BR-l)
6

FUNCTION: Batch reactor used to grow CHO Cells up to a density of3.0 '" 10 cells/mL to be used to
inoculate BR-2.

TYPE: New Brunswick Scientific BioFlo 5000 Fennentor with Conventional Heating Jacket

MATERIALS HAl'IlDLED:
Component
Complete Media
Cellular Material
Compressed Air
CO 2

Quantity per batch
30 L
3.5 kg
0.3 kglbatch (3% of one tauk)
0.025 kglbatch (0.1 % of one tauk)

CHARACTERISTICS:

Diameter:
Height:
Volume:
Working Capacity:
Material:
Agitator:
Insulation:

0.3m
0.6m
40L
30L
316 Stainless Steel
6-Blade Stainless Steel standard Marine Blade
2 in of Fiberglass Insulation

OPERATING CONDITIONS:

Temperature:
Pressure:
pH:
Compressed Air Flow Rate:
C02 Flow Rate (% of total air flow):
Agitator Speed:
Power Requirements:
Utility Cost/year
Sterilization:

37°C
14.7 psi
7.3
0.003 kglhr
0.0002 kglhr (5%)
10-30 rpm
1.5 hp
$355.00
Flush with water and Steam in Place at 130°C for 2
hours

PURCHASE COST: $85,000.00
REFERENCE PAGES: 54,225-230,232,244,254
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400L FERMENTOR (BR-2)
FUNCTION: Batch reactor used to grow CHO Cells up to a density of3.0
inoculate BR-3.

* 106 cells/mL to be used to

TYPE: New Brunswick Scientific custom-built 400 L bioreactor with Conventional Heating Jacket

MATERIALS HANDLED:
Component
Complete Media
Cellular Mass
Compressed Air
CO 2

Quantitv per batch
300 L
35.0 kg
4.5 kglbatch (50% of one tank)
0.33 kglbatch (2% of one tank)

CHARACTERISTICS:
Diameter:
Height:
Volume:
Working Capacity:
Material:
Agitator:
Insulation:

0.6m
1.2 m
400L
300L
316 Stainless Steel
6-Blade Stainless Steel Marine Blade
2 inch Fiberglass Insulation

OPERATING CONDITIONS:
Temperature:
Pressure:
pH:
Compressed Air Flow Rate:
C02 Flow Rate (% of total):
Agitator Speed:
Power Requirements:
Utility Cost/year
Sterilization:

PURCHASE COST: $125,000.00
REFERENCE PAGES: 57,231,232,243,254

37°C
14.7 psi
7.3
0.3 kg Ihr
0.02 kglhr (5%)
10-30 rpm
5 hp
$1180.00
Flush with water and Steam in Place at 130°C
for 5 hours
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5000 L FERMENTOR (BR-3)
FUNCTION: Batch reactor used to grow a CHO Cell-Line that produces the product protein tPA.

TYPE: New Brunswick Scientific custom-built 5000 L bioreactor with 4" half pipe Heating Jacket

MATERIALS HANDLED:
Component
Complete Media
Cellular Mass
Compressed Air
CO 2

Quantity per batch
4000L
460 kg
69.5 kg/batch (7 tanks)
5.5 kg/batch (0.25% of one tank)

CHARACTERISTICS:
Diameter:
Height:
Volume:
Working Capacity:
Material:
Harvest Pump:
Agitator:
Insulation:

1.5 m
3.0m
5000 L
4000 L
316 Stainless Steel
Peristaltic Harvest Pump
6-Blade Stainless Steel Marine Blade
2 inch Fiberglass Insulation

OPERATING CONDITIONS:
Temperature:
Pressure:
pH:
Compressed Air Flow Rate:
C02 Flow Rate (% of total air flow):
Agitator Speed:
Agitator Power Requirements:
Pump Power Requirements:
Utility Cost/year
Sterilization:

37°C
14.7 psi
7.3
0.3 kg lhr
0.025 kglhr (5%)
10-30 rpm
10 hp
5 hp
$3543.00
Flush with water and Steam in Place at 130°C
for 5 hours
•

PURCHASE COST: $225,000.00
REFERENCE PAGES: 59,231,232,233-242,254
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HEAT EXCHANGER (HX-l)
FUNCTION: Bring the temperature of the Media from 4 °C up to 38°C using warm water on the shell
side.

TYPE: Shell and Tube

MATERIALS HANDLED:
Component
Water
Complete Media

Flow Rates
2.2* 10 3 kglhr
455 kglhr

CHARACTERISTICS:
Heat Transfer Coefficient:
Heat Transfer Area:
No. of Tube Passes:
No. of Shell Passes:
Number of Tubes:
Nominal Outside Diameter:
Pitch:
Flow Direction:
Material:

75 BTUIhr*ft2*F
11.5 if

1
1
18
0.75 in
1.25 in, Square
Countercurrent
316 Stainless Steel

OPERATING CONDITIONS:
SHELL SIDE:
Pressure:
Temperature In:
Temperature Out:

29.7 psi
55°C
48°C

TUBE SIDE:
Pressure:
Temperature In:
Temperature Out:

29.7 psi
4°C
38 °C

Heat Duty:
Sterilization:

PL"RCHASE COST: $6500.00
REFERENCE PAGES: 62, 245-249

6.2* 10 4 BTUIhr
Flush with water and Steam in Place at 130°C for 2
hrs.
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BLENDING TANK (T-l)
FUNCTION: Mix Powdered Media and Sterile water for use in BR-l, BR-2, and BR-3.

TYPE: Walker Stationary Blending Tank with 6-blade Rushton agitator

MATERIALS HANDLED:
Component
Sterile Water
Media (powder)

Quantity per batch
4500 L
Powder equivalent to make 4500L of liquid media

CHARACTERISTICS:

Diameter:
Height:
Volume:
Capacity:
Retention Time:
Material:
Cooling Coils:
Refrigerator:

1.5 m
3.0m
5000L
4500 L
7 Days
316 Stainless Steel
2 in Copper Tubing
Standard freon refrigeration unit

OPERATING CONDITIONS:

Inlet Water Temperature:
Outlet Water Temperature
Pressure
Outlet Flow:
Agitator Speed:
Cooling duty:
Agitation Motor Power Requirements:
Refrigerator Energy Requirements:
Utility Cost per year (total):
Sterilization:

20°C
4°C
14.7 psi
2 gal/min
50 rpm
8 tons (95386 BTU/hr)
10 hp
63360 kW*hr
$4896.00
Flush with water and Steam in Place at 130°C for 2
hrs.

PURCHASE COST: $40,658.00
REFERENCE PAGES: 62, 250-252, 254-255
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FILTER PUMP (P-l)
FUNCTION: To pump the media from the blending tank through the 2.0J,t filter.

TYPE: Peristaltic

MATERIALS HANDLED:

Component

Quantity per batch

Complete Media

4500L

CHARACTERISTICS:
Material:
Length:
Width:
Height:

316 Stainless Steel
17 % in.
13 3/8 in.
7314 in.

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Cost/yr:
Sterilization:

4°C
14.7 psi
29.7 psi
2 gal/min
80%
0.25 hp
$59.00
Flush with water and Steam in Place at 130°C for 30

min

PURCHASE COST: $1595.00
REFERENCE PAGES: 65, 253, 256-259

10
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FILTER PUMP (P-2)
FUNCTION: To pump the media from F-l through F-2.

TYPE: Peristaltic

MATERIALS HANDLED:
Component
Complete Media

Quantity per batch
4500 L

CHARACTERISTICS:
Material:
Length:
Width:
Height:

316 Stainless Steel
17 y. in.
13 3/8 in.
73/4 in.

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Costlyr:
Sterilization:

4°C
14.7 psi
29.7 psi
2 gal/min
80%
0.25 hp
$59.00
Flush with water and Steam in Place at 130°C for 30
min

PURCHASE COST: $1595.00
REFERENCE PAGES: 65,253,256-259
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HEAT EXCHANGER PUMP (P-3)
FUNCTION: To pump the media through the heat exchanger and into the three bioreactors.

TYPE: Peristaltic

MATERIALS HANDLED:
Component
Complete Media

Quantity per batch

4500L

CHARACTERISTICS:
Material:
Length:
Width:
Height:

316 Stainless Steel
17 Y4 in.
13 3/8 in.
7 Y. in.

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Costlyr:
Sterilization:

37°C
14.7 psi
29.7 psi
2 gal/min

80%
0.25 hp
$59.00
Flush with water and Steam in Place at 130 °c for 30

min

PURCHASE COST: $1595.00
REFERENCE PAGES: 65, 253, 256-259
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CELL BROTH PUMP - 1 (P-4)
FUNCTION: To pump the cell broth from BR-l to BR-2.

TYPE: Peristaltic

MATERIALS HANDLED:
Component

2!!!!ntity per batch

Cell Broth

30 L

CHARACTERISTICS:
Material:
Length:
Width:
Height:

316 Stainless Steel
17 y.. in.
13 3(8 in.
7314 in.

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Costlyr:
Sterilization:

37°e
14,7 psi
29,7 psi
2 gal/min
80%

0.25 hp
$59.00
Flush with water and Steam in Place at 130°C for
30 min

PUR,CHASE COST: $1595.00
REFERENCE PAGES: 66, 253, 256-259
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CELL BROTH PUMP - 2 (P-5)
FUNCTION: To pump cell broth from BR-2 to BR-3.

TYPE: Peristaltic

MATERIALS HANDLED:
Component
Cell Broth

Quantity per batch
300 L

CHARACTERISTICS:
Material:
Length:
Width:
Height:

316 Stainless Steel
17 lj., in.
13 3/8 in.
73/4 in.

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Cost/yr:
Sterilization:

37°C
14.7 psi
29.7 psi
2 gal/min
80%
0.25 hp
$59.00
Flush with water Steam in Place at 130°C for 30
min

PURCHASE COST: $1595.00
REFERENCE PAGES: 65, 253, 256-259
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WATER JACKET PUMP (P-6)
FUNCTION: To pump water through a half pipe heating jacket surrounding BR-3.

T1"PE: Peristaltic

MATERIALS HANDLED:
Component
Water

Flow Rate
0.2 0.09 kg/sec

CHARACTERISTICS:
Material:
Length:
Width:
Height:

316 Stainless Steel
17 ~ in.
13 3/8 in.
7314 in.

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Costiyr:
Sterilization:

38°C
14.7 psi
29.7 psi
0.2 • 0.09 kg/sec
80%
0.25 hp
$59.00
Flush with water and Steam in Place at 130°C for 30
min

PURCHASE COST: $1595.00
REFERENCE PAGES: 67, 253, 256-259

1
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HEAT EXCHANGER WATER PUMP (P-7)
FUNCTION: To pump water through a recycle stream that passes through the shell side of the HX-l.

TYPE: Corcoran Company mode13000D-HDI centrifugal pump

MATERIALS HA.1'\lDLED:
Component
Water

Flow Rate
17 gal/min

CHARACTERISTICS:
Material:
Length:
Height:

316 Stainless Steel
1.5 feet
I foot

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Volumetric Flow Rate:
Pump Efficiency:
Power Requirement:
Utility Costlyr:

40°C
14.7 psi
29.7 psi
17 gal/min
80%
2 hp
$59.00

PURCHASE COST: $3250.00
REFERENCE PAGES: 67, 253, 260-261
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MEDIA FILTER (2~) F-l
FUNCTION: Filter out particles larger than 2 f.I in the prepared media and prevent clogging
of the 0.2 )l filter F-2.

TYPE: Osmonics Flotrex-AP Filter with 2 f.I absolute rating

MATERIALS HANDLED:
Component
Complete Media

Quantity per batch
4500L

CHARACTERISTICS:
Material:
Pore Size:
Diameter:
Length:
Filtration Area:

Polypropylene Fiber
2.0 !l
2.75 in
10 in
5.2 m 2

OPERATING CONDITIONS:
Temperature:
Pressure In:
Pressure Out:
Pressure Drop:
Volumetric Flow Rate:
Filters per Batch
Sterilization:

4°C
29.7 psi
14.7 psi
15 psi
2 galfmin
1
Flush with water and Steam in Place at 130°C for 30
min

PURCHASE COST: S32.00/carteriage
REFERENCE PAGES: 69, 262, 263-266
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MEDIA FILTER (O.2J.l) F-2
FUNCTION: Filter out particles larger than 0.2 "'" in the prepared media.

TYPE: Osmonics Memtrex-FE Filter with 0.2 "'" absolute rating

MATERIALS HANDLED:
Component
Complete Media

Quantity per batch
4500L

CHARACTERISTICS:

Material:
Pore Size:
Diameter:
Length:

PTFE Membrane
0.2 "'"
2.75 in
10 in

OPERATING CONDITIONS:

Temperature:
Pressure In:
Pressure Out:
Pressure Drop:
Volumetric Flow Rate:
Filter Cartridge Life:
Sterilization:

4"C
29.7 psi
14.7 psi
15 psi
2 gal/min
1 batch
Flush with water and Steam in Place at 130 "C for 30
mm

PURCHASE COST: $44.00/carteriage
REFERENCE PAGES: 70,262,267-270
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FERMENTOR AIR FILTERS (O.2g) F -3 - F -8
FUNCTION: Filter out particles larger than 0.2 J.l in the compressed air and CO2 that is sparged into the
base of the fermentors and filter the exhaust gasses from the bioreactors ..

TYPE~

Osmonics Memtrex-FE Filters with 2 J.l absolute rating

MATERIALS HANDLED:

Component
Compressed Air
CO 2

Quanti!YJ!~!:.batch

0.03 - 6.65 tanks
0.001 0.015 tanks

CHARACTERISTICS:
Material:
Pore Size:
Diameter:
Length:

PTFE Membrane
0.2 J.l
2.75 in
lOin

OPERATING CONDITIONS:
Temperarure:
Pressure Drop
Flow Rate:
Life Span of Filter
Sterilization:

4°C
2 psi
0.025 - 0.35 kg/hr
113 batch
Flush with water and Steam in Place at 130°C for
30 min

PURCHASE COST: $44.00 per filter
REFERENCE PAGES: 68, 262,267-270
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STEAM BOILER (B-1)
FUNCTION: Produce the Steam from sterile water for use in the entire plant.

TYPE: Standard Natural Gas fueled boiler with sanitary piping and fIxtures

MATERIALS HANDLED:

Component

Amount Heated per Hour

Sterile Water

500 LIhr

CHARACTERISTICS:
Capacity:
Material:

500 LIhr
316 Stainless Steel

OPERATING CONDITIONS:
Inlet Water Temperature:
Outlet Steam Temperature:
Pressure
Natural Gas Consumption:
Boiler Efficiency:

20°C
130 °C
39.16 psi
54.5lblhr
85%

PURCHASE COST: $112,000
REFERENCE PAGES: 71,279-281
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HOLDUP TANK
FUNCTION: Provide a place to keep bioreactor effluent if Centrifuge is down.

TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HANDLED:
Component
CHO cells
Media
TPA

Quantity per batch
457 kg
3565 L
2.16 kg

CHARACTERISTICS:
.
.
Capacity:
Height:
Diameter:
Material:

5000 L

3m

Um
316 Stainless Steel

OPERATING CONDITIONS:
Pressure:
Temperature:
Storage time:

14.7 psi
22°C
Only when Centrifuge is down.

CIP by flushing with a vessel volume of water, followed by a SIP cycle. This unit will probably never be
used because the centrifuge was quoted as very reliable. We included this tank because it is important to
remove 4000L Bioreactor contents promptly to eliminate process down time if something happens to go
wrong with the Centrifuge.

PURCHASE COST: $19,000
REFERENCE PAGE~-=. 72, 365
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UFITANK
FUNCTION: Blend arginine to a concentration of 1M and store at 4°C until needed. Act as a recycling
tank for UFI.

TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HANDLED:
Component
Media
Arginine
Tpa

Quantity per batch
3565 L
850 kg
2.05 kg

CHARACTERISTICS:
Capacity:
Height:
Diameter:
Material:

4000L
2.7m
104m

316 Stainless Steel

OPERATING CONDITIONS:
Pressure:
Temperature:
Arginine input:
Storage time:

14.7 psi
4°C
850 kg
Approx. 14 hrs. (overnight)

CIP by flushing with a vessel volume of water, followed by a SIP cycle.

PURCHASE COST: $17,000
REFERENCE PAGES: 73, 365
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UF2TANK
FUNCTION: Blend arginine to a concentration of 2M and store at 4°C until needed. Act as a recycling
tank for UF2.
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HANDLED:

Component
Media
Arginine
Tpa

Quantitv per batch
200L
115 kg
1.94 kg

CHARACTERISTICS:
Capacity:
Height:
Diameter:
Material:

400 L
l.3m
0.6m
316 Stainless steel

OPERATING CONDITIONS:
Pressure:
Temperature:
Arginine input:
Storage time:

14.7 psi
4°C
67.4 kg
Negligible unless UF2 is down

CIP by flushing with a vessel volume of water, followed by a SIP cycle.

PURCHASE COST: $10,000
REFERENCE PAGES: 73,365
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AFFINITY TANK
FUNCTION: Store UF2 filtrate at 4 "C before it is run through Affmity column. Each batch is split into
four equal volumes and applied to the column.

TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HANDLED:
Component
Media
Arginine

tPA

Quantity per batch
196 L
112.9 kg
1.89 kg

CHARACTERISTICS:

Capacity:
Height:
Diameter:
Material:

400 L
1.3m

0.6m
316 Stainless steel

OPERATING CONDITIONS:

Pressure:
Temperature:
Storage time:

14.7 psi
4°C
48 hrs

CIP by flushing with a vessel volume of water, followed by a SIP cycle.

PURCHASE COST: $10,000
REFERENCE PAGES: 73, 365
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ERTANK
FUNCTION: Store Affinity column elution at 4°C, increase pH to 7.0 with NaOH, and input 0.0258 kg
sucrose.
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HANDLED:
Component
WFI
Arginine
Glycine
Sucrose
1M NaOH
tPA

Quantity per batch
219L
175 kg
8.7 kg
0.026 kg
0.33 L
1.6 kg

CHARACTERISTICS:
Capacity:
Height:
Diameter:
Material:

400L
1.2 m
0.6m
316 Stainless steel

OPERATING
CONDITIONS:
_
....

Pressure:
Temperature:
NaOH input:
Sucrose input:
Storage time:

14.7 psi
4°C
0.33 L
0.026 kg
Negligible unless UF2 is down

CIP by flushing with a vessel volume of water, followed by a SIP cycle.

PURCHASE COST: $10,000
REFERENCE PAGES: 74, 365
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MFTANK
FUNCTION: Input 59 L WFI and store contents at 4°C.

TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HANDLED:
Component
WFI
Arginine
tPA
NaOH
Glycine
Sucrose

Quantity per batch
278 L
175 kg
1.6 kg
0.013 kg
8.7 kg
0.026 kg

CHARACTERISTICS:
Capacity:
Height:
Diameter:
Material:

500 L
1.4 m
0.7m
316 Stainless steel

OPERATING CONDITIONS:
Pressure:
Temperature:
WFI input:
Storage time:

14.7 psi
4°C
59 L
Negligible unless UF2 is down

CIP by flushing with a vessel volume of water, followed by a SIP cycle.

PURCHASE COST: $11,000
REFERENCE PAGES: 74, 365
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FDTANK
FUNCTION: Store MF filtrate at 4 °C before bottling. Each batch is split and bottled in five equal
volumes and freeze dried in the bottles in five batches.
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment

MATERIALS HA!~DLED:
Component
WFI
Arginine
tPA
NaOH
Glycine
Sucrose

Quantity per batch
278 L
175 kg
1.6 kg
0.013 kg
8.7 kg
0.026 kg

CHARACTERISTICS:
Capacity:
Height:
Diameter:
Material:

500L
1.4 m
0.7m
316 Stainless steel

OPERATING CONDITIONS:
Pressure:
Temperature:
Storage time:

14.7 psi
4°C
146 hrs

CIP by flushing with a vessel volume of water, followed by a SIP cycle.

PURCHASE COST: $11,000
REFERENCE PAGES: 74, 365
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CENTRIFUGE
FUNCTION: Separate CHO cells from harvest media.

TYPE: CSC 4 Clarifier, In-steam sterilizable from Westfalia Separator

MATERIALS HANDLED:
Component
CHO cells
Media
TPA

Quantity per batch
457 kg
3565 L
2.16 kg

CHARACTERISTICS:

Bowl Volume:
Bowl Speed:
Weight:
Material:

1.8L
approx. 10,000 rev/min
approx. 230 kg
Cr-Ni-Mo stainless steel

OPERATING CONDITIONS:

Rated capacity:
Maximum pressure:
Entering cell broth temperature:
Centrifuge temperature:
Cell removal:
Equipment uptime per batch:
tP A lost per run

400 LIhr
approx. 73.5 psi
37°C
4°C (room is at 4 0c)
100%
<10hr

5%

To be cleaned after each run with NaOH solution for 20-30 minutes. Followed by SIP.

PURCHASING COST: $355,000
REFERENCE PAGES:_75, 297-302, 367
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UFI PUMP
FrNCTION: Increase pressure ofUFI Tank contents to 40 psi.

TYPE: Peristaltic, Series 750-362; Randolph Austin Company

MATERIALS HAl~DLED:
Component
Media
Arginine
tPA

Quantity per batch
3565 L
850kg
2.05 kg

CHARACTERISTICS:
Material:

316 Stainless steel

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Volumetric flow rate:
Efficiency:
Power Requirement:
Equipment uptime per batch
Utility CostJyr

14.7 psi
40 psi
4°C
828 LIhr
80%
49W
6.09 hr
$16

PURCHASE COST: $2,656
REFERENCE PAGES: 76, 256-259, 366
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UF2PUMP
FUNCTION: Increase pressure ofUF2 Tank contents to 40 psi.

TYPE: Peristaltic, Series 750-362; Randolph Austin Company

MATERIALS HANDLED:
Component
Media
Arginine
tPA

Quantity per batch
200L
115 kg
1.94 kg

CHARACTERISTICS:
Material:

316 Stainless steel

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Volumetric flow rate:
Efficiency:
Power Requirement:
Equipment uptime per batch:
Utility Costlyr

14.7 psi
40 psi
4°C
1325 LIhr
80%
79W
<1 hr
$25

PURCHASE COST: $2,656
REFERENCE PAGES: 77, 256-259, 366
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MFPUMP
FUNCTION: Increase pressure ofMF Tank contents to 34.7 psi.

TYPE: Peristaltic, Series 610-362; Randolph Austin Company

MATERIALS HANDLED:
Component

WFI
Arginine
tPA
NaOH
Glycine
Sucrose

Quautity per batch
278 L
175 kg
1.6 kg
0.013 kg
8.7 kg
0.026 kg

CHARACTERISTICS:
Material:

316 Stainless steel

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Volumetric flow rate:
Efficiency:
Power Requirement:
Equipment uptime per batch:
Utility Costlyr

14.7 psi
34.7 psi

4°C
1140 LIhr
80%
53.27W
0.25 hr
$17

PURCHASE COST: $2,656
REFERENCE PAGES: 77, 256-259, 366
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AFFINITY SKID/PUMP
FUNCTION: Increase pressure of Affinity column inputs to 15.9 psi and control the volume of
equilibration and elution buffers used.

TYPE: Peristaltic pump with computer

MATERIALS HANDLED:
Component
Media
WFI

Arginine
Glycine
PBS
NaCI
tPA

Quantity per batch
196 L
285 L
126 kg
11.3 kg

1710 L
66 kg
1.89 kg

CHARACTERISTICS:
Material:

316 Stainless steel

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Volumetric flow rate:
Efficiency:
Power Requirement:
Equipment uptime per batch:
Utility Costlyr

15.9 psi
14.7 psi
4°C
135 LIhr
80%
0.4 W
12 hr

$1

PURCHASE COST: $100,000*
REFERENCE PAGES: 77,256-259,366
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ER SKID/PUMP
FUNCTION: Increase pressure of ER Tank contents to 16.6 psi.

TYPE: Peristaltic pump with computer

MATERIALS HANDLED:

Component

~antity

WFI
Arginine
Glycine
1M NaOH

266 L
9.96 kg
8.7kg
193 L
1.6 kg

tPA

per batch

CHARACTERISTICS:
Material:

316 Stainless steel

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Volumetric flow rate:
Efficiency:
Power Requirement:
Equipment uptime per batch:
Utility Costlyr

14.7 psi
16.6 psi

4°C
11 LIhr
80%
0.3 W
32 hr

negligible

PURCHASE COST: $100,000*
REFERENCE PAGES: 77, 256-259, 366
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UFI
FUNCTION: Concentrate tPA to a volume of approximately 200 L.

TYPE: Tangential flow filter, PM50 Hollow fiber cartridge; Koch Membrane Systems

MATERIALS HANDLED:

Component

Quantity per batch

Media
Arginine
tPA

3565 L
850 kg
2.05 kg

CHARACTERISTICS:
Diameter:
Length:
Membrane area:
MWCO;
Material:

3 in.
25 in.
14 ftz
50kDa
Polysulfone

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Pressure drop:
Temperature:
Mean flux (filtrate flow rate):
Split ratio (retentate/filtrate):
Filter cartridge life:
tPA lost per run

40 psi
30 psi
10 psi

4°C
550 LIhr
0.06
One year
2%

Retentate stream is split and recycled to UFI Tank where it again flows through the filter. Flow is
controlled using a ratio-flow controller.

PURCHASE COST: $785/cartridge
REFERENCE PAGES: 79, 303-313
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UF2
FUNCTION: Remove remaining components larger than 500 kDa that could damage or inhibit flow
through the affinity column.
TYPE: Tangential flow filter, PM500 Hollow fiber cartridge; Koch Membrane Systems

MATERIALS HANDLED:

Component
Media
Arginine
tPA

Quantitv per batch
200L
115 kg
1.94 kg

CHARACTERISTICS:
Diameter:
Length:
Membrane area:
MWCO:
Material:

3 in.
25 in.
14 ft2
500 kDa
Poly sulfone

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Pressure drop:
Temperature:
Mean flux (filtrate flow rate):
Filter cartridge life:
tPA lost per run

40 psi
30 psi
10 psi

4°C
880 LIhr
One year
5%

Retentate stream is recycled to UF2 Tank where it again flows through the filter. Entire volume ofUF2
Tank is collected as filtrate.

PURCHASE COST: $950/cartridge
REFERENCE PAGES: 81, 303-313
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MF
FUNCTION: Filter and sterilize final product stream before freeze drying.

TYPE: Tangential flow filter, 0.2 11m filter; Osmonics

MATERIALS HANDLED:
Component

WFI
Arginine

tPA
NaOH
Glycine
Sucrose

Quantity per batch
278 L
175 kg
1.6 kg
0.0l3 kg
8.7 kg
0.026 kg

CHARACTERISTICS:
Diameter:
Length:
Membrane area:
Pore size:
Material:

2.75 in.
10 in.
9 ft 2
0.2 11m
PTEF Membrane

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Pressure drop:
Temperature:
Max flow rate:
Filter cartridge life:
tPA lost per run

40 psi
20 psi
20 psi

4°C
1140 LIhr
One batch
1%

PURCHASE COST: $44!cartridge
REFERENCE PAGES: 81,267-270
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AFFINITY COLUMN
FUNCTION: Separate tPA from Affinity tank contents.

TYPE: Bioprocess stainless steel column; Amersham Pharmacia Biotech

MATERIALS HA."lULED:
Component
Media

WFI
Arginine
Glycine
PBS
NaCI
tPA

Quantity per batch
196L
285 L
340 kg
11.3 kg
1709 L
66.2 kg
1.89 kg

CHARACTERISTICS:
Column volume:
Bed volume:
Bed Height:
Diameter:
Resin:
Void volume:
Materials:

58 L
58 L
15 cm
70cm
CNBr-activated Sepharose 4 Fast Flow
20.2 L
316 Stainless steel

OPERATING CONDITIONS:
Superficial velocity:
Volumetric flow rate:
Pressure drop:
Temperature:
Load volume:
Equilibration volume:
Elution volume:
Wash volume:
tP A lost per run:
Equipment uptime per batch:

PURCHASE COST: $100,000*
REFERENCE PAGES: 82, 314-328

100 cmlhr

135 LIhr
1.2 psi

4°C
One quarter of Affinity tank contents
2.5 bed volumes (145 L)
1.3 bed volumes (75 L)
5 bed volumes (289 L)
15%
48 hrs
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AFFINITY RESIN
FUNCTION: Provide matrix to hold anti-tPA antibody.

TYPE: CNBr-activated Sepharose 4 Fast Flow; Amersham Pharmacia Biotech

MATERIALS HANDLED:
Component

Quantity per batch

Media
WFI
Arginine
Glycine
PBS
NaCI

196 L
285 L
340 kg
11.3 kg
1709 L
66.2 kg
1.89 kg

tPA

CHARACTERISTICS:
Bed volume:
Height:
Diameter:
Bead size:
Void volume:
Materials:

58 L
15 cm
70 cm
90 )lm
20.2 L
Highly cross-linked 4% agarose, spherical

OPERATING CONDITIONS:
Superficial velocity:
Volumetric flow rate:
Pressure drop:
Temperature:
Antibody binding:
Resin utilization:
Equipment uptime per batch:

100 cmlhr
134.6 LIhr
1.2 psi
4 DC
12.3mg AB/mL resin
85%
48 hrs

Store in 20% ethanol between batches.

PURCHASE COST: $350,000/year
REFERENCE PAGES: 82, 314-328
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ERCOLUMN
FUNCTION: Remove endotoxins from Affinity column elution.

TYPE: Bioprocess glass column 200/500; Amersham Pharmacia Biotech

l\'lATERIALS HANDLED:
Component

Quantity per batch

WFI
Arginine
Glycine
Sucrose
1M NaOH
tPA

266 L
175 kg
8.7 kg
0.026 kg
193 L
1.6 kg

CHARACTERISTICS:
Column volume:
Bed volume:
Bed Height:
Diameter:
Resin:
Void volume:
Materials:

15.7 L
8.2 L
26cm
20cm
Acticlean Etox
2.9 L
316 Stainless steel

OPERATING CONDITIONS:
Superficial velocity:
Volumetric flow rate:
Pressure drop:
Temperature:
Load volume:
Cleaning:
Regeneration volume:
tPA lost per run:
Equipment uptime per batch:

100 cmlhr
11.0 LIhr
1.9 psi
4°C
Entire volume of ER Tank contents
1M NaOH for 2 hrs
2 bed volumes (75 L)

5%
36hrs

PURCHASE COST: $6,190
REFERENCE PAGES: 84, 329-345
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ERRESIN
FUNCTION: Bind endotoxins while allowing tPA to flow through undamaged.

TYPE: Actic1ean Etox; Sterogene

MATERIALS HANDLED:
Component
WFI
Arginine
Glycine
Sucrose
1M NaOH

tPA

Quantity per batch
266 L
175 kg
8.7 kg
0.026 kg
193 L
1.6 kg

CHARACTERISTICS:
Bed volume:
Height:
Diameter:
Bead size:
Void volume:
Materials:

8.2 L
26cm
20cm
110!ID1
2.9 L
Actigel ALD; Sterogene

OPERATING CONDITIONS:
Superficial velocity:
Volumetric flow rate:
Pressure drop:
Temperature:
Endotoxin binding:
Cleaning:
Equipment uptime per batch:

100 cmlhr
11.0 LIhr
1.9 psi
4°C
200 - 20,000 EU/mL resin
1M NaOH for 2 hrs
36 hrs

Store in WFI between batches.

PURCHASE COST: $87,OOO/year
REFERENCE PAGES: 84,329-345
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BOTTLER
FUNCTION: Load approximately 25 mL final product solution into 100 mL vials and partially stopper
them. Load vials onto freeze dryer trays.
TYPE: Model VR 840S, BT15, AW160; Cozzoli Machine Company

MATERIALS HANDLED:

Component
WFI
Arginine
tPA
NaOH
Glycine
Sucrose

Q!Jantitv per batch
278 L
175 kg
1.6 kg
0.013 kg
8.7 kg
0.026 kg

CHARACTERISTICS:
Vials volume:
Materials:

100mL
316 Stainless steel

CIP and SIP capability.

OPERATL1'IJG CONDITIONS:
Pressure:
Temperature:
Bottling time/3200 100 mL vials:
Volume loaded per vial:
Tray loading time:
Power requirements:
Equipment uptime per batch:
Utility costlyr:

14.7 psi
4°C
1hr
-25 mL (depends on tPA conc. in FD Tank)
1hr
1.5 hp total
146 hrs
$330

PURCHASE COST: $1,265,000
REFERENCE PAGES: 85, 346-349,367

132

Unit Spec Sheets

Generic tPA

FREEZE DRYER
FUNCTION: Remove \VFI from tPA and form a stable, solid product that can be dissolved and injected.

TYPE: Virtis Benchmark 6000 SQ Stoppering Lyophilizer

MATERIALS HANDLED:
Component

WFI
Arginine
tPA
NaOH
Glycine
Sucrose

Quantitv per batch
278 L
175 kg
1.6 kg
0.013 kg
8.7 kg
0.026 kg

CHARACTERISTICS:
Shelves:
100 mL vials per shelf:
Heat transfer medium:
Condenser Capacity:
Material:

9
396
Silicon fluid
220 liters H 20 in 24 ills
316 Stainless steel

OPERATING CONDITIONS:
Liters per cycle:
100 mL vials per batch:
Cycle time:
Standard shelf temperature:
Cooling water requirements:
Power requirements:
Equipment uptime per batch:
Utility costlyr

-80L
-3200 (depends on tPA conc. in FD tank)
24 ills
-55 c C
6 gal/min
Max 46.1 kW
146 ills
$13,500

SIP for 30 minutes after each cycle.

PURCHAS~

COST: $640,000

REFERENCE PAGES: 85,350-361,367

133

-----------------------~ ..-~..- . 

Unit

Generic tPA

Sheets

REFRIGERATOR
FUNCTION: Keep entire Separation Process at 4°C at all times.

TYPE: Air conditioning system

MATERIALS HANDLED:

Component
Refrigerant

Quantity required:
16.67 tons

CHARACTERISTICS:
Refrigerant requirements:
Area to be cooled:
Power rating:
Load factor:

1.25 tons refrigerant'300 ft2 of cooled space
4,000 ft2 for two separation trains
1 kW/ton refrigerant for Jow temperature cooling*
0.6*

OPERATING CONDITIONS:
Cooling time/yr
Power requirements:
Utility cost'yr:

8760 hrs
lOkW
$3,504

PURCHASE COST: $10,000*
REFERENCE PAGES: 87, 356
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INITIAL PUMP (PW-l)
FUNCTION: To bring city water into the water purification process

TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company

MATERIALS HANDLED:

Component

Quantity per Day

City Water:

50000 L

CHARACTERISTICS:
Dimension L x W x H:
Material:
Motor Horse Power:
Pump Speed:

29x 17x21 (inch)
316 Stainless Steel
1 hp
190 RPM

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Flow Rate:

14.7 psi
34.7 psi
25°C
35 Llmin

PURCHASE COST: $5,250
REFERENCE PAGES: 87, 369, 387-388
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10 f.lM MICROFILTER (FW-1)
FUNCTION: To separate particles in feed water before it enters the reverse osmosis system, and to
prevent unwanted particles from damaging the reverse osmosis system membrane.

TYPE: Tangential flow filter model Flotrex™-AP Filters Polypropylene Microfiber from Osmonics.

MATERIALS HANDLED:
Component
City Water:

Quantity per Day
50000 L

CHARACTERISTICS:

Cartridge Dimension:
Cartridge Dimension:
Length:
Membrane Area:
Pore Size:
Membrane Material:

2.75 inch (outside diameter)
1.25 inch (inside diameter)
10 inches
6.7 ft2
10 JlIll
Polypropylene

OPERATING CONDITIONS:

Temperature:
Water Flow Rate:
Filter cartridge life:
Pressure in:
Pressure out:

25°C
18 Llmin
One Batch
34.7 psi
14.7 psi

PURCHASE COST: $44 per cartridge per 10 inches equivalent
REFERENCE PAGES: 88,376,389-390
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CARBON FILTER PUMP (PW-2)
FUNCTION: To compensate pressure drop in the carbon filter.

TYPE: Peristaltic pump model No. 750-362 varied flow, speed control from Randolph Austin Company

MATERIALS HANDLED:
Component
City Water:

Quantity per Day
50000 L

CHARACTERISTICS:
Material:
Pump Horse Power:
Pump Speed:

316 Stainless steel
0.25 bp
12-500 RPM

OPERATING CONDITIQNS:
Pressure in:
Pressure out:
Temperature:
Volumetric Flow Rate:
Efficiency:

14.7 psi
26.7 psi
25°C
18 Llmin
80%

PURCHAS:E: COST: $2,656
REFERENCE PAGES: 88, 369-370, 387-388
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CARBON FILTER (FW-2)
FUNCTION: To remove chlorine and organic particles from feed water stream and to protect water
softener's resin, micro filter, and reverse osmosis system from degradation.

TYPE: Model WTTS16C Carbon Filter from Ameriwater.

MATERIALS HANDLED:
Component
Municipal City Water:

Quantity per Da~'
50000 Llday

CHARACTERISTICS:

Material:
Diameter:
Height:
Absorbent:
Absorbent Weight:

Polyethylene
42 inches
87 inches
Bituminous Coal
1000lbs

OPERATING CONDITIONS:

Flow Rate:
Water Temperature:
Pressure in:
Pressure out:
Max Contact Time:

76 Llmin
25°C
26.7 psi
14.7 psi
5.3 min

Empty bed contact time at design flow and a bed density of28 Ib/ft3.

PURCHASE COST: $1,515
REFERENCE PAGES: 88
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WATER SOFTENER (FW -3)
FUNCTION: To remove to unwanted ions from the feed water before it enters the reverse osmosis system.

TYPE: Model WTMD 16 meter initiated system from Ameriwater

MA TERIALS HANDLED:
Component
City Water:

Quantity per Day
50000 L

CHARACTERISTICS:

Resin Type:
Life of Resin:
Flow Rate:
Amount of Resin filled:
Outer Tank Shell Material:
Inner Tank Shell Material:

Polystyrene Sulfonate Cation
10 years
4 gallon I(min ft3)
7
Fiberglass
Polyethylene

fe

OPERATING CONDITIONS:

Pressure in:
Pressure out:
Temperature:
Flow Rate:

24.7 psi
14.7 psi
25°C
76 Umin

PURCHASE COST: $4,537
REFERENCE PAGES: 89, 377-383
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WATER SOFTENER PUMP (PW-3)
FUNCTION: To compensate pressure drop in the water softener

TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company

MATERIALS HANDLED:
Component
City Water:

Quantitv per Day
50000 L

CHARACTERISTICS:

Material:
Dimension L x W X H:
Pump Speed:
Pump Horse Power:

316 Stainless steel
29 x 17 x 21 (inch)
190 RPM
1 hp

OPERATING CONDITIONS:

Pressure in:
Pressure out:
Temperature:
Flow Rate:
Efficiency:

14.7 psi
24.7 psi
25°C
76 Llmin
80%

PURCHASE COST: $5,250
REFERENCE PAGES: 89, 370, 377-378
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REVERSE OSMOSIS PUMP (PW-7)
FUNCTION: To compensate the pressure drop across the reverse osmosis system.

TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company

MATERIALS HANDLED:
Component
City Water:

Quantity per Day
50000 L

CHARACTERISTICS:
Material:
Pump Speed:
Pump Horse Power:

316 Stainless steel
190 RPM
1 hp

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Flow Rate:
Efficiency:

14.7 psi
34.7 psi
25°C
76 Llmin
80%

PURCHASE COST: $5,250
REFERENCE PAGES: 90, 373, 387-388
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REVERSE OSMOSIS SYSTEM (RO-I)
FUCTION: The reverse osmosis system separates salts, organic molecules, and bacteria from feed water
stream.
TYPE: Model IR06 Open Skid Style System from Ameriwater.

MATERIALS HANDLED:
Component

Quantitv per day

City Water:

50000 L

CHARACTERISTICS:
Membrane Size:
Membrane Type:
Number of Membranes:
Pump Horse Power:
Electricity:
Dimension H x W x D:

4 x 40 (inch)
Thin Film Composite

6
1.5 hp
220 V 7.5 Maximum Amp
72 x 24 x 35 (inch)

OPERATING CONDITIONS:
Rated Capacity:
Production per Day:
Temperature:
Operating pH Range:
Pressure in:
Pressure out:
Pressure Feed Range (psi):
Cleaning pH Range:
Prefiltration:

36 Llmin
52000 L
25°C
4-11
34.7 psi
14.7 psi
20-80
2-11.5
5 flm

PURCHASE COST: $22,500
REFERENCE PAGES: 90, 371, 393-395
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STORAGE TANK (TW-l)
FUNCTION: To store excess purified water for various uses through out the plant.

TYPE: 4000 Polyethylene, horizontal holding tank.

MATERIALS HANDLED:
Component
Purified Water:

Quantity per Dav
50000 L

CHARACTERISTICS:

Capacity:
Height:
Diameter:
Material:

50000 L
140 inches
94 inches
4000 Polyethylene

OPERATING CONDITIONS:

PURCHASE COST: $3,554
REFERENCE PAGES: 91
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UV SYSTEM PUMP (PW-4)
FUNCTION: To compensate the pressure drop in the Ultraviolet Light system

TYPE: Peristaltic pump model 750-362 vari-flow speed control from Randolph Austin Company

MATERIALS HANDLED:
Component
Purified Water:

Quantity per Day
50000 L

CHARACTERISTICS:
Material:
Pump Horse Power:
Pump RPM:

316 Stainless steel
0.25 hp
12-500 RPM

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Volumetric flow rate:
Efficiency:

14.7 psi
19.7 psi
25°C
23 Llmin
80%

PURCHASE COST: $2,656
REFERENCE PAGES: 91, 372, 387-388
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ULTRAVIOLET LIGHT SYSTEM (UV-l)
FUNCTION: To prevent bacterial growth and to destroy particles fonned in the Storage tank.

TYPE: UV Lamp Model ~1inipure-MIN6, and Lamp No. 05-1370 from Atlantic Ultraviolet Corporation.

MATERIALS HANDLED:
Component
Purified Water:

Quantity per Day
50000 L

CHARACTERISTICS:
Material for chamber and hardware:
Lamp Power Consumption:
Rated Effective Life:
Dimension L x W x H:

304 Stainless steel
21 Watts
10000 Hours
23 x 5 x 6 (inch)

Maximum rated output at 254 nanometers

OPERATING CONDITIONS:
Pressure Drop at Max Flow Rate:
Pressure in:
Pressure out:
Max Operating Pressure:
Flow Rate:

5 psi
19.7 psi
14.7 psi
100 psi
23 Llmin

PURCHASE COST: $1,567
REFERENCE PAGES: 92, 384-386
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0.2 gM MICROFILTER PUMP (PW-5)
FUNCTION: To compensate the pressure drop in 0.2 !lI11 microfilter.

TYPE: Peristaltic pump model 750-362 vari-flow speed control from Randolph Austin Company

MATERIALS HANDLED:

Component
Purified Water:

Quantity per Day
50000 L/min

CHARACTERISTICS:
Material:
Pump Horse Power:
Pump Speed:

316 Stainless Steel
0.25 hp
12-500 RPM

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Flow Rate:
Efficiency:

14.7 psi
24.7 psi
25°C
30 Umin
80%

PURCHASE COST: $2,656
REFERENCE PAGES: 92, 373,387-388
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0.2 MICRON FILTER (PW-4)
FUNCTION: To separate newly formed particles before the purified water enters the process.

TYPE: Model Memtrex™-FE-S by Osmonics

MATERIALS HANDLED:
Component
Purified Water:

Quantitv per Dav
50000 L

CHARACTERISTICS:
Material:
Cartridge Dimension:
Cartridge Dimension:
Length:
Membrane Area:
Pore Size:

Polypropylene Membrane
2.75 inch (outside diameter)
1.25 inch ( inside diameter)
10 inch
9 ft'
0.2 micron

OPERATING CONDITIONS:
Pressure in:
Pressure out:
Temperature:
Flow Rate:

24.7 psi
14.7 psi
25°C
18 Llmin

PURCHASE COST: $44 per cartridge per 10 inches equivalent.
REFERENCE PAGES: 93,391-392
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FINAL PUMP (PW-6)
FUNCTION: To adjust the pressure within pipes so that the desired flow rate can be achieved.

TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company

MATERIALS HANDLED:

Component
Purified water:

Quantity per Day
50000 L

CHARACTERISTICS:
Material
Horse Power Required
Pump Speed
Dimension L x W x H:

316 Stainless Steel
1 hp
190 RPM
29 x 17 x 21 (inch)

OPERATING CONDITIONS:
Water Temperature:
Flow Rate:
Pressure in:
Pressure out:
Efficiency:

25°C
18 Llmin
14.7 psi
34.7 psi
80%

PURCHASE COST: $5,250
REFERENCE PAGES: 93, 373, 387-388
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Generic tissue plasminogen activator (tPA) has the potential to take a large
portion of the thrombolytic therapy market. Genentech's Activase™ and streptokinase
are currently the primary treatment methods for heart disease and related illness.
Genentech sells their product for about $2,000 per dose, while streptokinase is priced at
about $200 per dose. We aim to enter the market at about $500 per dose, and this will
allow us to sell to consumers for whom cost is not an issue and also to those who cannot
afford premium medications. Activase™ is so expensive because Genentech must make
up for the billions of dollars spent on research and clinical trials for its products; we will
not have to worry about those expensives in production of generic tP A.
Genentech currently sells about $300 MM a year of tPA in the U.S. The rest of
the world, primarily Europe and Japan, use much less tPA and relies upon the less
expensive streptokinase. We are estimating that the total worldwide sales oftPA are
$400 MMlyr. When patents run out, pharmaceutical companies can lose half of their
market share to generic versions of their drug. Given that we will be selling our drug for
a quarter of the Activase™ price, we are estimating that we can acquire half of the tPA
sales worldwide.
Many studies have been completed that compare the effectiveness oftPA and
streptokinase for the treatment of heart-related illnesses. When taking into account
quality oflife, one-year mortality, and long-term medical costs tPA was concluded to be
much a more cost-effective treatment compared to streptokinase, even with the large
difference in price (Kalish et aI, 1995). This study used data from a widely published
study entitled the Global Utilization of Streptokinase and Tissue Plasminogen Activator
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for Occluded Coronary Arteries (GUSTO). A questionnaire from the GUSTO-l trial was
also used in an analysis ofpatient preferences for thrombolytic therapy. When costing
was not an issue, tP A was preferred overall due to its lower mortality and fewer
occurrences of side effects. When costing was introduced to the decision, especially
under self-pay circumstances streptokinase became more preferred (Stanek et aI, 1997).
Obviously the high cost oftPA causes it to lose market share to streptokinase, so
lowering the price would increase its use in hospitals in less wealthy areas. Streptokinase
is used much more widely overseas, so we estimate U.S. sales to be approximately $50

MM/year and worldwide sales to be $150 MM/year, based on a discussion with Prof.
Diamond. Cost and availability are the primary reasons streptokinase is used instead of
tPA in the world; so selling it at the comparable price of$500/dose would allow us to
gain two-thirds of the streptokinase. Calculating half of the tPA market and two-thirds of
the streptokinase market leads us to a production number of about 76,000 doses each
year, or 76 kg/yr. This yields about $380 MMiyear in sales, and given our production
and start-up costs, generic tPA can be very profitable. A detailed description of our costs
is presented in the next sections.

Capital C~sts
Capital costs for our plant are just over $100 MM. These include the purchase of
equipment, installation and construction, working capital, and accounts receivable. The
cost of purchasing all of our equipment is about $5.4 MM; over 75% of this comes from
the Separation Trains, in particular the Bottlers, Freeze Dryers, and chromatography
columns (see Figure 9 on page 153). The remaining costs are derived from the
Fermentors and Centrifuge. A list of equipment costs is presented in Table 6 on page

.
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152. Installation costs are set at 200% of the total equipment costs ($10.8 MM), a high
estimate because we are using sanitary piping throughout the plant. Other capital costs
are derived from cost factors recommended by Prof. Seider for the cost spreadsheet
created by Holger Nickisch (see page 160). These factors can be viewed in the Input
Summary on page 160. The final large portion of our capital costs comes from total
Accounts Receivable. This cost results from the fact that it takes time to collect
payments from customers, and this revenue is needed in advance to pay for yearly fixed
and variable costs. The number is so large because our sales sum to $360 MM/yr.

TABLE 6: Unit Purchase Costs
Unit Purchase Costs
Name

Purchase Cost

Description

Quantity

Total

BR-1
BR-2
BR-3

40 L Fermentor
400 L Fermentor
5000 L Fermentor

$85,000·
$125,000*
$250,000*

2
2
2

$170,000
$250,000
$500,000

HX-1
T-1
CTI
RFU
RF
P1
P2
P3
P4
P5
P6
P7
Holdup Tank
Centrifuge
UF1 Tank
LlF1 Pump
UF2 Tank
UF2 Pump
UF Cleaning
Affinity Tank

Heat Exchanger
Blending Tank
Copper tubing and insulation
Refrigeration Unit for media tank
Refrigerant for media
Peristoltic Pump
Peristoltic Pump
Peristoltic Pump
Peristoltic Pump
Peristoltic Pump
Peristoltic Pump
Centrifugal Pump
Tank after BR3
Centrifuge
Recycle tank for UF1
Pump for UF1
Recycle tank for UF2
Pump for UF2
Cleaning solution
Tank for Affinity Column

$6,456t
$28,658*
$2,000*
$20,000*
$250*
$1,595*
$1,595*
$1,595*
$1,595*
$1,595*
$1,595*
$3,250*
$19,000*
$355,000*
$17,000*
$2,656*
$9,000*
$2,656*
• $75*
$10,000*

2
2
2
2
16
2
2
2
2
2
2
2
1
1
1

1
1
2

$12,911
$57,316
$4,000
$40,000
$4,000
$3,190
$3,190
$3,190
$3,190
$3,190
$3,190
$6,500
$19,000
$355,000
$17,000
$2,656
$9,000
$2,656
$75
$20,000

Affinity Column

Affinity chromatography column

$100,OOOt

2

$200,000

Affinity Skid/Pump
ER Tank
ER Column

Controller/pump for Affinity Column
Tank for ER Column
Endotoxin removal column

$100,OOOt
$10,000*
$6,190*

2
2
2

$200,000
$20,000
$12,380
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Name
ER Skid/Pump
MFTank
MF Pump
FD Tank
Bottier
Freeze Dryer
Refrigerant
Refrigerator
B-1
RO-1
Water Softener
WP-1
WP-2
WP-3
WP-4
WP-5
WP-6
WP-7
WT-1
WT-2

Quantit~

Purchase Cost

Descrietion
Controller/pump for ER Column
Tank for MF
Pump for MF
Tank before Bottler
BottlerlTray Loader
Freeze Dryer
AC refrigerant
Air-conditioning system
Boiler
Reverse osmosis system
Ion removal
Initial pump
Pump for Carbon filter
Pump for Water Softener
Pump for UV lamp
Pump for microfilter
Final pump
Pump for RO-1
Holding tank for sterile water
Holding tank for waste

$100,000t
$11,000*
$2,656*
$11,000·
$865,000*
$640,000·
$250*
$10,000·
$112,000#
$7,500*
$4,537*
$5,250*
$2,656*
$5,250·
$2,656·
$2,656·
$5,250*
$5,250·
$15,000*
$10,000·

2
2
2
2
2
2
17
1
1
1
1
1
1
1
1
1

$200,000
$22,000
$5,312
$22,000
$1,730,000
$1,280,000
$4,250
$10,000
$112,000
$7,500
$4,537
$5,250
$2,656
$5,250
$2,656
$2,656
1
$5,250
$5,250
1
$45,000
3
$20,000
2
Total: $5,410,000

Key for the Table
Symbol
*
#
t

t

Price origin
Quote from vendor
IPE calculation
Quote from Prof. Diamond or Dr. Kivnick
Estimation from cost charts

FIGURE 9
Freeze Dryers
(24%)

Bottlers (32%)

Columns (11%)

Water
treatment «10/0)

Centrifuge _ _ _ ~~
(6.5%)
Refrige ration
(1%)

Boiler (2%)
Fermentors

\
Pumps (1%)

l

Tanks (4.5 0/0)
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Variable Costs
The variable costs for our process are made up of raw materials and utilities costs.
The raw materials account for almost all ofthe variable costs, primarily because most of
the materials we use are of the highest quality and purity. The powdered media is
extremely expensive; for this is essentially the "feed," and our reactors are the cells,
which require the best ingredients to yield the highest "conversion." Chemicals
introduced in the Separation section are also of the highest purity because we cannot
afford to introduce more contaminants or impurities (such as endotoxins). An enormous
amount of arginine is also required for the process because this keeps our protein "intact"
by preventing aggregation. More than half ofthe cost due to raw materials comes from
the purchase of arginine.
Other variable costs included are filters, which can be very expensive and are
replaced fairly often. The chromatography columns also increase our variable costs. The
resins used in our columns are extremely expensive; though they last an entire year. The
Affinity Resin costs $2,81 OIL, and the ER Resin costs $4,320/L. Finally, about 750 kg of
anti-tPA antibody are required for our Affinity Columns. This antibody will actually be
produced in our plant, but time constraints prevented us from designing the antibody
production (a design project in and of itself). Prof. Diamond recommended we use a cost
of$2,000/g of antibody for our calculations.

The waste disposal is also considered a raw material; one that we are buying for a
"negative price" in a sense. A phenomenal amount of waste is produced during
production and cleaning of our plant. This disposal is contracted out to EarthCare for a
price of$0.211gal, though we used $1.00/gal in our calculations to provide for
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transportation and excess waste. A list of the raw materials used in our plant is provided
below in Table 7.
The majority of our variable costs arise from expenses such as research,
management compensation, and administrative expenses. Factors from Prof. Seider's

Process Design Principles were used to detennine these costs. Direct and allocated
research factors were increased significantly to account for research and development for
our process. Pharmaceutical and biotechnology companies invest a significantly larger
portion of their profits toward research because it can be so costly and fruitless in some
instances. These other variable costs account for almost 80% of the $82 MM in variable
costs (see page 166).

TABLE 7: Raw Material Costs
Raw Materials
Item

Purchllse Cost (1 unit)

Quantity/yr

Yearly Cost

Affinity Resin
ER Resin
UF2 filters
UF1 filters
Arginine
Glycine
PBS
NaCI
Sucrose
NaOH
Powdered Media

$2,910*
$4,320*
$950*
$785*
$119*
$43*
$5*
$18*
$1*
$18*
$20*

120L
20L
1 unit
1 unit
74500 kg
770 kg
117000L
4500kg
3kg
550 kg
250000L

$349,200
$86,400
-$950
$785
$8,865,500
$32,879
$566,982
$81,000
$2
$9,625
$5,000,000

anti-tPA antibody
Waste
Tank Compressed Air
Carbon filter
10 micron filter
2 micron filter
0.2 micron filter

$2,000 t
$1*
$172*
$1,515*
$32*
$32*
$44*

750g
660400gal
360tank
1 unit
50 unit
50unit
170unit
Total:

$1,500,000
$660,400
$61,920
$1,515
$1,564
$1,564
$4,400
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FIGURE 10
-Media (29%)
Arginine (51.5%)'

Antibody (9%)
I

Affinity Resin
(2%)

I

PBS (3.5%)

Waste disposal
(4%)

Fixed Costs
Fixed costs for our plant were also calculated using the economic spreadsheet
provided by Holger Nickisch (see page 165). Salaries and wages for operators and
maintenance personnel contribute the majority of our fixed costs. These figures were
again calculated using Prof. Seider's recommendations in Process Design Principles.
Key differences lie in wages for our operators, which are significantly higher than those
for chemical plants. According to Prof. Diamond, most operators in biotechnology plants
have PhD's and require higher pay; for this reason our wages and benefits accounted for

$100,000 for 6 operators. There are many different unit operations that each requires
significant expertise to master, for example the affinity chromatography steps.
In addition to these costs we included $500,OOO/yr for a control laboratory. This
molecular biology laboratory is responsible for completing quality control tests
throughout the process (see Other Considerations page 174). This laboratory will require
expensive instrumentation, though some of this will certainly be available from the
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laboratory that derived our cell line. The $500,000/yr estimate was recommended by
Prof. Diamond in our design meeting, and the total fixed costs sum to $11.4 MM/yr.

Profitability Analysis
The production of generic tPA has the potential to be a very profitable venture.
The capital investment required from our plant is just over $104 MM, and the annual
costs required to run the plant are over $88 MM (see page 167). Fortunately, our product
is expensive enough to place our annual sales at $360 MMlyr. This value is derived from
a production rate of 80 kg/yr. The table below demonstrates that the market share we
predict will be available for generic tPA priced at $500/dose. Our calculations were
completed at a 90% production rate (72 kglyr), so our production works well with the
estimate market of 76 kg/yr.

TABLE 8: Market Share Analysis
US market ($/yr)
Europe/Japan market ($/yr)
World market ($/yr)
% of market share taken
Competitor price ($/dose)
pur price ($/dose)
lYearly sales from tPA & SK ($/yr)
Our total yearly sales ($/yr)
Production Rate
Production Rate (1 OOmg/dose)

SK
tPA
$300,000,000 $50,000,000
$100,000,000 $150,000,000
$400,000,000 $200,000,000
50
66
$2,000
$200
$500
$50,000,000 $330,000,000
$380,000,000
760,000 doses/year
76kg/year

Calculations obtained from the Nickisch spreadsheet provide and investor's rate
of return (IRR) at 59.7% and a return on investment (ROI) of 145.8% (see page 167).
These numbers make our plant extremely profitable. The payback period is less than two
years for our company, given that we allowed for three years of construction. This was
done to allow time for the production of a viable cell line by our research facility. After
eight years of production the net present value (NPV) of our plant is approximately $1
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billion. While these numbers are high, we feel confident that our numbers are
reasonable. Ifwe were unsure of any estimated costs, we made certain that they were
overstated. Our annual sales will be very sensitive to price, so a more detailed estimate
on the effect of price is presented below.
As the selling price of our generic tP A is lowered we will acquire a greater
percentage of both the SK and Activase™ markets. A decrease in price will also
decrease annual sales and revenue, so there will be a maximum in annual sales that we
can achieve for the range of selling prices from $200/dose to $2000/dose. The following
plot is presented to demonstrate the effect of price on sales. The percentage of SK and
Activase™ market share that we can attain was roughly estimated based on discussions
with Prof. Diamond. In order to determine the ideal selling price a comprehensive
marketing report would need to be completed, but Figure lIon page 169 is shown to
give a general idea of the strong effect that pricing can have on market share.
It is possible that there would not be such a large market for generic tPA; if so,

our plant would not run at capacity. In addition to the calculations presented above, we
have also performed calculation for our plant given an annual production of 40 kg/yr, or
half the previous value of 80 kg/yr. This cut in production only affects the variable costs
and annual sales: both of which are cut in half. Even with a $180 MM decrease in
annual sales our plant in still extremely profitable. The IRR is now 41 % and the ROI is
80.25%, very good values for a chemical process. The NPV after ten years of production
is $782 MM (see page 169).
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Annual sales per Year vs. Seiling Price
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FIGURE 11
Our calculations demonstrate that the production of generic recombinant tPA is a
very profitable and worthwhile venture. All cost estimates are either direct quotes from
company representatives or conservative estimates from Prof. Diamond and Dr. Kivnick.
Given the final values in our profitability analysis, it would not be surprising to see
generic tP A enter the market three or four years from now.
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April 21, 2000

General Information
Title of Process: Human Tissue Plasminogen Activator
Plant Site: U.S. Northeast
Starting Year:
2000
Years of DesIgn:
1
3
Years of Construction:
Years of Plant Life:
12
2004
First Year of Production:

Product Information

_.__._ _._._.____--'!:tIe proce~yields..! sin~:1'.r.?ducl_:_.~_.. _

....__ .t!'~_.

__._ .._.....__...

Capacity
Operating Hours per Year:
. The Process will Yield:

8,400
0.01

80

hour or

oftPA

Market Price
_ ..__.._._._ _ ---....!he Price per kg oftPAi~_~ __ ~_~ _ _ _ _ ._~000!l.!l0.0.!l ______.__._.._._. __ ._'_.__..__.

Equipment Costs
Equipment Tvpe
Fennentation Section
WaterIWaste Treatment
Separation Section
Steam Production
Cell Line Research

Cost
$1,075,000
$106,000
$4,132,000
$112,000
$1,000,000
Percentage of Purchased Costs for Installation Materials:
Percentage of Purchased Costs for Labor:
Percentage of Purchased Costs for Freight, Insurance and Taxes :
Percentage of Purchased Costs for Construction Overhead:
of Purchased Costs for

200.00 %
150.00 %
15.00 %
150.00 %
130.00 %

Total Capital Investment
Percentage of Total Bare Module Costs for Site Preparation and Service Facilities:
Allocated Utility and Related Facility Costs (see Table 9.4): $
Percentage of Direct Pennanent Investment for Contingencies:
Land: Enter either a dollar value or a percentage of Total Depreciable Capital:
Percentage of Total Depreciable Capital for Royalties:
Percentage of Total Depreciable Capital for Start·Up:
Table
Site Factor

10.00 %
15.00 %
2.00 %

%
20.00 %
1.10

Working Capital
Inventory will be kept of the following Materials:
Arginine:
Glycine:
Sucrose:
PBS:
NaOH:
NaCI:
Powdered Media:

Compressed Air:

14 days
14 days
14 days
14 days

10 micron filter:
2 micron filter:
0.2 micron filter:

-~~.----.---.

3,160
33
0
4,931
22
191
10,606

14 days
14 days
14 days
14 days
14 days
14 days
14 days

Accounts Receivable:
---._-._--

kg
kg
kg
L
kg
kg
L

16 tank
2 unit
2 unit
II umt
30

Raw Materials
kg Arginine per kg tPA:
kg Glycine per kg IPA:
kg Sucrose per kg tPA:
L PBS per kg IPA:
kg NaOH per kg tPA:
kg NaCl per kg IPA:

931.0430000
9.6158000
00290000
1452.9300000
6.5500000
56.3000000

Cost ($) per kg Arginine:
Cost ($) per kg Glycine:
Cost ($) per kg Sucrose:
Cost ($) per L PBS:
Cost ($) per kg NaOH:
Cost (S) per kg NaCl:

119.0000000
42.7100000
4.8500000
0.7990000
17.5400000
18.0500000
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L Powdered Media perkg tPA:
tank C02 per kg tPA:
tank Compressed Air per kg tPA:
g anti-tPA antibody per kg tPA:
unit [0 micron filter per kg tPA:
unit 2 micron filter per kg tPA:
unit 0.2 micron filter per kg tPA
L Affinity Resin per kg tPA:
L ER Resin per kg tPA:
unit Carbon Filter per kg tPA:
unit UF I /liter per kg tPA:
unit UF2 filter per kg tP A:

3125.0000000 Cost ($) per L Powdered Media:
0.3750000
Cost ($) per tank C02:
4.7500000 ost($) per tank Compressed Air:
9.3750000 Cost ($) per g anti-tPA antibody:
0.6250000Cost ($) per unit 10 micron filter:
0.6250000 Cost ($) per unit 2 micron filter:
3.3750000 ost ($) per unit 0.2 micron filter:
1.5000000
Cost ($) per L Affinity Resin:
0.2500000
Cost ($) per L ER Resin:
0.0125000 Cost ($) per unit Carbon Filter:
0.0125000
Cost (S) per unit UF! !liter:
0.0125000
Cost ($) per unit UF2 filter:
8255.0000000
Cost ($)pergal W~te:

.........~~____ ._._.~~_W~a~s.te_p!~~tP~:

20.0000000
1428000000
171.6300000
2000.0000000
320000000
32.0000000
44.0000000
2809.6000000
4320.0000000
2000.0000000
785.0000000
950.0000000
05000000

Utilities
gal Process Water per kg tPA:
MMBTU Natural Gas per kg tPA:
kW*hr Electricity per kg tPA:
tPA:

17,014.5000000
13.1700000
17,300.0000000
0.0125000

Cost per gal Process Water:
Cost per MMBTU Natural Gas:
Cost per kW*hr Electricity:
Cost per yr Anti-body License:

0.0005000
2.6000000
0.0400000
12000000

Other Variable Costs
1.00 % of sales
10.00 % of sales
2.00 % of sales
2.00 % ofsales
1.25 % of sales

SellingfTransfer Expense:
Direct Research:
Allocated Research:
Administrative Expense:
Management Incentive Compensation:
Packaging
Labor:
Materials:

0.00 per kg tPA
2000.00 per kg tP A

Fixed Costs
Operations
Number of Operators per Shift:
Annual Wages per Operator:
Direct Salaries and Benefil~:
Operating Supplies and Services:
Technical Assistance to Manuf.:
Control Laboratory:
Maintenance
Wages:
Salaries and Benefits:
Materials and Services:
Maintenance Overhead:
Operating Overhead
General Plant Overhead:
Mechanical Department Services:
Employee Relations Department:
Business Services:
Property Taxes and Insurance
Property Taxes and Insurance
Depreciation
Direct Plant
Allocated Plant

6
$100,000
15
6
$52,000
$500,000
3.50
25.00
100.00
5.00
7.10
2.40
5.90
7.40

(assuming 5 Shifts)
Including Benefits
% of wages
%ofwages
per labor year
per labor year
% ofTotal Depreciable Capital,
% of Maintenance Wages and Benefits
% of Maintenance Wages and Benefits
% of Maintenance Wages and Benefits

% of Maintenance and Operations Salaries,
% of Maintenance and Operations Salaries.
% of Maintenance and Operations Salaries,
% of Maintenance and Operations Salaries,

Including Benefits

Wages and
Wages and
Wages and
Wages and

Benefits
Benefits
Benefits
Benefits

1.50 % of Total Depreciable Capital
8.00 % of Total Depreciable Capital
6.00 % of Allocated Costs

Financial Information
Cost of Capital:
General Inflation Rate:
Income Tax Rate:

~o
37.00

%
%
Distribution of Investment

MACRS Tax-Basis Depreciation Schedule
YEAR I
10.00%
YEAR 2
18.00%
YEAR 3
14.40%
11.52%
YEAR4
9.22%
YEAR 5

I t> \

DESIGN I

25%

CONSTRUCTION I

25%

CONSTRUCTION 2

25%

CONSTRUCTION 3

25%
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YEAR 6
YEAR 7
YEARS
YEAR9
YEAR 10
YEAR II

7.37%
6.55%
6.55%
6.56%
6.55%
3.2S%
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April 21, 2000

TOTAL
Equipment
I.

fermentalion Section
WaterlWaste Treatment

Materials for Installation:

Total Direct l\1alerlalS:
'Total Direct Labor: =====
~Total

Direct Project Expenses

~

S12,850,000

$19,275,000
$9,638,000
S28,913,000

Working Capital
Inventory
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c)..

0.0

0.0

0.0

2002

ToOl

.\.

00.0

2010

1201s

00.0

90.0

~. O

-

-

$360,000,000
..

90.0

-

$360,000,000

5360,000,000

5360,000,000

- _

$360.000,000
_.
_.

2012
1
2013
1
2014

.

'2011'I 90.0

-

$360.000,000

00.0

-.- -

$360,000,000

5360,000,000

100:0

2009

..

$360,000,000

00.0

2007
12008

-

--

.

-

.

-- 

-

-

0

"*'

~o
..\'"

.
. .

~

<::'

--

I
,,0
,,"
.,1:1

l('+

-

-

$312,109,000

5272,582,000

-

($2,622,000)

---

($ 11 ,354,000)
($11 ,354,000)

(S11 ,354,ooo)

- -  ($73,442,000)
-
($73,442,000)
($73,442,000)
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Fixed Costs
Human Tissue Plasminogen Activator
April 21, 2000

TOTAL

Op,eration
....- - - $3,000,000
.~~. $450,000 1

:Wages and Benefits
iDirectSalaries and Benefits

Maintenance

Operating Overhead
General Plant Overhead

~.-~~-~.~

$43j,00~

~~anicalJ:)epartment Services
...~ .~. _ _ ~___
i~mployee~elatiol1s Department ._ _ _ _ _ ......_ _ .~. _ _.....

-

b~

$146,~00
$360,000
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TOTAL

April 2 I, 2000

Raw Materials

'Sucrose
iPBS

IPA
IPA
14.07¢ per klk tPA
tPA

Byproducts

Other Variable Costs

\ b~

~I

~I
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Input Summary
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General Information
Title of Process: Human Tissue Plasminogen Activator
Plant Site: t:.S. Northeast
Starting Year:
2000
1
Years of Design:
Years of Construction:
3
Years of Plant Life:
12
2004
First Year of Production:

- - - - - - .........

_

......... _ - 

Product Information
........ _ _ _ ~ ______._ ........ The process yields a single product:

Capacity
Operating Hours per Year:
The Process will Yield:

8,400
0.00

hour or

40

oftPA

Market Price
_ _ _ _T_h_e_P~ice p~Ekg oftPAis:

5000000.00
--------

........

_----_._-

Equipment Costs
Equipment Type
Fennentation Section
WaterlWaste Treatment
Separation Section
Stearn Production
Cell Line Research

Cost
$1,075,000
$106,000
$4,132,000
$112,000
$1,000,000
Percentage of Purchased Costs for Installation Materials:
Percentage of Purchased Costs for Labor:
Percentage of Purchased Costs for Freight, Insurance and Taxes:
Percentage of Purchased Costs for Construction Overhead:
of Purchased Costs for Contractor F'nninp.prin

200.00 %
150.00 %
15.00 %
150.00 %
130.00 %

Total Capital Investment
Percentage ofTotal Bare Module Costs for Site Preparation and Service Facilities:
Allocated Utility and Related Facility Costs (see Table 9.4): $
Percentage of Direct Pennanent Investment for Contingencies:
Land: Enter either a dollar value or a percentage ofTotal Depreciable Capital:
Percentage of Total Depreciable Capital for Royalties:
Percentage ofTotal Depreciable Capital for Start-Up:
Site Factor
Table

10.00 %
15.00 %
2.00 %
%
20.00 %
1.10

Working Capital
Inventory will be kept of the following Materials:
Arginine:
Glycine:
Sucrose:
PBS:
NaOH:
NaCI:
Powdered Media:

Compressed Air:

1,580 kg
16 kg
o kg
2,466 L
II kg
95 kg
5,303 L

14 days
14 days
14 days
14 days
14 days
14 days
14 days

8
2
2
II

14 days
14 days
14 days
14 days

10 micron !ilter:
2 micron filter:
0.2 micron filter:
Accounts Receivable:

tank
unit
unit
unit

30

Raw Materials
kg Arginine per kg tPA:
kg Glycine per kg tPA:
kg Sucrose per kg tPA:
L PBS per kg tPA:
kg NaOH per kg tP A:
kg NaCl per kg tPA:

931.0430000
9.6158000
0.0290000
1452.9300000
6.5500000
56.3000000

Cost ($) per kg Arginine:
Cost ($) per kg Glycine:
Cost ($) per kg Sucrose:
Cost ($) per L PBS:
Cost ($) per kg NaOH:
Cost ($) per kg NaCI:

1190000000
42.7100000
4.8500000
0.7990000
17.5400000
18.0500000

~I

•
Generic tPA

Other Considerations

OTHER CONSIDERATIONS

170

Generic tPA

Other Considerations

Scheduling
The most important consideration is running a batch process is proper scheduling
of each batch. The tissue plasminogen activator (tPA) process consists of two individual
fermentation trains and two separation trains that share a common centrifuge and set of
ultra filters. Batch scheduling had to be designed to fit 50 batches into one year without
any overlap at the common unit operations. As shown in Figure 12 on page 172, a new
batch is begun every 7 days in the 40 L fermentors and remains in the fermentation train
for a total of27 days.
The batch schedule is designed to run the 5000 L continuously over the course of
the year. In other words, once a batch is harvested from the vessel the bioreactor is
sterilized and filled with media for the next cell culture. Extra time was added into the
schedule during the cleaning and sterilization portion of the batch to ensure enough time
is available for routine maintenance or repairs. Each batch is properly scheduled to
stagger the inoculation of the 40 Land 400 L fermentors so they can be harvested when
the next fermentor in line is ready to start a new batch. The 40 L and the 400 L
fermentors have a down time of7 and 4 days respectively.
Another important consideration of the batch schedule is common equipment
used by each train. The centrifuge and the ultra filters begin the purification process of
the product protein. Cell cultures are sent immediately to the centrifuge after they are
harvested. Precise timing of the batches in each train, staggers the harvest of the two
5000 L fermentors every seven days. Subsequently, the centrifuge and the ultra filters are
used only every seven days. The large down time of these two pieces of equipment
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Figure 12 • Plant Widlt$cheduljngf9J 3 Fermentati91l Trains and 2 Separation Trains.
- 1 centnfuge and 1 Set 01 Ultra Filters for the whole plant

....._-_.
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prevents any bottlenecks from forming and allows enough time for maintenance and
repairs if they are needed.
The centrifuge and the ultra filters is the only area that bottlenecking could occur,
but the scheduling design prevents this from occurring. The rest of the fermentation
trains and the separation trains do not contain any other problematic areas. In fact, the
plant design contains many holding tanks in between unit operations to retain material in
the event of a shut down some where on the process line. Once the cells have been
harvested the tP A protein can be held at 4 °C for a long period of time.
The holding tanks are also part of a design for future expansion of the plant. In
order to fulfill the entire problem statement, the plant was designed to handle a yearly
production of 100 kg. The plant designed described in this report only has two
fermentation trains, but a study of a three fermentation train plant was also explored. It
was determined that the market was not large enough to sell 100 kg oftPAproduct, but
the market may expand in the future. The plant would contain three fermentation trains
and only 2 separation trains. Because of smaller batch lengths for the separation verse
the fermentation processes, only two separation trains would be more than adequate.

Quality Testing
Before, during, and after each batch begins, tests must be run in order to confirm
that we are making functional tP A and using good materials. It is always possible that
the media is no good or that a batch will be infected. Contamination is a great concern
given that our batches are worth approximately $15 MM each. In order to control for
quality throughout the process we will need to perform tests on the media, take cell
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samples from each reactor, and estimate tP A productivity at the beginning of the
Separation train. This information is also invaluable to process development researchers
who are working to optimize the production of tP A in our plant.
To prevent an entire batch from being lost because of low quality media, a sample
will be taken from the packaging when it is opened. This small sample of media will be
used to run a small, bottle-scale fermentation experiment to make sure the cells can grow
in that particular batch ofmedia. Ordinary non-recombinant CRO cells will be used for
this so as to avoid wasting the precious stock oftPA producing cells. For quality testing
purposes they will be sufficient.
Bacteria and viruses can contaminate mammalian cells very easily, so samples
will be taken from each bioreactor to verify that the tP A-CRO cells are surviving and
flourishing. In pharmaceutical plants such as this less than 1 percent of all batches are
lost due to contamination. The loss of any batches is unacceptable in a process such as
this given the shear value of the product being produced. Again, process development
researchers can use this growth information to improve the cells and techniques used to
grow them.
Our plant's primary goal is to produce tPA, so testing for tP A production
throughout the process is also very important. Unfortunately, it is quite difficult to
measure the concentration of a particular protein when it is mixed with all of the other
proteins produced in the cell's metabolism. The most effective test of protein presence or
concentration is a Western blot, which can be run by our molecular biology control
laboratory. The dead time of a Western blot is at least a day, so the results will serve as
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research tools and to save money on the latter steps in the separation sequence if the
batch is no good.
Finally the activity of the final product will need to be tested. Random doses are
used to test for functional tPA, i.e., the ability to activate plasminogen (see Introduction
page 14). At this point the batch is ready for shipment to hospitals throughout the world.
A relatively small molecular biology laboratory can easily complete all ofthe
required testing. This lab will also be responsible for determining the final concentration
of tP A in FD Tank and calculating the volume required per 100 mL viaL The price of
such a lab, including salary and equipment, is estimated at $500,000 based on
recommendations by Prof. Diamond.

Sterilization
Current Good Manufacturing Processes (cGMP's) require production of
therapeutic medications to take place in a sterile environment. As a result, all equipment
in our plant is capable of being cleaned-in-place (CIP) and sterilized-in-place (SIP). All
vessel-like equipment (blending tanks and bioreactors) contains stainless steel pipes with
nozzles that are lowered into the tank section. Sterile water is then sprayed out radially to
wash away any remaining cell or media waste. Approximately two vessel volumes of
water will be used during each cleaning. This step is then followed by SIP with 130°C
steam for 30 minutes or longer. Other units have their own cleaning and sterilizing
mechanisms and utilize caustic solution in some cases. The Centrifuge and ER Column
require application of NaOH, and UFI and UF2 are cleaned with a 0.01% caustic
cleaning solution.

175

Other Considerations

Generic tPA

In addition, sanitary piping is used throughout our process. This requires all pipes
to contain inlets and drains for sterile cleaning water. The sanitary pipes can also be
easily disconnected and scrubbed manually if necessary. These sterilization procedures
take place after each batch or after each cycle in the case of the Bottler and Freeze Dryer.
In following cGMP's we will minimize batch losses and produce a clean, functional
medication.

Start-Up
There are many steps needed to take the plant from its completed construction to a
full-scale operational plant. The steady-state operation of the plant, as designed in the
project, can only be obtained through careful start-up procedure. All of the plant
equipment and piping will have to be brought up to proper sterile conditions. The unit
operations will be rinsed with water and steam sterilized before the process begins. The
vessels can be pressurized through the use of pumps, while various utility streams can
help to control the temperature of the units.
Before the plant can become fully operational, the water recycle streams that
provide the warm water for used in HX-l and BR-3 must be charged. These two streams
are made up of city water that is heated with sparged steam. The initial load of water on
the system is necessary to bring the recycle stream up to steady state before any of the
process liquids are added to the system.
The final consideration for start-up is the purchase and application the
monoclonal anti-tP A antibody for the affinity chromatography column. We have
licensed a hybridoma cell line that produces this antibody for $100,000 (see Problem
Statement page 189). The antibody will be produced in our plant, using equipment
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purchased for tP A production. A detailed process for the antibody production cannot be
completed with the given information, so Prof. Diamond advised us to use a costing value
of$2,000/gram. Approximately 750 grams of antibody is necessary for each Affinity

Column (see Appendix D page 314). The antibody will be bound to the Affinity Resin
using the protocol provided by Amersham Pharmacia Biotech (see specification page
314) and will remain intact for a year; after which both the resin and antibody will be
replaced.

Sanitization/Waste Removal
The FDA has strict standards for the use and disposal of genetically modified
organisms and cell waste in generaL Any materials that come into contact with our
microorganisms must be disposed of properly. Our process will be producing an
enormous amount of this waste. Solid waste removed in the Centrifuge, water waste
from UFl, and the volumes not collected from Affinity Column and ER Column are all
process waste streams that need to disposal. In addition to process waste, all water that is
used for sterilization and cleaning is also considered hazardous biological waste. Given
these amounts it is estimated that 670,000 gal of waste will be produced each year. The
number has been rounded up because extra waste is certain to arise during the course of a
year. The simplest way of accomplishing this task is by contracting the disposal out to a
waste disposal company. The EarthCare Company can eradicate this waste at a cost of
$O.2l1gal (see Appendix E page 395). This price is rounded to $lIgal to account for
transportation and disposal charges.
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The analysis of our process indicates that production of generic human tissue
plasminogen activator (tP A) can be an extremely profitable venture. Economic
calculations yielded an investor's rate of return (IRR) of 59.7% and a net present value
(NPV) of $1.7 billion after ten years. This study was completed for the sale of
approximately 80 kg/yr, which was based on marketing estimates provided Prof.
Diamond. A more conservative economic analysis was also conducted, estimating sales
of only 40 kg/yr while holding our capital costs constant. This venture is also extremely
profitable, with an IRR of 41.0% and a NPV of almost $800 MM.
This is the first time the patent for a recombinant protein produced in mammalian
cells will be expiring. The price for the original product is extremely high due to the
large amount of research costs accumulated during its discovery and development. In
following the expired patent we will avoid these costs and produce an expensive
medication at cost.
The introduction of a cheap, generic version of tP A should cause a tremendous
increase in the market for recombinant thrombolytic agents. Streptokinase (SK), the only
other major anti-clot drug on the market is only preferred for its cheaper price. In
decreasing the price difference between tPA we will obtain a large share of the SK
market, which is quite sizable overseas.
Our production methods are fairly straightforward. Research in the form of a
pilot plant will be required in order to determine growth kinetics and optimal conditions
for the separation processes. Genentech obtained a cell production rate of 50 pg/celllday
in patent 4,766,075. Molecular biology techniques have improved significantly in the
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past fifteen years, so it is likely that our cells could attain higher production rates, further
increasing our profits.
Biological processes can be very unpredictable and there is no data published on
the downstream processing of tP A. A great deal of data would need to be obtained to
determine exact purification protocols. In order to account for these research needs an
extra year of construction (three years total) was included in our economic calculations.
The expiration of the patent for a recombinant tP A-producing cell line opens the
door to an extremely profitable venture. This is one of the first opportunities for
"horizontal growth" the biotechnology industry. We feel that generic tP A production
provides a tremendous opportunity for a company to enter the pharmaceutical market.
The profits gained from this venture could provide capital for research in other products.
It would not be surprising for a large pharmaceutical company to undertake a venture

such as this due to its growth potential and value. In conclusion, we strongly urge
construction of a generic tP A production plant in the near future.
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Appendix A

Generic Recombinant Human Tissue Plasminogen Activator (tPA)
(Recommended by Dr. Scott L. Diamond, University of Pennsylvania)
Setting:
Plasminogen activators are powerful enzymes that trigger the proteolytic degradation of
blood clots that cause strokes and heart attacks. Genentech owns the patent for tPA, and
currently sells 100 mg doses of recombinant tPA (activase) for about $2000. The annual
sales for tP A are about $300MMlyr. However, the patent for tP A will be expiring soon.
In response, Genentech has developed a next generation, FDA-approved, Plasminogen
activator called "TNK-tPA", which is slightly easier and safer for clinician to use.

While a generic form of tPA may not compete well against TNK-tPA in the U.S., there
may exist the opportunity to market a low-cost generic tPA in foreign markets, where
urokinase and streptokinase are low-cost (-$200/dose) alternatives that are associated
with increased bleeding risks. Additionally, reduced healthcare reimbursement to U.S.
hospitals may allow a generic tPA to compete against TNK-tPA or activase.

Process:
Produce recombinant tP A using CHO cells. Since Genentech will not license their CHO
cell, your group will be responsible for cloning the human tP A gene and creating a stably
expressing cell line for your process.
Constraints:
1. The product must be sold as lyophilized, sterile powder (100 mglbottle).
2. The product must be free of endotoxin contamination.
3. Affinity chromatography will be necessary.
4. Your separation system will operate as a batch system.
S. Your annual production will need to range from 30 to 100 kg/yr.

Determine:
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1. Compare the cost of batch and CSTR (4 month per run) bioreactor operations.
2. Design reverse osmosis/deionized water purification system to supply all process
water.
3. Determine the steam requirements for sterilization of the bioreactor.
4. Does an economic opportunity exist for the production of generic tPA? Assume that
Genentech is your only competitor.
5. Estimate the actual production cost per 100 mg/dose for Genentech to make tPA.
Assumptions:
1. Your reactor will use serum-free growth medium.
2. Your have licensed the use of a hybridoma cell line that secretes tP A monoclonal
antibody for the development of your affinity columns (life of column is 3 years). The
license costs $120000/yr.
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GTTCTGAGCACAGGGCTGGAGAGAAAACCTCTGCGAGGAAAGGGAAGGAGCAAGCCGTGA
-30

-35

met ISP ala .et I'SI~g gly leu
ATG GAT GCA AT' AAG AGA GGG CTC

ATTTAAGGGACGCTGTGAAGCAATC

-20

cY' cys vel leu leu leu cys Illy al. v.l phe VII ser pro ser
TGC TGT GTG eTG eTG CTG TGT GGA GCA GTe TTC GTT TCG cce AGC
~'" ~Iu

1
-10
lIe his .1& erg phe .~, .~g gly II •• rg SER TYA GLH

AG GAA ATC CAT GCC eGA TTC AGA AGA GGA GCC AGA TCT TAC CAA
10

VAL ILE eyS ARG ASP GLU LYS THIt GLH MET IlE TYII GLH Gllf HIS
GTG ATC TGC AGA GAT GAA AAA ACG CAG ATG ATA TAC CAG CAA CAT
30

20

GLII SEA TRP LEu ARG PliO VAL LEU AAG SEA ASH AIIG VAL GLU TVR
CAG TCA TGG CTG CGC CCT GTG CTC AGA AGe AAe eGG GTG GAA TAT
40

CVS TAP CYS ASH SEll GLV AIIG ALA GLH CYS HIS SEA VAL PRO VAL
TGC TGG TGC AAC AGT GGC AGG GCA CAG TGC CAC TCA GTG CCl GTC
60
SO
lVS SEA CVS SEA GLU PRO ARG evs PHE ASH GLY GlV THA CVS GLH
AAA AGT TGC AGC GAG CCA AGG TGT TTC AAC GGG GGe Ace TGe CAG
10

GLH ALA LEU TYA PH£ SEA ASP PH£ VAL eys GLH eys PRO GLU GlV
CAG GCC CTG TAC TTC TCA GAT TTC GTG TGC CAG TGC eee GAA GGA
gO
80
PHE ~LA GLY lYS eys CYS GLU ILE ASP THA AAG ALA THR CVS TVR
TTT GCT GGG AAG TGC TGT GAA ATA GAT ACC AGG GCC ACG TGC TAC
100
GLU ASP GLH GLY HE $fR HA AAG GLV THIt TRP SEA THR ALA GLU
GAG GAC CAG GGC ATC AGC TAC AGG GGC AeG TGG AGC ACA GCG GAG
120

110

SER GLV ALA GLU eys THA ASH TRP ASH SER SEA ALA LEU AlA GLH
AGT GGC GCC GAG TGC Ace AAe TGG AAC AGC AGC GCG fTG GCC CAG
130

LVS PRO TVA SER GLY A~G ARG PAO ASP ALA ILE ARG L£U GLV LEU
AAG cce TAC AGC GGG CGG AGG eCA GAe Gce ATC AGG CTG GGC CTG
140

150

GL v ASH HIS ASH HR CVS AAG ASH PRO ASP ARG ASP SEA US PAO
GGG AAC CAe AAC TAC TGC AGA AAC CCA GAT CGA GAC TCA AAG CCC
160

TRP OS TVA VAL PHE LVS ALA GL Y l YS TYR SEA S£A GLU PHE eys
TGG TGC TAC GTC TTT AAG GCG GGG AAG TAe AGC TCA GAG TTC TGC
170
180
THR PRO ALA OS SER GLU GLV ASH SEA ASP CVS TYI! PHE GLV
AGe Ace CCT GCC TGC TCT GAG GGA AAC AGT GAC TGC TAC TTT GGG

SEll

Fk].SA.
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190
ASH GLY SEA ALA nR ARG GL Y THR HIS SER LEU THR GLU SER GLY
AAT GGG TeA Gee TAe eGT GGe AeG CAC AGC eTC ACC GAG TCG GGT
210
200
ALA SER en LEU PRO TAP ASH SEA MET I LE LEU I LE GL Y LYS VAL
CTG
ATA
UG
ATC
GGC AAG GTl
TGG
AAT
Tee
Gce Tec TGC CTe ceG

220
TVR THR ALA GLH ASH PRO SEA ALA 6LH ALA LEU GLY LEu GL Y LYS
TAe ACA GeA CAG AAe CCC AGT Gce eAG GeA CTG GGe eTG GGe A4A
240
230
HIS ASH TYA eys ARG ASII PRO ASP GLY ASP ALA LYS PRO TAP eys
CAT AAT TAe TGC CGG AAT CCT GA T GGG GAT Gee UG eee TGG TGe
250
HIS VAL LEU LYS ASH ARG AAG LEU THA TRP GLU nil .eys ASP VAL
CAe GTG eTG AAS AAC CGC AGG eTG ACG TGG GAG TAe TGT GAT GTG
270

160

PRO SEA CY$ SER THR OS GLV LEU AAG GLII TYA SER GLH PRO GtH
eec Tce TGe ree Ace Tr.e GGe eTG AGA CAG TAC AGe CAG eCT CAG
lAO

PHE AI! G It ELY S GLY GLY LEU PHE ALA ASP ILE ALA SEA HIS PRO
TTT eGe ATe AU GGA GGG CTC TTC GCC GAC ATe Gec Tee CAC cee
,90

300

TAP GLN ALA ALA ILE pHE ALA LYS HIS ARG ARG SER PRO GLY GLU
TGG eAG GeT Gee ATe TTT Gec UG CAC AGG AGG TeG eee GGA GAG
310

ARG PIiE LEu en GL Y GL Y IL E LEU lLE S[It SER CYS TR PILE LEU
eGG TTC eTG TGC GGG GGC ATA CT eAT e AGe Tce TGe TGG ATT eTC
330

3<0

SEA ALA ALA HIS OS PHE GLII GLU ARG PHE PRO PRO HIS HIS LEU
TeT Gec Gec CAC TGC fTC CAG GAG AGG TTT eeG cee eAC CAC eTG
340

TIli! VAL 1LE LEU GL Y ARG THR nA AAG VAL VAL PRO GLY GLU GtU
ACG GTG Afe TTG GGe AGA ACA TAC CGG GTG GTC CCT GGe GAG GAG
350

360

GLU GLH LYS PHE GLU YAL GLU LYS nR IlE VAL HIS LVS GLU PHE
GAG eAG AAA TTT GAA GTe GAA AAA TAC ATT GTe CA r AAG GAA TTC
370
AS:' ASP ASP r Hi! TVR ASP ASH ASP ILE ALA LEU LEU GLH LEU LYS
GAT GAT GAC ACT TAC GAC AAT GAC ATT GCG CTG CTG CAG CTG AAA
380

390

SER ASP SER SER ARG CYS ALA GLH GLU SEi! SER YAL VAL ARG THR
TeG GAT TCG rec CGC TGT Gee CAG GAG AGe AGe GTG GTC CGC ACT
400

VAL CYS LEU PRO PRO ALA ASP LEU GLH LEU PRO ASP UP THR GLU
GrG TGC cn eec ceG GCG GAC eTG CAG CTG CCG GAC TGG ACG GAG
410
420
OS GlU LEu SER GLY TYR GlY LYS HIS GLU ALA LEU HR PRO PHE
TGT GAG CTC TCC GGC TAC GGC AAG CAT GAG GCC TTG TeT eCT iTC

Fig. 58.
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430

TYR SER GLU ARG LEU LYS GLU ALA HIS VAL ARG LEU TYR PRO SER
TAT TeG GAG eGG eTG AAG GAG GeT CAT GTe AGA eTG TAe eeA Tec
450

440

SER ARG eys TNR SER GLH HIS LEU LEU ASH ARG TNR YAL THR ASP
AGC CGe TGe ACA TeA CAA CAT TTA eTT AAe AGA AeA GTe Ace GAe
4~

ASH MET LEU eys ALA GLY ASP THR ARG SER GLY GLY PRO GLH ALA
AAe ATG eTG TGT GeT GGA GAe ACT eGG AGe GGe GSG eec eAG GeA
480

470

ASH LEU HIS ASP ALA eys GLH GLY ASP SER GLY GLY PRO LEU VAL
AAC TrG CAe GAe Gee TGe CAG GGe GAT TeG GGA GGe eee eTG GTG
4~

eys LEU A5H ASP GLY ARG MET TNR LEU VAL GLY ILE Ilr. SER TRP
raT eTG AAC GAT GGe CGe ATG ACT TTG GTG GGe ATC ATe AGC TGG
510

~O

GlY lEU GlY CYS GLY GLH LYS ASP VAL PAO GLY VAL TYR THR LYS
GGe eTG GGe raT GGA CAG AAG GAT GTe eeG GGT GTG TAC ACC AAG
527
520
VAL TNA ASH TTR LEU ASP TRP Ilt ARG ASP ASH MET ARG PRO OP
GTT Ace AAC TAe eTA GAC TGG ATT eGT GAe AAe ATG eGA etG TGA
CCAGGAACACCCGACTCCTCAAAAGCAAATGAGATCCCGCCTCTTCTTCTTCAGAAGACA
CTGCAAAGOOGCAGTGCTTCTCTACAGAcrTCTCCAGACCCACCACACCGCAGAAGCGGG
ACGAGACCCTACAGGAGAGGGAAGAGTGCATTTTCCCAGATAcrTCCCATTTTOGAACT
TTTCAGGAcrTGGTCTGATTTCAGGATACTCTGTCAGATGGGAACACATCAATGCACACT
AGCCTCTCCAGGAATGCCTCCTCCCTGGGCAGAAAGTGGCCATGCCACCCTGTTTTCAGCTA
AAGCCCAACCTCCTGACCTGTCACCGTGAGCAGCTTTGGAAACAGGACCACAAAAATGAA
AGCATGTCTCAATAGTAAAAGATAACAAGATCTTTCAGGAAAGACGGATTGCATTACAA
ATA~ACAGTATATTTATAGTCACAAGAGCCCAGCAGGGCCTCAAAGTTGGGGCACGCTCCC

TGGCCCGTCATGTTCCTCAAAAGCACCCTTGACGTCAAGTCTCCTTCCCCTTTCCCCACT
CCCTGGCTCTCAGAAGGTATTCCTTTTGTGTACAGTGTGTAAAGTGTAAATCCTTTTTCT
TTATAAACTTTAGAGTAGCATGAGAGAATTGTATCATTTGAACAACTAGGcrTCAGCATA
TTTATAGCAATCCATGTTAGTTTTTACTTTCTGTTGCCACAACCCTGTTTTATACTGTA
CTTAATAAATTCAGATATATTTTTCACAGTTTTTCa "'1~UAA.U» U..A

Fig. 5[,'
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HUMAN TISSUE PLASMINOGEN ACIlVATOR
This is a continWition-in-pan or IPPlica.tiollS Set. No.
393.003 rtJed July 14, 1982 and Ser. No. 314,160, raJed S

MAY S, 1982FIELD OP THE INVENTlON
The present invention relates to human pJumino,en
nctivator. correspondin, to that rOllDd In buman tIcrWll
and/or tiulIe&, and to novel rorms and compolliticml
thereof and particularly to the me&lll and mt"thoda ror
its prodllction to homo,endty in therapeudcally lianiflcant quantities.
The present iDvention ariIeI in pan from the disco\'>
ery or the DNA seqllence and dedl&Ced IlDino add
sequence or human pluminoaen acdvator. Thil diIeov>
ery enabled the production or human plumino,en !lCd·
vator via the application or recombinant DNA tecbnol·
ogy, in tum, enablin, the production oflllff1cient quality and quantity or material to Inlliate and conduct animlll and cliDlcaI testin, u prerequisites to market apo
proval, unimpeded by the restrictions necessarily Inher·
ent In the isolation methods hitherto employed involv.
ina production and extraction from exlltinl cell culture.
This invenlion iI directed to theM IIIIOClated embodiments in all respectl.
The publications and other materiaJa hereor uaed to
illuminate the bacqround or the invention. and in particular cases, to provide additionaldetalbi concemin, itl
prc.clice are incorporated herein by reference. and (or
convenience, are numerically referenced in the followins lext and respectively ,TOliped In the appended blbli·
ography.
BACKGROUND OP THE INVENTION
A. Human Tiuue P1.umIno,en Activator
The fibrinolytic sYltem iI in a dynamic equilibrium
with Ihe cOlilllation ')'Item. maintalnln, an Intact.
p:ltent vascular bcd. The COIIulation l)'Item depoaitl
libnn IS a matm lervln, to restore a hemOitatic coRdi·
tion_ The fibrinolytic l)'Item removes the fibrin network after the hemottatic condition iI achieved. The
fibrinolytic prOCell iI brou,ht about by the proteolytic
en:::yme plumln that iI,enerated from a pluma protein
precunor plumino,en. Plumino,en II converted to
plll.'lmin throuah activation by an activator.
Currently, two activatOR are commerc1ally available.
streptokinase and urok.lnue. Both are Indicated ror the
trClltmenl of acute vucular dbeuea such u myocardial
infarcl, lIroke. pulmonary embolism, deep vein thromb03is, peripheral arterial occlualon and other venolll
thromboses. Collectively. these diaeua account ror
mnjor health ha.u.tdl and rIab.
The underlyln, etiololical bull ror these dtseaaa
point. to either a panial. or in MVere cues, total ocelu.ion of a blood vessel by a blood clot-thrombus or
Ihromboembolus. Traditional antlcoa,ulant therapy, IS
with heparin and coumarin, does nothin, to directly
enhAnce dillOll.1tlon of thrombi or thromboemboll. The
thrombolytic a,entl referred to earller. ftreptoidnue
nnd urokinase. have enjoyed practical and effective \lie.
However, each has levere limitations. Neither has a
high IIffinity ror Rbrin; conaequently. both actlvlte clrculating and Rbrin-bound plumino,en relatively Indl..
criminlltely. The plumIn ronned In c:ltc:ulallnl blood II
neutrnlized rather quickly and Io.t ror Ulerul thrombol·
y~in, Residual plumln will de,rade leveral clonln,

z.o~
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factor proteins. for eumple. librino,en, Factor V and
Factor VIII. causina a bemorrbaaic potential. In addi
tion. streptokinase is Itron,ly anti,enic and patients
with hI,b antibody dtm respond inefficiently to treal
ment and cannot remain on continuous treatment. Uro
kinase therapy is expensive, owin, to ill involved isola
tion from buman urine or tissue culture, and it. there
fore. is not perally accepted in 'clinical practice. U rotinue bat been the subject of nllmerous invesligation
a-See.
uampJe. references 1-6.
So-called pJumino,en activators have been isolated
from variouI.human tissue, e.,.,.lIterine tissue, blood.
tIcrWll-Me perally references 7-11 and from cdl
culture (reference 94). CompositiOlll thereof have also
been dacribcd-aee references 12, 13. See allO refer
encG 14-11. The plumino,en activaton derived from
these 1OW'CeS have been claulfied Into two major
JfOupI: urokinase-type plumino,en actlvaton (u·PA)
and tissue-type plumlno,en actiVatOR (t-PA) based on
differacet in tbeir immunolo,ica' properties. (The
abbreviations t-PA and u-PA are those proposed at the
XXVIII Meetin, of the Inlemational Committee on
Thromboii. and Hemoltasi., Ber,amo, Italy. July 27.

ror
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Recently. a human melanoma line has been idenlified
which secretes t-PA. Characterization ofthis melanoma
plumino,en activator has Ihown II to be indistinguishable both Immunolo,lcali:, and in amino acid composi
don from the plumino,en ,<:(ivalor isolated rrom nOf
mal human tissue (Rererence 19, 88).
The product was isolated In l·-.Ialively pure rorm.
characterized and round to be a hi,,':l,.. active fibrino
lytic a,ent (20).
Several atudies (e.l. Rererences 9~ to 98) whl.;Ji used
t·PA purified rrom the melanoma cell line have dem ....;'\·
mated It1 hiJher amnily for librin, compared wilh uroidntle type plasmino,en activaton. More inlensive
Invesu,ation or human t·PA as a potential thrombolytic
a,ent bat. huwever, been hampered by Its extremely
low concentration iD blood, tillue utractl. 'Vessel perru
lit" and cell cultures.
It wu perceived that the application of recombinanl
DNA and IIIIOClated technolo,les would be a most
etrective way of providin, the requilite larae quantilics
orhi,h quality human dillie-type pluminoaen activator
(earlier referred to IS human plumino,en activator).
essentially free of other human protein. Such material~
would probably exhibit bioactivity admlulng of their
UIe clinically in the treatment ofvarious cardiovascular
conditions or diaeases.
B. Recombinant DNA TechnololY
Recombinant DNA technolo,y hu reacbed the age
or lOme IOphiltication. Molecular bloloaisu are nble 10
recombine various DNA sequences with some fllcility.
creatln, new DNA entities capable of producing copi·
ous amountl or elIopnous protein product in trans
formed microbes and cell cultures. The ,enera] means
and methocIa are In hand ror the In vitro lilllliion of
VulOIil blunt ended or "ltlcky" ended fragments of
DNA. prodllCin, potent expreuion vehicles lIIeful in
tranlrormln, particular or,anilml, thul directing their
emcient .ynthesil of desired exolenous product_ However. on an individual product buls, the palhwlIY remains IOmewhat tonuoUI and the science has not IId
vanced to a Ilaae where reaular predictions of succes~
can be made. Indeed. thOle who portend successful
relults without the underlylna experimental bub, do so
with conllderable rilk of Inoperability.
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DNA m:ombiaation of the essential elemenlS, Le., lID
origin o( replicadon, olle or more phenolypic selection
characleristic:s, an expression promoter, heteroloaous
sene insen and remainin, vector, pnerally is performed outside the host cell. The raullin. recombiDant 5
replicable expression vehicle. or plasmid, is introduced
inlo celb by transformation and Iar.e quantities of the
recombinant vehide obtained by lrowinl the transfermanto Where the lene is properly iDsened with refer·
c:nce to ponions whk:i'I ,overn the tnnICription ud 10
transladon ohhe eacoded DNA D1CSIIIICt the resultiaa
expression vehicle is IIICft&I to actually produre the
polypeptide sequence (or whicb the inserted aeae
codes, a procell referred to u e.lpreuioll. The resuiliD.
product may be obIained by Iysiq. If nClCellU')'. the 15
bost cell. in microbial syatema, and recoverinl the product by appropriate puriftcation (rom other proteins.
In practice. throu.h the laIC of recombinlal DNA
technolo,y. one can ClIpress eatircly heteroloaous polyv-:ptides-so-called direct expression-or alternatively 10
mllY express a heterololOUS polypeptide f'bsed to a portion of the amino acid aequence of a homololous polyv-:ptide. In the latter cues, the Intended bioactive product is sometimes readered bioinactive within the I'wed.
homoloB0us!heterololous polypeptide UIltU it is u
cleaved in an extracellular environment. See referenca
(21) and (22).
Similarly, the art of cell or tluue cultures ror .tudyin,
genetics and cell phyaiolol)' i. well established, MCIDI
and methods are in hand for mainca.in1n1 permanent cell 30
Un~, prepared by sUCCCS!ive aerial uansfen from iaolote normal celli. For laIC In reaearch. luch cell lines are
maintained on a eoUd .uppar: In UqlOld medium. or by
srow,1I iii s\l.~ulion contalilml IUPpon nutrimentL
S<:cle-up tor larlc preparations aeemlto pOle only me- JS
ch4nical problems. For (unher bKkaround. attention is
directed to references (23) and (24).
Litewile, protein biochemi.try is a usefUl. Indftd
necess.llry, adjunct in biotechnolo,y. Celli producinl
the dClired protein a1IO produce hundredl or other 40
proteins, endoBenous products of the cell'. metabolism.
Thoe contaminatinl proteiN, as well as other compounds. if not removed (rom the daired protein, could
prove tOltic if administered to an animal or human in the
coune of therapeutic treatment with desired protein."
Hence. the techniques of protein biochemlltry come to
be::r.lllowin, the dailn oheparation procedures .uit!lble for the panlcular .y.tem under coulderaLion and
providin, a homo,encous product l&Ie ror Intcnded laIC.
Protein biochemi.try aleo prova the Identity of lhe 50
doired product. characlerizinl it and CIIIurlnl that the
cells have produced It faitbtully with no alteratlona or
rnntation•. This branch ohcleace Is aleo involved In the
delign or biouaays. llabilily studies and other procedures neceuary to apply before IUCCCIIIfili cHnicalltlld-"
iC$ lind marketinl can take place.
SUMMARY OF THE INVENTION
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directed to methods of treatina vascular dborders in
human subjects tWll, I-PA and to suitable phannac:euti.
cal compositions thereor.
The present iDvention funher comprises essentililly
pun: human tissue pllsmillolen activator. The product
produced by IC1ICtically enlineered microorganisms or
cell cultun: S)'Items provides an opponunity to produce
human tislue pluminolen activator in a much more
etI1cIent lDUlDer than has been possible, enabling hith·
eno elualve commercial exploitation. In addition, de·
peadiq UpoD the hOlt cell, the human tissue plasmino
teD activator berllOf may contain usociated ,Iycosyla'
tioo to a arater or laser extent compared with native
material. In any event. the taPA will be free of Ihe con·
tamiDanta normally UIOCialed with it in its non-recom
binlat cellular environment.
The praent Invention Is also dim:led 10 replicable
DNA e.lpreuion vehicles harborinl lene sequences
encodln, human duue plasminolen activator in ell'
preuible form, 10 microorlanism strain. or cell cultures
tranaformed with them and to microbial or cell cultures
of such transformed .train. or cultures, capable of pro·
duc:i.al human duue plasminolen activator. In still fur·
Iher upeelS, the praentlnvention is directed to various
processes laIC(ul for preparinl said Bene sequences.
DNA expression vehicles, microorganism strains and
cell cultures, and speeirlc embodiments thereof. Still
funher, this iDvention is dim:ted to the preparation of
(ermentation cultures of said microoraanisms and cell
cultures.
BRIEF DESCRIPTION OF THE ORAWINGS

P10. 1 Ihowa a I~ lOdium dodecylsuJ(ate poly·
acrylamlde ,eI eJoctriphoresls (SDS PAGE) of 3S5
methionine labelled proteinl precipitable with anti t·PA
laO ICCreted from melanoma cells with and without
proteue inhibitOr.
P10. 1 lhoWl electrophoresis of the immuno
precipitated translation products of mRNA (ractions
derived from melanoma celli.
P10. 3lhowa the hybridization pall ern 0(96 bacterial
colonies tranaformed with cDNA uslnl the pool of 32p
labeled l4-met as probe prepared baaed on a 5 amino
acid sequence o( human t·PA.
FlO. 4 I. a restriction endonuclease map of the full
lenath human taPA eDNA.
FIOS. Scr. Jb and Ie .how the nucleotide sequcnce
and deduced amino acid aequence of the fuli length
human t·PA cDNA.
FlO. , lIa .chernalic of the CODltruclion o( the e~·
preuion plumid pARIPA',
FlO. 7 shoWl the results of a fibrin plate assay for
fibrinolytic activity of E. coil cellJ cransformed with
pARIPA'.
FIO. , II an HPLC trace or peplida from humnn
t·PA tryplln di.at.
FIO. t IhoWl the ~n.truction of a plasmid c~ding
ror the direct apres&lon of mature human I·PA In £.
The present Invention II based upon the discovery
coiL
that recombinant DNA technololY CUI be uaed .uee.... 60
FlO, 10 .haWlthe resulll of a librin plate assay for
fully 10 produce human liu\Ie plasmlnolen activator
fibrinolytic activity of Ihe human taPA produced by £.
(t·PA). preferably in direct (orm, and in amoUllts .um·
coiL
cient to Initiate and conduec animal aad clinical tatlnl
FIO. 11 .hoWl the con.uuction of DHFR (mutant or
l1S prerequi.ltes to markC\ :lpproval. The product human
wild lype)/t·PA CReodln, plasmid••uitable for trims·
[·PA i. lullable ror use, in an or It. rorm•• 1n the prophy. " farmln, into mammalian duuc culture cells.
P10, 12 I. a .chematic dia,ram or human tissue pins
Illctlc or Iherapeutic trealment or human belnl' ror
varioul cardiovascular eonditioDl or disc..... Accordminolen activalor II prepared by the mechod exempli.
ned In ILl herein.
ingly. the preaenllnven!lon. In one Imponant Upeel, i.
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DETAILED DESCRlmON
A. Definitions
As used herein, "human tiaue plasmino,ea lCuva·
tor" or "human I·PA" or '''.PA'' denotes human estrin· ,
sic (tissUe-lype) plasminopn activator, produced by
microbial or ceD cwture 1yst.emS, in bloac1ive forms
comprisina a protease portion and corrapondin, to
those:: tissue plasmino,en ICtivalora otherwiae _tive to
human tissue. The human lisaue plumlno,eD activalor 10
protein produced herein baa beea deaned by _
of
delermined DNA ICM and dedlolCtive amino ICId . .
quenclna. II will be underatood tbat DIIcllllllllebc van·
ations exist aad occur
IIIdlvklual to IIIdlvidual..
These variatiolll may be dClDOllltrated by (Ill) amiDo"
acid cUf!'erence(l) in the oYVlll IIqUCftCt or by deletiona, Il&bstilut!oaa, illlertionlo IDveraioDa or Iddltionl or
(an) amino lCid(s) In aid Mq1IIDCL.ln addldoa. the
location or and de,.... of aIycoIylation will depend on
20
the nalure or the hole cellular environment.
The potential ulab, in the \1M of recombinlllt DNA
technolo,y. for Ihe preparation or vanoUl human IIUIMI
pllUmino,en acdvalor derivatives, vanoUlI)' modified
by resu1tanl sin,le or multiple amino lCid lubalhutlonlo
deleliom. additions or replacemenb, for cumple. by 25
means· or Ihe directed mutaaenesll or the UDderlyin,
DNA. Included would be the preparation o(derivatives
retainin, the esaentlal krin,le realon and IeriM proteaIC
region characleriadc ,enerally of Ihe human tiuue pluminosen ICllvator described .pecUlcally herein, but 30
otherwise modlned u described above. All such allelic
variatiol1l and modil1catioDl mwtiq in derivatiyes of
human tissue plumino,en activalor are Included within
the scope of lhlI Invention. u well u other related
human extrilUic (tissue-type) plumlno,en ICtlyalOra, U
similar physically and biololically. 10 lon, u the euenlial. characlerildc human tiuue plasmino,en ICtivator
activity remaiDl unaffected in Idnd. Human tiuue plumino,en ICllvator is prepared (I) havin, methionine as
it! finl amino lCid (prelCtlt by virtue of the ATO start 40
signal codon Il1ICrtion In rronl of lhe atructural ,cne) or
(2) where the methionine II Intra-or elllracellularly
cleaved. havln, Its normally flnt amino 1Cid. or (3)
logether with either Its lipal polypepdde or a COI\JuSilled protein otber than tlle conventional Ilpal poly· ..,
peptide. the .lpaI polypeptide or cordu,ate
speciflcDlIy cleavable In an Intra· or extracellular environ·
ment (See reference 21). or (4) by direct expreulon in
mature form without the neceuity cleavin, away any
exlraneoua, SUperflUOUl polypepdde. The laUer II par- 50
ticularly Important where a ,liven hott may not, or nat
efficiently. remove a ai,naI peptide where the Cllpression vehicle II deailned to expreu tbe tilaue plumlnasen activator 10lether with Its Ilpal pepdde. tn any
event. the Ihlll prodgced human t·PA. in Its variolll "
forms. Is recovered and purined 10 a Icvel ftuln. It ror
use in the Ireatmenl of VarioUl vascular condldoDl or
dise.ues.
furthermore. tePA hu fOl1l1l which Include both the
single chain (I-chain) protein and the 2-chain protein. 60
The latter i. proteolytically derived rrom thc l-chain
compound. It II Iheorized thaI Ihe 2-eha1n proleln it
JUsocialed with produced fibrin and that proteolytic:
conversion from I· to 2· chain material occan at the
locus of the convenion or plumino,en to plaamin. The "
pretent invenlion provides for Ihe adminlstratioll of tbe
I-chain protein ror in vivo converalon II JllIt described
or (or the administration or 2-chaln protein. which hu

rrom

bein,

or

2:..10

6

also been shown to be active. The 2-cbain prolein can
be prepared by in vitro proteolytic conveniion afler the
l-chain material is produced. A so-called "kringle" area
is positioned upstreaftl Crom the serine protease portion
and is believed to play an important function in binding
the tisaue plaurlinoaen activator hereof to a fibrin ma·
em; hence. the observed specific activily ohhe present
lislue plumlnopn activalor loward tanaible. extant
IhrombL The tisaue plumino,en activator hereof is
produced containln, the enzymatically aclive portion
corrapcmdiq to Dlllive malerial aad the term human
tisaue plumiDopn ICtivator defina producll compris.
ina I\ICh poniun alone or loaether wilh additional
amino ICId Mq'IIeIlCa up to the Mllen,ch molecule.
To aummarize ID the presenlinvenlion, human I·PA
diu baa a fwIcdona1 deftnidon; it II capable of catalyz·
ID, the coaveraioa or pluminoaen 10 plumin. binds to
ftbrin, and II cIaulned u a I·PA baaed on Immunologi.
cal propertia u leI forth hereinabove.
"Eucntlally pure form" when·1IICd 10 dese::ribe the
llate hUIIIlD I-PA produced by the Invention means
rree or protein or olher materials normally associated
with human t·PA when produced by non-recombinant
celb, I.e. in Its "native" environmenl.
"DHFR protein" refen 10 a protein which is capBble
of the activity uaociated wilh dihydrorolale reductllSe
(DHFR) and which. therefore. II required to be pro
d1lCed by cells which are capable of survival on medium
def1cien1 in hypounthine. ,Iycine. and thymidine
(·HOT medium). In ,eneral. cells lackina DHFR pro·
teln are incapable of ,rowin, on this medium. cells
which contain DHFR protein are luccessful in doing

or

10.

"Ce1l1lClUitive 10 MTX" rerera 10 cells which ore
Incapable of &fOwin, on media which contain the
DHFR InhibilDr melhotreule (MTX). Thus. "cells
lCI1Iitiye to MTX" are cells which. unless ,enolically
altered or olhcrwllC supplemented. will fail to grow
under amblenl and medium conditions suitable for lhe
cell type when the MTX concenlration IJ 0.2 Jj.g/ml or
more. Some celb, luch u bacteria. fail to exhibil MTX
ICnsitivity due ID Iheir failure to permit MTX Inside
lheir cell boundaries. even Iho\llh they conlain DHfR
which would otherwise be lenlitive 10 thi. drug. In
,enera1. cells which contain. as their DHFR protein.
wild Iype DHFR will be lenlillve to methotrexate if
they are permeable or capable or uptake with respect to
MTX.
"Wild type DHFR" refen to dihydrofolate reductAse
U II ordinarily found Inlhe particular or,anism in ques
tioa. Wild type DHFR is ,eneraJly aenaitive in vitro to
low concenIratioDl of methotrelWe.
"DHR pro&cin with low bindlnl amnily for MTX"
hu • f\anctional definition. Thit i. a DHFR prolein
which, when ,enera,ed within cella, will permit the
lI'OW1h or MTX IClUitive cella In a medium containing
0.1 "'Jlml or more MTX. II it reco,nized that such II
f\anc:lional deflDidon dependl on the facility with which
Ihe oraanilm produces the "DHFR proleln with low
blndln, aIIlnity ror MTX" u well u upon the protein
IlIClf. Howcver. u IIICd in the context of thi. invention.
.gch a balance belween Ihese two mechanisms should
nol be troublesome. The Invenlion operates with reo
specl to confemn, the capability of surviving Ihese:
levels or MTX. and h is nol conlequential whelher the
ability to do 10 II impacled by increased exprenion in
addidon 10 Ihe inRlte nalure of the DHFR produced. A
convenient DHFR protein which fiu Ihis definition is

or
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disclosed in U.s. Appl. Ser. No. 459,151, med Jan. 19,
1983. now abandoned. inc;orporated herein by referen~.

"Eapression vector" includes veclon which are ca·
or elpmsin, DNA seqw:nc:es c;ontaiAed therein, 5
wh=re such sequences are operably llsWd to other leo
quences capable of efl'ccUq their apreuioL It is 1m.
plied. althou,h DOt always uplicitly Slated. that these
elpression vecton must be replicable in the holt OrpDisms tither u cpiIomes or u III Jntep part or.lhe 10
chromOlOmal DNA. Clearly a lack 01 rep1IcabilIty
would render them effectively Iaoperable. In lum, "a·
pression vector" II pven a ftmcdonal deftDidoto. and
lUIy DNA sequence whk:h II capable 01 efl'ectIn, u· .
presaion or a specified DNA code dilpoeed dIereiD iI IS
included In this Icrm u it iI applied to die specIfted
sequence. In pmcral. ellpnaioa YeCton or .tUlty III
recombinant DNA technlqllllil are onen in the rona 01
"plasmlcb" whk:h rerer to circular· double stranded
DNA loopt whleh. in their vectOr rorm are DOl bolllld 20
to the chromosome. In Ihe present lpeclf1cation, "plumid" and "vector" are v.sed Interchaqeably u the
plasmid is the moll commonly v.sed form or vector.
However. the Invention Is intended to IAclude luch
other forml of expression vecton which IeNe cqulva. 15
lent functions and which become known In the art 1Ilbsequently hereto.
"Recombinant bOlt cells" refen to ceUI which have
been transrormed with vecton conatl'l.lCted uain, recombinant DNA techniques. AI deli.ned llerlin. I·PA II 30
produced In tbe amoun" achieved by winuc or this
transformation. rather than III au.ch I...... IIDOWltl, or.
more commonly. in IlM:h IClithan detectable IIDOWltl,
as misht be prodllCCd by the Wllrud'ormed hOlt. I·PA
produced by IlM:h celli can be referred to u "recombl· :t,
nant t·PA",
B. HOlt Cell Cultures and Vecton
The vectOR and methods d\lcloeed herein are luitLIb Ie for uae In hoIl ceUI over a wide I'IIlJC or prokary·
otic and eulwy911c orpnilma.
40
In leneral. 01 coune, prolwyotes are preferred for
cioninl of DNA seqllencct In conatl'l.lClin. the vecton
wscful in the Invention. For e.umple. E. coli K 12 Itrain
294 (ATCC No. 31446) Is particularly uaeM. Other
microbial Itfaina which may be v.sed include E. coil 45
5Ir;!in. luch u E. roll D, and E. coil Xl176 (ATCC No.
) 1537). Thac eumpla arc, of counc. intended to be
illustrative ratber than IImltln,.
Prokaryota may also be v.sed ror eapreuion. The
aforementioned Itraln&, u well as B. coil W3110 50
(F - ,A -. protOtrophic. ATCC No. 21325), "-cUll IlM:h
:IS BtlcllllU l",btillU. and other enterobt.cterllceae au.ch u
Sa/mo"tlill typ/tilflllrl"'IfI or S,,.,.,,tfll lrutn:lftlfNl. and
various ptClldomonas tpCCiea may be v.sed.
In leneral. plasmid vecton containin, repllcon and 55
conlrol aequcncct which are derived rrom .pccla com·
pillible with the hOlt cell are v.sed In connection with
these hOlII. The vector ordinarily carries a repllcatlon
site. u well as maridn'lIeqllenclII which are capable of
providin& phenotypic Mlectlon in tranafol"lMd celli. 60
For example. E. coil II typk:ally tranalormed lllina
pBR322. a plumid derived from an E. rolllpccics (Boll·
var. et al.. Gt"t 2: 95 (1977». pDR311 contalna ,enes (or
nmpicillin and tetracycline resistance and thua provides
ellS), mlllni rOr identifyin, transformed cells. The 65
pBR312 plumld. or other microbial plumld must also
conlilio. or be modificd to contain. promoten which
CAn be uled by the microbill arlanilm ror ClprCllion of
p~ble
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itsowa proteins. Those promolen most commonly used
in recombinant DNA c;onstNclion include the ,,·Iacla·
mae (peni.cllUnase) and lactose promoter systems
(Chana et al, NalllN. 275: 617 (1978); hakura. ct III.
SdlIICf. 191: 1056 (1977); (Goeddel. et al NlIl",n 281:
544 (1979» and a tryptophan (trp) promoter system
(Ooedclel. ct ai, Nile/fie Acids Ru. I: 04057 (1980); EPO
Appl hbI No. 0036776). While these are the most com
mol'lly ..... other microbial promoten have been discovered IIIId \d:ilized. and details c;oncemin, their nucle·
odde tequeoca bave bca pllbllsbed. enablln, a s'killed
worker to Daate them f\mctiollally with plumid vcc:tors
(StdIeI'IIIat. et al, Q/120: 269 (1980».
hi Iddldoft to prokaryotes, e.lwyotic microbes. such
u yeIId ClIItva may abo be used. SlI«hllromycu ctmi·
. . or 00IDDl0Il baker's yeat is the moat commonly
IIIId
nkaryodc mic:roor,aniams. altbollsh a
l18mber or other ItraIna are commonly available. For
upr.ioa III SlI«.wI'Wlt~ the plumid YRp7, for
uample. (Sdnc:hcomb. It al. NlIt",,.. 282: 39 (1979);
Ki.npman et al. Ofll" .7: 141 (1979): Tsehemper. et Ill.
Ofll'. 10: 151 (1980» is commonly uled. This plasmid
already containlthe Irpl,ene whlcb provides a Idec::·
lion marker ror a mutant atrain or yeast tacking the
ability to ,row in tryptophan. for example ATCC No.
44016 ar PEP4-1 (Jones. Gtlltlia. 8S: 12 (1977». The
presence of tbe ttpl lClion u a cbaracteristic of Ihe
yeut hOlt cell ,enome then provides an effective en'lj·
ronmcnt for detectin, tranlrormation by srowtb in the
ablence or Iryptophan.
Suitable promotin, llequcnces In yeast vcc:ton in·
clude the promoten for 3-pboaphollyc::erale kinase
(HItzeman. ct al.. J. BloL Chtm.. 255: 12073 (1980» or
other .Iycolytic enzymes (H.... el al. J. Ad.,. E1Izyme
R".• 7: 149 (1961); Holland. et aI. Bi,dtmulry. 17: 4900
(1971»' au.ch u enolue. ,lyceraldehyde.J·phosphate
dehydrolenue. hellokinase. pYNnte decarbolylase.
pholphofl'l.lCtokinase. ,lucQIC.6-pbosphale isomerllse.
3·pholpho,lycerate mutuc. pYNvate kinase. triose
pbolphate isomerase. phOlpho,lucole IIomerase. and
.luoo1dnuc. In conatn&etinl luitable expression pins
mida, the tennination llequences uaociated with these
.enes are allO Il.ated inlo the expression vector 3' of the
IcqIlCftCe dairtd to be npresled to provide polyadeny
ladon or the mRNA and termination. Other promoters.
which have tile additional advantale of transcription
controlled by ,rowth conditionl are the promoter reIlona ror alc;ohol dehydrollnue 2. Isocytochrome C.
acid pbolphatuc. de,radatlve enlymlll uaociated with
nitroan metaboillm. and the aforementioned Ilyce
,raldehyde-J.phOlphate dehydro,CIWe. and enzymes
reaponalble ror maltOle and plactOIC utlllution (HoI
laneS. ibid.). An)' plumld vcctor c;ontainin, ycut·com·
patlble promoter. oripn of replication and termination
teqllCftCll 110 Iultable.
In Iddition to microorpnilma. cultures or cellI de
rived
muillcellular orpniaml may allO be uaed as
boa", In principle. any IlM:h cell cullure is workable.
whether from vertebrate or Invenebrate culture. How·
ever IIlterlllt hu been ,reatest In venebrale cells, Ilnd
propoptlon or venebrale cell. In culture (tissue cui·
lure) hu become a routine proccdllre in recenl years
[TWII' C"'/tllN. Academic Prcsa. KNIe and Patterson.
editon (1973»). Eumples of Illch uaet\al host cell lines
are VERO and HeLa cella. Chinese hamster ovary
(CHO) cell lines. and W131. DHK. COS-7 and MOCK
cell lin... Elprcsaion vecton for .uch cellI ordinarily
IAclude (if necessary) an ori,in of replication. a pro-
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moter located in rront of the aene 10 be expressed, alona
with any necessary ribosome bindin, sites., RNA splice
sites. polyldenylation site, mel trInICriptioDal terminalor sequences.
For use ill mammalian cells, the controll\mctiolll on
the expression vectors are onea provided bl vinJ material. For eu.mple, comm.oaJy used pl'OlllOla'l are derived from polyoma, AdCllOviM 2, mel !DOlt frequently
Simian Vinas <to (SV<to). The ..,ly and late procnotctl
o( SV40 vinas are pudcvlatly uef\Il becallle bolh are
obtained easily (rom the viM II • !tqmaat wlUcb allO
contalnl the SV40 viral orIaia of repllcatioD (Fieri, et
ai, Nfl"'" 273: 113 (1971) lDcorponted beteID by rererencc. Smaller or Jarac r SV<to ft'aamenca IDlY abo be
used, provided there Is Included the appromaately 250
bp sequence extendlnal'rom the HInd III alte toward the
BSII alle located In the viral orIain ofrepUcadon. Pur.
•
•
.A.
_1_ I
r.l1'_.
ther. It b also pouable, and ... u:n d .......b e. to u. -promoter or control sequ.cnces IIOf'Il\aIly ISIOCllted
. h h d-'.......
Yided uch
t I
Wit t e """' .... acDC.seqUence. pro
I
con ro
sequenc:a are compatible with the host cell I~teml.
An orl~ln of replication may .be provided ather by
co.n~u·\lCtion or the vector to IDctLide an exolenous
Qnlln. such as may be derived rrom SV40 or other viral
(e·l· Pol,Yom.. Adeno. VSV, BPV. etc.) 1OIU'Ce, or may
be provided by the host cell cbromOIOmal replk:atlon
mechanllm. If !he veclor Is Intearated Into the hOlt cell
c;hromOlOn,w. !he latter II often ",mclent.
In selccllnl a preferred bOlt cell (or tranalection by
the vectors or !he Invention which compriM DNA
lICquences enccdlna both ,·PA ad DHPR. protcin.1t Is
appropriate to aelect the bott aecordina to the type or
DHFR. prolein employed.lfwUd type DHFR. protein II
employed, It II prefcnble to Mlecl a host cell which II
deficient In DHPR, thus permitina !he use or the
DHFR. codlna sequence u a marker ror .ucceul\ll
transrection In selective medium which lacu hypounIhine. aJyclne, and thymidine. An appropriate host cell
in this cue II !he Chinese Iwnatcr ovary (CHO) cell line
deficient in DHFR activity, prepared and propeaated as
described by Urlaub and Chuin, hocl. N~tl. Aca:L St,
(USA) 11: 4216 (1980), Incorporated hereill by refer·
cnce.
On the other hand, If DHFR. protein with low blndin, amnily for MTX II used u the controllin, JCquencc.
it Is not tICCCIII&f)' to 11M DHPR. de&lent cells.. a.eallM
Ihe mutant DHFR. Is ra.latant to methotreuce, MTX
contalnlna media can be \lied u a means or MIec:t1on
provided that the host cells are themaclvea melhotrell·
ale ICIIIitive. MOlt eulr.aryotic cells which are capable of
absorblna MTX appear to be mcIhotreute ICIIIitlve.
OnCluch usef'lli cell line lIa CHO line. CH()'XJ ATCC
No. CCL 61.
Eumplct which are sel rorth her:einbelow describe
use of E.. coil uslnl the lac and up promoter I)'Item and
usc or CHO celli II hOlt cells, and eJlpraaion vecton
which include the SV40 ortaln of replication u a promoter. However. It would be well withln the 1k.i11 ofthe
an to use anaJoJOus techniques to conatnac:t eaprealon
vec;lon for ,Jlpreulon or desired protein JCquences In
ahemadve prouryotlc or .ulr.aryotlc holt cell culturea.
Salillactory amounts 01 human t-PA are produced by
cell cultures. bowever.laterreflnemenll usln,alCCOnd·
ary codlna JCquence Nrve 10 enhance production I.vell
even funher. The 1IC0ndary codlnl seqvcnc:e com·
prises dihydrorolate reductase (DHFR.) which II ar·
feeted by an ealemally controlled parameter, luch ...
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methoU'UAte. thus permiuina control of expr~ion by
control of the methotreute (MTX) conceniratlon.
C. Methods Employed
If cells withovt rormidable .ceU membrane barriers
are \lied as holt cells, tnnsf'cctIoD Is carried out by the
calcium pbOlpMte precipitation method as described by
GrIham. aad Vu der Eb, YlI'Vioo. ~2: 456 (1913). However, other m.edlods for iDtroducma .DNA into cells
IUCh as by aucl.., .oon or by protoplast (usion Imly
abo be \&Md.
•••
tr prokaryodc cells or cella which conwn .ubnanual
cell wall COM~tiOl\l are \lied, the ~rererred melhod
of traMfcctl~lI II c:alclvm tratment VIUla calcium chlo
ride as dacnbed by Cohen. P. N. et aI Prcc. Natl. Acad.
Sd. (USA), ~9: 2110 (1912).
.•
ConatnlC:ltiOn of Iwtable vectors containln, the dealred codIq and .conlrol seqllences employ standard
lipdon techrdques. IlOlated plasmldl or DNA fmB'
ments are cleaved, tailored, and relillted In the form
d-....... t r
th I
...t_
.......
.......... 0 lorm e p ami.... reqWI""'.
Cleavaae II perf'ormed by treatina with restriction
enzyme (or enyunes) In suitable buffer. In general.
about I "I plasmid or DNA fralments is used with
about I unit orenzyme in aboul 20 "I of buffer solution.
(Appropriate buffers and su.bstrate amountt for particu.
lar reatriction enzymes are .pccified by the manufnc·
turer.) Incubation times or about 1 hour al 37' C. orc
workable. After Incubations. protein is removed by
extraction with phenol and chlorororm. and the nuclcic
acid II recovered from the aqueous rrac;tion by precipi.
tation with ethanol.
If blunt endl are required. the preparation is treAted
for .., minutes at 15' C. with 10 u.nits of Polymerase I
(Xlcnow), phenol-ehlorororm extracted, and elhanol
precipitated.
Size aeparatlon or the cleaved rraaments il perrormed
lllina 6 percent polyacrylamide ael described by Goed·
del. D., et ai, Nllc/tic Acids Ru.. 8: 4051 (1980) iru::orpo'
rated herein by reference.
Por Uaatlon approllil'l'Ulteiy equimolar amounU of Ihe:
desired component&, Iwtably end tailored to provide
correct matchina are trealed wilh about 10 units T4
DNA lIa- per
"a DNA. (When cleaved 'veClOn
are used u component&, It may be useful 10 prevent
rellptlon or the cleaved veclor by pretreatment with
bacterial alkaline phOlphat_.)
For analysll to confirm correct sequencel in plasmids
COIIICl'1ICted. the lIaatlon mbtvrea are used to transform
B. to/I X12 Itrain 294 (ATCC 310446), and .ucceuful
tranaformants selected by ampicillin or letracycline
reslltance where appropriate. Plasmid. rrom the Irans·
(ormanll are prepared. analyzed by rest ric lion and/or
sequenced by !he method or Meulna. et al. Nucleic
Acids Ra. 9:309 (1911) or by the method or Maxam. el
al, Mtlltods i" ElUJ'mDloo. 65:499 (1980).
Ampl11lcatlon or DHFR. protein cod ina sequences is
effected by arowina hOlt cell culturea in the presence or
approdmacely 20-500,000 11M concentrations of melho
treUle, a competitive inhibitor or DHFR. activity. The:
effective ranle or concentration II hlahly dependent. or
eou.... upon the nature or the DHFR. lene. protein and
the charactetlstica of the hOlIt. Clearly. aenerally de·
lined upper and lower limits cannot be asc:ertaincd.
Suitable concentratlonl of other rollc acid analogs or
ocher eompoundl which Inhibit DHFR. eould_ also be
used. MTX itsellil. however, convenient. readily avail
able and effective.
D. Oeneral Deacriptlon or Preferred Embodiments
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Human tiuue plasmino,Cft activator was obtained
acc:ordin, to the roUowin, protocol:
I. HWIlan melanoma !;ells actively producin, tissue
plasmino,en activator were cultlUld 10 COIIIIucncy.
2. Cell pellets from luch ceO cu1tW'tl were utracted in
the presence or ribonuclease Inhibiton to iIolaae all
cytoplasmic RNA.
3. An oll,o-dT c:olwnn iIolaaed lhe lotal '!Ieaenaer
RNA ~mR.NA).1n polYat.H:nylaaed torm. ThiI mRNA
was me ~ed taIUII add·u.rea Ipmsc lei
electrophore:uL
4. The ,el trlCCioa cOIIllinin, tiuue plasmiaoJCft acdvllor apeciflc RNA was identified bI the rol:owina
manner: The RNA fromachortbead tr.cdon.l was
translated in I rabbil reliculocyte lysate in vitro aya.
tem lupplemcllted with doa pancreas 1Ilfc:rC*)ma.
The rauJtIna translation products were thea 1m.
munoprecipltatcd with bwnaa tluue pluminopa
activator apedfIc laO lUIti'body.
.5. The appropriate RNA (21 to 24S) was convened to
~orrapondlna 1in,IIIll'aDdcd c:ornplementary DNA
(eDNA) trom wllich was produced double Itra.ndcd
(;DNA. Arter poly-dC tailia•• It WII inMncd Into a
vector, luch III pwmld barin, one or more phenotypic marken.
6. The thus prepared vectol'l were \tied to trallltorm
bacterial cells providln, I cloned cDNA library. A
pool ot nldlolabeled Iyntbetlc cleolY oli,ollocleodda
complementary to codona for knowa amino acid
sequenca In I·PA. such II, ror example the pool o( I
l4-mers.

.
(complementary 10 seq~CII cedln, for the known-see. Infra-:-amlno acid MqllCnee: trypIOP~glutannc acid-t)'1"Oline-cyateine -aspanlc lCid
(W-E-Y:C-D) was prepared and \tied to probe the
colony library.
1. From the positive cDNA clona plumid DNA wu
i!lOll.led a.nd .q e ced
8. The sequenced uDNA ·encodln. t.PA was then tal.
lored in vitro for InIenlon Into an appropriate up.....
lion vehicle whlch WII UICd 10 lransrorm lUI appropriate host !;ell. which WII, In tum. pennilted to
,row In a culture and to produce the desired human
tilluc plasmlno,en activator.
9. Human tlilue plaamino,en activator thus produced
baa CL 251 amino acidl blltslUyrnatlc ICriac prote.
aac ponion and a "krinaJe" contalnin, ICqIlCDCl upatream Ihere(rom which II praently believed to be
responaible ror ftbrin blndln,. The mature protein
plUl Itlsl,na! PfCleqUCftCC. totall '62 amino addI.
The (oreaoin, proccdlll'l. in ItlClf. la lucceuruJ In
producin, pure t.PA. Methods or the Inventloft em.
ployin, an Iddiliona! codin, tequence ICnIidve to
melhotreute permit the prodoctlon In holt cell cultura
of anti,enically aclive t.PA prolein In amounts peater
than 0.1 PI per cell per day. With suitable application of
lImplifyin, conditions, amountsarca1er than 20 p, per
cell per day can be obtained. Stated In alternate lemu.
gene clI.pretlion level. raultln, In production or more
than 9x 10- 6 Plou,h unlu. per cell per day or, wlrh
suitable amplification. morc than II X 10- 4 Plou,h units
per cell per day of I-PA 1C1Ivlt)' are IChleved.
Advanta,e is taken In this llpeet or lbe Invent loa of
melholreute as a drv, wblch. wblle normally fatal to
celli capabl, or III uplIke. permlll cells to ,row in the

,

10

15

::0

2'

30

l5

40

..,

50

"

60

U

12

prescn!;e or controlled leyels or MTX by amplification
or the sene COtlin, for tbe DHFR coding sequence
(Schimke. Raben T. et ai, Sei",«, 202: 10,. (l978);
Biedler, J. L. el aI. 0,11«1' Ru. 31: 1'3 (1972): Chang, S.
E, et aI. e.l, 7: 391 (1976».
..
Ofimponance to tbil aspect or the Invention is the
showiq that ampHftcttion orlbe ,ene ror DHFR may
caue ampliftcttion or auociated .quences which code
ror other proteins. ThiI appeara to be the case when the
auoclaled protein la hepatitll B surtace antigen
•
J
(HBaAa) (Cbriatman. • II aI. ~ NatL ACQQ. s.ci.. 79:
1115 (1912». Ihe /l. coil prolem XOPRT (RIngold.
00nI0n. II aI. J. M_ Gild AppL Gtlt.. I: 16$ (1981));
_lUI endo,lIIous.quence t'rom a DHFlVSV40 pillS'
mid combiutloll (JCau~ R. F. et al, J. Mol«. 8iol.
1$9: flO! (1911».
Other mecbutillilt ror contertin, methotrexate resist
taace bldude diminution or the bindin, amnity of the
DHR protein. 10 that It 1,leu luxepdble to methow
treutl (Flintofl', W. F. It aI. ,somill. c.ll G~n'L. 2: 245
(1916» but III this instanCI. amplification appean to
occur II well.
It would appeal' that the ,enes both for wild type
DHR a.nd tor DHR which is resillant to MTX by
virtue of its own decreased bindln, capacity are ampli·
fted by tbe pmcnce of MTX. Hence. in principle, this
upeel or lha iIlv_1Ion herein concern, using the impact
or DHFJl.quence amplification on wociated protein
codln, MqueDCII to provide a control mechanism
which pennits enhanced expression levels of t·PA sew
quenca iA the pmcncc or MTX. or by vinue of prior
treatmenl or tnnsCormed !;ells with MTX.
E. Ewnpla
The rollowln, eumpla are Intended to illustrate but
nol to limit the invention. In the eumpln here an E. Coli
hOlt cuJtlll'l and a CHO cell line luitable for the type or
DHFR protein codin,.quence to be Introduced were:
employed II bolt cell cultures. However, other eukary.
Ie .M.I 100__' II
. bl ~ h
h d r
ot ...... P~"'.I'otlC ce I are IUlta e .or t e met 0 0
the InventlOD u well.
E.I Exp~lon otthe Human ,-PA Oene in E. coli
EI.A fl.url Leaendl
FlO. 1 is an autoradlo,rll!' ~"a 10 r,rcent S~S ~lIge
dllplayb!, the lmmunopreclpltaled ( S).methlonlone:
labeled prot.cln<l) ICCreted rrom human melanomll cells
durin,I1 hour pulle III vivo. In Ihe presence (lane b) or
ablencc (lane I.) or the proteaac inhibitor aprotinin.
After illUllunoprecipitation with tluue piliminogen
activator lpeelftc laO. three bands were observed (lline
a) havln, moJecuIar Wei,hts or approximately 65,000.
61.000 _3'.000. III the pmcnce or Ihe proleaac Inhib
lcor, however. no 35,000 molecular welSh! species is
obierved. No products are lmtnunoprecipitlted when
prcImmWIC ICrWIIII UICd (lane c). The migrations lind
molecular wci,hts or 14(:. labelled protein standards arc
shown to the left or lane L
FlO. 2 cleplctl the ,el electrophoresi. of the immuno
precipitated tnInIlatlon products of RNA fractiona iso·
lated rram an ICId u.rea &JIrOIC ,el. A major band was
oblerved In rrlCtion aumbenl 7 and 8 aner translation in
the presenr.c or do, pancreas microlOma followed by
Immune precipitation with tillue plasmino.en Ictivator
apeelrlc J,a. Tbil ba.nd hAl I. moleeular weight of ap·
prolimately 63.000 dalton" The liu of the mRNA
mi,rl.tia, I.a rractions 7 and I II approll.lmately :z I 10
245. The posilions or ribosomal RNA markers which
were determined after electrophornil on the RNA urea
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FIG. 15 is • schematic diapun of the construction of
a tissue ptasmiDopn activator ellpression plasmid
pARIPA·. The SlII'tin, plumid pPA25EI0 was lirst
di&ated with P,d to bolate a 376 lip. (raiment Ihat was
, then cIlaated as shoW1'l in the fllUfe.
FIG. 7 shows the reswt
a fibrin plate assay for
»P-dTCtaJCA~)TA(f)TCCCA(W-E-Y-C:-D)
ftllriaolytic activity o( the tllpression product obtained
• •
.
via pAlUPA' In traurormed cells.
FIG. • is III HPLC trace or peptides (rom tissllc
Pt?be.. 96 indIvidual U'IaII'OI"llWlU were ,roW1'l III a
lNCrotlter plate, replica plated UId powa OD a nitrocel· 10 plumlnopD lICtivator (hereof) trypsin diaest (Absor'
1~lose membrano. The colonia were then lyaed, bactebance at 210 IUD). The arrow identifies the peak corre·
nal DNA Ihed and the fIIten were hybridized with the
spondirI. to the peptide used. to deslan the nucleotide
llP·I4-mer (W·E-Y-C·D) probes. The tUterl were
probe \lied with the colony library. The peptide repre·
_ted by this peak was found to have the entire se·
washed to remove 1I0nhybridized probllllld expDIIed to
X·ray film. ~ autoradlopam It representative o( the " queace: LoT.W.E Y-C o.V.P-S-C-S·T.CG·L. The
pattema obtained wl&h 4Ilndtvldual fIIten (4«10 Indeother auYor peaks Ilkewile were sequenced and found
to confirm the correct amino sequence of human tissue
pendent colonia). All example or a poIltive tIsIue plumlno,en activator cDNA clone on fUcer number U Ia
plumbtopn activator. The peptide one leiter code
referrlnl to amino acid deslanations II II rollows:
labened u EIO (arrow).
FIG.• Is a restricdon endonucleue map or the Full 20
lenlth human tblue plumlno,en activator cDNA. The
bol",,~ln.
number and Iize o( frqmenll produced by restriction
AJp
D
A....nit: ",,14
lie
t
endonucleue cleava,e WII atlmated by cIectrophore.
'tlor
T
Tlu:_1M
u~
L
u ...inc
I. P
. io
r'
Set
S
Striae
T)'I'
Y
TytDIinc
III t h roulh 6 percent acry1amIdI p... cliln ns 0 uta
Ol~
I
Ol.._it: Kid
PIle
F
Phenylalanin.
were conftrmed by nucleic acid sequeace (preaented In 2S ""'
P
Prall..
HII
H
Hillidine
FlG. .I). The codlD, reFon or the Iar...t open radin,
(1),
0
OIJCIM
L)'I
It
Lylinc
(rame Is boled and the hatched reJion repraenll the
Ala
A
AIMIM
Ara"
Arlinine
putative "anal peptide sequence while the Idpled rea
C)'I
C
C)'IIIiM
Trp
W
Trypto~h.n
.
•
VII
V
VIlIM
0111
Q
Olullm,n.
lion repraenll the putative matlln! tblue plumlno,en
Net
to(
MtlhionlM
Am
N
Alp....in.
activator sequence ('27 amino IClda). The " end or the 30
mRNA II to the left while the 3' end II to the ript.
. '
FIGS. SA, 58. and 5C UIliltrate the nucleotide..
FIG. 9 depicu the constructIOn of & plasn: ld coding
ror the direct expreuioo or mature human lI~sue pIns·
quence and dedllCed amino acid sequence o( the fun
leolth human tluue pluminopn acdvator cDNA The
mlnolen activator in E. coIL 50 1" or pillmid pPAl7
3' amino acid. (-35 to _I) precedin, the rnatu;' . . 3S wu dl,ated with 5&u3AI. HinclJ and Hhat and elcc·
trop~oreud on a 6 percent polyacrylamide gel. Ap·
quence is depicted as an uninterrupted sequence. It II
believed thai this .l5.amIno acid acquence Ia comprised
prolUmately
orthe " bp Sau3At·Hhal fragmcn!
of a hydrophilic "pro" acquence, precedin, IIoerine (+ 1)
wu recovered. Similarly. approx~lIelY l f.Li of the 263
or the mature protein or about 12 to I' amino acids, In
bp Hhal·Narl (raament wu punned from 80 f.LB or
turn preceded by. "~nventional" hydrophobic alpal 40 clone pPA25BI0 by .nnt.lsolat~nl a 300 lip ~sd.Nnr!
(e:uendin, ,'to - 3'). ThIs type or pre-pro .It'UCture on
rrqment and then dl,Htlna thl. rra,ment with HhaI.
All dl,all were performed at 37' C. for I hour and the
ICCreted proteiftl hal been dacribcd prevloUlly, e.,.
reaction prod'UClI resolved and electr~l~ted from 6
with preproalbumin. AIIumlo, this theory, all or the
ICCreted l\uue plumino,en activator molccwa will
percent polYlCrylamlde ,els. The two lndu:ated dco~·
SW1 with the IIoerine (+ 1) as the amino-tarmina A ., yoll,on'UCleotida
"
dAATTCATOTCTTAT·
ICCOnd theory II that the hydrophIlic sequence could be
CAAGT (I) and " GATCACTTGAT AAGACATO
involved with the rllnction ortluue pluminolen ICtlva.
(II) were Iynthalzed by the lOUd phue phosphotric:sler
method (51). 100 pmole or oli,onllCleotide II WILS phos
tor In a manner anaIo,OIll to that obIerved with pJu.
minolen where a peptide or 10.000 daltons can'"
phorylated In a 30 ,,1 reaction mixture containing 60
cleaved (rom the amino termlnaJ ponlon ofnativ. pJu. 50 mM Tria (pH 1),10 mM M,Ch. 15 mM p·mercaptoe·
mino,en (Olu·pJuminopn. named for the amino tennlthanel and 50 "CI [yllP)ATP (Amenham 5,000 Ci
nat ralduc). resultln,in alllUlller molecule, with alteW
mmol- I) 12 unlll of T4 polynucleotide kinase were
amino lerminUl, desi,nated Lys-pJumIno,en. Lys-pJu.
lidded and the reaction allowed to proceed at 37' C. for
minoaen II more cuily activated to plumin, and alto
" min. One '" or 10 mM ATP and 11 units ofn kiM.e
}w a ,realer amnlty ror nbrin than Glu plumiDolen. 55 were then Idded and the reaction allOwed 10 proceed
for an Iddltional 30 min. Alter phenol/CHCb elt(rac·
Plasmin hal been thown to catatyu the convenion of
OIu· to LYI.plumlno,en. Thil type or control mecha.
tlon, the photphoryllted oll,omer II and the 5' hy·
drollyl oll,omer I were combined wilh 0.' f.Li of the
nl.m mulll in a "poeilive feedback" meclwdam. The
lint amounll of plumln rormed. beside de,radin, ft·
eluted" bp Sau3AI-Hhal rralment and 2 Jl.1 of the 263
brin. allO result In the ,enention of plumlnoaen mole- 60 bp Hhal·Nul rr.ament and ethanol precipitated. These
cules which are more cully ICtivated. and abo bind
rrapen" were Ii,lted at room temperature for 4 hour;
tilhter to their tubltr.te, than native pJumIno,en. The
In 60 '" or 20 mM Tri..HCI (pH 7.'), 10 mM MiCh. 10
result is. futer de,radation of fibrin. The hydrophilic
mM dlthlotbreltol. 0.' mM ATP and 1000 units of To!
peptide or tlMue plumino,en ICllv.tor could.,. In·
DNA lipse. The multure wu dl,ested ror I hour wi!h
volved In a .lmUar mechanism. III clcava,e raultin, in " 41 unlll of Nul. 20 unlll or EcoRI and 40 unit. of BEll i
modilled bind In. Or thl Inayml to nbrln. In any evml
(10 IlImlnace polymlrlution throu,h lI,atlon of c:ohc·
the 3' amino ICld sequence II coftlidered. presequence
live Sau3AI terminI) and electrophoresed on a 6 perof the maCure protein.
cent pI. The 331 bp product (approximately 0.1 ,.,.B)
ael and visualized by etbidiwn bromide stalnln, are
labeled above the appropriate pI lanes.
FIG. 3 displays the hybridiution pattern or 96 colonies with
.
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was recovered by e1ectroe1ution. The remainder of the
precipitated pfodUC1S were displayed by electrophoresis
I-PA codin, seqUCDCCS (ammo Kids 111-511) were
Oft a 10 pen:eat SDs.ac:rylamide leI. The slab ael was
rued, dried aDd subjected to OllOro.raphy.
isolaled on a 1645 bp fra,ment by di,estiq plasmid
pPA2jEIO with Narl and BalIl. The· plasmid pLeI·
E.1.e Meueuaer RNA IsolatioD IDd Size Fractionation
FAtrpl03 is a derivacive of the plasmid pLelFAl5 (52) STotal RNA from mellDOm& cell cultures was exin which the EcolU site distal to the LeIF A aeoe bas
tracted eucndally IS reported by Ward et aI. (55). Cells
l:1:cn removed (53). Three VI or pLeIFAtrplOl were
were peJletcd by CCDtrifUptioo and then resuspended in
digested with 20 Wliu or£coRI and 20 1Iftks or Blillfor
10 mM NaCI, 10 mM Tris-HCl pH 7.!I.
mM MaCh.
90 min. at 37" C.• e1eccrophorelCd on a 6 perc:CD1 polyCells were lyad by the addition o( NP-40 (I percenl
:lcrylamide le1ud tile larp ( -4.200 bp) vector fraa- 10 final cooc;atratiaD), and ftuclei were pelleted by cen·
ment was recovered by e1ectroehadoD. For the IInaI
trifUpdoD. '1'he supem&Wlt contained the total RNA
construction. 80 na of EcolU.BIIII pLeIFAtrp103 was
wJdcb WIll ftutber purified by-mwtiple phenol and chic
roform.trIICtioIu. The aqueolll phue was made 0.2 M
li!l:lted with 100 al or the 164!1 bp Narl B,UI rr..-t
ill NaCllDd tJ:aea total RNA was precipitated by the
ar.d 20 nl or the 331 bp £coRI·Narl I'rapIoeDt for 10
hOUD at room tcmpcmure. This Uption IIIixIare was I' addition of two volumes of elhanoL Olilo-dT cellulose
used to lI"IIIII'orm B. coil K-12 StraiD 2M. PIatmid DNA
cbrolllollOlfIPIa:y WllllIdlized to puriry mIlNA from the
WIIS prepared rrom 31 or theM tranatOl'lD&DtI IDd ditotal RNA prepe.radoftI (54). Tfl)ical yields from 10
gelted with EcolU. Tea ofthae plumic:lacontalned the
Jr&IDI of cultured melanoma cells were' to 10 milli
de:lired 600 bp and 471 bp EcolU fraammts. DNA
Jr&IDI ortotalRNA and 50-200 mieroaraml of Poly(A)
sequence analysia verified tbat ODC or thCM ptumida :10 plUl dNA.
(pl-PAtrpI2) had the desired nudeotlde Mquence at the
FractionatioD or PolyA + dNA (200 Ill> ('6) was
junclions between the trp promoter, Iynthetic DNA
performed by electrophoresis throulh urea-a,arose
.lnd eDNA.
-lela. The Ilab aptOlC lel(.57, ,a) was composed or
flO. 10 &hOWl the result or a fibrin plate .....y ror
pen;:ent aJ&l'OlC, 0.02.5 M lOdium citrate, pH 3.a and 6
fli;';nolytic activit)' or a liuue plasminolen activator ~ M urea. Eleccrophorail was performed for 7 hours al
cltpre... .ion product hereof. An ovemi,ht culture of E.
25 milliampl and •• C. The ,el was then fraelionaled
coli W~ i 10 (ATCC 2732') conwninl a t.PA .prCllion
with a razor blade. The Individualilices were melted al
'lector in L.;~~ !-roth containinl' lit mI- 1tetracycline
70' and eJltracted twice with phenol and once wilh
Wl!.S diluted 1:100 ill M9 medium conialruna 0.2 percent
chloroform. FractioDi were then ethanol precipilated
glucose, 0.5 perce:at cuamiDo 1CId. IDd , '" mI- 1 30 and .ublequcndy .....yed by ill vitro translation in a
ICll1lcycline. The celli were grown at 37" C. to an A"o
rabbit redcu.loc;rte l)'Iate l)'Stem. Bethesda Rescarch
of 0.2 and indole acrylic acid WII added to a ftJW conLab. (59.60), aupplemented with dOl pancreas micro
IOIIleI as (01l0W'l: TranaiatioDi were performed using 25
ccnlnation or 20 "JlmI. Samples Were conected by
ccntrifuption at ..4,»-0.514-0.6 (-2X 101 celli mI- l )
,,0 of [l'S] methionine and !lOG nanolrams or each gel
4I1d immediately froZCft. The eell pellell were 1111- 3S alice RNA ill a ftJW volume of JO pJ containin, 25 mM
HEPES. 41.3 mM polaUium chloride. 10 mM crealine
p:/ided in 6M ,uanidine hydrochloride at 5x 101
phOlpbate. 19 amiGo acids It 50 mM each, 1.1 mM
cclb/ml. IOnicated ror 10 ICC. Incubated at I.· (or 30
min and then dialyzed lor 4 hnq&inlt 2' mMTril-HCI
mapesi'llDl chloride 16.6 mM EDTA. 0.16 mM dithio
pH 8.0. 2$0 mM NaCI. 0.2' mM EDTA and 0.01 per·
lhreitoll.3 mM hcmI.n. 16.6 "Jlml creatine kinase. 0.33
cenl Tween 80. After dialysis tile aampla were ccatri· 40 mM c:aJci'llDl chloride. 0.66 mM EOTA. 23.3 mM sodlum chloride.
fused It IJ.OOOX, ror 2 mJn aDd 10 f'I of the Illperna1~1lt.s analyzed (or tillue plumiDo,en activator .clivity.
Incubidoal were carried out at 30" C. ror 90 minules.
Followin, the proccdureorOrauelll·Pipemoand Reich
puc..... microIomal membranes prepared from
roup IDic:roIonIa UIinJ EDTA for removal of the
(31). tbe pllte was incubated ror 3.' boun It 37· C. and
1)'3is ;tones measured. Plumin produca a clear lysis .., r1b01oma (61) were treated with nucleue as described
lone in the fibrin plate and the area o( this zone CID be
(62) and were praent III the translation mixture at a final
concentration or 7 Auo uniU/mi. Tranllatlon producls
correlated to the amount titaue pluminolen activator In
or lmmW'lO'precipitaced traDIlatlon productl were analhe slImple.
Jyled by elecuophorall on 10 percent polyacrylamide
E.I.B Source ofTlaaue Plumlnolen Activator mRNA
Human melanoma celli (Bown Melanoma Ceo line. ~ ,el. In 1Odi'llDl dodec:yllulrate II previoully described
(63). The \lDIItalned slab pll were fixed. dried and 5ub·
ATCC acceuion number CIlL9607) were ued. The
melMoma celli were cultured to collflucnt moaolayen
jeeted to fluoropaphy (64).
in 100 ml Earles Minimal Euential Media .upplemented
The rtlultiD, lraDIIatlon prOducti (rom cach ,cl frac
tion were lmmWlOPreclpitated with rabbit anti-human
wilh sodium biealbonate (0.12 percent Rnal coacentra·
lion), 2 mM Ilutamiae and 10 percent hat·lnact1vated 55 tlullC pluminoJca actlvltor specific: 1,0. One major
(ellli cal( sefllm. To confirm that the melanoma eelll
lmmlUlOpl'Cdpitated polypeptide band was observed in
were actively productnl human tluue pJaamlno,en
the trIIIIIadoa 01 RNA fraction Dumben 7 and I (mi,ra·
activator. human melanoma celli Were cultured to con·
tIon or 21 to 24 S) havill, a molecular wel,ht or approx
\mately 63,000 daJtOIll. This band WII not observed
flllency in a 24 well mlcrotlter dla.h. Either Itl the pr...
cnee or ablence of 0.33 "M the prol.elLle inhibitor 60 wben prdmm\IM laO was \lied for immunoprecipil.
don which .ugated thete polypeptides were tissue
nprotinin. che cell. were wllhed once with pholpbate
buriered saline and 0.3 ml of Mrum free methloDine free
plumlnolen activltor 'pecific.
medium WII added. " "CI of [lsS].methlonlne was
E.1.D Prepl.:atioD o( a Colony Library Conlaining
Twue PWminolen Activator Sequences
added and Ihe cella were labeled It 37· (or 3 houn. At
lhe end o( the 3 hour tabellln, period the media was 65
Five '" of ,el fractionated mRNA (lei slice 7
removed rrom the cell. and treated with either twue
mRNA) w~ \lied (or the preparation or double
plll~minOlen acllvator .peciRe laO or pre-Immune
.tranded eDNA by .tandard procedureJ ('2.6'.66). The
~crum for immunoprecipllatlon ('.). The ImmuneeDNA was liz« iractionaled on a 6 percent polyacryl.
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amide lei. The eDNA IlUtu than 3~ base pairs in
lenlth (12S Ill> was ekctroeillted. JO III of eDNA was
extended with deoxy(C) residua usinl terminal deox
)'nucleotidyl transferase (67) II'Id Il'lne&1ed with 300 nl
of the plasmid pBRJ22 (61) which had been similarly
tailed with deoxy(O) residues at the Pst I site (67). The
annealed mixtllre was then transformed into E. coU Kl1
strain 294 (ATCC No. 31446), Approximately 4.600
(,
ts
obtained
t
~o ; . ; e r e f DNA
•
.
.
on 0 •
~rified h~ uaue pluaunolen ~uvator was
obwnedaccon:bnltodMproc:cdureofdIllCIOIcdreferenea (19.20).
•
.
The molec\lle ~ ICIIUIed 1ft order to locate re~ns
best suited for ~ syntbetic probes. as ~OUOWl.
To mate dM protems lUlCeptible to dlaCition by trypsin II was redu:ed IUId carboxymethylated. A 2 m.
sample or tiuue plumiDolen activator was flnt diaIyzcd aillast 0.01 pctCCIlt.TWlllln 10 over lllaht at room
temperature. The l)'Opbllizcd protein was then dissolved in Il mI of 0.56 M TN-HCI bllffer (PH 1.6), 8
molar In urea II'Id , ~ ~DTA. The dlsllifide bonds
were reduced by Ihe additIon oro. I ml ora·mercaptoe·
thll'lol. Thil reaction wu carried Ollt under nitrolen ror
2 hours at 45' C. The reduced diauifidCl were a1kylatcd
to tbe carbo~ymethyl ~vatiye by Ihe addition of 1:0
ml Of .... M lodOllCetic aad in IN NaOH. After 20 DIln
at room temperature Ihe reaction was stopped by dlaly,is apinst 0.01 percent Tween 80 for II hours at room
temperature ~ lYOP~izcd.
.
The n:sulttnllyophilized carbolIymclhylated protllUl
was rediuolved in 3 mJ of 0.1 M sodium phosphate
buffer (PH 7.'). TryptiD (TI'CK) was added (l to ~
ratio) II'Id dileated at 37' C. Allquots (0.1 ml) were
taken at J hollrs, 6 hours, and 12 hr. A teeond addition
of tryplln wu made .II 12 hr. The ~Ion was ItOpped
after 24 hI' by frllllzini the sample until It could be injeeted on tbe HPLC. The proJrell of the dllCition was
delCrmincd by SDS lela on the a1iqllOts. All leI, were
blank except (or a raint bind on the J hour aliquot. Thls
indicated that the 24 hour dllCitlon was complete and
no larle peptides remained.
A sample (CL 0.' ml) was Injected into a hllh resollllion Altex C·8 IIltrasphere 51' column with two run•. A
Iradient or IICCtonitriJe was made Irldual (I pel:QCnt to
.5 pen:cnl in , min, , percent to 3' pereent in 100 min,
l5-~ pen:cnt in JO min). In OM of the two preparative
runs. the el\lll'll was monitored atlwo wavelenJlM (210
nm and 210 nm). The ratio of the two wavelenath abSOtptiOM was \lied 10 indicate the tryptophan containinl pepcides.
The peptide peW moet likely to conllin tryllloPhan.
or that were believed 1IIII!'u1 for other :..aIOIII, were
Mqucnced nrst. This enabled the det,. ....ul'l.Idon or the
sequence around most of the tryptopllana. After IIIqllencinllbout 25 or the best poIIible peptide peab, all
Ihe sequence data thaI could be a1lped was pooled to
obtain a preliminary model or the primary structure o(
tiss1.lC! plasmlnolen activator. Prom this data and model,
several pouible probes were located.
E.l.F Identification of Bacterial Clones Containinl
Ti.,lIe P1asminolen Activator cDNA SeqllllllCCl
The colonies were Individually Inoculated into weill
of microliter piates contalnlnl LB (93)+ 5 J'vml tttra·
cycllne and stored at - 20· C. aner addition of DMSO
10 7 percent. Two copies of the colony library were
,rown lip on nilrocelllllose nllers and the DNA (rom
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each colony rllled to the filter by che Grunslein Hogness
proc:cdure (69).
The
,

J2p-IabcIltd.TC~)cA(~)TA(~ITCCCA

10

U

10

2'

30

l~

..0

.. ~

~

"

60

"

2.1

.
.
probe was prepami (from the I~thetlc oligomer)
(W.E-y..c.D) l4-mer pool as descnbed above. Fillers
COlitainlnl 4.600 tnnsformants. were prehyb~idized ror
2 hoW"l at room temperature 1ft 50 mm sodium ph05.
phate pH 6.8. 'x SSC (80). I~ J'vml sonicated
ulman
.I'm DNA, 5X Denbatdt's solution (8.5) 10
pm:eDt To~de II'Id then hybridized with !lOx 10.
counts per minute of the libelled probe in the same
solullol1. Af\er 11'1 ovemllbt incubation It room temper.
ature. dM ftlters were washed 3 timea at rcom tempera.
ture Ia 6X SSC.O.I percent SDS for JO minutes. once
ill lX sse II'Id then exposed to K.odak n.' x-rllY film
with Dllpont Lilbtninl PillS intensifyin, screens for 16
hours
.
P~d DNA was Isolated by a rapid method (71)
from all colonies showinl a positive hybridiution relic.
lion. The eDNA Inserts rrom these clones were then
MqllCnced after 'lIbelonin, (raiments into the M I J
vector mp 7 (73) II'Id by the Maxam Gilbert chemicnl
proc:cdure (74). FlO. 3 dl.plays filter number 2!1 show.
Inl the hybridi.ution pattern of a positive !issue plas.
minopn avator clone. The cDNA insert in clonc
25EIO was demonltrated to be the DNA coding for
tissue plasmlnolen activator by comparing ilS amino
acid MqIlllnCe with peptide sequcnce (See Supra) ob·
tsined from pllrifled tissue plasminogen activator and
by Its expression product produced in E. coli as de·
ICribcd in more detail infrL The cDNA lnser! of clone
25£10 (Plasmid pPAl5£10) was 2304 base pairs in
!enlth with the lonlesl open readin, frlme encodinE 3
protein of 508 amino acids (MW of !l6.7S6) and contnin·
Inl a 772 bp 3' untrll'lilated re,ion. This cDNA clone
lICked tbe N-termi.na1 codinl sequence•.
BlCteriai clone E. coIl (pPA2'EI0). as well as II sam·
pie of plasmid pPAl5£IO, have been deposited with Ihe
American Type CUltllre Collection II'Id accorded acces·
lion numbers 67587 and 40401. respectively.
£,1.0 Direct Eltpreuion of I Hllman Tissue Plasmino·
.en Activator Clone In E. coli '
With reference to FlO." 50 1" of pPA2!1EIO (supra)
were dilCited witb Pst I and tbe 376 bp fraamcnl i~o·
laled by electrophoresis on a 6 percent polyacryillmide
pl. Approximately 3 J" of this (ra,ment was i.soltllcd
from the lei by eleclroelutlnl. di,ested with 30 units or
Ode I for I hr at 37' phenolll'ld chloroform elllrnctcd.
and ethanol precipitated. The reaultinl Dde I slicky
ends were ClItended to blunt ends by adding S units of
DNA polymerase I (Klenow fra.ment) and 0.\ mM
each of dATP. dCTP. dOTP, dTTP to the reaclion
mixture II'Id Inc\lbltinl at 4' C. (or 8 hours. After ~~.
trlCtion wilh phenol and chloroform. the DNA W~.~
d1lestcd with U IInits or Nar I ror 2 hours and the
reaction mixture electrophoresed on a 6 percent poly.
ICrylamide leI. Approximately 0.5 111 of the desired
125 bp blllnt end Nar I fralment was recovered. This
(raiment codes for amino acids number 69 through t lO
of tbe mature full lerilth li.,ue plasminoien activator
protein.
For isolation of the 1600 bp Nar I • 8al·ll fragmenl.
JO J'I of pPA25El0 were dl.ested with 30 units of I'Inr
I and 35 unitl of BII 11 (or 2 hours at 37' and the re;,,;.
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tion mixture electrophoresed 011. a 6 perceIIt pol)'Cl')'lanUde ad. Approltimatdy 6 '" or tbe desired 164' bp
Nar I • 811 11 £raplent were recovered.
The plasmid pdel1llUSRC is a derivative ortbe piamid pSRCul6 (79) in which the Eco RI.tes proDmll S
to the trp promoter and distal to the SRC
have
been removed by repair with DNA polyme..... I (21),
and the sctr-complemenwy oli,odeoltynucJeocidc
AATTATOAATTCAT (synthesized by the pbolphotriester method (75) wu inIened mto the remaiainl 10
Eco Itllile immediately acUacent to the Xba I lite. 20
1'1 or pdeitaRlSRC were di,ested to colDpledoD with
Eco Itl, phenol and chlorororm utnctcd, Il.ci ethaaoI
preeipitated. Tbe plumid wu thea dilated witb 100
units or nuel.... SI at 16· C. tor .10 mlDuta m 25 mY 15
sodium accute (pH 4.6)., I mYZaCb and 0.3M N.cJ to
ctUlII a blunt cud witb the IIeQ1ICDCC ATO. Attar p....
nol and chlorororm utnlc:don and ethanol pn:cipill.
lion, the DNA wu dl,ated with Bam HL electrophoresed on a 6 percent polyscrylamidc pI, &nd the 20
larle (4,j()() bp) vector rnpmlt recovered by dectroelution.
The: expreaaion plumid wu uaembled by lI,atlnl
toaether 0.2 1'1 of vector, 0.06 '" or the 125 bp blunt
end· Nil I rrapent and 0.6", or the 164' bp Nat I - 2'
Balli rrapnent witb 10 unllI orT. DNA Ilple ror 7
houn at room temperature and UIed to traaaCom B. coil
slrain 294 (ATCC No. 31446) to amplcUUn resiatuce.
Plumid DNA was prepared 'rolD 26 orthe colonia and
diicsted with Xba I and Eco RI. Twelve or tblle pi... 30
midi conWned the dalred 415 bp Xba I-Eco JU and
412 bp Eco JU·rlqllllllta. DNA teqUCllee aaaJfIlI veri.
lied that several of these plum1dl hid an A TO iDidation
codon correctly pllCed at the start or amino ICId Dum·
ber 69 (serine). One or thae pl.umidt, pAJUPA· wu 3S
teated and produced the desired tiasue plaaminoaen
activator (FlO. 7).
BacterialcloneE.t:Oll(pARIPA·),uweUu ...mple
o( plasmid pARIPA·. have been dcpoIited witb tbe
American Type Cullure ConecUon and ac:c:orded ar::c:a- 40
5ion numben 675., and 40400, respectively.
E.I.H Full Lcnllh Tiasuc Pluminopn Activator
eDNA
a. Preparation of a Colony Library Conl&lnlnl N.termi.,
nal Tillue Pluminolen Activator Sequenca
0.4 1'1 or the Iynthetic: oIpucleotlde"
TTCTOAOCACAQQOCO J' wu UIed ror priminl
7.' 1" or ,el frICtion number a mRNA (supra) to prepare double llranded cDNA by .tandard procedures
(65,66). ThecDNA was aiu fractionatedoD 16petCCftt 50
polyacrylamide ,el. A size fraction ,realer lhan 300
b:uc: pain (36 n,) wu electroeluted. , III cDNA wu
extended with deoxy(C) residua uain, tmninal dCOlt·
ycytidyltranarerue (61) and annealed with 50 nl or the
plasmid pBRJ22 (61) which hid been alnillarly tailed "
with deoxy(O) residues .t the Pat I lite (67). TIle anncaled miltture wu then transformed IAto B. coI/Je12
strain 294. Approximalllly 1,5(}() t.ra.nalormants were
oblJlined.
b. Southem Hybrldlutlon ot Human Oenomlc DNA 60
Since the cDNA primln, rac:tloft hid been done
usina a synthetic: (r.,ment that bybridlzed Il bale pairI
from Ibe N·terminal orclone pPAl'El0, no COftvenlent
restriction (raiment wu available In this 29 bale pair
reJio" (whkh Includa the 160mer &eqll4l1lCe) rOr ICrnn- "
In, the cDNA clona. Therefore, It wu neceuary to
isolate a human tiNue plumlno,en acllvator ,enomlc
cione In order to Identify any primer eltcnded cDNA

,Iae
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dODeS contaiainl N-terminaltissuc plasminogen ICliva·
tor codiq tequences.
TIle ftnt step in lhis precess involved establishing the
r.:t that only a sin,le boll'lOlolOUS tissue plasminogen
IIC1i.vacor
is present in huma.a IComic DNA. To

,me

dctermiDe this, a Southern hybridizatiou. was per·
Formed. Ira thia procedure (77), 5 1'1 or high molecular
weiPt huma.a lymphocyte DNA (prepared as in 80)
was di.-ted to completion with various restriction
eadoauc:leues. eIectropboreied on 1.0 percent asaros,~
n1a (11) ad blotted to a nitrocellulose mter (77). A
J1P_1aheIled DNA probe wu prepared (16) rrom the S'
ad or the eDNA Wert or pPAl5EIO (a 230 bp Hpa iI
- ilia I hpent) &nd hybridized (12) witb tbe: nitrocel·
IaIoM IIlter. 3.sx lOll counts per minute or the: probe
were bybdcUzed for 40 houra &ad then wuhed lIS de·
IC:ri'becI (11). Two adonuclease d1le.tion patterns pro
viele only a liqIe bybridl.z.lnl DNA rralment: Ogl 11
('.1 Jtbp) and Pw II (4.2 Kbp). Two hybridizinS DNA
rnpents were obIerved with Hlnc II (S,l Kbp lind 4.3
Jebp). Tlkcu to,ether, thae data IUlleat the presence
or only a.nlle tisaue plasminolc:n activator aene: in the
buma.a ,cuome, &ad that this lene contains It least one
mtervenift'teq\llJlCc.
c. Sc:reeninl or the Human ). Phale Library ror Tissue
PlumInoICft Activator Oenes.
The atratelY UIed to ldentiCy ). phale recombinants
c:anyia, tIIIuc plumiftolcu activalor aenes consisted in
dctectm. nvcJcotide homololY with a radioacti ve
probe prepared rrom the tiasuc pluminoaen .ctivalor
CDNA 1 pPA2'EI0. One million reeombinant). phage
were plated out Oft DP 50 Sup F II a den.sity o( 10.000
plull' em platc, and nitrocellulose filter replica.. were
prepared tor each plate by the method or Benlon lind
Daw (71). A UP-libelled DNA probe wu prepared by
llaDdard procedures (13) (rom a 230 base pair Hp4 II 
Itt I Crapent located 34 bue pain rrom the S' end or
the plumid pPA2'EIO. Each nitrocellulose filler was
prchybridlzed at 42' ror 1 boun in SO mM sodium
pbolphate (PH 6.'). 'X SSC (11), 0.0' mllmlsonieated
IIImotl sperm DNA, 5X DenJwdt'l solution (84). SO
percent tomwnlde and then hybridized with 'Ox 10<'
counll per minute ot the labelled probe in the same
IOll.ltioft COftI&lnIn, 10 percenl sodium dutran sulfate
(IS). After an ovemilhl Incubation at 42· C .. the filters
were w..hed 4 tima al SO' In 0.2X SSC. 0.1 percent
SDS ror .10 minutes, once In 2 x sse It room temper.:!
lure and then expoted to Kodak XR·' X-ray IiIm with
Dupont Cronex Intenlifyinl ICreena ovemiahl. A lota1
or 19 clones were obtained which hybridized with Ihe
probe. Phqe DNA w.. prepared u previously deICn'bed (16) from 6 recombin&ats. ). Clone C WAS 5e·
lected ror prepltltlon or a Pvu II (raiment ror colony
30 1" or DNA w.. dllCiled with Pvu n ror
I how at 37·, and electrophoresed on 1.0 percent 1I8a
roll lela. A 4.2 JeDobale pair fr'lment previously
Ihowu to COftI&ln tisaue pluminolen activator sequen.
c:&I wu tlecltolluted &ad purif1eci. A up labelled probe
WII prepared by .tandard procedura (U) for colony
hybrtdiUtJona u dac:ribed InCra.
d. kreenln, or Colony Library for " Tillue Plumino
,en Activator Sequcncet.
The coIOftiea were tranarerred from plates and grown
OIl nitrocellulOll ruters and the DNA from e:ach colony
ftud CO the IUter by the Orunateln • HOineaa procedure
(69). A UP-labelled probe wu made by c:alf.lhymu~
primin, ('3) a 4.2 Idlobue pair Pvu II (raimenl from an
isolated tissue plumlno,cu ICtivator ). lenomie clone.
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Fillen containin, the 1.m 1RDSf0rmanlS were hybrid·
ized with 112 x 10' cpm or llP.pnomic Pw II rrq·
ment. Hybridization was ror 16 boun usia, CODditiODS
described by FrilJeh et. al (12). F'llteR were exte:nsively
washed and then exposed to Kodak XIl·' X·ray film ,
with Dupont Uahtnin,·P!us iIltensilYina screeas ror
16-41 houn. Eiptccn colonies clearly hybridized with
the ,enomic probe. Plasmid DNA wasilolated rrom
each or these colonies and waa bound to nitroccllulOie
filteR and hybridized with the llP·labeUed syDthctic 10
oli,oDucleotide (l6-mer) used ror the onpw priminJ
~ction. or the II cloDCl, IeYCD hybr;ldUcd with the
kinased l6-mer. Upon ICqIaence analym after sabcloa·
in, rraamenta Into the mU ~r DIP' (73~ ODe cl?De
(pP.A 17) w~ shown to conWD ~ correct '. N terminal "
re,lon or tiSsue plumln~aca Kavator, a. aipallader
sequence and an 14 bp' UDtraDIlated rel1OD. From the
two clona pPAl'EIO and pPAI7 the complete nuc~
tide sequence FlO. S and restriction pattern (FlO. 4) or
a rull I~n'th tissue plumino,CD activator clODe were 20
determln~.
_
Bac.terial clone E. coli (pPAI7), ~ wel~ u a umple ~r
plasmid pPAI7. have been deposited WIth the Amen·
can Type· Culture Collection and ICCOrded accession
"16 and MYN'I
t' I
."
numbeR 67 oJ
- 6 0 respec tve y.
6"
The native t\saue pl..m1 l101en activator molecule hat
lhe potentlal to be ltabllized by 17 dilulflde brid,es
based on homolo,y with other terine proceua. There
Olrc rour potential N.,IYCClylation aitCl, three located in
the "Ir.rin,le" reliona at aN1I17, unll40 aN1111 and one JO
potential aite in the Upt chain reJlon. at &ID44I- Varia.
lionl in the Itructure or the oliaouccharide llganda may
be retponalble for the different molecular rOrml (6'.000
and 63 000 mol WI lpecies).
E.!.l Direct Exp~on or Full Lcn,th Tillue Plumln. 35
ogen Acti".'alor cDNA CloDe in B. coil
A reconatruction or the entire codln, lCquence w..
pouible cmployin, the common HhaI reatriction cndonucl_lite shared by both partial cloncl pPAI7 and
pPA25EI0. A "bp Sau3A1.Hh&I reatriction rnament .a
correspondln, to amino acids S-23 w.. iIolated rrom
the plasmid pPAI7. The SaJa3AI reatrlcdoD lite was
located at codon rour or the preaumed mature codin,
sequencc and w.. used to remove the llpal peptldc
codin, re,ion. A 26J bp Hhal.Nul rralJDCllt (codln, .,
ror amino acids 24-110) w.. allO iIOlated rrom plumld
pPA25E10. Two Iynthetlc deoxyoll,onucleoddes wcre
designed which restore the codona ror amino acldt I.....
Incorporatc an ATO truwlatlonal initiation codon and
crealc an EcoRI coheslvc termlnu&. These three rra,•. 50
menta were then lI,ated to,cther to rorm a 331 bp rra,.
menl codIn, ror amino acids 1-110. ThIa rrapent and
Ol 164' bp Nul.B,1II rraament rrom pPAl'EIO were
lhen lI,ated between the EcoRl and B,JJI litel or the
plasmid pLelFAtrPI03 ('3) to Jive tbe expresaion plu- "
mid pt PAtrp12. The cloned t·PA ,etlC II traDlCribed
undcr the control or a 300 bp rraament or the E. coil trp
operon which contalna thc trp promoter. operator, and
lhe 5hine·Dalgarno aequence or the trp leader peptide
bUI lacuthe leader peptide ATO Initiation codon ('2). 60
A sample of pl..mid pt.PAtrpl2 baa been deposited
Wilh the American Type Culture Collection and ac·
corded accCllion number 40404.
E.l.1 Sequence AnalYlis
Sequencc analYlil was bued on the Edman de,rada· 65
lion. (l3b) Thc sample was introduced into the cup of
lhe Beckman 1908 or 190<: Ipinnln, cup lCquencer.
Polybrene TM (poly N.N.NINI·tetramethyl.N.trlme·
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thylenehexamethylene diammonium diacetate) was
used as a carrier in the cup. (6JC) The sequencer WllS
modified with a cold trap and some pro,ram changes to
reduce backJl'OUDd peaks. The ret,ents were Beck·
maD·s. sequenc:e arade 0.1 molar Quadrol buffer.
pbenylisothiocyanate, and heptal]uorabutyric acid.
The collected Edman cyclcswere manually convened to 2-Milino-5-thiuolinone derivatives. The l
cblorobutane wu dried imder nitro,en. Then 1.0N Hel
ill water wu added to the 2-anilino-'·thiazolinone lind
heated to 70' C ror 10 min to conven it into the )-phc·
nyJ.2.thiohydantoin (PTH derivative). The PTH
&IIIinI:Hcid residue wu then dissolved In '0 percent
ecetoDitrile and water and injected into a reverse-phase
hiP-pressure liquid cruomato,raph. Each PTH.amino
acid wu then ideDtined by comparison to the retention
times or a standard mixture or PTH.amino acids thllt
waa Introduced iIlto the conversion vial and treated the
same way u a cycle rrom the lCquencer.
E.I.K. Assays ror Detection or Expression or Tissue
Plumino,en Activator
I. Direct Assay or Plasmin Formation
L Theory
..
...
.
A aenllUve as.ay ror tissue plasmmo,en actlvlltor cnn
be ob . ed b
..
h'
I'
.
taln
y mODlton~, t e tluue. p asmlnogen DC.tI.
vator ca~yzed convenlon ~r plasminogen to plasml~.
Plumln .. an enzyme for which there are chromogenic
lubltrate as.ays. These. as.a~ are based on the proteo:>.
lytic cleava,e or a tripeptide ~rom a chromophonc
JI'Oup. The .rate or cleavage b dJr~lly related to both
the speclftclty and the concentration or the proten.· ~
bcIn,lcIted. The balil ~r thc .... y is the.det~rminllti In
or the amount or plasmm rormed follOWing mcubnon
or the tiuue plumino,cn activator containing sohtion
with alOlution orplumlno,en. The ,reater l~e ar.JOunr
or activator. the ,reater the amo~nt of plasmin fOI rncd.
Plasmin II ~easured by monitonn, lis cleavage 01 .th~
chromo,enJc lubltra~e 522'1 (purchased rrom t.llbl
Oroup, Inc.• Oreenwlch. Conn.).
b. Procedurc
...
An aliquot or the sample II mixed with 0.10 ml orO.7
mplml pl..mino,en (In 0.05M Tris.HCI. pH 7.4, con·
0.~12M ~aCI) and the vol~me adjusted ~o 0.1 S
mi. The mixture .. incubated at .37 .C. ror 10 mmutc~.
0.3' ml or 522'1 (1.0 mM IOlullon In above buffer) IS
added. and the reaction continued ror 30 minut.es at 37'
C. Olacial acetic acid (2' ~L) II ~ded to termmate the
reaction. The umples arc ccntnruged and the IIbsor
bance at 40' nm II measured. Quantitation or the
amount or activity II obtained by comparison with n
ltandard urokinue IOlution. Activity was recorded in
Plou,h unit&, wherein 90,000 Plou,h unitl il equal 10
the activity exhibited by I m, or purined tiuue plamino
am activator.
2. Indirect Assay or Plasmin Formation
L Theory
A aenaltive ....y ror tiuue plasmino,en activlltor
activity baa been dcveloped (87). The assay is based on
determination or pl..min rormation by measuring lhe
extent or plasmin digestion or fibrin in an agar plate
contalnin, fibrin and plasminogen. Plasmin produces II
clear IYIII zone In the fibrin plale. The area of this lysis
zone can be correllted 10 the amount of tissue plasmino·
,en activator In the sample.
b. Procedure
Followln, the procedure of Oranelli·Piperno lind
Reich (87). the plales were incubaled 3.5 hours 11137' C.

tainln,.
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and lysis zones measwed. QuIIlulation was obtained by
comparison 10 a stIJIdard III"Okiftase solution.
E.1.L. Decection of Tissue Plumiooaen Activacor At:tivity
1. Bacterial Growth and Sample Preparation.
A colony or E. t:oil conWninJ the plasmid (p4JUPA.) was inoculated into a rat tube CODtainiq 5 alL of
LB If'Owtb media CODtaIniq 20 p.JlmI ampiciUln. The
cells were .roWD ovemi,ht at 3r c. An aliquot or this
cuh~ was dihatcd I: 100 inlO 300 ral o( M9 media CCIIto
wnin, 20 p.Jlm! ampicUIia. The celli were powIllD a
shaker nuk at 31' C. for fOW' boan, with a raultlD,
nbsorbance at 550 nm 0(0.419. The tryptophan analo.
indole acrylic IICid was lidded to a concentration or 30
"simi. The c:clb were Incubated 90 aniDula., with a
rcsultin. abIorb&Dce at 550 lUll 0(0.621. The celli wen
hMvcsted. by ceotrill.l,atioa ud ralllpeftded In o.a m!
of O.OIM Tria, pH 1.0, CODtIIInJna O.OIM EDTA. The
resultin,llIIpenaioD was.tIned rapidly at room temperl'IIure for 18 hOW'L Thc sample was CCfttdfu,ed and the
supernatant lSIayed ror tislue plumino,en activator
!'Jctivity.
2. Activity Detection.
Table I shoWi the raulta of the a.ctivalion of pluminogen by E. t:oil alra.cta wbeD asaayed. An activity II
gcnerated. which II dependent on the presence of pJu.
minolcn. Tbia ICtivity II not affected by pre-Immune
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TABLE l-continued.

, s.m,Ic

I'IuIIIiIIopll Ac:tivaIioII by E. t.vIl EXlIKIS o(
Cullures Containill. pUIPA
l'erceftl
Calc1ll,ucd
A.IOS
Actlvlt)'1
Plou.h Unitslml

::1ftIi=?=I'P;A~IIIII-=bad-::-ln--;':;"'-";';;;;';';;'---~:;;"';;""';;""';~
, _ lIC'IMIy ............ II, _ - . .

................. 1If ......_ ....-

10

,!Ie ..... 1< IO.om fNM '0 ..I.... ,010

r""" ,.......,..•.

PIG. 10 repments the resulb or a fibrin platc assay
performed wll.h eltnlCb (rom 10 L fermcntation cui·
tures o( E. t:oil containin,a tlaue pluminolcn activ.tor
. ap..... plumid. The ftbrinolytic ac:dvity or thc tis·
1110 pl&lmino.en acllvetor containin. eltract is reprc:
IS 1CIl1ed ill PIG. 10 by Wen A. Tbia fibrinolytic aClivity
Ii IDhlbkecl by IftlI t-PA laO (Well C) but not by preim·
raVoU laO (Well B) or anll uroldnuc I,G (Wcll D) and
DO ICdvity II Melt frora an atract prepared. rrom cells
CODtaiDiD. u a control the leukocyte interfcron plasmid
20 pulPAtrp 103 (Well H).
E.1 ProdllCtion or tPA Usin, DHPR Protein with a
Low Bindla, Amnity for MTX
E.1.A Vector Construction
The tequence encoc1ln. human tissue plasminogen
2' a.ctlvator (t-PA) II insened. into an clpression plasmid
contain1n,a mutant DHPR with low binding affmity
for MTX. d.eacdbed In the now abandoned copending
. ~erumohrabbitbutllmarkedlyinhibitcdbyutilerum
appl.lcation U.s. Set. No. 459.151. filed. Jan. 19. 1983.
which wu railed apinat puri1Ied melanoma cell dec:om:apoadin, to European Paleftt Application Publ.
rived twue pluminoaen ICtivalor (88,. Tbia demon- 30 No. 111.0&) Incorporated. herein by reference::, by the
followia. procedure (ace FIG. II):
Mrales tbal the E. coil extracts are prod.lICln,a pluminogen activatia, a.ctivity which II inhibited. by antibodiea
Three (rapenta from overlappinl I·PA plasmids,
"SlUnst the tlaue plaam.ino.en acovacor.
pPAl5EI0, and pPAI1. and pt.PATrp11 (supra) were
FIG. 7 allows the rault or a fibrin plate lSIay for 3' prepared u follows: Plumid pPAI7 was di,csled with
fibrinolytic: activity. A standard amollDt of urokiDaIe . Ode I, rdled In usin. Klenow DNA polymerase 1. and
was added to the center row in concentratiolll, from left
IUbelIt with Pst Ii the approximately 200 bp rragment
contalniD' 5' terminal t.PA sequcnce thlll generaled
to right. of 0.24, 0.14. 0.10. 0.05 and 0.01 PlouJh Unlta.
The bonom row II aampla
natlH'll tl..ue plumi.sloowu IIolated. The KCOnd t.PA fra.ment was obtained
8cn activator. witb the aame UDOIIDt ofeuyme lD eacb 040 by d.I,atla, pt.PATrp12 with Pst [ and Nar I and iso·
lilJA, the approximately 310 bp fra,menl. The third
wcll. The wei.. contalft, (rom left 10 d,ht, tislue pJu.
t-PA frapent was obtained by di.atin, pPA23EIO
mino,CII activator. anti·plumlDo.en ICtivator pllll preimmune aerum. and IiIaue pluminoaen ICtivelOr pllll
with Nat I and B.I II and IIolatin, the approlimalcly
tiMuc plumloo,eft ICtivalOr antibodies. Tlse weDa In
1645 bp fn.ment which contalna., in addition to much
the lOp row each contaln I pJ ohhe recombinant tiIIuc "5 of the l-PA codln. repn. lOme 3' non-translated se·
quenca
piasmioolen ICtivator E. t:oil atracta. The nnt well II
the extra.ct alone. the aecond well hal preimmune ICfUID
Plamld pEl42 which expreues HBV surface antigen
added. and the third well baa the tislue pluraino.eft
(abo ,..fctted 10 u pHBa34a.E) hal been described by
I.evIraIOa It al. patent application Ser. No. 326,980. filed
activalor antibodia added. It II obviolll that the preimmune ICrllm doea not affect natural or recombinant 50 Dec. 3, 1911. now abandoned in ravor of continuing
ti!!Sue p\aamlno.enlCtivalOt, and thai tiKve pJumlno.
application Ser. No. 603.519. ftIed. Apr. 14. 1984. now
Bcn a.c!ivator antibodialnhibit the activity O(lIItlH'llu
U.S. Pat. No. 4,741,9011av.ed May 31. 1988, and corre
lpondln. to European Patent Application Publ. No.
well u the E. coil extract&. Baaed OIl the urolr.inue 1Ian13,656, which II incorporated. herein by reference.
dnrds. the eJ.tracta contain Illahtly leal thM 1.5 Ploup
the Simian virul SV40 wu i$O
unitt per mi. Tbia c:omparea favorably with the value 5J (Briefly. the oriJin
obtained in Table I of 1.3 P10up unlta per mI.
latcd by dl,atln, SV40 DNA with HindIlI, and conwrtia. the Hlndlll ends to &oRl ends by the addition
Table I ICU forth the multa or 1SIa)'l performed u
d~ribed above in E.I.K.I.b.:
or a COIlverter (AOCTOAATTC). Thll DNA wu CUI
TABLE I
with Pwll. and Rlllnken lidded. Pollowlng digestion
---~PI~_-lfIO-""-A.c1-::-=I;';YaI-=:_~..,~£:-..tI~E:"s-II"IIC""'Il-fIIO:--- 60 with EeoIU, the 341 bue-palt (rqmcnt spanning Ihc
CY'IY'"
p4 RI PA
0 . wu iIolated by polyacrylamide ,cl electrophore·
I'm:ftl
CaIc"'ltd
iii and elect.".lution. and cloned in pB1l322. Expre ••
SAmple
A«I'
Mti..IIJ'
PkMIlh U,,'lsIInL
alon plaamld pHBa348.E _
constructed by cloning
E.rllel
101
the 1916 bue-pair (n,IDCnt rnultinl from EcoRI and
(with itO "lumlllO....l
., B,III dilation or HBV (,4111",,,/ VI,,", O'lI,t/cs. (Ch. 3)
(1(1))
fioUlC1
u
Acad. PteII, N.Y. (1910» (which .pana the icne encod·
0.411
106
E'''ICI ply,
HBIAJ) Into the plamld pML (LUlky et al .• Natul't,
rrnmrnUM "rum
0.01.
E1"1C1 plua
9
293: 79 (1911)at the Ecolll and BamHI.itea. (pML is II
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denvllive of pSR3ll which has a deletion ellmiaatin,
sequences which are inhibitory to plasmid repUcation in
monkey cells). The resultin, plasmid (PRI-B,I) was
then linearized with Ec:oRI, lAd llIe 348 bile pair
ment representinl the SV40 oriain ,.Jion was Intro 5
duced into the Ec:oR.I site of pR.l.B,I. The oriain trl,'
ment CIA in&en in ellher orienlatioa. Since tlUl rraament
cncodes both the early lAd late SV40 promoten In
l!ddition to the oriJin of ,.pllcation. HBV paea c:ould
be e~preued ".nder the eontrol or either proIDOter de- 10
~ndln, on this orielltatioll (pHBS34I-E n:preICDdDl
HDs expreued under ClODtrol or the carly promoter).
pE.342.is modtned by panlllly dileatlna willi Ece RI,
filling In the cleaved aite uainl Klenow DNA ploymefa.5C I, and nptln, the plumld bIck toptber, 1lI1Il,.. 15
:novina !he Ec:o RI lite Pm:edJn1 the SV40 orip In
pEl.l. The reau1t1na p1umld, daifl1&ted pE341ARI, 11
digC'Sted with Ec:o R.I, ruled In ur.In. Klenow DNA
polymerase I, and aubeut with Bam HI. Arter electro
phoresin, on acrylamide ,ei, the Ipproxlmately 3500 bp 20
fragment is electroeluted, phenol-chloroform extracted,
and ethanol prec:lpllaled u above.
The thus prepared p.l42E 3500 b.p. vector. an~ lbove
d<:scribed t-PA .fraamenu compOlln. Ipprol1m&tely
2160 bp were Jipted lO.ether UIIn. ltandard tech· :.U
niqllCS. A plumld c:ontaininltbe IlIr.. t~PA enc::odlna
fragmenu In Ihe proper orientation wu 1JOI~ted, chat
~cterized, and desipted pEJ.42.t-PA. 11ul plasmid
W1I! di,ated with SIC II IDd treated with bliCterial
alk~lne pbOlphataM (BRL). To provide lhe DHFIl 3D
sequence (alon. with controllCQIICIICCI lor lu «aprea
,ion) In approximately 1700 bp rnpent wu ,enerated
by S&cll dl,estlon or pEHEIl. (PEHER II I plumld
e~preuinl mUllAt DHB dacribed In U.S. Set. No.
459.ljl (.&IIP'I). TbiI fraam ent wu Ilpted Into the
pE342-t PA plumid 10 create pETPAER400, • plumid
whicb i.a anaIa,OIll to pEHER elCCpt that the HBaA,
codln, reaion baa been replac:cd by the cDNA lequenCC3 from t-PA.
E.2.S Elpreillon IDd Amplification 01 the t.PA Se- 40
qucnee
pETPAER400 (pETPER) wu tranII'ected Into both
dhfr- CHo..DUX BII cella and DHPR.+ CHo..KI
(A TCC CCL61) cella by the method or Oraham and
VAn der Eb (IUPI1l). Tranaformed dhrr- celli were.'
~d<:eled by irowlh in ,lyelne, hypounlhine and thymidine deficient medium. Tr&I1Iformed DHFIl+ celli
wcre telected by ,rowth In • 100 nM MTX. Colonies
which IrOle on tlte Ippropn.te selection medium were
isol3tc:d u.inl elonin, rinp and propqated In the ame 50
medium to several .encrallon,a.
For amplification celli from the colonies are Ipllt Into
medii contain!n,'x 1()4. lOS, 2.'X IOS,'X lOS, ~lId IO'
II M MTX and .,.....ed severiLI tima. Cell, are plaCed II
vcry low (1()l-10l cella/pllte) cell denllties in 10 em "
dishes and tbe resullin, colonies are iIolated.
E.2' C. AKay Methoda
Eltpreuion of t.PA In the tranlfected amplified colo
nio mly cpnvC'llicntly be UIIyed by the methods aim!
1M 10 thOle sel ronh in E.1. K.I.b (.uprl).
60
COilmplillcalion of DHFIl and I-PA IeqUC1lCCl Is
a531\yed by iJolalin, DNA (rom connuenl lIIOftollyen
of :'Impliraed colonies u rollows: Connuent monollyen
in 1'0 mm pilles Ire wuhed wilh 50 millerile PBS and
1Y' cd by the addition or, ml of 0.1 percent SDS, 0.4M "
ColC!:, O.IM EDTA. pH I. Arter '-10 minules, the
mixture II ,.moved. phenol eltracted. chlorororm elIr:lclcd. Ind ethanol preclpil.lted. The DNA Is resus

h.
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pcnded in 1 ml (per UO mm plate) 10 mM Tris·HCI pH
I, I mM EDTA (TE), RNase added to 0.1 ma/ml. and
the solution incubated 30 minutes at 37" SDS is then
added 10 0.1 pcrcelltlAd pronase (SI.ml) iSldded to O.j
mJ/ml. After 3-16 houn 1nc:ubation at 37" the solution
is qain phenol extracted, chloroform extracted. and
ethuol precipitated. The DNA pellet Is I'ftuspended in
0.5 1111 WIler aDd dileated with restriction enzymes.
ApproxJmate1y S-IO 1" or dlaated DNA is electro
phoreaed In 1Il.,&rOIe pi [I perc:eDt Ilarose in Tris 
acetate bv.fI'er (40 mM TriI. I mM EDTA, made to pH
1.2 with acetic Kid)]. Crouse, et ILl, J. BioL Chlm.. 2j7:
7117 (1912». Af'tc:- bromphenol blue dye had mi,rlled
f
the way down the &el, the ,el is removed Ind
atalned willi cthJdlum bromide. After visullizing the
DNA with ultraviolet Uaht the DNA is trln.fened
from the pi to nltrocellul~ nllen accordin. 10 the
proced\lte or Soulhem (J. Mol. BloL 91: jOl. (1975)).
The mten are then hybridized with I niclt trlnsllted
probe made from the 1700bp Sacll frllment of
pEHER (prepared and hybridized u described lbove).
or rrom the Ipproximately 1970 bp Sll II frlgment of
pETPER.
E.3 Production oft-PA in Conjunction with Wild Type
OHB Pr tain
E.3.A. V::tor Con.&truction
In a manner ana!o.oua to thlt used In the construe
.
tlon of pETPER, plasmid PETPFR w~ eon.llructed
containln. the DNA lequence enco~:hnl. Wild type
OHFIl. The cONtruc:tion was as dac~bed In Example
E.1.A. eleept thaI In plliCC or plumld pEHER IS •
IOUn:e tor the DHB protein .ene.lCQuence, the P~ISmid pE342.HBV.E400.D22 descnbed In copendmg
U.S. Ser. No. 459,152, filed Ian. 19, 1913. now U.S. Pit.
No. 4,713,339 illued Dec: U, 19.7. conapond~ng to
European Pltent Application Publ. No. I I7.0j 8, lDcor·
ponied herein by refe,.nce, wu aubsdtutc:d. The pll.·
mid pB341.HBV.E400.D21 ill the ame u pEHER exeepl for a .&Inale base pal: difference between wild type
IDd mallAt DRPR.. Thill the raultlni plasmid
pBTPFIl II ana!o,oua in every way to pETPER except
that the DNA lequence encodin. for wild type DHFR
II lubltltuled ror lhat of Ihe mUllAt.
.A ample of.plumld pETPPR. has bce~ depolited
WIth the Am~n Type Culture Collecllon and ac·
corded &ccClllon number 40403.
£.3.B ExprcMion or t-PA lequence
pETPPR wu ur.ed 10 tr~lfect DHF~ defidenl
CHO eell. (lJrlaub and Chuln (Iuprl» u.lnl the cal
clum pholphale precipitation method or Orlblm Ind
VIIl der Eb. Twenty-one colonia whicb arose ~n the
selectivlI medium (-HOT) were UIIyed by detection of
plumln fonnatlon u UICIIed by the dilation of fibrin
In III Ipr plate c:ontainln. fibrin and pluminoien, dcICribed by OraneUl.Plpemo, et ai, J. ~p. MId.. 148: 223
(1971).
Four or the IIIOIt Itron,ly positive clones were then
UIIyed qUlAtll.ltlvely ror plasmin formllion on I per
cell bulll.ccordin. 10 lhe method set fonh in E. UU .b.
Upon luch qUIAtitative determination it was found
that the rour clonea tested uhlblled the lime or comp.·
flble I-PA _redon Into tbe medium. determined IS
unlu/cclVday. Subc:lones were prepared by trlnsfer·
rin,lnocula (rom two of the clones into separlte plates
contalnin, -HOT medium. Two or the resulting sub
clona. liB lAd I were ur.ed for runher Inllysis.
E.3.C. Amplificltion lAd I-PA Production Levels
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The above subc:lOD.eS were plated at 2x I()$ cells per
hereby mcorponted by reference. Such compositions
100 mm plates ia 30 nM MTX to promote amplification.
will contaiD an effecdve amount of the protein hereof
to.ether with a suitable amount of vehicle in order to
Those cells which survived, when assayed as described
prepare plwmaceudcally acceptable compositions suitabove, .ave, ill aU cues, about 10 times the WW1Iplified
amount of tissue plasmino,en.activatOf activity. Two of S able for effective IIdmiAistratioo to the host.
these clones were chosen for funher study and were
For eumple. the human tissue plumino,en activator
hereof' ma)' be pItCIlterall)' administered to subjects
named 1-15 and 1&8-9.
Subclooe .1-15 was funher lID~iftecI by Media,
suft'erina from canliovuculat diseases or conditions.
2 X 1()$ cells m 100 mm plates .con~ 500 aM MTX.
Douae and de. late may parallel that cllrrently in use
Assay of the cells thus ~fIccI YlClded a fUrther la- 10 ill c:IinbI iIlvestiptiona ofother cardiovascular, throm.
crease (or ~t 3 fold) 1ft ~-PA prodllCdon; what Do
bolydc qeD'" e.,.. about 440 [U/ka. body wei,ht as an
iDtraVCftOUl primiD, dOrIC rollowed bya continuous
sayed quanutadveJy bl the method of C.I-c.. levela
were in the J'1:ftP of1x 10-4UDiralce1llday. A pordoD
IatraVCftOUl iaI\aaion at abollt 440 lU/kalhr for 12
of tbete amplilled cells wa dIetl tranarerrecl anJ maiD. ' • •
tained in the pnscnce fo,OOO nM MTX. Subclona or
boI&n. III palienll suft'efUl, rrom p.ulmonary embolism.
1-15, and 118-9 were f\u1her tested aft.ct bela, main- IS
As OM eumple or an appropnat~ desale f'o:m ror
taincd for approalmatcJy 1-2 moaths at the COIIdidonl
CllCfttiaU), IIomopllCOus human. ClSIue pl~mlnog~n
lpec:ilied in Table 3
activator III pereIlteraJ form applicable herem. a VIal
•
contaiain,l5OOO W tissue plasmino,en activator activo
TABLE 3
kyo 25 m,. manaitol and 45 m,. NaCI. may be reconsti·
Cell U...
O~ CCNMIil10u
IIII.PAlctlVday· 20 lUted with 5 mL lterile water ror bijection and milled
I.Ul!.ll
:100 11M MTX
2U X 10·)
with a lultable volume o( 0.9 percent Sodium Chloride
I· Ul!.ll
:100 11M MTX
16.0 X 10·J
bVection or 5 percent Dextrose Injection for intrave·
1.15,..,
(-HOT IMdlum. flO MTX)
U x 10-)
nous admiDistration.
1
I,U:Ql
(-HOTlMdiIlllloIlOMTXI
11.0 x 10.
l·U,o.tm
10 I'M MT)(
29.l x 10.,.J
2'
O. Detailed Description of Recombinant Human
1.Il'MlQ
10 I'M MTX
x 10-J
t-PA
::~:
~
:~! :~:!
The Itructure of the particular embodiment or human
119-9
(-HOT IMdI-. 110 MTX)
14.1 x 10·J
t-PA prepared In the examples herein has been studied
(-HOT 1IIItd1...... 110 MTX)
1404 )( 10·J
Ia lOme detail, both by elucidation or the ,ene coding
1
(-HOT IMCII-.IIO WTX)
\.0 x 10-;
)0 aequence lAd by protein biochemistry techniques. The
I
(-HOT IIItdIIllll, 110 MTX)
0.' x \0CWTent undentandln, of the protein structure is iIIus
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It has alIo previously been demonstrated by Collcn
and coworbra (II)• that two chain •human t·PA
is
.

_ ........

15 formed by proteolytic cleavale or the Imlle cham mol·
ecule lato two polypeptides connected by disullidc:
•
boadill,. The present work permillthe conclUSIon that
.....nIIllo....trOfIWO ......... _ _ _.n. _ _ ........ ~I...
the heavy chain (lOIB2 mol. wt.) is derived rrom the
~::==!:':"'..:..--:.":"'=:;:::....:.!:
NH1 terminal pe.rt and the li,ht chain (lBI16.mol. WI.)
_ ....... c _..._ ..... _ ..... ~ _ _ _ 'M ,.,.,..,. - 40 CQmprila the COOH·terminal re,ion. N-terminal se:
~.nI.
qucnc:in, of the two chain molecule SUliests that the

froo'_ .... _ ........

The c:ellllnes an u rollowa: Ccllllne "." is an 1UWftpillied clone from the orilinallet of'rour. "I.UXlO" ia u
amplined lubc:lone of c:eUline "I" whIch wu amplined
initially in SO nM MTX to live 1-15 and then U'anI(erred (or further ampMc:atlon lato ~M MTX
1.1'10.000 ia lubc:lone of H5XlO whk:h hal beea further
amplified the pracnce of 10.000 aM MTX. Cell 11M
I8B.9 ia I lubc:lone or one ohlle orilinal rO\lf detected
which had been ampUfIed on 30 nM MTX.
A urnple ofCHO c:eI1I1M 1-15:100 hal beea depolited
with the American Type CWture ColJecdoa and accorded acccuioa number eRL 9606.
All or the amplified celli show increued levels or
I.FA production over thatelhlbtted by the unampllned
cell culture. Even the WW1Iplifled culture produces
amounll or t·PA ,rcater than 0.' pa/c:eIVday; ampllflcation resulll in Ievell approchin, 30 pJ/ccIVday.
F. Phannac:eutic.al Compolitions
The compounds of the pretentlaventlon C&II be rormulated accordln, to k.nown methoda to prepue pharmaeeutlcally _ful compolitiolU, whereby the human
tillue plumino,en activator product hereof II com·
bined In admixture wlih a pharmaceutically acceptable
carrier vehicle. Suitable vehlcl. and their rormulatlon,
human ..rum
inclUllve of other hllman proteiDl.
:llbumln. are described for eumple In llemln,ton',
PhOfm{lClutlctll &IInClI by E. W. Manln, which II

It.,.
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two chain rorm ia ,enerated by cleava,e of a singk
ariinyl-lioleucine bond (FlO. 12: arrow depicted).
The primary ,tructure of a portion of the heavy chain
reAlon of human f-PA (FlO. 12) reveals a hi"h degree
.'
•
or aequence homolo,y with the "krinlle" regions of
plumlDO,en (19) and prOt~romb~n (~, 41). "K.ringlc"
reaion refen to a chanctenatlc tnple dIsulfide .tructure
oriJinally dllcovercd in the "pron·rralment of prothrombin, nnt dClCribed In detail by Maanuuon et al.
(91.91l: From,!he ~rimary aequ~e of ~.PA, two 50
called kriDaJe reJlOnl, or 12 imino acIds each. thllt
share a hi,h dear- or bomoloJ)' with the 5 "kringle"
reJlonl of plumiao,en an apparenL The remainins
N-termlnal 91 amino lCida ,hare little homololY to the
conventional "krlll,le" relion. One cln speculate how
ever that thia reaten may allO Ulume a structure con·
tainina multiple diaulftde bonda u 11 additlonll cysteine:
ralduea an round here.
The catalytic aite of the Il,ht chain or human t·PA,
the ao-called serine proteue re,lon. u in other serine
enzymes, ia moat 1Iltely formed by the histidinem. as·
partlcm and 1letla14.,. residues. Furthermore. the amino
acid teq\lenCCl 'Ul'Toundin, these residues are very
bomoloJOUI to corrapolldln, parts of other acrlne pro
&I.... luch u trypIln. prothrombin and plasminogen.
Notwlthltandln, that reference baa been made to
pll1i1:u1ar prererrld embodlmen.II,1t will be understood
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I. A DNA !Iolate conlislln, _ntially of a DNA
lCquence encodln, human lillue pillminolcn aClivalor.
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1. The DNA isolae or claim 1 wherein Slid buman
6. AA Ii. coil mic:roorpnism accordinl to claim 5.
tissue piasminoaen ldivator bas the amino ICicI Ie7. The mic:rootpDism or claim 5 wherein said human
quencc I.S:n set rorth in FIGS. Sa. 5b and 5c.
tiuue pJuminoaea activator has the amino acid se·
3. A recombinant ....pmIioa vector containiDl a
qwmce 1·'27 lit rorth in FIGS. k 5b and 5C".
DNA lICQueuc::. ellCOdin, hUllWl tissue plasminoaen'
.. A. ceU culture capable or expra.siq human tissue
.
r _~
plumino,eIl aetivator. obtained by transforming a
:lctlvator. wherein ~ vector ~ c:apable 0
mamlNliaa cell line with a vector accordina to claim 3.
h~ tIss~ pluminoaen lCuvaIOr in • transformed
f. A. ceU culture accordin. to claim. wherein the cell
mlcroorpnlSltl or.cell cultW'C. •
.
line Is a Chinele Hamster Ovary cell line.
4. The recombinant uprauoa vector or claim 3 10
10. The ceU culture or claim • wherein said human
tissue p1uanir1opm acdvaor has the amino acid se·
wherein Slid hWI"IUI tiuue plumiaopn acdvator baa
qllCl'lCe 1.'27 let ranh in FIGS. k 5b IIId 5C".
the amino acid 'lIqueDce I·S27 act t'onh In FlGS. k 5b
~nd 5c.
11. The cell cultun or claim , wherein said human
5. It. microor.1IIiam uanatonaed with the vector or
t1uue plumiaopn acdvator hal the amino acid Je
cJllim 3. Slid microorprdam beIn. capable or....praalna IS queac:e 1.'21 or FlOS. k 5b and 5c.
human duue plumlnopn activalOl'.
• • • • •
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BIOFLO@ 5000
Mobile Pilot Plant Fermentor

• For Process
Development
and Small-Scale
Production

• 40, 80 or 120 l
Capacities

• Automatic
In-Place
Sterilization

• Space Efficient

• Equipped with
Resterilizable
Valves for
Addition, Sample
and Harvest

• Thermal Mass
Flow Meter or
Controller

r{n\ii

~)

NEW BRUNSWICK SCIENTIFIC
Where Quality and Innovation Have Bewme Tradition

BIOFLO® 5000 PILOT PLANT FEI
ew Brunswick Scientific offers the most compact
and complete pilot plant fermentor in the industry.
Designed for culturing both aerobic and anaero~ic
organisms, the versatile BioFlo 5000 fermentor is capable of
process development and small-scale production of
bacterial, insect, yeast, plant, fungal and algal cells. This
sterilizable-in-place system is available in 40, 80 and 120
liter (total volume) capacities, yet occupies just 7.3 square
feet (0.70 m2 ) of floor space. It comes equipped with all
accessories needed for out*of-the-box start up, as well
as for convenient and contamination-free operation.
Automated data logging, process control and optimization
are made possible with an optional software package.
With its outstanding array of standard features, this proven
system provides an exceptional value.
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Easy-To-Read, 8" (20.3 cm) Vacuum Fluorescent Display
is clearly visible under all light conditions. Simultaneously
displays current value, setpoint and control mode for
(4) parameters
Membrane Keypad facilitates activation of setpoint
entry, calibration and sterilization cycles. vVatertight
and easily cleanable
Swing-Away Headplate provides easy access to vessel interior
Resterilizable Addition/Inoculation, Harvest and
Sampling Valves for aseptic operation are readily
removable and cleanable. Straight-through flow path
attains complete sterilization of the valve and transfer
lines. (See diagram.) All valves utilize quick connect
fittings. Sample valve provides variable flow

II

Large Window allows viewing the culture above and
below maximum working level

II

Sterilizable-In-Place vessel, ASME coded, available in
40, 80 and 120 L capacities. Type 316L jacketed
stainless steel provides rapid sterilization and precise
temperature; Internal finish of 15 - 20 Ra facilitates
cleaning and prevents residue build-up

II

DO, pH, Foam, Level, Temperature RTD Sensors
Choice of Ingold or Broadley-James pH and DO
Probes. In-Line Amplifiers for pH and DO sensors,
compatible with polarographic and galvaniC DO probes.
(pH probe and pressurizable housing shown)

• Most complete, fully accessorized, pilot plant fermentor

[I

• Set-up and start-up assistance provided, with optional
validation and training packages available. Process develop
ment and scale-up assistance can also be provided

Mobile System with Lockable Casters facilitates prepara
tion/ clean-up, maintenance and servicing

II:

Addition Bottles and Support Stand for acid, base
and antifoam provided for added convenience

• Most comprehensive warranty in the industry. One year
on parts and labor

lm

Three Peristaltic Pumps provided for acid, base and
antiioam addition

• Only NBS has an in-house ASME-accredited vessel shop,
microbiology and cell culture labs, software and instru
mentation development group, and integrated cGMP
bioprocess area to provide added customer support

III

Two Switched Outlets for optional remote pumps to
control nutrient and level

II

In-line Sterilizable Air and Exhaust Filters designed for
100% removal of viable organisms

III

Lamp illuminates vessei contents

UNIQUE ADVANTAGES
• Guaranteed high oxygen transfer rates (OTR) of 350 mM
0!UHr or higher enable high-density microbial culture*.
Up to 1,500 mM O/L/Hr attainable via O 2 supplementa
tion utilizing an optional NBS 2-gas mixer
• Capable of rapid temperature shifts in growth phase, to allow
for heat induction (1 °C/minute in range of 23°C to 45°C*)
• Capable of remote control, data logging and process
programming using optional AFS-BioCommand® software
• Smallest footprint of any pilot plant fermentor

• Optional on 120 L systems

TWO-POSITION
ADDITION VALVE
SHOWN CLOSED

Resterilizable Valve is coupled to a welded
fitting (Al by a retaining ring (B). A steam
inlet line (C) delivers pressurized steam to
the interior and exterior of the valve before
and after each use. Liquid is transferred via
quick-connect fitting (0) maintained sterile
by steam cap (E). Outlet steam IF) is fed to a
condensate trap (not shown). This design
eliminates "blind" pockets and crevices to
ensure sterile operation. The two-position
Addition Valve (shown closed) is spring
loaded so that Entrance Port (G) opens a
steam path through the hollow tube (as
shown). When in the forward position, the
tube is extended into the vessel for addition
of sterile liquid. An optional Quick Connect
(inset) can be readily coupled to the valve
for sterile and adjustable flow of additives.

d~l.o
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Extra-Large Powder/Fill Port with septum
Exhaust line with heat exchanger and view
glass. Heaters keep moisture-laden gases above
the dew-point and prevent condensation and
clogging of the exhaust filter

il:l

Features 16 - 28 are not visible in the photo

11

Choice of Thermal Mass Flow Controller or
Thermal Mass Flow Meter

D

Automatic In-Place Steam Sterilization of vessel,
process piping, valves and filters

l1

Safety override permits manual operation of the
pneumatic control valves in the sterilization!cool
ing system to protect pe~sonnel and culture

jj

Automatic Cool Down from sterilization tempera
ture to growth temperature

ill

Steam Traps, multiple traps guarantee the steriliza
tion temperature is maintained in all process lines

n

13

I]
12

11

15

10

Powerful Bottom-Drive Motor, 1.5 hPJ allows
easy access to headplate ports and vessel interior

~

Double Mechanical Agitator Seal, carbon-to
tungsten carbide, mounted in a pressurized
steam/steam-condensate environment maintains
constant pressure and protects contents of both the
vessel and the environment from contamination

D

Rupture Disk Safety Device, side mounted, of
316L
steel. prevents over-pressurization of
vessel; includes discharge tube to convey liquid to
bottom of reactor

I)

Three Additional Ports, 19 & 25 mm Ingold-type,
allow for insertion of extra sensors

H

High-Level Foam Control for the exhaust line shuts off
air and reduces agitation while signaling alarm

1i

Rear Connection for All Utilities. Open frame
piping facilitates cleaning, maintenance and servicing

l]

Pre-Filter Regulator Kits for air, water and steam
fo~ removal of particulates or impurities

B

Serial Port for data logging and computer control

r ......

l~

SIDE WAll PENETRATIONS

HEADPlATE PENETRATIONS
•
•
•
•

Foam Probe Port *
Level Probe Port *
Diaphragm-Type Pressure Gauge
High Foam-Sensing Probe * in Exhaust Gas Line
or in Optional Exhaust Gas Condenser
• Combination Filling and Inoculation Port

BOTTOM PENETRATIONS
• Bottom Agitator Double Mechanical Seal Housing
• Resterilizable Bottom Drain Valve with Quick Connect

•
•
•
•
•
•
•

Ring Sparger and Gas Overlay
Three Septum Addition Ports
Resterilizable Addition/Inoculation Port with Quick Connect
Rupture Disc
Five Ingold-Type Probe Ports for pH*, DO*and other sensors
Resterilizable Sample Port with Quick Connect
Jacket Pressure-Relief Valve

* Sensors supplied
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OPTIONAL
ACCESSORIES

120 Liters
25  100 Liters
3:1

Total Capacity
Working Volume
Aspect Ratio (H:D)
Geometry

40 Liters
10 - 30 Liters
2:1
Cylindrical with dished bottom

80 Liters
20 - 60 Liters
2:1

Pressure Rating

Vessel is ASME-coded, rated for 40 psig (2.8 kg/cm 2)
Jacket rated for 50 psig (3.5 kglcm2 ) /149' C

(
• Gas Overlay

Rectangular, sidewall mounted above and below the maximum working level.
40 L: 8.5" x 1.25" (21.6 x 3.2 cm); 80 & 120 L: 11.25" x 2.5" (29.2 x 6.4 cm)
(4) 316 L stainless steel removable baffles
Baffles
15.625" 10 x 28.625" H
Dlm&nslons Inches 11.625" 10 x 23.25" H
'cm
29.53 x 59.06 cm
39.69 x 72.72 cm

• Viewing Window

f'.

!

316 L stainless steel, orbitally welded and electropolished
All piping fabricated of 316 L stainless steel including valves and fittings

Vessel

MATERIALS
& FINISH

IMPELLERS

Process Piping
Gaskets/O-Rlngs

Gaskets of Silicone; O-Rings of EPDM

Diameter

4.87" (12.38 cm)

Type

(2) Six-bladed 316 L stainless steel, Rushton blade, standard
Marine blade and pitched blade optional
(1) Powder/Liquid Fill Port with Septum; (1) Pressure Gauge; (1) Exhaust/High
Foam; (1) Level; (1) Foam
(3) 19 mm septum ports; (1) 25 mm port and resterilizable valve;
(1 j 19 mm spare port, plugged
(1) 19 mm port and resterilizable septum valve;
25 mm ports, plugged: (4) in 40 L vessels and (5) in 80 & 120 L vessels

Headplate
Upper Side Wall
PENETRATIONS
Lower Side Wan
. Bottom

AGITATION

• Aerosol Containment
System to prevent aerosol
formation when sampling

Sensor

Platinum ATD in thermowell
Microprocessor-based via Plo control of tempered water, employing a pulse-width
modulation of steam and coolino control vaive
5°C above coolant supply temperature to 85'C, ± 0.2·C. (See also sterilization, below)
1·C/minute in growth phase in a range from 23· C to 45·C(l)
Sterilizable-in-place absolute 0.2 IJ filter with 316 L stainless steel housing
Depth filter
Choice of Thermal Mass Controller or Thermal Mass Flow Meter
0- 60 SLPM
0-90 SLPM
Manual back oressure control standard. Automatic back pressure control optional
Automatic sterilization and cool down
Selectable temperature from 105°C - 130·C with duration of 1 ·120 minutes
RS 422 BioCommand port for automatic data logging and control
630 Ibs. (286 Kg)
670 Ibs. (304 Kg)
880 Ibs. (400 Kg)
920 Ibs. (418 Kg)
680 Ibs. (309 Kg)
700 Ibs. (318 Kg)
34" Wide x 32" Deep x 70" High
86A Wide x 81.3 Deeo x 178 Hiah
0- 1 V AC lor logging pH, DO, temperature and agitation on optional recorder
Receptacle for optional nutrient pump, 120 V AC (2 Amps) or 220/230 V AC (1 Amp)
Receptacle for optional harvest pump, 120 V AC (2 Amps) or 2201230 V AC (1 Amp)

Inlet Filter
Outlet Filter
Control
Range

PRESSURE
STERILIZATION
COMMUNICATIONS PORT
Net
WEIGHT
Gross
DIMENSIONS, Inches
OVERALL
cm

• Steam Generator for
utility and clean steam

I

Recorder Output
ELECTRICAL

• Adaptable to Recirculation
of Tempered Water with
optional chiller to con
serve water

1.5 HP, AC motor, bottom-entry drive
Magnetic speed pick-up sensor
80 - 800 rpm ± 2 rpm
55 - 550 rpm ± 2 rpm
Plo regulation of speed VIa microprocessor feedback circuit
Double mechanical seal

Range
Shift

I

6.44" (16.35 cm)

Drive
Sensor
Range
Control
Bearing Housing

TEMPERATURE

AIRFLOW

• Resterilizable Ouick
Connect for inoculation!
addition, sampling and
harvest valves

Bottom drive; Steam-sterilizable ball drain valve

Control

,•

• Exhaust Condenser,
water-cooled installed in
headplate to minimize
evaporation of culture
medium

Connections

• 2-Gas Controller for
oxygen supplementation
and gas mixing

(

• Low-Shear Impellers,
marine blade or pitched
blade for insect cell culture
• Auxiliary Pump, aSSignable
peristaltic pump
• Validation Documentation,
10 & 00 packages
• cGMP ValidatIon,
hardware upgrades
• Chart Recorder, 4 channel
for data logging

200 V / 208 V 50/60 Hz or 230 V 60 Hz AC, 1 Phase, 20 Amps
Meets UL CSA VDE and British Standards

Power
UTIUTIES

Requires appropriate utilities for steam, air, water, exhaust, water return and drain
-

• Specifications subject to change without notice.

Q) In

the 120 L system, this is an optional feature.

New Brunswick Scientific Co., Inc.
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'>el> ~runswick Scientific N.V'/SA.
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, ADVANCED FEATURES OF
THE TOUCH-SCREEN
CONTROLLER

" The entire process is regulated
by the Ml-6100 controller.
This controller is capable of
operating up to sixteen
process loops. Setpoints are
easily specified along with
high and low-limit alarms that
warn of any deviation.

~~
I

..

TEMP
..~.-----l

lOC!.O

Add ancillary equip- ,
ment, from simple
pumps to complex ana·
Iyzers, right on screen
without factory instal.
lation or added cost
, • Control and display up
to 16 parameters on a
large' color VGA display

I 36.9

I

DegC

i

ip..j.l)

Intuitive Control
The menu-driven system is
designed for simplified control
using on-screen programming
of Loop Configuration, Pump

o.n

I

Soft 32.0
Oft: JO.O

pH

and Sensor Calibration,
Display Configuration, x- Y
Trend Graphs, Cascade
Control, Sterilization, and
Alarms. Change setpoints by

, ...0

touching the appropriate
gauge to bring up a numerical
display for that parameter.
Then, simply key in the new
setpoint.

0.0

7.111

!

• Graphic user-interface
repfaces alpha-numeric.
based controllers

1 :'7~
Oft: 56.J

From the main scrSB(1
'can easily aCcess programs for
sterilization, cascadecon.trol, lo()pconfiguration:calibration,. trend
graphs, and alarms:.:~ ", ' , '
The touch-screen controller
.
',
,:',:
has the built-in intelligence t o · "

.
'-- '

L.

fnu~~~e~~:~:~
operator
:;~u~ht~:ery

NBS

TOUCH-SCR1E~f.'~b'NTROl(ER'"
"~:~~~r;1f
.
'
" ,'" ., '
, control 0.0::

WO RKS SMA RT~~;::~t~;I.l."~ I M~~~R" '}~~~~~i~~ion,
~~~~S~dding
THAN ANY OJH~~~,;:~
,.' ~~8,~~~:~,,;:,~;-I,,~;;1 ~L~~~~~~~~i:';
such instrumentation as glu
additional interfa i , T~o~-' ':,;ren'~:"d:~'G'"ra"nh',' 'D','splay

cose, optica' density or C02
analyzers, the loop Config
uration Screen will help link
each facet of the control loop.
The controller can be adapted
to the signaI requirements of
all instrumentation right at the
touch-screen. just choose the
appropriate loop from a menu
of options and set the input,
the control algorithm and the
output. The display screen
shows you exactly where each
connection is made, obviating
the need for a service repre
sentative to install an optional
circuit board.
There is no longer a need to
order special factory-installed
control loops at extra cost
Now, you can immediately
create and name your own
specialized loops electronical
ly from a menu of options.
The controller accommodates
a wide range of input/output
signals from different sensors
and actuators, and may be
connected without requiring

,'.,

ics. These ·inclUd~J~~Tris,,"Jte'm~·

"',J

r

peraturesensors};ro~rri andi3y"gr~~hslare,dispiayed
level (conductance) probesi
through the TrEmd Graph " " '
.,:rT.!.~nlJ,~which are programmed "
tachometers, p~andP70. .
transmitters; as~w~ll'aspumps ;'.: • Jo,plot data against time: Up,
and other devices thah.isei~ ,
to fou(graph~ maybe dis~:'l; .
,playedsimul!arieously ,in .real,".
voltage or current-outputs.
(See loop Configwation
' ~ime,whichcan help to deter~,'
Screen tl5)'$
" mine the influence orone vari
able uroriaflother: With this
Cascade Control," '
information 'available right at ,
Create cascadesfg;'uptQ fi~~ '" ,Jbelermeritor, the data may~ ~ ,
parameters from a,;single;;:'
,,:, used tp make rapid process:"
screen. Control any parameter " ",' Cidju,stmEmtS during the~.:·-{""
using serial, parallell"or'over-", .':',fefftl,:nt~tion. '
"
.
";;"~"'<':: ;
SPECIFICATIONS, TOUCH-SCREEN CONTROLLER
,I.

Console
Types

I

Controller interiace available in various console
configurations: 1) In a floor-mounted water-tight
mobile console; 2) As a benchtop console; or
3) As a Hat-screen monitor mounted directly on
the piping console.

Signal
Inputs

Signal conditioning included for DO, pH, RTD,
Tachometer, and conductance probes, Controller
accepts 4 - 20 mA, 0 - 5 and 0 -10 VDC,
conductance, resistance, 0 - 30 kHz, fiber optic signals.

Signal
Outputs

Supports 0 • 5 V, 0 - 10 V (analog and digital), 4 - 20 rnA.
Available modes include PID, ON"()FF, PWM, Dead
Band, Gas Mix, mutti-channel outputs, and cascades.
Alarm output.

• Select high and low
process hmits and
alarms
.. Simplified, menu-driven
calibration of D.O., pH
and other parameters
• Automatic sterilization
.screen enhances scale
, up by duplicating
tfiermal conditions of
industrial reactors
• Valve se~uences and
, . sterilization time easily
programmed directly
from the touch screen
• All control operations
easily performed from
the main screen for
simplified control
• Multiple controller
configurations can be
easily recalled to
accommodate different
processes
• Password feature ensures
process security
• Battery back-up prevents
loss of setpoints In event
of power failure
• Serial port for data
lo~ing and control
usmg optional AFS
BioCommand® 
software package.

)5 CONTROL RIGHT·AT YOUR FINGERTIPS
-

,..,. .. - ~ ,.::,. ~:.-<!"

>~'.

,.::.• '-";,

hI!.fM§t.J§¥

100.0

0.0

I
I

II

ii

I!

36.9
Deg C

!

l

pH
I

7.01

I

I
I 100.0

np:.~o!1

i 1

l

300
RPM'
P-I-D
Sed'1:

30.0

Clut'lOc

no

U

========'1

I

50

LI

";='1

8.0

I

i
I

'1

500

i,

32.0

Out%, 30.0

I

AGIT

~i

NO
""""

i

[i
I I

TEMP

r

I

D.O.

5o.oJ

P·I-D
Soft
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FOAM
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10.0
PSIG

Manual
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80
SLPM

1
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AIRFLOW
200.0
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60.0
Manual

SetPt
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:Pracess Status Screen: Uses bar graph gauges to display up
to:16 process loops'on 2 screens, presenting an on-line
pano'?lTlaot the process.
The StertIiZatlo., Menu: To enhance scale-up capability you
. can program a laboratory or pilot fermentor to perform the
same as an-industrial fermentor. This menu permits the selec
-1ion'of heat-up, sterilization and jacket drain time, as well as
. valve operating sequences, etc. to duplicate the thermal condi
-tions of larger fermentors.
Alarm Shutdown Selection Menu: With this menu a selection
of pamrrleters can be programmed to shut down in the event an
. alarm condition is reached, and continued operation would have
"anaav8rSe
effect on the process.
,0"_'"
,-",.

_.

'J'

<

Trend Graphs: Up to four on-line graphs may be displayed at
011~ ti!'1 e.
Loop Configuration Screen: Displays precise configuration of
each loop, showing exactly where the appropriate connections
are to be made, and allowing the user to create optional loops
electronically without extra cost.

-a3b
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Custom Fermentation and Cell Culture Equipment :-:::

"J.~

New Bnmswk.k Sde.ndfk Is sUuc:tured to
pnMde specialized equipment desIsn and
construction seMces for a full range of
custom-built c:.GMP compliant fermentors
and bloreactors (10 to 10.000 L range)
which sdsI'y reguIamry vaIIdadon requh
ment by fDA. EMEA and national authoJi..
des.

Destsn PhIlosophy
A design philosophy similar to the computer
industry's ·open systems approach Is
practiced by New Brunswick Scientific.
Cu.staneIs can purchase fermentors. bloreac
ft

tor.; or other skId-m.ounted systems designed

and fabricated utilizing proven off-the-shelf
componenfs. This approach ensures that
technical and service support, induding
replacement components. are readily
available from mUltiple sources. The
selection of proven components increases
reliability and accelerates validation.

f.D&Ineedng CapabDity

A dedicated engineering group, spedaIlzlng
in custom system design. Is staffed with
mechanical. electrical, automation and
process engineering experts. A complete
support staff consisting of AutoCAD
designers and derlcal per.;onneI back up the
group's engineers.
AutcC.AD R14 Is used as the primary design
tool. with all of the engineering drawings
supplied In hard copy and on magnetic
media. Software tools are used in the design
of pressure vessels and process piping.
DetaIled protocols have been developed for
executing validatable cGMP compliant
projects to ensure that the systems meet
regulatory validation criteria.
An experienced project manager is assigned
to each project. ServIng as the dlent's pri
mary contact during the project's execution
cycle and ReId start-up of the equipmart, the
project manager provides continuity through
completion of the entire scope ofWOlk..

Process InsCrumentadon
Our fully-staffed automation group utilizes
Industry-proven PLC (programmable logic
controller) based systems to solve a broad
range of control applications. NBS has
standardized on such Industry leaders as
Allen Bradley and Siemens to offer our OJS
tomers added Oexlbllity in system configura
tion. processing pa.NeI' and I/O capadiy.
NBS \nteglates process control. data logging.
recipe management and Internet appIk:ations
with Microsoft Windows-based, 32-bit
object-oriented graphical hurnan-rnachine
Interfaces (HMI) such as Wonderware's
In Touch and Intellutlon's Fix software
programs. These industry-sta.ndard applica
tions offer our' customers the latest in
technology Indudlng VBA. Active X, OPC
and DOE.

Manufadudng CapabDity

NBS utilizes the manufacturing capabilities 01'
its 250,000 square foot manufacturing
plant, iocated in Edison, New Jersey. for the

execution of Its projects. The plant Includes the
most advanced manufacturing machinery In the
rermentation business, Indudlng automated
CNC milling madlines, orbital welding devices
and an ASME certified vessel shop which
enables NBS to directly control quality and
delivery Of its projects.
The manufacturing facility routinely executes
wstom-engineere projects lndudlng:

• d:MP Compliant Fennentors and
BIoreactors
• ASME Code Compliant Process Vessels
•
•
•
•

Clean-in-Place Systems
Validatable Process Control Systems
Addition. Mixing. Hold and KIll Tanks
Sterile FdtratIon Systems

v..Idadon SeMc:es
New Brunswick has consIdeIabIe experience in

using actual cultures or biological solutions.
Process corrections can therefore be made
before shipment. speeding InstAlJlation, start-up.
and validation.

fleJdSeMce
For decades. NBS has sold and installed fer
mentation and bioreactor suites allover the
world. These installations are serviced by
New Brunswick Scientific's ten U.s.-based
field service offices and worid-wlde service
offices located in the UK, the Netherlands. '
Belgium, France. Germany and China.
Due to the customized nature of most of our
projects. service engineers from our field
service organizations are typically trained on
each individual piece of equipment at the
factory prior to shipment. After delivery.,
service engineers partldpate In the commis
sioning of the equipment at the customer's

site.

providing valldatable bioprocess systems. which
Spare parts are stocked in our Edison, NJ
are in full compliance with cCMP regulations. quarters, as well as at our domestic " ..nlln"'t..
To more fully support the diem's IQ and OQ.
centers and worldwide offices ready
efforts. NBS can supply the following
ment to the customer at short
documentation:
Complete spare parts lists, with rArlvnMrlPnl
• Boroscope Weld MappIng with Videotape
on-hand quantities, are prepared during
. detailed engineering phase of each project.
• As-Bullt EngineeQng DrawIng
• Material Certificates

• Instrumentation Calibration Log
• ASME Pressure Vessel Calculations
• Temperature Maps

• BIll of MaterlaIs/OFM Part Numbers
• CIP Coverage Test Reports
• BIoI0gIcaI Challenge Test Report
The material used In the manufacturing of any
d:MP compliant system Is carefully controlled.
incoming raw materials are carefully inspected,
tagged, segregated and secured in a locked
area within our fadlity. !lllateial certificates are
carefully controlled to assure full traceability.
In addition. NBS performs control loop tuning

Support ServIces
New Brunswick Scientific can ofrer a
,"
range of consulting engineering services, trOll'!
preliminary conceptual design studies to
complete bioprocess facility design and pro-,
ject management.
'."'~""""'",'
To help support our customer's PQs and
.'
dients with biological processes that are not'·..,
fully characterized, we otrer process develoP
ment and optimization services that are unl~~"~,,l
In our Industry. We are the only fermentof,,'l
manufacturer with biochemical engineers, moI-". " "
ecular biologists, cell biologists and mlcroblOk>- ( ,
"
g ists on staff who operate a mode~n,
obIoI....;,.,,1 rer~
fully-equlpped pilot plant, a micr
V.5~30 L£>,,1j,;'
mentation lab and a cell culture lab up to t I, ",~;; ~

I

Appendix C

Generic tPA

***Correspondence with New Brunswick Scientific Co. All other correspondence
occurred over the phone with Ted Sheilds.***
X-Sender: tshields@207.162.131.33 (Unverified)
Date: Wed, 29 Mar 2000 08:19:15 -0500
To: maudette@seas.upenn.edu
From: Ted Shields <tshields@blast.net>
Subject: Fermentor Pricing you requested
X-Status:
X-Keywords:
X-UID: 84
Dear Melissa,
Here are the "ballpark" prices you requested, if you need any additional
information please don't hesitate to ask.
BF-5000 (30 liter max working volume)
400 Liter Industrial Fermentor
5000 Liter Industrial Fermentor

$ 85,000

$ 125,000
$ 250,000

These are strictly estimates, actual prices can vary substantially
depending on options and configuration.
Sincerely.
New Brunswick Scientific. Co.
Ted Shields

------------------------

---~--~~-

Appendix C

(Jeneric tPA
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Design Calculations for the Heat Exchanger used to Heat up the Media for the 3 Fermentors
1) Overall Energy Balance:
Q = total Energy needed to heat up media (BTU/hr)
m'=2.

.

m

1

,

1

.'60:

164TI 1.00.10- 3 ',T I

= 454.253

Volumetric Flow of 2gallmin converted into kg/hr

kg/hr

H out := 159.1

Enthalpy of water at 38 C in KJ/kg

Hin:= 16.8

Enthalpy of water at 4 C in KJ/kg

Q ..- m· i'H out - H in)\
Q = 6.464.104

KJ/hr

[i.

9 .486.1O- 4
1.- Q . 1000
tota , - '
.
I

total = 6,132.104

]

Conversion of KJ/hr into BTU/hr

BTU/hr

Calculate the flow rate of the warm water

H outw := 200.9

Enthalpy of water at 48 C in KJ/kg

H inw :=230.2

Enthalpy of water at 55 C in KJ/kg

m w := --...---Q--.-.-

H outw- H inw'

2.206.10 3

mw

kg
"Fir

Flow rate of the water on the shell side

2) Estimate overall heat transfer coefficient for a water-water heat exchanger
Ui BTUlF*ft/'2*hr

=

U i :=70
3) Assume 1-1 heat exchanger
4) Calulate Ai from equation 8.7
Calculation of the correction factor
,_ (55 - 48)
R =0.206
R. (38-4)
F T := 0.95

S:_(38-4)
(55 - 4)

From graph on page 323 of Seider and Seader

1

S

=0.667
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Calculation of the log mean temperature

T

a

,«48-38)-(55-4»

LM'-

aT LM

[(48-38)]
In (55 _ 4)

= 11.929

25.165

C

ilT LMF :=25.165·1.8+ 32
.1T LMF = 77.297 F

total
Ai:= Uj,ilTLMF.FT
Ai

=

ftA2

1

Conversion to mA2 from ftA2

A' '=A" --...,..2
1m .
1 3,2808

5) Choose ui to be between 1 and 10 ftlsec

fUsec

U

i := 0.6

U

1
im := U i'J:L'8i}'8
U

Conversion of u into m/sec from fUsec
m/sec

im = 0.183

6} Calculate Ad for the shell side

mw = the flow rate of the water that is being cooled (kg/hr)
p = the average density of the water stream
.
I
._ [ 1.01l·1O- 3 ;
P avg .

+
2

J

1
'
1.021.10- 3 ,

kg/mll3

mw

A CI.'.

36Oi)
P avg ·u·1m

A ci = 3.404.10- 3

mll2

Assuming 3/4in Steel Pipe tubing
0.0. = 0.75 in
1.0. = 0.62 in
1

ID :=0.62'39.37
\4·A Ci

Nt

ID ::: 0.016

:= n;.(1D)2

meters

1

00 :=0.75'39.37
Nt:

17.478

00 = 0.019 meters

2

cd4l.o

Convert temp to F

•
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7) Assume Tube Length L= 3 ft

At'" 0.06

N

m"2

Aim
'
P .- A eN t

8) Determine the diameter of the shell
Using table in the Process Design Book found on page 333, the diameter of the shell
was found from extrapolating the given data to apply to smaller number of tubes. The following
equation was found by graphing the points in excel and drawing a trend line.

Guess Value

x :=5
Given
IS=0.757S·x 2 - 2.7436·x
Find(x) = 6.516

+ 3.701

Equation of the line from Excel using the number of tubes
found above (NT)
Shell 10 in inches

9) Calculate hi, ho, Ui
Oshell :=6.6

Diameter of shell in inches

b

length of tubes in ft.

4

clearance := 0.25

P t := 1

12
D sheWclearance·b· T
Acfu:--------np~t------A cfo

= 79.2

in

m w = 2.206.10 3

2
kg

m

mw
G o :=-

Gj :=p avg' u im

Acfo

Go

=

27.S55

Flow rate of the water on the shell side

kg
hr.in 2

39.3i

G om :=G o'T'3()OQ

G i = IS0.007

kg
2

m ·s
kg

G om = 11.993 ----..

s·m"

3

d41

inch

inches
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Properties of the fluids:

',567.2.10- 6 + 504.6.10- 6

6

2

J1 h :-

)1

J1 h :: 5.359·1 (} ,J<g
m·s

)1 C ::

1.648,10- 3 + 641.10- 3
"

k h:=

k h :: 0.645

k

w

!

6

1560.10- + 695.10- )
'\

m·s

(577.2.10- 3 + 629.10- 3 ,
/

2

c'-

0.603

2

C pc

J
kg·K

Viscosity of Fluids

kg

1.127.10- 3

Thermal
Conductivity

w
rn:-K
Heat Capacity

._ (4200+ 41 78)
C pc'2

C ph:= (4183+4180)
3

.-

kc

rn:-K

C ph=4.181·10

c :=

4.189.103

J
kg·K

The Nusault numbers are calculated for the shell and tube side of the exchanger
I

Nu

Nu

o

:=0.36.

0 :::

[

OD·G ~m.
]0.55 [[C ph'

J1h:
kh

J1h

J]J

!Nu o·k h
ho:=~

15.243

Nu i :=0.023.

[

!D.G ']0.8 [[C pc'
I.

J1 c

J]O.4
h·I

kc

Ilc

Nu j·k c

Nu i = 27.516
The calculation of the overall heat transfer coeffiCient

Uie

w

U · = 391.849 --r,;'K
Ie
m.
U i := U ie·0.17612

U i :: 69.012

Conversion of the units back into BTUlh*ftI'l2*F

BTU

-;-;::r;:
h·ft ·F

4

~L\8
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Design Calculations and Utility Requirements for the Fermentor Section
of the tPA Process
All Pumps used in the Fermentor Section of the tPA process are identical. The
flow rates, pressure drops, and size of each of the pumps is within a close
enough range that the same type of pump can be used for each application.
The pumps are Randolph Austin Series 610-362 peristalic pumps.
Pump Characteristics for P-1, P-2, P-3, P-4, P-5, and P-6:
F:= 1001.4·

Ib

AP:= I5'psi

Ib
p :=63.72'ft!
l]

Assume an average pressure drop

Flow through Pump

nr

Oenisity of Water
Pump efficiency

:=0.80

Using the specifications provided by Randolph Austin Co. for the Series 610-362 Vari-flow
speed control peristolic pump:
Motor power :=O.2S·hp

Total power! := Motor power·7920·hr

'-2-S gal

'nr

FI ow max'- :>

Total powerl

3

1.476·10 okW·hr

._
gal
Flow min .-12·

nr
UtilityCost :=Total

Costing the pump

powerl·0.04·k~.hr

UtilityCost "" 59.0S9

The Cost of the pump as quoted by Randolph Austin Company is $1595.00

Pump P-7, Heat Exchanger water Pump
F :=4862.02·

lb

nr

lb
p ::;:; 63.72'-;3
ft
l]

:=0.80

Flow through Pump

Assume an average pressure drop
dP := IS ,psi

Oenisity of Water
Pump efficiency

Using the specifications provided by the Corcoran Company for the Model 30000-H01 (AA05):
Motor power :=2·hp
Total power? := Motor pO\\/er·?920·hr
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Total power7 = I.IS1·10 okW·hr

UtilityCost := Total powerTO.04.

I

KW1iT

UtilityCost = 472.475

Costing the pump
The Cost of the pump as quoted by Corcoran Company to be $3250.00.

Total Energy needs for all the pumps per year: (50 Batches)
totalUtility := \Total powerl·6 + Total power7, ·2
totalUtility = 4.134·10 4okW·hr
I
UtilityCost := totaIUtility.0.04.l<W1iT

Cost perpump := 1595.00

(there are 14 pumps total in the plant, 7 in each
fermentor train)

TotalPC := Cost perpump·12 + 2 ·3250

UtilityCost:; 1.654.103

TotalPC :; 2.564.104

Utility Requirement for the Fermentors, Blending Tank, and Harvest Pumps.
40L Fermentor

400L Fermentor

Agitationmotor 40 := 1.5·hp

Agitationmotor 400 := 5 ·hp

Power I := Agitationmotor 40' 7920·hr

Power 2 :=Agitationmotor 400·7920·hr

Power 1= S.S59·10 3okW·hr

Power 2

I
UtCost I := Power 1 ·0.04· KWlif

UtCost 2 ;= Power 2 ·0.04· l<W1iT

UtCost 1 = 354.357

UtCost 2 = I.\SI· 103

5000L Fermentor

5000 L Harvest Pump

Agitationmotor 5000 := lO·hp

Harvestmotor 5000 := 5 . hp

Power 3 := Agitationmotor 5000·7920·hr

Power 4 := Harvestmotor 5000' 7920·hr

Power 3 = 5.906· 10.t okW ·hr

Power 4 = 2.953·104okW·hr

1
UtCost 3 := Power 3 ·0.04· KWlif'

; I
UtCost 4 := Power 4 .0.04.·l<W1iT

= 2.953·104okW·hr
I

3

J

25L\
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Generic tPA
UtCost 3 = 2.362,103

UtCost 4 = 1.181· 10

3

The power for the media blending tank is equilvalent to the largest fermentor.
Blending Tank

Blending Tank Refrigerator

Agitationmotor tank := 10·hp

refrig := 8 ·ton

Power 5 := Agitationmotor tank' 7920· hr

,I kW.
energytocool :=refrig· 1·-' ·7920·hr
\ ton l

4

energytocool

Power 5 = 5.906·10 okW·hr

,
energy cost :=energytocool.0.04·:

, 1 \
UtCost 5 := Power 5 ·0.04·: 'T:Ti"f"'I:" •
\KVV

6.336.104 okW ·hr

1

kWliT

'nf/

energy cost = 2.534·10

UtCost 5 = 2.362.103

3

Total Utility Requirements for the Fermentors, Pumps, and Blending Tanks:
Total := total Utility + Power I + Power 2 + Power 3 + Power 4 + Power 5 + energytocool ·2
Total

= 5.401·10 5okW·hr

TotalCost := Total·0.04
TotalCost

'KWlif

The total Energy Requirement (with a large over
estimation) is 5.4*10"5. kW"hr per year and the cost of
the electricity is $21610Iyear.

= 2.161,104

25S
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Cat. No.
500-200,
610-200,
750-200

Explosion Proof Model
Fixed Speed
Cat. No. 500-200 shown
Cat. Nos. -200 are complete with pulley - belt - 114 hp - 115/volt - 60 hz - single phase - sleeve bearing
explosion proof motor and switch with 10 feet of flexible three wire electrical conduit and explosion
proof plug. All class I group D electrical equipment. Units are mounted on a durable metal base. Series
750 model is equipped with 113 hp motor. Refer to page 8 for flow rates, specifications and shipping
weight.
Dimensions: 500-200 - L 18-3/4" x W 12-1/2" H 8"
610-200 - L 18-3/4" x W 12-1/2" H 8-1/2"
750-200 - L 24-1/2" x W 14" x H 11-1/4"

Technical data
Cat. No.
500-201,
610-201,
750-201

Explosion Proof Model
and Speed Control
Cat. No. 750-201 shown
Cat. Nos. -201 are complete with a zero max speed control, 114 hp 
115/volt - 60 hz single phase - sleeve bearing - explosion proof
motor and explosion proof switch with 10 feet of flexible three wire electrical conduit and explosion
proofplug. All class I group D electrical equipment. Units are mounted on a durable metal base. Series
750 model is equipped with 112 hp motor. Refer to page 8 for flow rates, specifications and shipping
weight.
Dimensions: 500-201 - L 25-1/2" x W 12" x H 8-3/4"
610-201 - L 24-1/2" x W 12" x H 8-3/4"
750-201 - L 32" x W 14" x H 12-1/2"

Technical data
Cat. No.
500-332, 500-342, 500-352, 500-362
610-332,610-342,610-352,610-362
750-332, 750-342, 750-352, 750-362

Vari-flow DC Speed control Model
Cat. No. 610-362 shown
The Vari-Flow models meet IPC-44 specifications and are available with a
L....----.....;;;.-----I'variety of DC motors, each spanning a specific rpm range. Units are complete

20f4
~
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with a 114 hp - 115N - 60 hzmulti-speed motor (112 hp on 750-362), an integrated controller capable of
accepting a 4-20 Ma signal, and a reversing switch, all mounted on a durable metal base. The IPC-44
protection rating allows for intermittent contact with water without damaging the motor. Refer to page 8
for flow rates, specifications and shipping weight.
Dimensions: 500 Model - L 17-1/4" x W 13-3/8" x H 6-1/2"
610 Model - L 17-1/4" x W 13-3/8" x H 7-3/4"
750 Model - L 21" x W 17" x H 11-1/4"

Technical data
Cat. No.
500-400,610-400,610-425,610-450
750-400, 750-450, 880-400

Air Drive Model
Cat. No. 500-400 shown
Cat. Nos. -400 are equipped with an ARO air motor, regulator, and
pressure gauge. Cat. Nos. -425, 450, are equipped with a GAST air
motor. The 610-425 is belt driven while the -450's are equipped with
air motor and gearhead. Both models also are supplied with pressure
gauge, regulator, and muffler. Operation of 500 and 610 series (all models) require compressed air to 90
psi and 15 cfm, while on the 750 and 880 series 90 psi and 30 cfm, are required. Pumps are suitable for
use in hazardous areas and are variable speed by adjusting the air regulator. All units are mounted on a
durable metal base. Refer to pages 8 and 9 (model 880) for flow rates, specifications and shipping
weight.
Dimensions: 500-400
610-400
610-425
610-450
750-400
750-450
880-400

-

L
L
L
L
L
L
L

16" x W
16-1/2"
15-1/4"
16-1/2"
21" x W
16-1/2"
28" x W

9-1/2" x H 8-1/4"
x W 9-1/2" x H 9"
x W 10-1/4" x H 9-1/2"
x W 9-1/2" x H 9"
11" x H 11-1/4"
x W 9-1/2" x H 11-1/2"
14-1/2" x H 20-1/2"

Technical data

RANDOLPH AUSTIN
COMPANY
Made In U. S~ A. By
Randolph Austin Company
P.O. Box 988, Manchaca, Texas 78652
(512) 282-1590· Fax (512) 280-0678
email mikem@randolphaustin.com
800-462-1590

Pumps Flexible Tubing

30f4
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model
10-90psi

500-400 Air drive
model

7 .1331.1

8.356.5

17 lb.

Back to Intermediate Volume Page
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Series 610 - Models

Cat.#.

Model

Pump
Speed
rpm.

Motor
hp.

Output gph
Flow Rate
1/2" ID
3/8" ID
Tubing
Tubing

Ship.

wt.

610-PHO Pumphead only

8 lb.

610-000 Pumphead and pulley

8 lb.

430

1/4

125

200

610-101 Zero-max
0-400
speed control
model

1/4

0-116

0-186

610-200 Explosion
proof model

430

1/4

125

200

69 lb.

610-201 Expl. proof
model/speed
control

0-400

1/4

0-116

0-186

75 lb.

610-332 Vari-flow
3-125
speed control
model

1/4

2.4-41

3.2-65

38 lb.

610-100 Std. model
single phase
motor

29 lb.

40 lb.

---------_._-----------------------------------------------
610-342 Vari-flow
4-165
speed control
model

1/4

3-56

4.7-86

38 lb.

610-352 Vari-flow
6-250
speed control
model

1/4

4.4-81

7-123

38 lb.

1/4

8-174

12-255

38 lb.

~610-362 Vari-flow

12-500
speed control
model

610-400 Air drive
model - ARO

10-90psi

28.4-150

35-225

19 lb.

610-425 Air drive
model - Gast
(Belt Drive)

10-90psi

30-155

40-230

35 lb.

610-450 Air drive
model - Gast
(Direct Drive)

10-90 psi

27-144

34-224

20 lb.

zS8

:of4

..
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Series 750 - Models

Cat.#.

Model

Pump
Speed
rpm.

Motor
hp.

Output gph
Flow Rate
5/8" IO
3/4" IO
Tubing
Tubing

Ship.
wt.

750-PHO Pumphead only

20 lb.

750-000 ?umphead and pulley

20 lb.

750-100 Std. model
single phase
motor

430

1/3

390

570

65 lb.

750-101 Zero-max
0-400
speed control
model

1/2

360

470

120 lb.

750-200 Explosion
proof model

430

1/3

390

570

120 lb.

750-201 Expl. proof 0-400
model/speed
control

1/2

360

470 140 lb.

750-332 Vari-flow
3-125
speed control
model

1/4

8.2-113

12-<166

66 lb.

750-342 Vari-flow
4-165
speed control
model

1/4

10-150

14.6-219

661b.

750-352 Vari-f1ow
6-250
speed control
model

1/4

14-227

20-332

66 lb.

~750-362 Vari-flow 12-500
speed control
model

1/4

24-454

36-662

66 lb.

750-400 Air drive
model - ARO

10-90 psi

102-390

126-570

42 lb.

750-450 Air drive
model - Gast

10-90 psi

92-288

111-544

38 lb.

$ Z19 S\.$I·OO

Back to Intermediate Volume Page
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Close Coupled Centritugal Pumps Problem Solver
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Shipboard "Plastics waste
processor" required fresh water
recirculation Cup to 3SO"FI at 200 PSI
inlet pressure at rates of 12 GPM @
125 FT TH and 21 GPM @ '17 FT TM.
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Model: 3OOOD·HD1 !AA051

Material of Construction:

316 Stainless Steel
'-.. Size: 1/t" x 1" RF FL (301)#)
,~

........,......

----.......
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Features:
1.
2.
3.
.

Lightweight (65 Ibs.) heavy-duty design: 350 PSI hydrostatic test
LOW FLOWIHIGH HEAD design: enclosed impeller (5.50" dia.) with 1/4" wide vanes (5)
Single internal mechanical seal: Carpenter 20 Cb-3 metal bellows, chemical grade carbon vs
silicon carbide mating faces, EPDM elastomers. No stuffing box or chamber bore restrictions; no
flush required
4. Deep-drawn and fabricated casing with self-venting top horizontal discharge and drain
5. Marine-duty chemical Processina hostile environment motor: 2 HP 3450 RPM, 230/460 V AC,
TEFC, 1.15 SF, 145 TC frame with base, cast iron frame.

Click here to return to the Close Coupled Centrifugal Pumps page.
For Centrifugal Pumps, see:
Z1.90
10[2

4/13/003:43 PM

Close Coupled Centrifugal Pumps Problem Solver

1.
2.
3.
4.
5.
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Close Coupled Centrifugal Pumps
Pedestal Mount Centrifugal Pumps
Self Priming Centrifugal Pumps
Vertical Sump Pumps
Vertical Options

Table of Contents
•
•
•
•
•

Return to Corcoran Home Page
General Catalog of Corrosion-Resistant Pumps: Size and Styles
Centrifugal Pumps
Mag Drive Pumps
Pump Questionnaire
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P.O. BOX 429
500 N. VINE STREET
NEW LENOX, IL 60451-0429
Phone: 815-485-2156
Fax: 815-485-5840

TOLL FREE: 800-637-1067
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Subject: Technical Question - Your E-mail, 28 Feb 00
Date: Wed, 1 Mar 200009:01:35 -0600
From: "Lewis, James" <JLewis@osmonics.com>
To: "'kasidit@seas.upenn.edu'" <kasidit@seas.upenn.edu>
Dear Mr. Nootong,
Thank you for inquiry regarding Osmonics' Pleated Filter Cartridges.
For
any of our cartridges, we recommend a maximum flow rate of 5 gpm/Ten Inch
Equivalent (TIE) length.
Thus, a 20" long cartridge would have a maximum
flow rate of 10 gpm. The maximum can be reduced by other factors such as
the micron rating of the cartridge, the solution viscosity and available
pressure drop.

'7_ IJ. 'N\

When we size a ousing for a given filtration, typically we would include
enough TIEs to eep the initial differential pressure at 2 psid or less.
For the F t e -AP021 cartridge this rate would be 5 gpm.
For the
M~mtrex-~~21, this rate would be about 3.5 gpm.
In each case, a fluid with
a ViSCOSit~fwater was assumed. The data necessary for these calculations
is availabl op ou website, osmonics.com.
Please let us know if you have further questions.
project.
O~~~
Best regards,

Good luck on your

Jim Lewis
Application Engineer

(fu r('/t(e '/..
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FlotrexTM..AP Filters

OSMONICS

Polypropylene Microfiber

Product Infonnation

(0.65, 1,2,3,5, 10,20, and 40 J.lm Absolute Ratings)

Constructed of thermally-bonded polypropylene fiber media, absolute-rated Flotrex -AP (FAP)
filters combine exceptional solids holding capacities with precise micron retention ratings.
The FAP filters are constructed of high-purity polypropylene and are made with all
FDA-acceptable materials.
F AP filters are absolute-rated for air, gas and liquid filtration with low pressure drop across
the wide range of 0.65 to 40 micron. The graded sheets of melt-blown media are layered to
provide absolute particle retention, high solids loading and long service life.
The FAP filter is just one example of our strong commitment to liquid, gas and air treatment.
Our complete portfolio includes filters for every stage of processing, and we offer custom
solutions for your unique applications. Osmonics is your complete source for filters, housings
and other filtration equipment.
Whether you require an integrated solution or a single component for a specific application,
look to Osmonics first. From one end of the filtration spectrum to the other, Osmonics has a
total commitment to fluid purity.

FAP Advantages

lof5
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<nobr>Flotrex™-AP Filters<lnobr><br><small>Polypropylene Microfiber<lsmall>
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• Broad chemical compatibility
• Dependable protection for final
filters
• Efficient removal of
Cryptosporidium and Giardia
cysts
• High throughput
• High efficiency
• Long service life
• Absolute rating (99.9%)
• Fast rinse up to 18 megohm
• Thermally-bonded
polypropylene fiber media
• All FDA-acceptable materials
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ACFM = Actual Cubic Feet per Min.
ACFM = SCFM at 70°F and 14.7 psia
Note: For pressures and temperatures other than 14.7 psia (0 psig) and 70° F, ACFM can be
approximated with the following formula:
ACFM = SCFM
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<nobr>Flotrex™-AP Filters</nobr><br><small>Polypropylene Microfiber</small>
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Specifications

Polypropylene Microfibers

Effective Filtration Area for lO-inch Equivalent Cartridge Dimensions (Nominal)
Outside diameter 
0.65J.1m - 5.0 ft2 (0.45 m2)
2.75 inches (70 mm)
2
1J.1m - 5.0 ft2 (0.45 m )
Inside diameter 
2J.1m - 5.2 ft2 (0.48 m2)
1.25 inch (31 mm)
3J.1m - 5.2 ft2 (0.48 m 2)
5J.1m - 6.1 ft2 (0.57 m 2)
10J.1m - 6.7 ft2 (0.62 m 2)
20J.1m - 6.9 ft2 (0.64 m 2)
40J.1m - 7.2 ft2 (0.67 m 2)
Operational Data
Maximum Rated Differential Pressure 
Forward flow - 60 psi (4.14 bar)
Reverse flow - 30 psi (2.07 bar)
Maximum Rated Operating Temperature
1800 F (82 0 C) at 10 psid
(0.69 bar) in water
Integrity test and particle retention data available on request.

Applications

Flotrex-AP filters are specifically designed for pharmaceutical prefiltration. Typical

3 of;
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<nobr>Flotrex™·AP Filters<lnobr><br><small>Polypropylene Microfiber<lsmal1>

applications include:

Prefiltration and Final Chemical
Filtration
• Broad chemical compatibility

Bottled Water Final Filtration
• Efficient removal of Giardia and
Cryptosporidium cysts

Prefiltration of Pharmaceuticals
and Biological Fluids

High Throughput for Beer
Filtration

• Dependable protection for final filters

Ordering Information

Type

Absolute
Micron
Rating

Cartridge
Length

FAP

96 =0.65J.1m
01 1. 0J.1m
02 2.0J.1m
03 =3.0J.1m
05 = 5.0J.1m
10 = 10.0J.1m
20 20.0J.1m
40 =40.0J.1m

1 = 10 Inch
2 = 20 Inch
3 = 30 Inch
4 = 40 Inch

I

End #1
Adapter

IA

Open End

I Gasket

i B = 120 O-Ring

ICE == 222
213 O-Ring
O-Ring
i

IFJ = 020
226 O-Ring
O-Ring

End #2
Adapter

i

Elastomer
Material

A = Open End 1 B = Buna-N
Gasket
E = EPDM
B = 120 O-Ring S = Silicone
C = 213 O-Ring T = Teflon* Encapsulated «
G = Closed End
2 and 226 Sizes)
H Fin Adapter V = Viton*

I Q 222 O-Ring

I Stainless Steel

IZSupport
Ring
= 226 O-Ring
ISteelSupport
Stainless
Ring
* Viton and Teflon are registered trademarks ofE.1. DuPont de Nemours and Company, Inc.

Downloads

Flotrex-AP Filters Polvpropylene Microfiber
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Memtrex™-FE Filters

OSMONICS

PTFE Membrane

Product Information

(0.1, 0.2, 0.45, and 1J-lID Absolute Ratings)

Memtrex-FE (MFE) filters consistently achieve absolute filtration with low extractables.
Constructed using a 100% PTFE membrane, they are especially designed for reliable general
chemical and air filtration.
The PTFE membranes achieve absolute filtration and are ideal for aggressive chemicals. They
are designed with all FDA-acceptable materials. MFE filters are ideal for air and process gas
filtration and vent uses. These highly hydrophobic membranes from 0.1 to 1.0 micron provide
critical control over your processes. MFE filters are integrity testable.
The MFE filter is just one example of our strong commitment to liquid, gas and air. Our
complete portfolio includes filters for every stage of processing, and we offer custom solutions
for your unique applications. Osmonics is your complete source for filters, housings and other
filtration equipment.
Whether you require an integrated solution or a single component for a specific application,
look to Osmonics first. From one end of the filtration spectrum to the other, Osmonics has a
total commitment to fluid purity.

:MFE Advantages

04/02/20008:01 PM
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Electronics Grade Chemical Filtration
• High purity

Bulk Chemical Filtration
• Broad chemical compatibility

Acids, Base, and Oxidant Filtration
• Highly hydrophobic membrane
• High air flow

Process Air and Gas Filtration
• Excellent vent filter

Ordering Information

F'

Type i Absolute
1Micron
1, Rating

Cartridge
Length

End #1
Adapter

End #2
Adapter

Elastomer
Material

MFE 91 =
92
94 =
01

1 = 10 Inch
2 20 Inch
3 = 30 Inch
4 = 40 Inch

A

A=Open End
Gasket
B = 120 O-Ring
C = 213 O-Ring
G = Closed End
Cap
H = Fin Adapter

B
E
S
T

O.lllm
0.2 11m
0,451lm
1.01lm

Open End
Gasket
B 120 O-Ring
C ;::: 2.13 O-Ring
E = 222 O-Ring
F ;::: 226 O-Ring

J = 020 O-Ring

Buna-N

= EPDM
= Silicone
= Teflon* Encapsulated

(Only in 222 and 226
Sizes)
V = Viton*

Q = 222 O-Ring
Z

Stainless Steel
Support Ring
= 226 O-Ring
Stainless Stee I
Support Ring

.. VUon and Teflon are registered trademarks ofE.!. DuPont de Nemours and Company. Inc.

Downloads

Memtrex™- FE Filters PTFE Membrane

Associated
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<nobr>Memtrex™-FE Filters</nobr><br><small>PTFE Membrane</small>
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Specifications

PTFE Membrane

Effective Filtration Area for 10-inch
Equivalent

Sterilization

0.1, 0.2,0.45, and 1.0J,1m - 6.6 ft2 (0.52
m2)

Operational Data
Maximum Rated Differential Pressure 
Forward flow - 60 psi (4.14 bar)
Reverse flow - 30 psi (2.07 bar)
Maximum Rated Operating Temperature

Autoclave at 250°F (121°C) -Maximum
10 hours
Steam-in-Place at 257°F (125°C) 
Maximum 10 hours

Integrity Test: Diffusional Flow (60% IPA)
0.1 J,1m - <15 cc/min at 20 psi (1.38 bar)
0.2!lm - <15 cc/min at 13 psi (0.90 bar)
0.45!lm - <10 cc/min at 9 psi (0.62 bar)
1.0!lm - <8 cclmin at 5 psi (0.34 bar)

I800 P (82°C) at 10 psid
(0.69 bar) in water

Cartridge Dimensions (Nominal)
Outside diameter - 2.75 inches (70
mm)
Inside diameter - 1.25 inch (31 mm)
Retention data available on request.

Applications

Memtrex-FE filters are specifically designed for chemical and vent filtration. Typical
applications include:

30f5
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<nobr>MemtrexTM. FE Filters</nobr><br><small>PTFE Membrane<lsmall>

PTFE membrane from Gore *
Low extractables
Ideal for aggressive chemicals
Ideal for vent filtration
All FDA -acceptable materials
Highly hydrophobic membrane

•
•
•
•
•
•

* Gore is a registered trademark ofWI. Gore & Associates, Inc.
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ACFM = Actual Cubic Feet per Min.
ACFM = SCFM at 70° and 14.7 psia
Note: For pressures and temperatures other than 14.7 psia (0 psig) and 70°, ACFM can be
approximated with the following formula:
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Appendix C

***Correspondence with Hyc10ne Media Company. All other correspondence occurred
over the phone with Neil Collins.***
From: mark.wight@perbio.com
X-Lotus-FromDomain: PPUS22@PPUS35@PIERCE
To: maudette@seas.upenn.edu
Date: Mon, 6 Mar 200009: 12:30 -0700
Subject: Request for information
Content-Disposition: inline
X-Status:
X-Keywords:
X-UID: 33
Melissa,
Thanks for visiting the HyClone website and for your request for information.
Neil Collins would best address your questions about the mixing tank and I will
give you his email and contact information below. Another option for you to
consider would be to allow HyClone to produce the media for you and deliver it
in BioProcess Containers up to 900L in volume. Either way we would be happy to
work with you.
Here is Neil's contact information:
Here is Neil's contact information:
Neil Collins
neil.collins@perbio.com
800-492-5663 ext. 7182

Please feel free to contact me as well:
Mark Wight
Technical Services
HyClone Labs
mark.wight@perbio.com
800-492-5663 ext. 7223
Thanks
Mark
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HyQ PF-CHO is a protein-free medium designed for growing
suspension cultures of Chinese Hamster Ovary (CHO-Kl) cells as well as
many derivatives of this parent line. HyQ PF-CHO has been specifically
engineered for minimal adaptation, making it an excellent choice for
producing and purifying recombinant proteins. Cell densities obtained
using HyQ PF-CHO compare favorably to those of serum-free and
serum-containing media. This product has been designed to decrease the
cost of manufacturing and purifying recombinant proteins.

HyQ PF-CHO MPSTM
HyQ PF-CHO Multi-Powder System is a two-powder protein-free
medium designed for the suspension growth of Chinese Hamster Ovary
(CHO) cells. the medium is designed to maintain high cell densities and
high protein output.
HyQ PF-CHO MPS is ideal for large scale recombinant protein
production because it contains only minimal animal-derived material
and plant hydrolysates with no peptides > 10,000 Daltons MW.
HyQ PF-CHO MPS gives you the convenience and stability ofa
dry powder medium. The two-powder system is economical for
large volume users. Powders are packaged in matching aliquots so
no measuring is required and hydration is easy.

(

HyQ PF-CHO MPS can be used with Dihydro Folate Reductase
selection systems because HyQ PF-CHO MPS contains no
glutamine and is deficient in hypoxanthine and thymidine.
HyQ PF-CHO Multi-Powder System performs as well as
HyClone's liquid medium (SH30220) and supports greater cell
growth and sustained viability compared to competitive products.
Cells maintained in HyQ PF-CHO MPS show consistent
performance over the long term. Population doubling times wer
constant over more than 10 weeks with cell viability over 90%.

~. iproduct

:!pF-CHO MPS : Proteiii=free medium for CHO cells 
. Multi-powder system
ICataloiN~b~r-rSH303i3 -- .. - ...- ._..... H~'
--

IPackaging .

• • • • •__• • • • •

.

.... IsftoioooL

I$;;~~:?t~............ i-c-~-.o';"!~-s-~er-O-l-fr-O-m-S-h-ee-p-'-,s-.. w-....-~o-..~-.~-~-.~-~-l-iv-e-r-o-il---ICell Density
1>3.0 x 106/ml in 5 days; viability >95%
ISelectionsystem IDihydro Folate Reductase,Glutamme Synthetase
lNutri~ion .. . . .. !thYmiaine,'hypo~anthine, deficient, futamme ttee:J
(Protem ExpressIon 1>5 mg/L
.
.
Icumulati~epopulation doubling >90 days
1"'T""'r--:---:"'----lminimal
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HyQ PF-CHO MPS supports higher cell density and longer sustained viability than the
competitive product.

Media Development CHO
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Cells maintained in HyQ PF-CHO show consistent performance over the long term. Popu
doubling times were constant over more than 10 weeks with cells viability over 90%
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The multi-powder system is composed of two parts .. main powder and base powder. The
powders are packaged in matching aliquots so no measuring is required.
'
bicarbon
(2g/L) is added when the medium is hydrated to achieve a pH of7.2-7.8. No 0 er supple
are required, but some cell clones may show improved growth with addition of glutamine
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+Pluronic F-68®. For culture systems which require more buffering capacity, HEPES rna
added (up to 25 mM).
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Comparison of cell growth and protein (hm-CSF) production in HyQ PF-CHO MPS and HyQ PF
liquid medium (Catalog No. SH30220)

Features and Benefits ofHyQ PF-CHO Multi-Powder System

((
Dry powder system
Multi-powder system
Propri~tary

lipid blend

HyClone powdered medium
No glutamine
Deficient in hypoxanthine and
thymidine
No Pluronic F-68
Metabolically designed
Simplified medium composition
Protein-free

Stability, economy, and convenience of a powd
Two powder components combined without the
need to measure makes hydration easy.
Powder is stable and the requirement to add
supplements is limited.
Lots of up to 400,000 L-eq. can be produced.
Medium can be used with glutamine synthetase
(GS) selection. Glutamine levels can be adjuste
for individual cell line requirements.
Medium may be used with dihydrofolate reduct
(DHFR) selection.
Pluronic may be added for suspension cultures
require extra surfactant.
All components of the medium are identified fo
simplified protein purification.
Supplements may be added to meet requiremen
of particular cell lines.
Medium components will not interfere with
recombinant protein purification.
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BOC: Special Gases: Product Catalog

To Order Call:

·SOO-BOC·GASES

Carbon Dioxide
I

!Cylinder Contents @ Pressure
.
Equipment .
g
ISize*
N.TP . . . (P.Si )..
vaiV.e Recommendations
IU.S.ICan.IIb
~1@70 of Outlet
..

·
, - - - - - . - - - IPurity

''''S-p-ec-;-tr-a--C~le-an--'®''''R \99 999<Y<

IGrade 5™
Research
Grade5TM

A colorless, odorless, liquefied
gas. Also available in bulk
2 quantities and tube trailers.

hS..2

rs;s--..I.33~
C. GA ,iRegulator
b~~~o~rass,
rs;s--jCGA
'I Stage High Flow
lVoJU
320
ModelBSR310

~.
O.
118 14
[V
. f"'v.
199.999<Y< ['152 rt52~'118.14
'.

0

(15.. 2

.-1

'L ........ ,"..,

0

Model

\~~~~;!~~n

\99.995% [200

r--.
ILasershleld

199.995%ree Lasershle

fg:~~M

[99.99%[200 f [60••'[27.22 [838lfgA !~:~:~5~cron,

~:~~O:l~
iBone Dry
'Grade 2.8TM
j

I

r------~

ILiquid
I

~9% kS

199.99%
.i

199.8%.

I

,12001.~0
....... \27.22 F . [~~A
. .
. ld G
'
ases Section

Purge

Brass Deep Purge
Model 481 0

1200IKI60***127.22'FI~~A . iFlowmeter

"P'"FT".F'W'
fLB.iFFFW
""r-' 60*. ** 2.7.22 838

200 K

p o o '

I

•

choose
. CA.IModelB7920
owtu e or reqUIre
320
!flowrate)

anollS SIzes an
request.

* Other sizes available upon request.
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BOC: Special Gases: Product Catalog

Purity
Specifications
(ppm unless
otherwise noted)

http://www.boc.comJgases/proaucls/ ... menl:i:IJ plUUU~L'>1 gd'>C'>1 PUlC, "Vk.HLll1

Maximum
Minimum Impurities
Purity
(ppm)

Grade

ISpectra-Clean® [99.999%

10

IResearch

199.999%

1
10
1

Ipure-clean

199.995%

150

FFFFF
IrflFf
rf8!2l o.5

Iliff
IFFfIOfW
Ilrll
IIIII
.

!Coleman**
.IAnaerobic
12 .8**

1

99 .99 %
99 .99 %

1

199 .8%

Technical Data:
Mol. Wt.
Boiling Point
Sp. Volume
Critical Temp.
Critical Press
Flammable Limits
Toxicity
Compatibility

I
I
I

r

.

.

..

Shipping Information:
44.01
-109.3 of (-78.4 DC)
8.74 cfllb (0.547 m3/kg)
87.8 OF (31 DC)
1071 psia (7381.5 kPa)
Nonflammable
TLV 5000 ppm
Moisture promotes corrosion

DOT/TDG Name
HazardITDG Class
IDNo.
DOT/TDG Label
WHMIS
CAS No.
MSDSNo.

Carbon Dioxide
2.2
UN 1013
Nonflammable Gas
Class A, D2B
124-38-9
G-8

* Available with a dip tube upon request.
** Liquid phase.
*** In Canada volume is 50 lbs (22.68 kg).

20f2
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BOC: Special Gases: Product Catalog

Order Call:

-soo·aOC·GASES

Air

Also available in bulk quantities, tube trailers and aluminum cylinders.

~---- r=-c~,.-- ~--;-----;---r;;;:----"-"

·
I

.."

IC'yIi:der Iconten.ts. IPr.~ssure
jSlZe
,j@ NTP l(pSIg) . Valve
r--------U.S.Can.Jcf~I@700F OutIet***

IIZero O.ITM
[TOC Grade'
\

1300 ~131018.7012640
230 6
[200r. 1 1 ...3.8..... '122.00....'
~fSb1238 12200

I:: ~

i;!~ :~. :~.~ li~
2200

,

.....

,

..

.. ..

Equipment
Recommendations

ICGA 590 =Ro--e-gu-'l-at"--o-r- - 
A 590 2 Sta!:te Brass Model
ICG
BHT300
ICGA.590 1 Stage Brass Model
BHS500

.·ICGA590
[eGA 590 High Pressure
A 0 1 Stage Brass, Model
ICG
. . ' 59 . BHS 4 Lecture Bottle,

[<r 186[2381
Model 325
\Zero Ambient
ISee Environmental Section
.
1300
pro 18.70 12640ICGA 590 Filter
~~~~~~n**zero '200 EI230I6.3~12200 ICGA590 10micron,Model
~ 186 , \2.3 8.• =-12.2-;-;;0~0_______."""IC"""G-,-A.,.,.59"",0;-- _752_o
I
13 00
18.70 -12640
[CGA 590 Flowmeter
zero 1.0TM
C-::- ~ f230 [638[2200. ICGA 590 Model B7920 (choose
2UU
OO
I
1
~18612.3812200
[CGA 590 iH6::~erorregUlred
~----POO~1310poI2640
jCGA590
IC02 Free
1
rr-[230 16.38 12200
[CGA590
200
,
[<rfSbfD8[2200ICGA 590
1300 ~pmI8.70 12640
jCGA590

r

,-------1

rplO

l

200 EI23o[O.38. 12.20~
[<r18612.38 '12200
I
[L.B.
r~II775
.,-----rr-1310 18.70 12640

. JCGA 590
jCGA590
ICGA 170
ICGA 590

Zero 2.0TM

1

IDry

c-::-rr-f230[638[2200
[200 [<r186[D812200

ICGA 590
[CGA 590

IL.B·r--!2~11775
It=H;:-;-ig-:-h-;;P=--re-s-su-r'e-f500r--1502j13.92 16000

ICGA 170
ICGA 702

I

I

He

...

...

*** Other sizes available upon request.
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BOC: Special Gases: Product Catalog

HU.

Shipping Information:

Technical Data:
Mol. Wt.
Sp. Volume
Critical Temp
Critical Press
Flammable Limits
Toxicity
Compatibility

n«p://www.ooc.conllgasl:slprUUU-':lbl ... lHell\..:1; ill u",,,,,,,,, 0"""'" p ...... , .......

28.97
13.3 cf/lb (0.833 m3/kg)
-221.1 of (140.6 0c)
546.8 psia (3774 kPa)
Supports Combustion
Nontoxic
Noncorrosive

DOT/TDG Name
HazardlTDG Class
ID No.
DOT/TDG Label
WHMIS Class
CAS No.

Air, Compressed
2.2
UN 1002
Nonflammable Gas

MSDSNo.

0-113

A

(02) 7782-44-7
(N 2) 7727-37-9

* TOC Grade is used on a Total Organic Carbon analyzer which measures carbon
compounds in water.
** Prepared and certified to meet Federal Register Specifications, Title 40 CFR 86.
114-78.
*** The Valve Outlet for Canada is CGA 346.

20f2
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Generic cPA
BOILER.lCS

(Project Summary)
UNITS

ITEM

VALUE

PROJECT INFORMATION
TPA-2

Project Name
Project Description
Analysis Date and Time
Simulator Type
Simulator Version
Simulator Report File
Simulator Report Date
Economic Analysis Type
IPE Version
Project Directory
Scenario Name
Scenario Description

Thu APr 2014:08:392000
AspenTech
10.1-0 Build 25
C:\boiler.rep
Sunday, April 09, 2000
IPE

5
C;\PROJECTS.lPE\Projects\TPA-2

CAPITAL COST EVALUATION BASIS
Date
Country
Units of Measure
Currency (Cost} Symbol
Currency Conversion Rate
System Cost Base Date
Project Type
. Design code
Prepared By
Plant Location
Capacity
Time Difference Between System Cost Base Date and Start Date for Engineering
User Currency Name
User Currency Description
User Currency Symbol

20-Apr..Q0
US
I-P
U.S. DOLLAR
USD/U.S. DOLLAR
1Q 98
Grass roots/Clear field
ASME
IPE 5.0 User
North America
1.#INF
276

Days
USD
US Dollar
USD

PROJECT RESULTS SUMMARY
Total
Total
Total
Total
Total
Total

Project Capital Cost
Raw Materials Cost
Products Sales
Operating Labor and Maintenance Cost
Utilities Cost
Operating Cost

Operating Labor Cost
Maintenance Cost
Operating Charges
Plant Overhead
Subtotal Operating Cost
G and A Cost

Cost
CosUperiod
CosUperiod
CosVperiod
CosVperiod
Cost/period
Cost/period
Cost/period
Cost/period
Cost/period
Cost/period

0

O
o

12E+O

o

440000
10682.3
843137
440000

o
110000
220000
780682
62454.6
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-AP3F. tmp
Aspen stream report for the design of the plant steam boiler:
1 2
STREAM ID
FROM
TO

1

2

B1
B1

SUBSTREAM: MIXED
PHASE:
LIQUID
VAPOR
COMPONENTS: LBMOL/HR
WATER
61.0849
61.0849
TOTAL FLOW:
LBMOL/HR
61.0849
61.0849
LB/HR
1100.4617 1100.4617
CUFT/HR
17.6573 1. 2148+04
STATE VARIABLES:
TEMP
F
68.0000
266.0000
PRES
PSI
14.7000
39.1600
VFRAC
0.0
1. 0000
LFRAC
1. 0000
0.0
SFRAC
0.0
0.0
ENTHALPY:
BTU/LBMOL
-1.2297+05 -1.0243+05
BTU/LB
-6825.8988 -5685.8179
BTU/HR
-7.5116+06 -6.2570+06
ENTROPY:
BTU/LBMOL-R
-39.1336
-10.0992
BTU/LB-R
-2.1722
-0.5605
DENSITY:
LBMOL/CUFT
3.4594 5.0286-03
LB/CUFT
62.3232
9.0592-02
AVG MW
18.0152
18.0152

Page 1
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-AP3D.tmp
Aspen Block Report for the plant wide steam boiler:

BLOCK:

B1

MODEL: HEATER

INLET STREAM:
OUTLET STREAM:
PROPERTY OPTION SET:

1
2
IDEAL

MASS AND ENERGY BALANCE
IN

***

E DIFF.
TOTAL BALANCE
MOLE (LBMOL/HR)
OOE+OO
MASS (LB/HR
OOE+OO
ENTHALPY (BTU/HR
23
ONE
PHASE TP FLASH
SPECIFIED TEMPERATURE

IDEAL GAS
***
OUT

RELATIV

61.0849

61.0849

0.0000

1100.46

1100.46

0.0000

-0.751164E+07
***

o

IDEAL LIQUID /

INPUT DATA ***
SPECIFIED PHASE IS
F

SPECIFIED PRESSURE

PSI

-0.625703E+07

-0.1670

VAPOR
266.00
39.16

00
30
0.00

MAXIMUM NO. ITERATIONS
CONVERGENCE TOLERANCE
010000

RESULTS

***

***

OUTLET TEMPERATURE

F

266.00

OUTLET PRESSURE

PSI

39.160

HEAT DUTY

BTU/HR

0.12546E+

07

Page 1
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THE FOLLOWING IS A PRINTOUT OF THE SUPERPRO DESIGNER STREAM REPORT.
IT PROVIDES COMPONENT FLOWS FOR STREAMS THROUGHOUT THE SEPARATION SECTION.

BULK RAW MATERIAL REQUIREMENTS PER SECTION
====================================================== ========~===========

SECTIONS IN:

Main Branch

Separation Section
Raw Material

kg/kg MP

kg/Year

kg/Batch

Arginine
WFI
Glycine
NaOH {I Ml
Media
Biomass
tPA
Sodium Chloride
PBS
Sucrose

72491.27
20811.12
540.29
13106.55
242386.00
31094.70
146.88
4500.97
116234.76
1. 75

1066.048
306.046
7.945
192.743
3564.500
457.275
2.160
66.191
1709.335
0.026

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Section Total

501314.31

7372.269

N/A

SUMMARY (Entire Flowsheetl
Raw Material

kg/kg MP

kg/Year

kg/Batch

Sodium Chloride
PBS
Sucrose

72491. 27
20811.12
540.29
13106.55
242386.00
31094.70
146.88
4500.97
116234.76
1. 75

1066.048
306.046
7.945
192.743
3564.500
457.275
2.160
66.191
1709.335
0.026

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

F10wsheet Total

501314.31

7372.269

N/A

A!:ginine

WFI
Glycine
NaOH (I
Media
Biomass

M)

t ?l\

======================~===============~=============== ====================

.2.83
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Appendix D

BREAKDOWN PER RAW MATERIAL AND SECTION {kg/batch}
=====================================~================

Raw Material

Separation Section

Subtotal

Arginine
WFI
Glycine
NaOH {1 M}
Media
Biomass
tPA
Sodium Chloride
PBS
Sucrose

1066.048
306.046
7.945
192.743
3564.500
457.275
2.160
66.191
1709.335
0.026

1066.048
306.046
7.945
192.743
3564.500
457.275
2.160
66.191
1709.335
0.026

TOTAL

7372.269

7372.269

======================================================

BREAKDOWN PER RAW MATERIAL AND SECTION (kg/year)
======================================================

Raw Material

Separation Section

Subtotal

Arginine
WFI
Glycine
NaOH (1 M)
Media
Biomass
tPA
Sodium Chloride
PBS
Sucrose

72491.3
20811.1
540.3
13106.6
242386.0
31094.7
146.9
4501.0
116234.8
1.8

72491. 3
20811.1
540.3
13106.6
242386.0
31094.7
14 6.9
4501.0
116234.8
1.8

TOTAL

501314.3

501314.3

264
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COMPONENT BALANCE AND STREAM REPORT
========================~==~=============================================~=====

STREAM NAME
SOURCE
DESTINATION

P-2
Centrifuge
OUTPUT

P-16
P-19
P-11
UF2 Pump
INPUT Affinity Co
UF2 Affinity Co
ER Tank

P-20
INPUT
ER Tank

==========~===========================================================~========

STREAM PROPERTIES
ACTIVITY
TEMP
PRES
DENSITY

U/ml

°c
bar
gil

0.0
4.0
1.0
1050.0

0.0
5.7
3.0
1150.5

0.0
4.0
1.0
1187.7

0.0
4.0
1.0
1186.8

0.0
25.0
1.0
1043.0

115.1645
0.0000
0.0000
200.3153
0.0000
1.9375
0.0000
0.0000

148.6561
0.0000
7.9455
0.0000
0.0000
0.0000
0.0000
199.9221

114.3509
0.0000
6.1119
0.0000
0.0000
1.6068
0.0000
153.7862

0.0000
0.0000
0.0000
0.0000
0.0126
0.0000
0.3154
0.0000

COMPONENT FLOWRATES (kg/Batch)
Arginine
Biomass
Glycine
Media
Sodium Hydroxid
tPA
Water
WFI

0.0000
457.2750
0.0000
0.3565
0.0000
0.1080
0.0000
0.0000

========~============================================= =========================

TOTAL (kg/batch)
TOTAL (m3/batch)

457.7394
0.4360

317.4173
0.2759

356.5237
0.3002

275.8558
0.2324

0.3280
0.0003

===============================================================================
===============================================================================

STRElo.M NAME
SOURCE
DESTINATION

P-4
INPUT
un Tank

P-27
INPUT
MF Tank

P-25
ER Column
MF Tank

P-7
UFl
OUTPUT

P-5

un Tank
un Pump

===============================================================================

STREfu\1 PROPERTIES
ACTIVI7Y
TEMP
PRES
DENSITY

U/m1

°c
bar
gil

0.0
4.0
1.0
1562.0

0.0
25.0
1.0
1000.0

0.0
25.0
1.0
1186.6

0.0
4.0
3.0
1074.4

0.0
30.6
1.0
1074.4

0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
59.0000

114.3509
6.1119
0.0000
0.0126
0.0258
1.6028
0.3154
153.7862

802.2275
0.0000
3363.8282
0.0000
0.0000
0.1145
0.0000
0.0000

850.0000
0.0000
3564.1436
0.0000
0.0000
2.0520
0.0000
0.0000

COt-1PONENT FLOWRATES (kg/Batch)
Arginine
Glycine
Media
SodiL:.m Hydroxid
Sucrose
tPA
Water
1'1FI

850.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000

Generic tPA
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======~===:=========================================== =========================

TOTAL (kg/batch)
TOTAL (m3/batch)

850.0000
0.5442

59.0000
0.0590

276.2056
0.2328

4166.1702
3.8775

4416.1956
4.ll03

=====~================================================ =========================
=========~============================================ =========================

STREAi.'1 NAME
SOURCE
DESTINATION

P-8

UFl
UF2 Tank

P-10
P-13
P-14
UF2 Tank
UF2 Affinity Ta
UF2 Pump Affinity Ta Affinity Co

P-22
INPUT
ER Column

================================================~=========================~====

STREAM PROPERTIES
ACTIVITY
TEMP
PRES
-DENSITY

U/ml

°c
bar
gil

0.0
4.0
3.0
1074.2

0.0
4.0
1.0
ll50.5

0.0
4.0
3.0
1150.5

0.0
4.0
1.0
ll50.5

0.0
4.0
1.0
1043.0

115.1645
200.3153
0.0000
1.9375
0.0000

112.8646
196.3148
0.0000
1.8904
0.0000

112.8646
196.3148
0.0000
1.8904
0.0000

0.0000
0.0000
7.3888
0.0000
185.0267

COMPONENT FLOWRATES (kg/Batch)
Arginine
Media
Sodium Hydroxid
tPA
Water

47.7725
200.3153
0.0000
1.9375
0.0000

===============================================================================

TOTAL (kg/batch)
TOTAL (m3/batch)

250.0253
0.2327

317.4173
0.2759

311.0698
0.2704

311.0698
0.2704

192.4154
0.1845

==========~=========================================== =========================
=============================~======================== =========================

STREAM NAl-'lE
SOURCE
DESTINATION

P-23
P-32
P-31
INPUT Microfilter Microfilter
ER Column
FD Tank
OUTPUT

P-l
P-18
INPUT Affinity Co
Centrifuge
OUTPUT

======================~====================~==============~=======~============

STREAM PROPERTIES
ACTIVITY
TEMP
PRES
DENSITY

U/ml

°c
bar
g/1

0.0
4.0
1.0
1000.0

0.0
4.0
2.3
ll48.9

0.0
4.0
2.3
ll48.8

0.0
37.0
1.0
1005.5

0.0
4.0
1.0
1047.0

114.3497
0.0000
6.1119
0.0000
0.0000
0.0000
0.0000
0.0000
0.0126
0.0258
1. 6028
0.3154
212.7841

O. 0011
0.0000
0.0001
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0021

0.0000
457.2750
0.0000
0.0000
0.0000
3564.5000
0.0000
0.0000
0.0000
0.0000
2.1600
0.0000
0.0000

147.1698
0.0000
1. 8336
0.0034
0.0034
196.3148
1.8803
79.8655
0.0000
0.0000
0.2836
0.0000
1739.9087

COMPONENT FLOWRATES (kg/Batch)
Arginine
Biomass
Glycine
KCl
KH2P04
Media
Na2HP04
Sodium Chloride
Sodium Hydroxid
Sucrose
tPA
Water
WFI

0.0000
0.0000

o.odoo

0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
47.1239

===============================================================================
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47.1239
O. 0471

335.2022
0.2918

0.0034
0.0000

4023.9350
4.0021

2167.2631
2.0699

=================~==================================== =========================

===============================================================================

STREAM NAME
SOURCE
DESTINATION

P-17
P-24
P-15
INPUT
ER Column
INPUT
OUTPUT Affinity Co Affinity Co

P-12
UF2
OUTPUT

P-3
Centrifuge
UFl Tank

===============================================================================

STREAM PROPERTIES
ACTIVITY
TEMP
PRES
DENSIT'f

U/ml

°c
bar
gil

0.0
4.0
1.0
1016.6

0.0
4.0
1.0
1020.5

0.0
4.0
1.0
1020.5

0.0
4.0
3.0
1150.4

0.0
37.0
1.0
1000.0

0.0000
O. 0011
O. 0011
0.0000
0.6268
26.6218
0.0000
0.0000
0.0000
564.5910

0.0000
0.0023
0.0023
0.0000
1.2535
53.2436
0.0000
0.0000
0.0000
1129.1819

2.2999
0.0000
0.0000
4.0005
0.0000
0.0000
0.0000
O. 0471
0.0000
0.0000

0.0000
0.0000
0.0000
3564.1436
0.0000
0.0000
0.0000
2.0520
0.0000
0.0000

COMPONENT FLOWRATES (kg/Batch)
Arginine
KCl
KH2P04
Media
Na2HP04
Sodium Chloride
Sodium Hydroxid
tPA
Water

WFI

0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
7.3888
0.0040
185.0267
47.1239

===============================================================================

TOTAL (kg/batch)
TOTAL (m3/batch)

239.5433
0.2356

59"-.8418
0.5800

1183.6836
1. 1599

6.3475
0.0055

3566.1956
3.5661

===============================================================================
============================~============~============ =========================

STREAM NAME
SOURCE
DESTINATION

P-6
UFI Pump

on

P-2l
P-30
P-33
P-35
Tank
MF Pump
FD Tank Freeze Drye
ER Column Microfilter Freeze Drye
OUTPUT
E~

============~========================================= =========================

STREA~l

PROPERTIES

ACTIVITY
TEMP
PRES
DENSITY

U/ml

°c
bar
gil

0.0
32.2
3.0
1074.4

0.0
4.0
1.0
1186.6

0.0
5.1
2.3
1148.9

0.0
4.0
1.0
1148.9

0.0
12.0
1.0
1000.0

IH.3509
6.1119

114.3509
6.1119
0.0000
0.0126
0.0258
1. 6028
0.3154
212.7862

114.3497
6.1119
0.0000
0.0126
0.0258
1. 6028
0.3154
212.7841

0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.3154
212.7841

COMPONENT FLOWRATES (kg/Batch)
Arginine
Glycine
Media
Sodium Hydroxid
Sucrose
tPA
Water
loJFI

850.0000
0.0000
3564.1436
0.0000
0.0000
2.0520
0.0000
0.0000

C.OOOO
0.0126
0.0258
1.6068
C.3154
153.7862

=========~============================================ =========================

2.81

Generic tPA
TOTAL (kg/batch)
TOTAL (m3/batch)
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4416.1956
4.1103

276.2096
0.2328

335.2056
0.2918

213.0995
0.2131

335.2022
0.2918

===============================================================================
===================================================================

STREAM NAME
SOURCE
DESTINATION

P-29
P-36
MF Tank Freeze Drye
MF Pump
OUTPUT

P-9
INPUT
UF2 Tank

P-26
INPUT
ER Tank

===================================================================

STREAM PROPERTIES
ACTIVITY
TEMP
PRES
DENSITY

U/ml

°c
bar
gil

0.0
4.0
1.0
1148.9

0.0
12.0
1.0
1552.1

0.0
4.0
1.0
1562.0

0.0
4.0
1.0
1581.0

COMPONENT FLOWRATES (kg/Batch)
Arginine
Glycine
Sodium Hydroxid
Sucrose
tPA
Water
WFI

114.3509
6.1119
0.0126
0.0258
1. 6028
0.3154
212.7862

114.3497
6.1119
0.0126
0.0258
1. 6028
0.0000
0.0000

67.3920
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000

0.0000
0.0000
0.0000
0.0258
0.0000
0.0000
0.0000

TOTAL (kg/batch)
TOTAL (m3/batch)

335.2056
0.2918

122.1027
0.0787

67.3920
0.0431

0.0258
0.0000

====================================================== =============

OVERALL

CO~PONEN~

BALANCE (kg/Batch)

====================================================== ========================

COMPONENT

IN

OUT

(OUT-IN)

Arginine
Biomass
Glycine
KCl
KH2P04
Media
Na2HP04
Sodium Chloride
Sodium Hydroxid
SClcrose
:PA
Water
t-JFI

1066.048129
457.275000
7.945491
0.003419
0.003419
3564.500000
1.880268
79.865456
7.401347
0.025800
2.160000
185.342066
1999.818810

1066.048129
457.275000
7.945491
0.003419
0.003419
3564.500000
1.880268
79.865456
7.401347
0.025800
2.160000
185.342066
1999.818810

0.000000
0.000000
0.000000
0.000000
0.000000
0.000000
0.000000
0.000000
0.000000
-0.000000
0.000000
0.000000
0.000000

TOTAL

7372.269205

7372.269205

0.000000

288

Re: Senior Design Project

Generic tPA

Subject:
Date:
From:
To:
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Re: Senior Design Project
Thu, 02 Mar 2000 13:55:03 +0000
Scott Diamond <sld@seas.upenn.edu>
Christian M Metallo <cmetallo@seas.upenn.edu>

tpa is shipped at lOO-retPA per bottle. When the tPA is dissolved in 100
of
sterile water, the result is 2 M arginine, I think.
I do not know the
sucrose level but
I suspect that it is between 10 uM and 200 uM sucrose.
As long as the final salt concentration after dissolving the tPA in 100 m
of sterile W~'
is .less than,lSO u it will look like a balanced saline solution suitable
for inj ection" 
Ccri"('E"ctEd ~ \51)1'V\ H 1'1'1. ~O"t)cJ
Dr. Diamond
c..erm~\Jl'hC.o..+t ~ ~I ?ro~. 0\.Q 1K'IO"(tJ.
Christian M Metallo wrote:

>
>
>
>
>
>
>
>
>
>

1 of I

Prof. Diamond,
Do you know where I can find info on the exact packing "recipe" for tPA
I need to know how much tPA per dose.
I'm assuming the rest would be
sucrose and arginine.
There would also be some salts left from adjusti
the pH after the anion exchange.
Will that be a problem?
Please get back to me when you get a chance.
Thanks
Chris
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Product Number: A6969
Product Name: L-Arginine Hydrochloride

Product Infomation
• Description
.. Certificate of Analysis

-:-1[Wi

• MSDS
___' _ __
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.. Add To Shelf
• Print Preview
• Bulk Quote
• Ask A Scientist

Go To
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.. §lama-Aldrich Home

Molecular Weight: 210.6
CAS: 1119-34-2
Purity Grade: Biotechnology Performance Certified, EP, JP, USP, >=98.5%
Quality/Application: Cell culture tested
Form/Aspect: Powder
Assay: >=98.5%
Comments: Source: Non-animal source
Soluble in water (100 mg/ml) .
Endotoxin tested
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Glycine
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Glycocoll
Molecular Formula: C2 H5N0 2
Molecular Weight: 75.07
CAS: 56-40-6
Purity Grade: Biotechnology Performance Certified, >=98.5%
Quality/Application: Cell culture tested
Form/Aspect: Powder
Assay: >=98.5%
Comments: Source: Non-animal source
Soluble in water (100 mg/ml).
Endotoxin tested
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Product Number: 84105
Product Name: D(+)-Sucrose

Update Profile

-

MSDS Search

Order Centlll!!'

Contact Us

Home

Help

c

Productlnfomatian

.. Description

.~ ~s.w. 2:z.

• Certificate of Analysis

• MSDS
• Structure Image

-Options

Synonyms: Beet sugar; Cane sugar;
~-D-Fructofuranosyl-a-D-glucopyranoside;

0(+)-Saccharose; Sugar

Molecular Formula: C12H22011
Molecular Weight: 342.30
CAS: 57-50-1
Purity Grade: BioChemika for biotechnological purposes; ~ 98.0% (HPLC)
Comments:
a20546
+78.0± 10 (c= 26 in H 20)
• ~ma-A1drich Home

a 2 0D

Solubility (0.1 glml H 2 0)
mp

•

J
"'1$!{'/~_

+66.5± 10 (c= 26 in H 20)
soluble
~185°C (dec.) (Lit.)

ELINCS/EINECS Number: 2003349
BRN: 90825
Merck Index: 12,9051
Beilstein Index: 17, 8, V, 399
R&S: F: 3
Compliance: RTECS WN6500000 • WGK 0
Miscellaneous: Mono- and oligosaccharides; Culture media, additives for

10fl
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Product Number: 07030
Product Name: Oulbecco's Phosphate Buffered Saline Hybri-Max®
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Help
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Product InfollatiGD

~

Description

• Certificate of Analysis
.,MSDS
~.,,,,----~-~

Options

• Add To Shelf
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Synonyms:
Quality/Application: Hybridoma tested.
Form/Aspect: Powder
Comments: Without calcium chloride and magnesium chloride.
Endotoxin tested.
Formulated to contain 9.6 grams of powder per liter of medium.
Storage Temp: Store at 2-8°C
R&S: R: 36/37/38, S: 26,36
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Molecular Weight: 40
CAS: 1310-73-2
Purity Grade: Minimum 98%
Form/Aspect: Pellets
Assay: Minimum 98%
Comments: Bulk packages
Storage Temp: Store at RT.
R&S: R: 35, S: 26,37/39,45
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Product Number:
Product Name:

71376
Sodium chloride

Product Into.alion
Description

~ Certificate of Analysis

~MSDS
~ Structure Image

~ Add To Shelf

Molecular Weight: 58.44
CAS: 7647-14-5
Purity Grade: BioChemika MicroSelect for molecular biology;
Comments: Sales restrictions

Total nitrogen (N)

~

99.5% (AT)

~

Iodide (I)

~

0.001%

K

0.001%

~0.005%

Mg

~0.0005%

0.00001%

Mo

~0.0005%

Bi

~0.0005%

Ph

~

Cd

~0.0005%

Zn

~0.0005%

Cr

~0.0005%

A(run): 260

Amax: 0.01

As

~

0.0005%

ELINCS/EINECS Number: 2315983
Merck Index: 12, 8742
Literature References: Component of lysis buffer and extraction buffer in
the large-scale phenol extraction of RNA: D.M. Wallace, Meths. Enzymol.
152, 39 (1987); Simple salting out procedure for extracting DNA from human
nucleated cells: SA Miller, et al., Nucleic Acids Res. 16,1215 (1988)
Compliance: RTECS VZ4725000 ·CH-Giftkl. free· WGK 0
Miscellaneous: Density gradient centrifugation; Crystallization of
biopolymers; Sodium salts (MicroSelect); Molecular biology, common
reagents
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847·742-0800

Westfalia Separator,

Fax:
To:

Christian Metallo

From:

falc

215-573-7601

pages=i
Date~

Phone:
Re:

Derek Ettie

:20 \-7 f.Ll-6 g1 J

03129/00

cc:

CHOcelis

:::
Cl Urgent

0 For Review

• Comments:

bPIe;tSe Comment

Cl Please Reply

Cl Please Reqcle

,;

esc

PRICE FOR
4 IS $355,OOO:~SKlD MOUNTED • MOTOR AND CONTROLS.
THIS UNIT IS 40()..500 LlHR.
:i
.,

ANY QUESTIONS PLEASE CALL~E
DEE1@WSUS.COM

d~\.o

CAPACITY OF

$
Generic tPA
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CSC 4 Clarifier
<

In steam-sterilizable design
CSC 4-06-476
Complete plant systems
with automatic or manual SIP
for down-stream processing
of fermentation broths under
sterile conditions

Fields of application
Biotechnology, pharmaceutical
and food industry

;Jq

Operating principles and constructional features
esc 4-06-476 Bowl with turbidity measurements
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1
2
3
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Feed
Discharge
Disc stack
Hydrohermetic feed system
Cooling, hood
Sediment ejection ports
Annular valve
Discharge nozzle
Cooling, solids collector
Storage chamber
Operating water discharge
Sealing liquid discharge
Slide-ring packing
Operating-water feed

15 Valve (dosing and pre-filling)
16 Valve (Opening)
17 Leakage outlet
18 Sealing liquid feed
19 Sliding piston
20 Closing chamber
21 Feed, solids collector cooling
22 Discharge, solids collector cooling
23 Feed, hood cooling
24 Control unit
25 Centripetal pump
26 Discharge, hood cooling
27 Turbidity meter

".

Typical product applications
• Starter cultures for the food and pharmaceutical sectors
<e.g. lactic acid bacteria).
• Recovery of biomass for pharmaceutical products (e.g.
E-Coli).
• Treatment of genetically engineered micro-organisms
and vaccines, made possible by the dosed machine and
installation concept (biocontainment).
• Gentle discharge of biomass with product-damaging
cell constituents.
This clarifier incorporates the very latest developments in
centrifuge constructio~.
The basic features of this new development are:
• Clarifier bowl in sanitary design.
• Cleaning-in-place - capacity of the clarifier.
• Steam-sterilizable (SIP) up to 1.5 bar steam pressure
(127°C).
• Double-acting slide-ring packing as interface to the drive
chamber.
• Closed product feed and gentle treatment of shear-sensi
tive micro-organisms due to the hydrohermetic feed
system.
• No product contamination due to wear of lip seals and
mechanical seals as is the case with hermetically sealed
machines.
• Low noise pollution due to double-walled coolable hood
and solids collector suitable for connection to a closed
sealing system up to 1 bar overpressure.
• "Hydrostop" system for controlled partial solids ejec
tions.

Bowl
The product enters the bowl via the inlet (1) and is clarified
in this disc stack (3). Centripetal pump (25) then conveys
the clarified liquid under pressure to outlet (2), where it is
discharged without foam ..
The separated solids collect in sediment holding space and
are ejected periodically via ports (6).
Operating water is used only during the actual process of
ejection. ,

• Photoe!ectnc control usmg a turbIdlty measurement ~.:./ )
to monitor the clarified liquid. If a pre-set turbidity level
is exceeded, a signal is passed to the control unit (24)
which then initiates the solids ejection process. Recom
mended for use with translucent liquids in which the
solids content is not constant or if the throughput capaci
ty varies. This monitoring system can be installed on
every standard centrifuge.

The "hydrostop" system for
controlled partial solids ejections
When product is processed, only partial solids ejections are
performed.
The solids ejections is initiated by the control unit.
In the case of partial solids ejection, the hydraulically oper
ated sliding piston (19) must be opened within as short a
time as possible so as to ensure that the ejection ports are
opend wide enough to allow unimpeded solids ejection.
The sliding piston (19) is in closed position (left side of fig
ure) when the closing chamber (20) is full. The annular
valve (7) is hydraulically opened via valve (16) (right side
og fig.). The operating-water flows from the closing cham
ber (20) into the storage chamber (10). When the storage
chamber (10) is full, the flow of liquid from the closing
chamber (20) will automatically stop, although the annular
piston (7) is still open ("hydrostop" system). The bowl then
opens and the solids are discharged rapidly through the
ejection ports (6).
The amount of solids ejected depends on the liquid level in
the storage chamber (10) (controlled partial solids ejection).
The amount of solids to be ejected can be pre-selected by
partially filling the storage chamber (10) before the solids
ejection is initiated. This is done by opening valve (15).
After the ejection process, the closing chamber (20) is
topped up via valve (15). The annular valve (7) then closes.
The storage chamber empties through discharge nozzle (8).
This new "hydrostop" system reduces the actual solids ejec
tion time to less than 1/10 second. In the case of solids
which are difficult to eject, a longer solids ejection cycle is
initiated after several partial solids ejections, which has the
effect of flushing out remaining solids while the product
feed is still open.

Automatic solids ejection
Bowl ejections are controlled automatically by control unit
(24)
The following operations are possible:
• partial ejections
• a combination of short and long partial ejections
• Displacement of the liquid phase from the bowl before a
total ejection
• Flush ejection after every total ejection

Total solids ejection sequence
For total solids ejection, the closing chamber (20) is emptied
via the annular valve (7) and the nozzle (8) by the addition
of operating-water via valve (15). The sliding piston (19)
remains open until the whole bowl contents have been
ejected. The sliding piston (19) is then closed by supplying
closing water via valve (15).

Control systems
The following systems are available for controlling the au
tomatic bowl ejections:
• Time-dependent control to suit the particular operation.
Recommended for use with products in which the solids
content remains constant.

30C

Feed and discharge
The product is fed into the centrifuge by means of a closed
system of pipes. The clarified liquid is discharged foam-free
and under pressure via a centripetal pump.

Hydrohermetic product feed
In this design the centrifuge is equipped with a hydroher
metic product feed (4). This new inlet system prevents
shearing forces from acting on the product when entering
the bowl. Similar as with the fully hermetic design, the
product stream is accelerated by the product itself in the
filled bowl. This makes for gentle treatment and optimum
clarifying efficiency, especially in the case of sensitive prod
ucts and low throughput capacities.

The machine is driven by a three-phase AC motor with fre
quency converter for smooth starting. Power is transferred
to the bowl spindle via a flexible coupling and worm wheel
gear. All bearings and the gear are splashlubricated from a
central oil bath.

Monitoring
Cooling
The solids collector and the hood are of double-wall design
for cooling the discharged solids (5, 9).

• Lube oil sight glass
• Temperature feeler and overcurrent release for motor
protection in case of overload ..
• Speed measuring device
• Vibration monitoring system ..
• Turbidity meter for monitoring the discharge ..
• Level probes in the solids tank in case of enclosed solids
discharge
•Additional parts available at extra charge

Cleaning~in-place (CIP)
Once the centrifugation process has been completed, the
machine can be cleaned-in-place. The cleaning solution is
circulated round the centrifuge and the connected system.
Total ejections are initiated during CIP manually or auto
matically on the control unit via an external CIP control.

Sterilization
The stationary installation is sterilized with hot steam
(127°C) under an excess pressure of 1.5 bar. The duration
of sterilization is dependent on the nature of the bacteria
and the number of germs. Experience suggests a time
between 60 minutes.
The condensate is conveyed from the lowest point of the
system to the killing line.
Following sterilization, the whole system is blanketed with
sterile air until the next product run.

Frame and drive
The cast-iron frame is equipped with brakes, a rev indicator
and an oil level sight glass.

Materials
All parts coming into contact with the product are made of
austenitic Cr-Ni-Mo stainless steel or, in the case of highly
stressed bowl parts, of soft martensitic Cr-Ni-Mo steel or
duplex alloys.
The gaskets are made of ethylene-propylene-diene
caoutchouc (EPDM) and Polyamid.

Assembly and dismantling
Special tools for installing and removing the bowl are
included in the supply schedule.

Additional equipment
(available at extra charge)
Complete plant systems with automatic or manual SIP
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Technical data

I
Technical data
Bowl
Speed
Total bowl volume
Volumen of sediment holding space
Max. pressure produced
by centripetal pump
Three-phase AC motor
Motor power
Speed at 87 Hz
Type
Type of protection

up to 12000 min-!
1.8 I
0.7 I

approx. 5 bar
up to 7.5 kW
3000 min-1
IM:B5

IP55

Weights
Separator complete
Bowl

approx. 230 kg
approx. 50 kg

Capacity
Rated capacity
with one channel centripetal pump
with three channel centripetal pump

I

approx. 100 l/h
approx .. 300 l/h

The rated capacity indicates the maximum throughput rate of the bowl. The actual
operating capacity .is usually lower. It depends on the particular product and on the
required level of clarification.

Height 900mm
Width 1000mm
750mm
Depth

I

Subject to modification
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KOCH PRODUCT SPECIFICATIONS

PRODUCT TYPE:

HF .14-43-PMSO

PART NUMBER:
DATE;

0720082
7/18/95

REVISION:
CONFIGURATION:

1

3" X 25" HOLLOW FIBER CARTRIDGE

COMPONENTS;
MEMBRANE:

POLYSULFONE

HOUSING SHELLJEND CAPS:

POLYSULFONE

CONWED:

YELLOW

FDA

STATUS~

APPROVED MATERiAlS OF CONSTRUCTION

DIMENSIONS/PROPERTIES:
MODULE DIAMETER:

3.0 11 .

(7.6 em)

MODULE LENGTH:

25n

(63.5 em)

~

MEMBRANE AREA (NOMINAL):
FIBER-COUNT

MAXIMUM
MINIMUM

b[;Qt-jhr

~

MEAN WATER FLUX@25/15 ps',4S"C:
TYPICAL RANGE:
(Based on New Membrane USing RO Water)

(1.3 m2 )

~
Q

FEED FLOW VS. PRESSURE DROP:

660

625

G<!I/-r+

-

Idi

=12.1261 x In(L\p) - 5.1685 ~

RECOMMENDED OPERATING LIMITS (PROCESS TECHNOLOGY MUST APPROVE/DEFINE OPERATING AND
CLEANING CONDITIONS FOR AlL NEW PLANTS AS WELL AS ANY CHANGES TO EXISTING PLANTS):

t-,.

')......'Sj J..

MAXIMUM INLET PRESSURE @ 25"C:

40 psi

MAXIMUM TRANSMEMBRANE PRESSURE @ 2S"C:

35 psi

MAXIMUM BACKFLUSH PRESSURE @ 2S"C:

20 psi

MAXIMUM TEMPERATURE AT pH 6:

140°F (60 D C)

MAXIMUM pH RANGE AT 130"F (54°C):

1.5-13.0

MAXIMUM CHLORINE (CLEANING):

200 ppm @ pH 10·10.5, 130G F (54°C)
o ppm @ pH less than 9.5

*

J~",)SD
,
I ~ {--t~

-

3DL\

'.,.

A~~
('11111'.

KOCH PRODUCT SPECIFICATfONS

PRODUCT TYPE:

PART NUMBER:

HF 14-43-PM500

DATE:
REVISION:
CONFIGURATION:

0720083
7/18/95

1

3" X 25" HOLLOW FIBER CARTRIDGE

COMPONENTS:
MEMBRANE:

POLYSULFONE

HOUSING SHELUEND CAPS:

POL.YSULFONE

CONWED:

YELLOW

FDA STATUS:

APPROVED MATERIALS OF CONSTRUCTION

DIMENSIONS/PROPERTIES:
MODULE DIAMETER:

3.0"

(7.6 em)

MODULE LENGTH:

25"

(63.5 em)

MEMBRANE AREA (NOMINAL):

14 ft2

(1.3 m2)

FIBER COUNT

MAXIMUM
MINIMUM

690
650

MEAN WATER FLUX@ 25115 psi, 45°C:

>400GFO

TYPICAL RANGE:
(Based on New Membrane Using RO Water)

a::: 12.6419 x In(Ap). 5.3779

FEED FLOW VS. PRESSURE DROP:

RECOMMENDED OPERATING LIMITS (PROCESS TECHNOLOGY MUST APPROVE/DEFINE OPERATING AND
CLEANING CONDITIONS FOR ALL. NEW PlANTS AS WEL.L AS ANY CHANGES TO EXISTING PLANTS):

MAXIMUM INLET PRESSURE @ 25"C:

40 psi

MAXIMUM TRANSMEMBRANE PRESSURE @ 25°C:

35 psi

MAXIMUM BACKFLUSH PRESSURE @ 25 DC:

20 psi

MAXIMUM TEMPERATURE AT pH 6:

140°F (SO°C)

MAXIMUM pH RANGE AT 130°F (54'C):

1.5-13.0

MAXIMUM CHLORINE (CL.EANING):

200 ppm @ pH 10-10.5. 130"F (54°C)
p~m @ pH less than 9.5

o
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SYNERGIES BETWEEN ULTRAFILTRATION AND ION
EXCHANGE, or
WHY UF SHOULD BE USED AS IX PRE- AND POST-TREATMENT
by Dr. Jamie P. Monat

Ion Exchange (IX) is a unit operation widely used for water softening, boiler feed water conditioning, ultrapure
water generation for electronics manufacture, pharmaceutical-grade water, and other applications. Ultrafiltration
(UF) is another unit operation often used to remove suspended solids, colloids, and macromolecules from liquid
streams. There is a natural synergy between these two unit operations, which has largely been unexploited. As
pre-treatment to IX, UF can significantly increase resin life and time between cleanings, thereby reducing
operating expense. As post-treatment to IX, UF can eliminate resin fines, bacteria, organics, and colloids, thus
improving product water quality.

Overview of Ultrafiltration
Ultrafiltration (UF) is a pressure-driven unit operation in which particulates, colloids, emulsified oils, and
macromolecules are separated from a liquid feed stream upon passage through a porous semi-permeable
membrane (Figures 1 and 2).

Cross Flow Membrane Filtration
Bacterium

tf'Virus
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Sugar

•
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Protein

•

Alcohol

~
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~~
Metal Hydroxides

Membrane
Figure 1
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Basic Membrane Concepts
Pressure, P
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Suspended Solids
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Eoulsions

Flow, Q
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R=10V
AsyTTIlltlCIic Membrane

~
Water
Sals

BOD
COD

DissollPed

SI1liIII Polysaccharides

Solids

Figure 2
The separation is based primarily on the size of the species in the liquid relative to the size of the membrane
pores (Le. a simple sieving process) although geometry of the pores, geometry of the species to be separated,
electric charge, and membrane surface chemistry may also playa part. On the separation size spectrum, UF falls
between Nanofiltration or NF ( membrane pore sizes below approximately 0.01 micrometer) and Microfiltration or
MF (pore sizes greater than 1.0 micrometer; see Figure 3).

Tangential Flow Filtration
Reverse Osmosis

Ultra1iltralion
Nanoliltration

Microjltration

I

I

I

I

I

I

0.0001

0.001

0.01

0.1

1.0

10.0

Dewatering
Solute
Co noentr.m on

Oesahing
[I. -.a lent Ion:!!

Remove
Trace Os.G

BODiCOD

Fi ne Particulate Remo\l3l:
Macromolecule:!!
OilS. Grease
Suspended Solids
Proteins
Colloids
BaC1l!ria
\Aruses

Microns
Coarse
Clarilicati on
Suspended Solids
Removal

Operating Pressures (psi)
400·1.000

200·600

20·11)0

20·100

Figure 3
In ultrafiltration, small molecules such as water, monosaccharides, simple alcohols, and all ionic species pass
through the membrane while larger molecules, particulates, bacteria, and emulsified oils and fats are retained.
The UF membrane is usually a polymer such as polyethersulfone, polysulfone, polvinylidene fluoride, or
polyamide and is typically cast on either a flat sheet or on the inside diameter of a tube. It may also be extruded as
a hollow fiber. Tubular membrane products are excellent for high solids loadings as may be found in wastewater
streams. but their low surface area-to- volume ratio makes them too expensive for pure water applications (Figure

4).
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Membrane Configurations
Open, Wide

Channel Height>

Narrow, Thin

©J
Tubular

Hollow Fiber

Spiral
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Uariable Fiber DiarrBer20,43,60,15 & 106 mil

Uariable S pecers

UlTRA-COR UII (112")
SUPER-COR (112'"

4",6"& 8"

3"& 5" sizes

Figure 4
Spirals, on the other hand, have a high surface area-to- volume ratio, but their narrow flow channel renders them
susceptible to plugging. Hollow Fibers strike an excellent balance between high surface area-to- volume (and
hence reasonable cost) and resistance to plugging, and are typically the configuration of choice for IX pre- and
post-treatment. In addition, because hollow fibers are not cast on a backing they are not subject to delamination;
this allows hollow fibers to be back-pulsed which is crucial in cleaning foulants from the membrane surface.
Ultrafiltration is a well-known, proven unit operation that has historically been widely used in the food, dairy, juice,
pharmaceutical, biotech, automotive paint, environmental control, textile, and potable water industries. Typical
applications include the concentration of whey protein during cheese-making, clarification of fruit juices, removal
of emulsified oils and particulates from wastewaters, separation of water from pigment in electrocoat paint, and
removal of microorganisms from potable water. There are dozens of other applications as well. Removal and
concentration capabilities of UF vs reverse osmosis (RO), nanofiltration (NF), and microfiltration (MF) are shown
in Figure 3.
Either batch or continuous process designs are available with UFo Batch processing is preferred when the feed
stream is available intermittently in batches (as opposed to continuously) as may be the case when a small
volume of pharmaceutical liquid needs to be clarified or concentrated, or when larger volumes of wastewater are
processed once per week. Continuous designs are preferred when the feed stream is continuous as in a potable
water filtration application or in the continual filtration of an automotive electrocoat paint bath; or when a
biologically active feed must be processed quickly as in food and dairy streams.
Hollow fiber systems are constructed with from 1 to 80 hollow-fiber cartridges on a single "stage" which is
comprised of the membrane cartridges, a pump, feed and permeate manifolds, and appropriate valves, pipe, and
fittings. Up to 6 stages may be ganged together for increased capacity. Hollow fiber UF membranes come with
membrane pore sizes from 10,000 to over 2,000,000 daltons and with fiber inside diameters between 10 mils and
106 mils, while hollow fiber cartridges come in diameters of 1,2,3,5. and 8 inches and in lengths ranging from 6
to 72 inches. Several hundred to many thousand hollow fibers are potted together in a single hollow fiber
cartridge. Typical cartridge membrane areas are between 10 and 132 square feet per cartridge.
Hollow fiber water ultrafiltration systems typically operate at feed pressures of about 25 pSig and with capacities
between 50 and 2 million gallons per day. On each hollow fiber system stage. for a typical 5" diameter x 43" long
cartridge, the pump must have the capacity to output approximately 20 gpm per hollow fiber cartridge at 25 psig.
Thus, a 50-cartridge skid would require a 1000 gpm pump at 25-30 psig.
As an adjunct to IX, UF is commonly used in three places: Before the IX system as pre-treatment, after the IX
system as post-treatment, and between the cation exchange column and the anion exchange column in
multiple-bed systems (Figure 5).
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Enhancing Water Purification
with Ultrafiltration Technology

RO Pretreatment
Improved RO Performance
Longer RO Membrane Life
Lower RO Operating Pressure

Pre Ion Exchange
Imploved Resin Performance
Longer Resin Life
Rdduced Particulate Fouling

Post Ion Exchange
Removal of Resin Fines
Microorganism Removal
Low Particulates

Figure 5

UF As Pre-Treatment to IX
Resin beds are often fouled by particulates deriving from upstream processes, bacteria, RO membrane particle
shedding, or suspended matter in the feed stream such as colloidal or "non-reactive" silica. Colloidal silica is often
naturally present in well waters and river waters. Polymerization (the linking together of silica molecules in long
chains) of silica may occur if the pH is maintained below 7.0. This polymerized silica is extremely difficult to
remove from the resin. The typical result is long bed rinses and ineffective resin regeneration. A UF system
upstream of the IX column typically removes more than 95% of the colloidal silica (and often more than 98%)
before it reaches the IX resin, preventing irreversible silica fouling.
In addition, in those instances where an IX column follows a reverse osmosis systems, bacteria growth in the
upstream RO system can result in resin bed fouling. Many RO systems and RO membrane cartridges for
industrial use are not designed to high sanitary standards and contain "dead zones" or spaces that are not
adequately flushed by cleaning solutions, as well as non-sanitary valves and seals and unpolished wetted
surfaces. If conditions of temperature and pH favor their growth, bacteria may build up in these regions. A
well-designed sanitary-standard ultrafiltration system, however, will reduce the bacterial concentration in the RO
effluent by 4-6 orders of magnitude. Note that in this scenario, the UF system would be located between the RO
system and the IX system. Of course, in those instances where there is no upstream RO system, bacteria may
still be present and present a fouling problem for the IX column. A UF system also obviates this problem.
Many liquid streams contain particulates that are too small to be removed by bag filters, strainers, or conventional
dead-end filters, or even by microfiltration upstream of the IX system. Particulates in the size range 0.01-0.1
micrometers would fit into this category. Unfortunately, IX resin beds tend to remove these particulates quite
effectively, but the resin becomes fouled in the process. Reducing the turbidity of the influent to less than 3
Nephelometric Turbidity Units (NTU's) is usually suffiCient to avoid particulate fouling; UF typically addresses this
problem fully and can often achieve NTU's less than 1.
For some water types such as those found in chemical processes, petrochemical recycle, or wastewater recycle,
oil contamination is another problem affecting resin performance. Oil is often present naturally or it may be present
as a result of lubricating or cooling fluids having made their way into the feed stream. While free oil is easily
removed via settling, coalescence, and skimming, this is not true for naturally, chemically, or mechanically
emulsified oil. In severe cases, resin fouling by emulsified oil has been so serious and difficult to correct that it has
proven more economical to replace the resin bed than to attempt to clean it of oil! Fortunately. UF is extremely
effective (>99% removal) at removing emulsified oil prior to the resin bed.
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UF is also very good at removing large molecular weight dissolved organics from process streams. These
organics may be present in the feed water or may be leached from wetted surfaces upstream of the IX column.
Organics can seriously foul resin beds, significantly increasing operating expense due to cleaning chemicals,
downtime, and ineffective regeneration. The organics can foul both the surface of the resin beads and the pores.
Although activated carbon is often used to address this problem, it is typically not effective at removing high
molecular weight organics, and it is often selective in the organics it removes. Activated carbon also tends to grow
microorganisms, which are removed by UFo UF, on the other hand, is selective only based on molecular weight
and can remove organics with molecular weights as low as 10,000 daltons, provided that the correct UF
membrane is selected. The optimum UF membrane will be one whose pore size is sufficiently small to remove the
organics, whose surface charge is the same as that of the organics (typically negative, but not always) so that
membrane fouling is minimized, and whose chemistry will resist the temperature, pH, and chemicals that may be
present in the feed and during cleaning so that an adequate membrane life is achieved.

UF As Post-Treatment to IX
A common problem with IX effluent is the presence of resin fines due to bead breakage and oxidation. A certain
amount of resin attrition is inescapable due to attack by chlorine and other oxidizers, and without post-treatment,
the fines contaminate the effluent. The oxidizing agents attack the bonds of the plastic from which the IX resin
beads are made. Over time, a sufficient number of these bonds break, yielding fracturing of the resin bead.
Thermal shock due to cleaning and regeneration chemicals also contributes to resin bead breakage, as do friction
and abrasion as the beads scrape against each other and against the IX vessel walls. Finally, shrinking and
swelling of resin beads due to drying and re-wetting causes mechanical stresses which can fracture the beads.
Resin attrition rates of 3-5% per year due to bead breakage are not uncommon; these fractured beads
contaminate the effluent. UF is very effective at removing these fragments.
Another problem is the growth of bacteria within the resin bed or within the RO system upstream of the resin bed.
As for RO systems, many industrial-grade IX systems are not designed to high sanitary standards and contain
"dead zones" or spaces, unpolished wetted surfaces, and non-sanitary valves and seals that are not adequately
flushed by cleaning solutions. If conditions of temperature and pH are favorable, bacteria may build up in these
regions. A well-designed sanitary-standard ultrafiltration system, however, will reduce the bacterial concentration
in the IX effluent by 4-6 orders of magnitude, eliminating this as an effluent quality problem.
Still another problem with IX effluent is the leaching of high molecular weight organics from the resin itself. UF
effectively removes these contaminants, as well as any other high molecular weight organics that were not
removed by pre-treatment or by the IX process itself.
To quantify the improvements in post-IX water that can be afforded by ultrafiltration, Kunin (3) has developed the
following data:
Water Property

Mixed-Bed De-Ionized Water
10 .50 JTU*

rurbidity

FTU*

[Non--reaCti·ve··Si6;·m.._ . . . . ..

ro· 01

I

'Sacterl"aTCou';;T"------"--'

IElectrical reSistivity

Mixed-Bed De-Ionized Water
After Ultrafiltration

17mL

i12,000,000 ohm-cm

18,000,000 ohm-cm

* JTU= Jackson Turbidity Units
These data show that in this example, ultrafiltration reduced the water turbidity by a factor of 2.5; removed 95% of
the non-reactive silica, reduced the bacteria count by four orders of magnitude, and increased the electrical
reSistivity of the water to near its theoretical limit.

Economics
Ultrafiltration as pre-treatment to IX reduces down-time, cleaning frequency, and regeneration frequency, and
increases resin life. There are clear direct economic benefits of this. UF as post-treatment to IX yields higher
quality de-ionized water that is free of particulates, which also has direct economic and performance benefits.
The data below from Owens (4) show that for a 500 gpm demineralization system, ion exchange annual operating
costs can be reduced by $361,000 if the influent water is upgraded from "poor" to ·'excellent".

Ion Exchange Annual Operating Costs as a Function of Feedwater Quality
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(500 gpm system)
Influent Water Quality
Resin Cleaning
Frequency:
Annual Cost:
Cation Replacement
Frequency:
Annual Cost:

Excellent

Poor
1 month

2 years

$24,000

$2,000

8-10 years

Anion Replacement
Frequency:

5-6 years

Annual Cost:
Cation Regenerations
Frequency:

3 years
$2,200

$6,700

1.5 years
$18,400

$4,600

1 per day

2 per day

Annual Acid:

$35,000

$70,000

Annual Water

$63,000

$126,000

Anion Regenerations
Frequency:
Annual Acid:
Annual Water:
Annual Totals

1 per day

2 per day
$173,000
$60,000

$346,000
$120,000

$340,000

$701,000

Upgrading the influent water to this degree should be achieved by a well-designed hollow fiber ultrafilter
positioned upstream of the IX system.
The operating costs of the UF system must be subtracted from the IX system cost savings. Annual operating costs
for the UF system are estimated to be $104,000, broken down as follows:
:Membrane Replacement
1$50,000
""iE'T:le:--=c7":tr"'=ic'7:ity-:-----------[$33,000
'CTe"i3nmgCfiemicals
1$10,000
Ir:;O::-p-e-ra-;t7"'in-g--:L-a-:-'b-o-r- - - - - - - - [ $ 1 1 ,000
,---"-----..

------------------r-----~~-"---

=,=--0:-:--·----------;$104,000
Thus the NET ANNUAL BENEFIT of the UF system is $361,000-$104,000, or $257,000 per year.
To determine return on investment or simple payback, the capital cost of the UF system must next be considered.
A hollow-fiber ultrafiltration system to accommodate 500 gpm of water would cost approximately $650,000
installed, broken down as follows:

60[8
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Synergies Between Ultrafiltration and Ion Exchange

[Hollow Fiber UF System, complete with (100) 5"-diameter hollow fiber
icartridges

-'$500,000

fConcrefePad,EqulpmenfSeHing;- mil1ty"ConnecUons~prplng~ana------ [$1"00,006
,Transportation to site
!Start-Up and Operator Training

;
,-- [$"25,000

IMiscelianeous and contingency

1$25,000

I

I

iTOTAL

=1$=65=0'-;;,0=0=0

The investment of $650,000 in this UF system would result in an annual net savings in IX operating costs of
$257,000, resulting in a simple payback for the operation of the IX system of ($650,000)/($257,000/year) = 2.5
years, Or, looked at another way, the Return on Investment for this project would be ($257,000)/($650,000)= 40%
, which is an excellent investment. (Please note that these simple calculations account for neither depreciation nor
taxes, both of which must be considered for an accurate analysis, They have not been included here because
they are highly variable and dependent upon the location and business practices of each individual firm.) And
these values take -0- credit for improved IX effluent quality or for the economic and process benefits associated
with no suspended solids, low NTU's. and no bacteria in the effluent Installation of a UF system in this case would
be a clear money-saver.
Pre-treatment options other than UF should also be considered, Nanofiltration and Reverse Osmosis would clarify
the feedwater as effectively as UFo However. the lower flux rates inherent in these unit operations together with
much higher-pressure pumping energy requirements would yield a larger system with substantially more
membrane area and pump horsepower and hence substantially higher first costs and operating costs,
Microfiltration. on the other hand. (as well as sand filtration, cartridge filtration, and diatomaceous earth filtration)
would not be effective in removing colloidal silica, some bacteria, smaller particulates, and large molecular-weight
organics,

Sources of UF Equipment
The thirteen largest North American vendors of Ultrafiltration membranes and equipment are:
VENDOR

MEMBRANE CONFIGURATIONS

h Membrane Systems, Inc.
ington, MA

S, T, HF*

OsmonicslDeSal
Minnetonka, MN

S

!AMT
ISan Diego, CA
'IrUOP/F-IUid Syste'ms
,San Diego, CA

S
I

rp'cT'-'--'~"---"--"----'-'-"-'--~-'---'-------'---'---------- ,-----------~---='----'------''''''''---'---','---'--''-

IEden Prairie. MN
lsynder
Vacaville, CS
[Ffoec1i"st-Celanese------,Charlotte, NC
r""----"'--

--~-

r

S

,-

j2enon
Burlington, Ontario, Canada

""", -AF

~~e~~~,6~~y""
fMillipore
IBedford, MA

'pafl/Asahi:kaseT"'---'-'------------------

!

East Hills, NY

[Rydranautics
,San Diego, CA

IMembrex

Fairfield, NJ
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*S=Spirals, T=Tubes, HF=Holiow Fibers

Conclusion
Ultrafiltration is an under-utilized unit operation that can significantly enhance both the economics and product
water quality deriving from IX systems for water purification. As both pre-treatment and post-treatment, UF can
reduce chemical consumption, increase resin life, reduce down time, eliminate microorganisms, and scavenge
resin fines from product water resulting in higher produced water quality at lower net operating cost.
References:
1. "Ion Exchange System Troubleshooting", Ken Frederick, ION EXCHANGE ASSOCIATES, P.O. Box 6167,
Reading, PA 19610, WaterTech '96 Conference, November 1996.
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Appendix D

Generic tPA

Pumps for chromatography columns
Affinity Column Pump
cm
v 0 := 100'hr

E

1:= 15'cm

J.I :=.015·poise

:= 0.35

p:=

1000.~
m

L\P

Assume pressure drop across column is 10 psi

ka
F:= I 34.6'-ii

Flow through Pump

ft

l]

:=0.80

L\P := lO'psi

Size :=F.L\P
p
Size
Power:=

Ib

P :=63.72'3

= 1.216"Psi

l]

Density of Water

L\P

Pump efficiency

Size = 3.457·10- 3ohp

Head :=

p.g

Hours per batch:

t := 7920·hr

Power = 3.222 W
Electricity := Power·t
Head

= 22.599oft

Electricity

= 25.521 okW·hr

~>-t...:::---
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TO:

Chris Metallo

FAX:

2155737601

PHONE:

2158982180

PAGES:

Cover+

FROM:

Andy Mitchell Ph.D.

DEPT:

Technical Support

PHONE:

800-526-3593

FAX

732-457-8643

DATE:

Monday, February 21,2000

amersham pharmacia biotech

\!).

TAKE A LOOK Ai OUR NEW PRODUCTS
Purify GST fusion proteins in one step
High binding capacity
• GSTrapTM
1 ml and 5 ml prelJacked HiTrapTt.I columns
• Glutathione Sepharose™ 4 Fast Flow 25 ml
For more information and to place your order, call
Amersham Pharmacia Biotech today.

Dear Chris,

Here is the information that you requested on CNBr Sepharose & Superdex 200 pg.
CNBr4 FF

250g $3514
2Kg

$2~96

lA (Jt.;; ~ <k;k.on, NL/ "\17:)\ u~ ~
11 -- 5""rf\ \..

..J

Superdex 200 pg

1L
5L

MCS'::l 1.

\~'500· )(f.b ~ '35'93

$1703
$8499

Regards,

G - ie-c~ ~u~~

Andy Mitchell

CD

Technical Support

(i) CV"Dhmer

~~<:>i-<X)J ~u.lc')

()r

~t~ ~

$Q,\\J\ C Q...

Amersnam Pharmaca Bkdec::h USA. lei

8Q0..526-3593

800 CenJanntal Ave fax 732-45708643
p.O. Box 1327 www.apbiatec::h.com
Pi&<:ataway,
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NJ 08855-1327
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CNBr"activated Sepharose® 4 Fast Flow
INSTRUCTIONS

Important user infonnation
Please read these instrUctions carefully before using
CNBr-activated SeEharose 4 Fast Flow media. Should you have
any comments on tbls insuuction m.anual, we will be pleased to
receive them ar:
Pharmacia Biotech AB
5-751 82. Uppsala
Sweden

Warranty and liability
Pharmada Biotech warrants mat the Product(s} has been tested
according to the established test procedures of Pharmacia Biotech
and that it conforms with the specifications published by
Pharmacia Biotech. This warranty shall be void if the Product(s}
has not been used in accordance with the operating instructions
supplied by Pharmacia Biotech. or if the Praduct(s) has been
altered, misused. or damaged.

I

Pharmac:ia Biotech disclaims any warranty for merchantability
and any responsibilicy for me suitability of the Producr(s) for any
particular pW:pose. Nor shall Pharmacja Biotech be held liable fot
any incidental or consequential damages t including without
limitation, lost profits or loss of use caused by any defect or
malfunction of the Product{s}.

171-5000-15
Edition AA

1

Pharmacia
Biotech

-

- - ..........

-

...... 

The ddiv"rv of ch~ Produce(s) ma)" hI!' ,ubier:r {O llnd cundirion::!1
co rh~ ",lwa'ning (If an t:lCport licen$e or ofh~r requisire
gO"c!rnment:11 ~U[hori:t<lfiul\5. rharm.:u:ia Siotc:<:h ShOlU not be
rc:sponsihlc: fu( :.my JI/bv or non deli"ety Q1uSlld by ueoial. with
dr:lwal. or other obscacleJ in obr.o.ining $uch li~es or

1. Introduction
The p"parlltion lind use <If .lffinity .:hr<Jrnllto~r;lph<· medi:1 h,
coupling biospeclfic lillonds C(J CNBr-;J<:tivlIteJ m:un.:!!> I~ ;1
widely used. ~uccessiul :md ",dl·docum.:nretl r..-.:hnu.lu".

aurhoriz.uions.

Trademarks
BioProo:ss"", I!!PG...... INdEX'" and So:pharose(!l ate tmdcmar1c5

CNBr-aaivlIred Scpharosc" FOlit Flow is :l new Ilrc·.J..:ti\-:\u;J
::Iffilliey matrix rhar '::Qmbinl:S che :1dvanf:1~eli <Ii C:"Br ":l)tJl'lfI1~
IWirh rhO! high flow and ;mbiliry chl'l(l'I<."Temtics of Seph<HI)~< ..
F:lSr Flo.." In our experience. me CNBr ':ol.lplins tc:'~hni4ue h:I' .1
well-proven trnc:1t record for rhe purifkuion r>f thcr:lpcuci.:
prOtelllll, This. plus the perform:1nce of the rt1l1rril<: ,it l;lr~e .,.:.\1.,;,
makes rhc use of C~Bl'-actlVllred Sephll(Ose 4 Fan FJ"W
parficulacll' atfracri'"e for manl.1f:u:tIJ.rin" :1"plic3ril1r1~ in the
biopharmac:e:utical industry. Ful'thermure,
medium i.. a
mllmber of the BioProccSJ media familv and ~frit:S
comprehensive technical and regul:atory- support for produ..:rillll
applu:.atlQns.

or

Pharm~ Biotech Alt Tris{f) is a rradem;1rk owned bv Rohm IX
Haas Inl;. In viII.... of .he risk of trademark delcneration. it is

re'pecrfully sugg~(ed chat audlon wishing to UIII ehese desisna
rions refer to their rradem<lck starus at least once in each arm:le.

me

Copyrighto 1996 Phannacia Biotech AB
.~II riRhrs rcscrvecL No pan- ofthis publianio/! ma~ be
reproduced. scored in a retrieval sysrem. or tf:ansmirr,d in any
form or by .1I1Y mean! wirb.ouf permission in wriring.
•

To ellS11te best performa.n~ and trOuble-fre" oper3tiofl.
rc:ad ekese in$tructions bc:fore using CNlh··acti.... 3ttd

Fast Flow.

plt::l)e
Sepharu~<: .j

2.

3

2. Media characteristics

Sepharose 4 Fasr Flow matrix

CNBt"activared Sepharose 4 Fast Flow is a bead-Eonned. highly
craM-linked pre-:1CbYli1!ed. maW produced by reacring Sepnarose
4 fa.~[ Flow wi-cb qanogcn brornii:ie (CN'rl_ This collpliDg makt&
me medium more rigid ,¥bich ill turn impfO'Ve.S the preuW'C:IHow
c:hara.c;~ristk.s, sec FiS' 2. !>rotc:'ins and other molecules containing
primary amino groups £!::In be coupled direcdy to the prc:-activaU:Q
medium. Multi-point attacbmen~ ot profeins provides the immo
bili\ted product "'lith good chemical stability_ Tile rc.su1rini .affinity
medium can i.'lol&(.I; a specifk substance aom ;I complvc m.L"tture,
ohem achieving very high yield :add purity in a single step, 'Many
references dc:monsrr;lte that binding affinity is frequendy weU
maintained after CNBr coupling.
A typic:1l application of pre-acr:iv:l.I:ed affinity media lik.", CNBr
activated Seph:uO!Oe 4 Fasr Flow is bas,d on antigen-antibody
reactions wuh immobil.ized mOlloclonal antibodic:.s as ligands. In
such cases. purification f:lcton; of 2 000-20 000 can be obtained.
Table 1 summarizes the main characeeriscics of CN'Br·activaced
Sc:pharosc 4 Fasr Flow.

Sepharose 4 Fase Plow is a highly I.TOss-linked agamSe llIarris. In
irs prc-activared CNBr form. it otfers much imprnved
performance Wheil compared with ,he well escablish~d CS-lk
activated Sephilt()llC 4B. The Seph;l(oR 4 1':15t F1uw marri.'t h,u
higher rigidity and clln thus be run at high flow tatcl!
(s.:e "able 1). 1\5 the ;lvailable cal'aeirie.~ for proreins liN '1imil.Jr
in barh 1.<1.5115, th", ra$[ Flo'" lnllrri.-": offeri gte<lrt:r prod ucri,·i~.
The higher mechanical nren~h of the cross-linked m:!trix n\~kc~
ir well-5ui~d fnt use in largt! columns. Scaling up a purifictlrion

hP/IB'_ 4 FNt !'law Malrf"
90 ~MI
!!olean particle a~"
45-11:5 fill!
Particle i = '&n<;Ie
Sad 911Ucwre
HIgI'tIy C7'0SS-4In'1\90

de....eloped nn CNBMlctlvared Sephatoll! 4 fOIst Flow is rheretute
simple o.nd more predictable. The coupled product is sr:1blt .It low
pH. which is often required for elution from some
immunoadsorbt:nts.
(!-=nr app\i.:::l[iuos ,hat rllC)uire operation at hiSh pH. nott: tllJ[ [he:
:imide bond formed ..,hen !.Ising [he l;omp:1I1100 pmdu<:t ;-\H$
a<:nv:m:d SlIph:1ros(' 4 fast Flow il stable up to pH. 13 i.)r n<lrm~1
use).

3. Coupling
CNBr-a.ctiv;lted Seph:uos", 4 F:I.~[ Flow is suPl'licd ~~-drie<.1 ill
[he pre~~.lee of additiveS. Insrructions for swclUng. the medium
and pr-cpararion k)r coupling the Iipilld .Jor", I&i"t:n below. In ord~r

4"" "9IIf01il, $phetical

[0

4-5 (I'll rhifIed m8<llum/9

C;QUplin9 IlGPI'dty

YJ-26 mg Cl'cnym"!l\Ip&lnl;lglltlltn[

pH $l1:Ibi&IY
long Iem'I

5Ilarr """' !eIF,

oI:ffk:ienc), ~void IInnt::ce55<lrilr dilufe .'!t'llurion$ IRc.:omnl.:ndc:d
ratio af volumes, couplil\g solucionimedium is 0.5; I I.
The couplinG pH depends on [he ligand. Normallv pH ill the
ranl:le 7-9 is u5ecL
.
2. CNBI'-Ilaiv;lted S"pbaro~e " FaSt Row is supplied freeze·,lrieJ
wi,h sugar additj"(:$ :lod i;:l wMhed initially with' lJ-15

3-11
~11

• Oepends an Rgand $I;1bi1ity. T6$t I'1!SUWI are with Prllteln A Q:; Uglll1d

4

.olu

rinns. The cim~ interval hctWc:'Cn washin~ i1lld coupling mu.! Ill.:
minimiseul d,£rcfore prcpararions of all rcquin:d ~QluritJl'Is prior
fQ coupli"S is n:comme:nded.
1. Prepare rhe coupli,1S foluri..,n. Le. diS$olvl: th~ IiganJ II) be
l."Ou"led in 11 suitable coupling bufll=r. Fur good clluplin~

CNIiINlcll.......d Se,1'I::IraoI.e 4 fIast Flow

S-mng 11lCIQ1"

r"rain ma:timum binding ~-::Iplltity of CNBr-lIcti"<I{cd s.:pharo.c

-4 Flisr Flo.... prior to cnup1ins [he li",,-od, Ule cold (U-4 'CI

3\5

5

A.Mt!J/tf6d- A$1 p:lmDns 01 .:a.

JOO

100

.' L· «
FI;. 1. Th" cantll"t 01 "'-'qaIln :lie

vrolrpn~ '"

.-
.........

cold 1 I'IIM Hel,

C:OlLlmn "".""Ie CQkI , m.. HCI.
srlr ""d ',","_lsi\' _ . t/Ioit
101\011·

IH'M"': A<llI_ 01 !

",,111_ ""kI",. Cold 1 ""'" HCI.
511' lor BPI''''''' S nm <l1'l<I 11\""

-'''''lIqUId.

4..1 Recommended columns
ubQfllrory scale

• HRIOftO (10 mm i.d.1 for bed vol"mc.~ up co ~ ml.lc h.'J

"'InII" 311e1 "'&oiling ",UI1 llIlfarlilnl medillln

medium volumel of cold 1 m.."l HCL See Fig 1. Usc: small wash
portiol\l (e.g. 1 medium volume) and Ict me nUlCt\.InI
tquilibmte II. few minutes durin, ench washing step. A.ftc:r
washing, detern1im: rhe c::aCt mlldium "Olumt.: obt:lLncd using
e.g. centrifugation or PD-I0 column (the medium volume
may vlIry berwl!en rexpc;.rimenrs).
3. ~li.x me washed medium ll!ld coupling solurion. AdjuSt pH to
rhe desired vlllue. To obrain good repradw:ibillp:y it is wise to
adjun toral reacrion volWlle ro a fixed value with coupling
buffef.
... CoupLing is normally vary
At room ~ra~fllturc: t:be
reaeriort is U5ua.lI~ I:ompletc:d after 2-4 hQurs..1E coupling is
performed ;1.[ 4 ·C. it can be performed overnIght. It may be
praerical tl'l follu.., rhe tellerion uiing lJV·ab$orbance
measurements.
5. After .::ouplinS. non·reac~ groups on rhe m<!clium 5hol.lld be
blocked 0'1 keeping rhe coupLl!d medium in Tns bulEc:'C or
~th3,nol amine tor ~ few huurs.
6. Wa$h rhe coupled medium ",sing al.temarc 10"'" and higb pH.
Recommended buffers are Ilcc:t:1cc: pH 3-4 and Tm Hel pH
8-9. A suit'ilble procedure could be Jxl medium volume Tns
HCL buffe, followed by 3..:1 VoIWlle5 acemte: buffllr. R.epear
thi$ evcle .3-6 rimes.
7. The c~l.lpled mc:dillm is no",," reltdl' for use. To pn:v~nf
micrl)bial grou.·ch. srore in 2.0% ethanol for c:xample.

rut.

4.2 Packing laboratory scale columJ\$
L Equilibrate :Ill mi'lfcn:JI to the rc:mpel":1tu'Ce at which rhe
chromarographY will be performed.
2. Deg.il5 [he slurry.
J. Elimin.He ait from th~ column ch:.ad spac;c$ hy f~lIlihjns [he .md
pieces with binding buffer. Make sure thar no air hu been
trap~)ed under rhe column neC. Close rhe colUlnn nuder Ic;aving
a few centimctre:s of binding buffer tellllJining in the: column.
4. Pnur rhl!! durC}' inEo tilt: column in one conrill:uous morion.
Pouring the slurry down a "Iau rod held as::unsr rhe .....all of
the column will minimize: th( intrueJur::tion uf air bubbles.
5. [mmediatd. fill [he te",aind~r of Eno:: calumn wirh bindini
buffer, motint the I:olumn rup-I'ic:c:e ontQ rhe column and
connccr the colum., [0 a pur1lp.
6. Open the outlet of the column and .~t th~ pump (0 run at rhe:
de:sired Ro..... r';ltc. Ideally, Fast flow me:d(.(l l1re packed at
CUIl~t:1nr pre~~u~ nor c.xc""ding I bar crl.l lwlra" in XK
column5. If [hc: p'l.::king t'qllirmenc dncs nuf includ<! a rteSJUl1\!
gl1lJ1l.e. ulle a packing flo"" rat!: uf at lo:ast 400 emlh
em b4d
height. l.S 'C, low vil;co~ity buffer). If tht recornmcnd~d
pres.<ure or flow rafe cannot br:lllhtllim:d, use tlte mUlmum
flow ..te: the J:lump ~"tln deliver. This .~hould nlso IPv" a
n:allnnably wdl-plle!r:ed bed.
Nute: Do no[ cxc~d 75% of rhe p;:IckinS flow mre in
!>uluequcnr chmmarographit.: proce:dul'<:s.
7. ~Iaintajn [he p:ll:kin;l flow rate. fnr 3 bEd volumcs aftt:r a
connaOr bed height IS ubcnineli.

,1.

Using an adaptor
Adapto/'S sfJl:ilJld be fltrs<lll5 tolklW$:

I. Afrer the mediunl hOI! b.:t:n pnr::ktd :IS described above, dose
d'llt column nutlet and n:mullt the rop:-pi<:e:e from the t;nlwnn.
Cal"l!:fully fill the relit (If the ,..,Iumn with bindinK b~,ffer to
form all upward meni,cl'$ :1t the tnp.

8

4. Colum" packing guidelines
Gener:!1 ..:ollJmn packing guiddinr:s for Se:p";]m,,, 4 F:lH H""
bas~d media.

height up to 10 em.

• XI( 16110 116 nlm i.d.1 for bed "oilima up w.i() ml
height' up tu IS em.

O{

h"J

• XK :!.6Il0 126 mm i.d.) for bed volumd "p co SO 1"l..lr "~d
heighr up ro 15 em.
Large st:.I~

• BPe 100/500 (lOa mm i.d.) for bed volWlles "'? (0 2.4 L.n J
maximum bc:d height of 30 ~m.
• BPG 200/500 (laO mm i.d.) for bed volumes up 10 9 .... L .l( ,\
maJ(inlum bed height of .30 em.
• BPG 30015'00 (300 mm i.d.) for bed voilima up to 11 L.le.l
maximul"l bed heilht of 30 em.
• BPe 4501500 (450 ram Ld.l for bed volumes up co 43 L ,If .\
ma.'Cimum bed. heighr of 17 era.
• PS 370 1170 mm i.d.l with a Ih:ed bed volume!li L6 L olr.l
fixed bed height of 15 cm.
10 roceu Stainless Src:c1400l150, 600/150. 8001150.
1000/150. 1200/150 and 140011.50 (400-1400 mm i.d.l. \\:ith
illCe:c1 bed volumes ranging from U ro 231) L 11[ .1 Ii ;(r:d bed
. he t.lt IS em.
• INdEX 1001500 1100 mm i.d.) for bed volumes up ru 2.-1 L .lr.l
maximum bed height at .30 em.
• 1;:'Il.j£X lO0l500 1200 mm i.d.l for bed volurn". up co 9.-1 L .It J
maximum bed height of 3Q em.

2. Insert the adaprot a[ :In angle into the column. ertSlIring rhat
nu air ill tra.pped under !:he ner.
3. Make all tubing eonnecdons at tbis Stage. The!€' mUit be i\

bubble-free liquid I.:onncai..,n bet.....een [he I:olumn ami rhe
pump "'lid the sample application IIYste:m {l.V-.~ or LV4 1':1IVe:51.
4. Slide the pillnger slowl" down the column so thllr the air .. hm.'c
rhe net a.nd in the: cllpiOl1ry tubing is displaced by [he eluent.
Valve:; 00 rhe inlet slQe of the column should be: rurned in all
din:ccions during rhis proa!Sl to ensure thar air is remlwed.
5. Lo..k rhe !lliapror in pOlirion. open the \:I'llumn mlrie[ and H;ln
che eluen~ flow. Pass eluent throul/;b [hc column :at the packing
flow rate: until ~"e bed i~ 5tabl~. Rc-position the adapror on tn<:
med.ium :surface :1.5 Ilc:l..-r:ssa roy.
11.3 Packing large scale columns
Genet'S1 packing prOcedure!;
Columns can be packed in diffe:rent ways depending on tho I}'rr:
nf column and equiJ"'I'1enr used. Always read and milo..... the
rde:\llInr column instruction mnnual carefully.
S<!ph:lrase 4 Fast Flow bncd media III'1lCllliY tu pa.;k sinc~ [htl"ir
rigidir:v allows rhe use of high flo.... I'ilt.-:$, sec Fig. 1. Four ~Uir:lhk
~c:s
p~clcing llle~hod5 ate given:
• Pressure pnd:in; fro~ column, with :Ilupron.l
• Combined Pl'c.r;suw$uctlon p'aeking (for medium Ai7.ed

uf

culUll1n, wlrh S~d bed heiilusl
• Suc:tion p;J.cking (fot large columfL1 wirh fixed b..-d heigrlCs)

• Hydraulic pl'CS5Ute" p.~king

How well the ..;ulumn is packed will ha.ve a m3jor e:ff~r nn tht'
re:suJE of the scparacio>n. Ir is; tberefore very import.lnt Co p,l.::k l1nd
tc:sc the column at."C()rding 1:0 the following re.:ommcmlar;(lO!1.
Besin me: packing proct:dLlte by determini~ th", optimal plleking
flow rate. Guideunes are given for dctenninll', rhe uptimal
p:l.cking flow r:lfe8 mr corumn$ with ad<lpeon; and ~"jxllld bed
hl!:ighu.

9

.;. Th~ mJ:lximum E1o,", rate j, rt:;lched when !h~ pre~lUrclfll)\V
curvc levds off or the lruI:<imum ptusure I)f (h..: CIllumn "
re:u::hcd. Stop cheJllldldns: and do nt)t e~o::d chiS fin", r.He. Th,
optimOiI packing flo ... r;lI:dpr~ur~ is 70-IOO~, 'lf rh.:
maximum flow I1m:fpTcssure.
6. Plt)[ the prcssurc:lflow rate curve ;\S in fig. .1 JOlI .1 ..rcrI"'u,' rIll'
optimal pllcking flow rOltc:.
The operOitiunal now ratc:/prrssure dlOUkl b.;- <7'0''1" lit the
p'lI:kinl,'; flaw titre/pressure.
Not;: For 8PSS columns, first pOlck the culumn by ,,,ctinn
pllcking :It ~ low flow r~rc chcn determine ehe nowl
pressure ch;.lfllcterlnio::s U .lb.).... e Ill' pumping Wlth
downward flow through rne column .

~""IQ'n'~'
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4.5 Pres.sLrre paek.in;
BPGcohlmna
BPC; Columns are supplied ...ith a mOllOlblc adOlpror. The~ ;tr~
packed by eonvflntinnal prlfssun: packing b~ p~lmping che p:lo.:bnf,:
sohni!)" throllgh me chromllrolJl'OIpnic bed at COlIsranr tll>w r.lt'l:
(or bade pres$u~cl.
1. Pour some Wlltll't for packing buffer) into the colunll''l. _"l.lk~
sure rh:st then: is no air rrapped under the bottom lIet. Lc;! "0
.about 1 em of liquid in rhe column.
2. Mix thc pac;king bulkr with the medium ro form a 50_70""
slurry. (Sed.lmentcd bed yolume/slucl'V volume :; 0.5-0.7.)
Pour the slurry inca the column. rnsm the ;daptor and lowcr
it to the surface of the slimy. making 'Sure no OIir is tr:lpped
under the ad:lptolO Secure the adaptor In plar:-e:.
3.Seal [he :ldapt:or O-ring and lower the adapcar .1 lictlil into the
slUJ;J;f, enoup co fill rlie ad1ipcar inlet with paclr:ing soluriun.
4. Connect a pump and a PCl!'f5ure meter ;md SUrt packing <It eh.:
pcedea:nnincd packing flow rare (or l'ressurel. t..::~ep the flow
rat:e: (or pressure) constant during paclcing ~Rd cht:ek the
pressure at the c:olumn inlet. N~r eXceed the !?t'U$ur" limit
tor <;olumn or medium.

FItI. Z. Prasurill""", r.tIIt CUM> I"r PnotaIn A S<oph_S8 ... F.... ",,,,,,
media (BPG 1CO: 1 ba'; !!. 1 C/T1

~

he'llhl).

4.4 Determining optimal packing flow rates
The opc:imal packing flow I'lm: is deperul.enr on column size ;md

~~, medi\l~ volume. packing solurion and temp.enltuR. Th",
oj:mmal p'acklng Ao"" r:1tc must r"('rcEon be dctl:nnincd
empiricall}' for cach individual system.
To decennU;e the optimal packing flow rarl:, procecd as folloW3!
I. Calcu1are rhe amOr,l/lr of mcdil,llIl nc:c:d~ for the slurry (this is
especially impo!'t.:Lnt lor columns 'l"'ifh fixed bed heights). 1ft,:
quantity of medium raquired per litre packed volume is
approximately L 15 lirrc.s sedimented medium.
l. Prepare the column cxac:t\y liS for <;olurrtn pa<;King.
3. Begin packing the medium :u a 10,,", flow Brill (30 anlh).
.... Incre:ue dll: presaure in inc:rcmel\l:!l and record tht: flow rare
when fhe pressure has st:1biliud. Do nor exceed rhe maximum
pn:ssure or rhe column, or (he mL'l:im<lm flo"" rare for the
medium.

10
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5. When the medium has serried, dose the butTOm val"1l lind stuI'
the pump. Thc bc:cl sram rising in the: column. L005~n the:
O-ring Bod IOW<:'f rhe adapror {n abol.lr 0.5-1.0 cm from the
bed surfQ:ce.
6.S<lal the O-ring, sam the ,Pump lind contin ...e packins- Repeat
Step... 5 and.6 uncil there IS II mnICimum I em be~cen
bed 5UrfaC~ <lna adaptor when rhe:: bed has mlbilize,j. Mark rhe::
bed ht!ight em the column tube.
7. Close rhe: butcom V1l v e, s{np thc pump, disl:o,\necr the column
inlet and push rhe: adaptor auw,\ rn apPt'o;<:imatdy ,) mm bduw
the mark on the column tub<l. withuut kum:ning [h.: adaptot
O·rillg. The p.u:kjng -tolulion will flush rh~ adilptor inlet.
RIf:1.Tlnve any tr:lppe(J air by pumpinG liquid frnm the botrnm
(afrcr the inlet tubing (lnd [he bortnm v<lllIlj. have btcn
properly filledl.

or

4.6 Combined pressure/suction packing
Procl!I5$ Stac:k (PS 370) Column
Tnt: ProcCIIS Stack Column is supplied with fi;P;eQ cnd-pieces ;md :l
fixcd bed heighr of 15 em. It is packed by a comhined
pressure/suction technique.
1. Fit:m ex{1'll column !;Caion on !:Op of the column mhe, for use
as /I p:J.<:k.ing: devicc.
2.P<.iur some warer (or paclc;"lg buffi:rl into rhe ,;o1 ..lI\n. MaJ<",
$urc rhat there is no {rllpped air under the borrom nero l.c:3ve
:lbout :z. em of liq\1id in che column.
J.PnuT the: ~Iur ...y inru rh.. column. Add bufft::~ m wiehin 1-2 em
of the rim of the upper 5c.:rion. Stir genrly [0 give Il.
hnmogenel)t.I.~ slurry. Add buffer I,Inrillevd wirh rhO' UPFer rim
and 1i:ccun: tho! lid in pla.:.;-.
4. Connect :l pump lind a ilrEl$$urc meret' ilnd St:let packin~ ae tile
pn:de{cnnined p;!cking How ratt:: (or pro;:ssure). Keep th~ flow
rate lor pressure) conseant during par;:king and che.:k the
pressure at the cnlumtl inlcr. Nt!"er exceed [ile pro!>llre limit for
column ur lucdium.

----------- --- .
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5. When tho! bed has stabilizcd, the t'Op of tl'te bed sh<)uld be
txac:tlv I~vd with rhe top of .he column cube. Ar ehis point,
exclude the buffer rank from the system by;;iOluir::mt:ousi v
s'lAlicchinG che 1Ia.lve at che column outlet and the val"~ an 'the
SlIccinn :lIde of the pump, :u ~hown in Fig. 3. PackillG buffer i ~
flOW ret:itculll:a:d tbrough the S}'!Item. If. when ~C'.Ihili~ed, th"
packed bcd is oor el(:Ictly level wiJ:h the rop pf rhe c(llunlll, add
or remove slurry. A.lwa!'S seit ihe slurry rhoroughly bef...rc:
packing.
6. Keeping the pump rUllninl,l. disconnect the CQlumn hIler from
the lid and dlrec[ it to \valilil. The packing solurion in the
p.1cking secci011 e:tn be remnved by s...aion thr"ush rhe bed.
7. Whilc rht:: packing set:tion is beizl$ emptied, loosen th..: boll:;
holding the column :lnd th ... pnckmg secrinn togefher ~o that th.:
packing scc:cion C<ln be removed. Durill@: thil oper:tcion.
manu.llly press down on the packing .o;ccciOIl to prevent leakage
between th. [WI) sections.

"I

'I

J
FIg. 1 Eqr,dpmem ''''' up lor P""=J"l'lliVctlol1 packing.
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s. Wh,uI the pll.:king so~u[ion is ""irhin 5-8 mm of rile bed 5urf:1
ce, dose {he v:llve lit ch~ column nuder, sroll rhe pump, quickly
remo"l: rl'le packing se<:dQn and replace it with the lid.
':\<[an\,l;l.II" preS'> down on the tid ",hile ic.is secureJ in plOlce.
This final oper:nion should bill .:omll'lercd ;as ql.ll;lcly ll.S possible
heclluse the hed wil[ ,,~plll'ld when tit, f1nw StOps.
9. St:m pumping buftl:r with I.lpw::Ird flow through the column to
remo"e :111)' ,ur bwbblc:.~ tr:lpped under thl: lid.

---.....

<I.\lickly :IS pnssible l1eO:lIl.15e: the hed will cxp:mJ whl·n rh\·
flt)w;;cops.
1.SCltt pumpln~ buffer with upw:!rd
rhr!luf?/! ehe ,;oIUIl'" '"
rem'}-'e any :llr bubbles trl1pped unr.J,:r che: Illi.
::15

fI"""

4.8 Hydraulic packing
INdEX CalulTlrttl

INJEX Columns are supplied wirk n hydr.lu1ic functil1l1 :,·tll.h
:tl!ow!i:m ntremely simple, n:lpid ;tnd repmJu':lhl~ p~lcktll1-'
procedure. The rnllclium is packed :1t the same tIm!: ,I:> rhe ,IU.IP:I"
15 lowered into position acene correct pttl$$"r~,
Thll ad::lpcor is pushed down bY:l J:on$r:Int h~'('r:lu!i<: pr,,""I\J'I:.

4.7 Suction packing
BioP(oc::c:u StalnJe!l!l Steel (BPSS) Columns

BioProce:ss Sl:lIinle.iS Steel Columns :Ire supplied with fixed ~d
pieces. Thev lue p:lI::kcd by suction, i.lII. by sucking packll'lJl
solution through the cntomacogtillphic bed lit :I consrllnr flow
fl'lte.

furc:ing waccr through che slurry and cl)mpresmg It ;'11 th'lt :L
Pil..:kec bed i$ Sn:ldual1y huilt up. The h:"drauli': pres~ure ':.1n l'c
gener:1to:<i using ::I pllmp ::IDd I pressure reli.tf V':1h-e.
When the 3dii.p~a( r=hllll the surface of the serrIed medi~I"'. lr
condnues downward" III'1dc:r hyd.raulic pressure compr~s$lnj:! tn"
medium. The c::xtmt to which cb. medium i$ cnmpr~o;eJ J~p~nJ,
upon the pressure from the adllptor and ~he d::lsricit;' (?t th~
medium. The qllllnti.:y of medium required when packm!;.
Sephl'l(oSC >4 Fa,( Flo", m.di:l by hydrnullc pressure is
approxilnlltely 1.2 litre s<:dimentc:d medium per litre p,\ckcd r.cJ.
1. Pour some warIJr (or f:l8clcing solution) into the CQlumn. :\,I;\l.~
sure: rhat there i$ no air trapped under rhe bottom ncr. l':;HC
about 2 ern of liquid in the column.
2. Pour the slurry inco the column. Fill the ..:oh.l~nwitl'l p:lckln!;
solutiOl1 up to the tOP of che glass Nbc :lnd mil< the siurr:;-.
Allow rhe: medium to sediment to jusr kKllow the bevd at tn~
glass Nbe (G). Ht Fig. 4.
3. Put the adapror in II rucl~ position :lj?insr the hc:v.:1 of rhe
glass rube..Avoid uappinr; air .bubbles ~ndr::r the :lrJaptor b~
i1ighdy tIlt:u!.& me adaptor while mounting.
~. Lower the lid and seCure it in place.

I. Fir l'l packing device on tOP of rhe c:olumn rube.
l.Pour some warer (or packing solutionl into ~he .:olumn. Make
S\l(¢, rhl'lt there is no air tr.apr;n:d under the bon-om nero L~::Ive
:lbouc 1-3 o:n of liquid in rne c:alumn.
.LMi..'C rlK- packing b",ffet with rhe medium to form 3 50% slurry
(scd.imenred bed volumclslurry = 0.51. PoW" rhl': slurrY inro the
column. Srir gently to give ii. nomogeneous slurry.
4. Connect the column oud«t wive to the sUcOon sid!: of a £lumP
and starr p,:u;:ldng rhe bet!. by suction through thl\' bed at the
predetermined tlow rat:c:., .ic:c: Fig. 3. Keep the flow rate constant
during packinJ.
5. Wben the bed hu stabilized., the top of the b.d should be jU$r
below the junction of the COlumn and the paclcing device.. If,
when stabilized. fM level of the bed is im::orrCdf a.dd or
remolle siurr'l". Always stir the slurry r:horaughij' before packin!l.
6.Ju.sr beforl\' the Lut of the solution has el'ltered me packed bed
(before thl\' surface scatts to drY). dose the valve Ill: the column
outlet, stOp rhll pump, quicklv'remove me :padc:ing dltvil:e and
~pl;!,ce ir with the lid. This
operation $bould he completed

nn31
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lQ. Close (AI and (D) and Stop the pump.
1 L Run rht: column with upward fl",w fot a fC'\" minutes (II
remove residual air t:nIpp~d ii, the :tdaptor. Th~ Cl\(,,Jn1n is
nnw rc:ady .fur use.
12. To unpack die column. col'lne.::r the: outler from tho': plln,p co
Ill) and npcn IC) while kt'l'ing (D) do.sc:d, This will cause the
adllpcor to rist: from (he bed. siirf.ac:e.

ng. 4. Sdlerlulllc tellteeentaUOl1 01 INdex call/mn wntl a 4-part (2.-.y) valvg
_""""" ;n IIu: bc:IlklrII ouIJeL

i.Connect a. pump fO rho inlet of me hydralilic c:h>tmber IAl. with
a manometer and :1 prc5$ure rclief valvc in-line between rhe
pump and the hyd.rllufic c:h.:1mhcr. The Inllnomerer should be
pl:u::cd after me: val...&: in the din:c:cion of me fluw.
6. Open the hydtll..,li.: inlet IA). and the hydt;lulic outler (e). Starr
rhe punlp and flush the hydrl'lulic chamber (E) free of air :mtl
any residual medium.
7. Cioslil (Cland Opel! {ke elution inler/olJrler IB) m :1l1ow rrlilppcd
air iI' the adlll'tor nct to e!W:apc.
S.Close (B) and open the elution inlct'lolltlet (D) ro Staft the
p.,,;king, Ilpplyi"8 ;) 1)tI::d.;ifined co.l!tunr hrdraulic packing
prc:.ssurc. When packing Sepharose 4 Fan Flu", media in lm
INdEX column to a bed hei~ht of 15 em, rhe recommended
hydraulic packing pressure 1.5 bar for INdEX 100 :md
0.9 bar for INdEX 200.
9. When the 3dapror has tear:hed rh" sll~face nf the ~errled hed.
(.vnrin",e (0 run the pump until rhe l'ldaptor ha5 been IO,",I\'n:d
.) InOll inco the packed bed.

is
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CaJ.:ularc HET!' ::md A. from the UV .:urvc (or ~onlJu~"",:
curYc) :1$ follows:

:So E,va1uation of packing
. -To ~heck [h~ '1....a1iry of rhe pa~king and to moniror this durin.:
th. working lite r)f the column. column cffidency shoull! be (i."Stc:d
dir:=ctiy "frer p"c1dn~, ;It regular in~""ill$ afterw:mis, and when

HETl' '" UN
.. nd

scpar;lcion p.lrformant:., is seen to dt[eriorQ~.
The recommended method of II'lCpt"s5ing rhtl effkic:nc:y of a
plI.::ked t:<)lumn i~ in terms of [htl height cqllival"nt ro a rheorctiOlI
p!.:m:. HE"'. and the asymmetry factor. AS" These v.dues :I..." e:l$i
Iy d"ctrmined by lIppl~ing II $;Imple such :15 1% 3c:erone soluci.m
to ehe .::oluml\. Sodium ch\('>ridc an al~o be used lIS ;t telll 511h
mmce. U$1r a .::oncc:nrracion of l.O ;"'1 NaCI in water wich 0..5 .M
"""el in Water as c:l<l~nr.
It is
utmost imporrance to te"lIze 'that the calc:ulafed 'plant
number will ":1r)' dll'pending on the test condicion$ ')lld It sholiid
therefore be used as a rc:retence: value only. It is also importnne
that conditions .uld e:quipmlrnt are kept constant $0 rhat results
Me .:.omp'anble. Changes in solute, solvent.. .eluent. sample
volume, flow r:lre. liquid path.,.,a!'. tcmperacure. etc. will influence
rhe res141cs.
For oprimal results, the sample volume should be i t maximum
2.5% of the ..:olumn volume and the flow cate berwecn 15 ~nd
)0 cmlh.
If an 3cceprancl: limir is dclfined in relation to column
perfQtmanC:iI, the column plate numbo:t can be I.Ised 35 part of the:
~CXC;pClnce crireria for column use.

N '" S54IV,fWh,L
where l. " Bc:<l height «m)
N " Numhc:r of theorc:ci.:::d plates
ViC " Peak d utinn di st;! nce
'IlIIh " P~:1k width :It half peak heigh!

Vc an.:! Wit :Ire in th" S<1me units

or

Method for measuring i"iETP arKS A's .
To 3void dilution of thc: sample, <lPP{Y it as close to
inlet as possible.
•

To facilic:ue comparisnn of column performance rhe con..:"pc .. f
reduCt:d pl:lrc heiSht is oiten used.
The rc:dlJccci plate height ;5 .:alc:ulated :1.S

HETP

-r

""here d is the diamerer of the bead. As a guid,f/ine. a ":lluo:: I)f
<l is normally ar:o:ptable.
The peak skould be symmtltrir;.al. and Chd asymmerry t~etnr .1S
.;\05e u possible co IlvaluC5 betwftn 0.8-1.5 :lre usII"llr
ac:e-epmble). A chante in the $hape of the pe:!1c is usually t~c first
indication of bed deterioration due l:I:I
Peak asymmetty faCtOr calculation:

eke column

.

As" b/a

where

CondIt/Qna
Hl!lpI$

use.

voI...,a:

ample"""".:
/toow ",,,,"
IJV:

2.5% 01

~.

a

b.a .on.ne

15 tlmIh
28Q nm.

, em. 0.1

=1st hal! p\!l'1k widch at 10% of peak lleiglH

h .. 2nd hOllf penk "'idth ae 10% of peale height

1.0-Ya vN aQ9l'OC"18

Figure 5 shows a LN traCt: for :leetone in :I t'!'Pica.1 teSt
diromacogl'a.m in whidl the HETP lind A, values arc: cal..:ulaced:

AU
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W';J.Sh ..,ith 2 column volumes ",f
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substances immedi;ltc:ly with Ole lel1st
5 column vollllPl!t5 of $cefile filtered binding
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6. Maintenance
rnr beSt performance of coupled CNBI"l\cciva(cd Sclpharose 4 FMr
Fin"" j)v"r a long w()rldng life, fullnw the geneml proc"dllrt::S
described below. tn all cases, we: recommenu {C5till!! [he
prucedures at ~Fru111 seal" first.

't'Uash the column wich 2 column IfolumllS of
a non-Ionic dercrgent (cone. 0.1-0..5%),
Wa.sh immediately with a. leut S column
volumc:~ of sn:rile fil=ed binding buffer.
or
Wash the column with 3-4 column volumes
of 70% ethanol. Wash immedill~!y wirh at
leaSt 5 colnran volumes of sterile filrerc:d

binding bulfer.
Saniriz;p.tion

Eqm'/ibraJiun
After pacldng. ilnd before <1 chromatographic: nul, equilihrate
wit!> working buff... by <V:lsbing with ;it least 5 hed !lolumes.

Sanitization inactivates microbial conmmin:>.nts ilt rhe p~ckc:<.!

CItIItJJ'1irrg-in.PltJ~t:

CI"'lning-in-placc. (CIP). i$ a denning procedure: .... hich r"move>;
<:nnClllninan~ such as lipids. pre.::ipir:ltes or denllcured proteins
thaI may remai.1 ill the packed cnlumn after regen~ratiul\. Such
cont:3rttinatiun is ..s@eciilily likely whJ;n ....orkin; with crucl_
!naterials. RCl'luh\r ell' p'rt:!ltlnts the build-up ..,t the~e
conmminllncs ill tht: packed bc<.!, :md hdps rn mainmin the
c:lpllcity, flo'" propl'rries and &e:neral perlurmancc ut the Itl<ldlum.
A ,pcci fie ew protocol ~hould be oesig'lcd fur e::ICh prOl.'eltS
llccording to th~ type of ~"OntaminiltlCl rm:sent and stability uf
coupled ligand. The m:4uency nf CIP depends on the nature and

column and re\;m,d equipment'. A ipl:l-ific sanitization protocol
shol.lld bel dcsi,gncd for .acb p'roce5S llecocdins to the type of
cotltaminaIlts present an" stabili;y of coupled ligand. 1'01/0\l1inl:
are geRenlly recomme.\ded procedures.

Equilibrate with i1 buHw~ e:onsisting of 2 % hibitane digluconar"
and 20% ethanoL Allnw to stand tor" hours, rhen ""~$h with 3.[
least S column volumes of srerilc binding butrer.
or

Equilibrate with 70% erhanol. Allo'" to mlOd for 12 hUllrs, then
",uh with at \.eaSt 5 column volumes of sterile: bind in!!'. bufftlc.
2~
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Note: Specific regularioru mlly apply ",hen using 70% ethanol
sincr: it can ro:quirc the use of explosion-proof arc.:1S and
equipment. COl'l6ulr your local saftey regulations for mare
informacion.
Sroraglll

CNBr-activlIted Sepharose 4 F3~t flow is Sl.Ipplied freeze dried.
Additives ;ITC: included. ro preser". the bead FOrm of the Inedium.
When stored below g .c, the shelf life is at least 18 munths.
Packed o;Qlumns should preferebly be: equilibrated in binding
buffet containing 20% ethanol (ligand dependent) to Pfevcnt
mi"'"\'Qbiai growm.

7. Trouble-shooting
High baCk pnaS$ure
1. Check that aU valves between the pump and me collection
"elIsc! are fully open.
2. Check that aU ";lIves are dean and fret: from blockase.
3. Check if equiplncnt in usc: up to and alter the cahllDn is
generating any back-pressure. (For exa.mplc valves ,md How

cells of incorrecf dimenllians.)
4. PlICform ClI' to rcmove..,tigbdy bound mawi;l.1 from
S. Check column .earn s11ch as filret:S, net>
columfl instruction manual.

Ir"ections

t. Check the cClnncctiull$ :1nd prdilters.
2. Ch~ck the in-soing compunel1tS ~uch n$ huffo:,;, sampic
componentS, erc.
3. Check th:n the cuI limn has b~n prtJpcrly sanitized.
TllIpped air
1. Check that
buFfen are equitibrim:ci to (he 5..me
rc:mper.uure ;as the packed column.
2. Chel;k th.:1t there arl!' 110 loole: ,,"emnec!ioos or Illilkin~ ",lives.
If air hll$ entered rh~ column, rhe column ~hodd be: t~~,;)ckeu.
Ho... evc:t, if only a $m:1l1 amount of aie h:1s been trapped on r<lp
of the b.,d, or between th~ adapt'" nct and heau, ie ClIon b<I remo
ved by !lumping eluent in the opposite direction. J\ner this, ,'htck
me efficiency of the p;1cked bcd, set' page 18• .:lnd o.;omp:o.r. the
result
rho:: original effidency v"lues.

mo:

wim

8. Ordering Information

me media.

etc., according to the

Unupecrad chromatographic 1'8SUl1s
L Check the recorder speed/siglla!.

2. Check the tlaw rate.
3. Check the bl,lffi:n;.
4. Check that mete ar,,;: no ,&ap:; bc:tween the ad;1l:Jmr alII;!. the:
medium bed. or back rru.-ung of me samplli beron: al'pliClIioll.
5. Check the d£icienC)' of the column padcing, $ct: page 18.
6. Check if'rlu::rc: have bet:n 3ny changes in the pretre::u:mcnt of

me .~ample.
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All product$ are supplied fre:ese d.ied In thl: prec~l1c. of
;ldclltives.
Fot adclitionlll lnfuclllliclon, including O:1ta File:, appJicadon

fl:fl!:n:nOls ;lnd RCS\1lat:Or)' Supporr File:, picas<: conroCt your loc~1
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BioProcess-rM Stainless
Steel ColUIlUlS

BioPracess Columns

BioProcess Stainless Steel Columns are specially
constructed fixed bed height columns intended for
routine production. The range of columns has
been constructed from component materials of the
highest quality to meet the most stringent demands
of production chromatography. and to resist
sanitizing and cleaning agents such as sodium
hydroxide and ethanol. Furthermore, the design of
the columns wIth fixed end-pieces provides the
highest standards of hygiene.
•
•
•
•

Hygienic design and operation
300 kPa (3 bar) operating pressure
High throughput
Materials include high grade elecrropoUshed
stainless steel
• Standard bed heights of 150, 300. 600 and
lOOOmm
• Supported with procedures for packing.
sanitizing, cleaning and trouble-shooting

BioProcess Stainless Steel Columns, BPSS, are
derived from the range of Sephamatic Gel Filter
columns with improvements made in both column
construction and design of the accessories.
Columns are available in standard heights and
both 10 mm and 22 mm .internal diameter tubing
can be obtained for the 400. 600 and 800 mm
diameter dimensions. Sanitary tti-clamps facilitate
quick and hygienic connection of all tubing.
High pressure specification and low flow resistance
make these columns suitable for use in ion
exchange. gel filtration. aftlnity. and hydrophobic
interaction chromatography. They are compatible
with all Pharma.da Biotech gel media and permit
flow rates of up to 150 ]/min. enabling kHograms
of product to be processed.

.FJg. 1. A sellllCtion ofBioProc:ess.... Stainle,.., Su. .e l Columm.

All gaskets are made of recognized EPDM rubber,
and electropolished stainless steel to ASTM 316L
is now a standard material. Each column is issued
wjth a pressure test certificate and a materia]
certificate for the steel. BPSS columns can also be
made to specific dimensions and custom
requirements.
The range of columns is fully supported with an
Instruction Manual which gives details of packing.
sanitizing and cleaning procedures, trouble
shooting and lists all spare parts and accessories.

Pharmacia
Biotech

118- 11 21-08\
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Column components
The column components are the stainless steel
column tube, lid. 2 filter nets which are ordered
separately, and 2 support nets with jet stream
stoppers. Lids and column tubes are constructed of
electro polished stainless steel; tubes are avallable
in diameters of 400,600.800. 1000 and 1200
mm. Depending on diameter; different standard
tube heights are avaUable. refer to Table 1. Other
tube heights can be constructed to order, Contact
your Pharmacia Biotech representative for details.

Valve assemblies
The inlet and outlet valve assembly configurations
differ for the diameter of column in use. Two sizes
of tubing are available for the 400. 600 and
800 mm diameter columns. either 10 mm or
ZZ mm internal diameter. The 22 mm Ld. tubing is
standard for the 1000 and 1200 mm diameter
columns. All gaskets and tubing used in the inlet
and outlet assemblies are made from EPDM
rubber. The columns are supplied for upward flow
with the flow-through pressure sensor and safety
va1ve fitted to the bottom of the column, Reversed
flow kits are available as an accessory,

Flg. 2. BPSS 8001150 colUlIm show.lng main assemblies.

Column Description
BioProcess Stainless Steel Co]umns comprise three
major assemblies: column components; inlet and
outlet valve assemblies, safety valve and pressure
sensor: end-piece and stand. These are illustrated
in Figure 6. As an option a complete BloProcess
Stainless Steel Column can be fluoroplastic coated,
in which case 22 pm polyester nets are required.

Table 1, Primary lo-pec.ificati.cns and characterIstics of the range of BPSS l;olumns .
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End-piece and stand

Accessories

The combined end-piece and stand is supplied
with adjustable feet and lifting bars as standard.
The 400 and 600 mm diameter columns can be
fitted with the optional wheel kit. The wheels
incorporate foot operated brakes.

The accessories available for BioProcess StairJless
Steel Columns include an Air Trap. Reversed Flow
Kit, Packing Device, and connectors with damps
and gaskets.
The Packing Device facilitates the packing of
media using the suction method. The packing
device is supplied With a flat gasket and sufficient
clamps (4.6 or 8) to secure it to the column tube.
Haste1loy nets are an alternative to stainless steel
nelS when using fiuoroplastic coated columns.
They are available for all diameters.

Column Perfonnance

Fig. 3. Some components and lJo;~rics for BPSS columns;
flow-through pressure sensor with manomlttcr. safety V\'l!ve.
filb:'r nets. support nets. valve. eye bolts. steering bolts. torque
wrench. tQbjng connectors with damps and gaskets.

Standard components

BioProcess Stainless Steel Columns are easy to
pack. test, run and maintain. Their compatibility
with BloProcess chromatography system and
BioProcess Media (Sephadex G-25, Sepharose Fast
Flow and Sephacryl High Resolution) greatly
(.:ontribute.s to safe. effective and reliable
bioprocessing, as the folloWing example
demonstrates.

BioProcess Stainless Steel Columns are supplied
with a number of components. includlng a flow
through pressure sensor with manometer, a safety
valve. 3-way manually operated valves. support
nets. steering bolts. eye bolts. a box wrench and a
torque wrench.

Fig. 5. Rmclent desaldnB and remoV\'l! af low molecullJr
weight impurities on a BPSS 4001600 packed with Sephadexllt
G-25 Coarse.

Fig. 4. The Air TF<lp is one of the so:e..'lSOJies
Elvsilablc for BPSS colurnns.
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Contaminated Peptone Water was pumped into
the column from the top at a flow rate of 36 IIh
and a pressure of 80 kPa. The column was then
left at room temperature for 18-20 hours with no
pressure applied.

Large scale desalting
Figure 5 shows how a BPSS 400/600 packed with
Sephadex G~25 Coarse to a bed height of 60 em
effectively desalts Factor IX depleted plasma,
leaving it free of low molecular weight impurities.
After centIifugatlon and pH adjustment. the
plasma is loaded onto an ion exchange column for
further purification. The productivity of this step
was 53,3 litres of plasma per hOlJr.

0.5 M NaOH was introduced into the collJmn and
circulated at a presslJre of 80 kPa for 60 minutes,
After this time interval 5 lltres of sterile
phySiological saline were pumped thrOlJgh the
column. The outlet sample was taken before the
saline wash was completed,

Hygiene
BioProcess Stalnless Steel Columns have been
designed to give the highest level of hygiene. They
contain the minimum of components to facilitate
simple cleaning methods and reliable operation.

The teSt sites were sampled following sanitization
with NaOH and despite very high infection
through the introdlJction of highly contaminated
solutions no bacteria, yeast or fungi were detected.

All the steel surfaces are electropolished to hinder
microbial attachment and the clamp fittings used
permit the use of clearung-in-place (CIP)
procedures. All column parts can be cleaned with
the most commonly used agents. such as
detergents. ethanol, weak adds, sodium hydroxide
and high salt concentrations. Regular CIP of
packed columns between production batches
removes precipitated material, strongly bound
substances and other contaminants from the
column bed without dismantling the column.

The results confirm that NaOH is an effective anti
microbial agent, and that it. is appropriate for use
wlth BPSS columns. Pharmacia Biotech
recommends. however, that this method be applied
in conjunction with other carefully controlled
hygiene routines and rigorous control of buffers,
water and other materials,

Challenge test procedure
To test the effectiveness of the hygienic design a
BioProce5s Stainless Steel. CO]lJmn was challenge
tested with a combination of microbes (Table 2).
The column, a BPSS 400/600. was packed with
Sephac:ryl 5-200 High Resolution and connected to
an RRA 7lB/l pump, The column was first
infected, then sanitized, and then tested to
determine the number of viable organisms.
Table 2. Microbes used in th' challenge tests are from ATCC.
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Challenge test results

Materials
The materials used in the construction of BPSS
columns have been carefully selected for their
compatibility with the solvents rnost commonly
used in liquid chromatography, column
maintenance and cleaning procedlJres.
The components of the column may be consIdered
to contain wet and dry parts. Table 3 shows the
major components of the columns and identifies
the materials from which the wet and dry parts are
manufactured.
Table 4 is a guide to the resistance of the materials
used in BPSS columns to chemicals used as
solvents. and also to autoclaving.
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ER Column Pump

v

0''=

cm
lOO'-=nr

E

I :=26·cm

J.I :=.0 15'poise

:= 0.35

p:= 1000.~

kg

,·.2
'1-£
2',/1 -E)']
3 + 1.75·p'v 0 '----y ·1
Dp2'E
Dp'E

1iP:= 150,J.I·V 0'\
[

Assume pressure drop across column is 10 psi

F:= 10,99'

kg
hr

Ib
p :=63,72'ft!
1]

:=0.80

D p := 1l0·1O-4·cm

Flow through Pump

liP '" l.92"si

1iP:= 10'psi

Size := F. LiP
p
Power := Size
fJ

Density of Water

Head:= liP
p.g

Pump efficiency

Size = 2.823·\O- 4 "hp
Power = 0.263 W

Hours per batch:

t := 7920·hr

Electricity := Power·t

Head = 22.599ofi
Electricity = 2.084 okW ·hr

b := 1.5·hp
b = 1.119 okW
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earlier today. EDclosed please find lIIe prieiDg infonnati<m you
on Aeti lean Etox. The pricing info is as follows:
Cat#
2705-01
2705-02

Vol.
20ml
100m)

Priee
$420.00
51575.00

,-~

2705-05

10~
5
SOL

$4320.0~
SO.OOJL
S3840.001L

being used' for the manufacture ofthcrapcutics which are approved
trials. In addition we ha\lc a ReguIatmy Support File and a Drug
Master F e on the sin to assist you with regulatory issues 'With the resin.
furthe questions or need additionaiassistance. please give me a call. I can
be reaCh at 800. 35-0735 or througb email atbshoffm.an@eartblink.net. Thank. you
your' terest - Sterogene Bioseparations, Inc. We look forward to working with you.
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sterogene
sterogene technical profile

Acticlean Etox
Easy, rapid endotoxin removal from biologics

· High binding capacity
· Dissociates endotoxin-protein complexes
· Nontoxic, stable ligand
· Stable linkage chemistry
· Sanitize with 1 M NaOH
· Reusable
· Drug Master File
Removing endotoxins from proteins and other biologics can be difficult and expensive. The most commonly used
methods include ultrafiltration, size exclusion and ion exchange chromatography. Recently, SOlid-phase
endotoxin-adsorbing reagents have become available, however, their binding affinities are often too low to
dissociate endotoxin-protein complexes effectively. Nonspecific binding of proteins to these reagents is another
common problem.
To address these issues, Sterogene has developed Acticlean Etox, a solid-phase reagent with a high affinity for
endotoxin. Acticlean Etox effectively removes endotoxin from all biological media of interest, including water,
buffers, cell culture media, and purified proteins. Affinity of the immobilized ligand for proteins is very low,
delivering a mass yield of proteins which typically exceeds 95%.

High Binding Capacity
The endotoxin binding capacity of Acticlean Etox has been measured in buffers and protein solutions. Capacities
vary from 20,000 EUlmi in aqueous buffers to 200 EU/ml in a 25% serum albumin solution. Capacity is a function
of sample composition, buffer condition, contact time and to a smaller degree pH. Binding capacity is typically
inversely proportional to the protein concentration in the sample. The nature and concentration of the protein in
the sample also have a major effect on the available capacities.
In a comparative study, Acticlean Etox exhibited significantly higher endotoxin binding capacity than immobilized
polymixin:

Stable Linkage Chemistry
Acticlean Etox utilizes Sterogene's proprietary ALD coupling chemistry. an immobilization technique that produces
a highly stable secondary amine linkage. Leaching is negligible (less than 0.1 ppm).

Column Chromatography
lof6
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Acticlean Etox can be used in either a batch mode or a chromatography column. Columns are easily prepared by
packing with the depyrogenated resin as a 50% slurry in sterile buffer. Contact time with the resin should be
optimized for every application. To further increase endotoxin binding efficiency, the protein solution can be
passed through more than one column. Column operation is generally more effective than batch processing.

Batch Processing
For batch depyrogenation, the settled gel is simply added directly to the protein solution. Several contact times
ranging from 3 to 20 min should be tested to determine the most complete removal of endotoxin.

Nontoxic Ligand
The immobilized ligand is nontoxic, nonmutagenic and biodegradable. Both acute and chronic animal studies are
completed.

Specifications

Sanitization
Acticlean Etox is the only endotoxin-removing resin that can be regenerated with 1 M NaOH. This is made
possible by the stability of the ligand and matrix, as well as the ALD linkage chemistry. Acticlean Etox can be
sterilized by autoclaving at pH 7.

Drug Master File
Sterogene is a cGMP manufacturer of bioprocessing resins. A Drug Master File is on file with regulatory agencies
in the US and Europe.

Applications
The following applications were developed to demonstrate endotoxin removal from plasma derivatives. The final
endotoxin levels reflect application needs. Lower final endotoxin levels can be achieved by increasing residence
times on the column or increasing resin-to-sample ratios.
All solutions were prepared in endotoxin-free water (LAL Reagent Water, Bio-Whittaker Inc .• Walkersville, MD).
Endotoxin was measured using the Pyrogent Plus and chromogenic QCL-1000 LAL test kits from Bio-Whittaker.
Sterile, disposable plasticware and glassware were used at all times to reduce the chance of endotoxin
contamination. Acticlean Etox resin was packed into 2 ml bed volume columns. The columns were cleaned by
perfusion with 30 ml of 1M NaOH. allowed to stand at 40C overnight. and washed with LAL water until neutrality.
A sample of the final wash must test negative for endotoxin.
1. Sterile, 25% human serum albumin solution (HSA, Alpha Therapeutic Corp., Los Angeles, CA) was spiked with
standard E. coli endotoxin to 30 EU/ml and adjusted to pH 7.0. Ten ml of the HSA solution were perfused through
two columns set in series at approximately 0.3 ml/min. Five fractions were collected at 2.0 ml increments, then
diluted 1 to 10 and heat inactivated (70 OC for 10 min) to prevent any enhancement or inhibition of the endotoxin
assay. The fraction with the highest protein concentration was selected, and further dilutions were made to the
maximum of expected lysate sensitivity.
A Significant reduction in endotoxin was achieved while more than 99% of HSA was recovered.
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Endotoxin Remoyal from Human
Serum Albumin Using Acticlean Etox
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2. A pyrogenic lot of human Intravenous Immunoglobulin solution (5%) was treated with Acticlean Etox. Ten ml of
the IgG sample were perfused through the column at approximately 0.3 ml/min. Five fractions were collected at
2.0 ml increments, then diluted 1 to 3 and heat inactivated at 700C for 10 min. The fraction with the highest protein
concentration was selected, and further dilutions made to the maximum of expected lysate sensitivity.
A 10-fold reduction in endotoxin was achieved while more than 98% of IgG was recovered.

Endotoxin Remoyal from 5X IgG Solution
Using Acticlean Etox
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3. A sterile, affinity-purified Factor VIII solution (Alpha Therapeutic Corp., Los Angeles, CA) containing 100 units
Factor Vlll/mi was spiked with E. coli endotoxin to 20 EU/ml final concentration and adjusted to pH 7.0. Ten ml of
the Factor VIII solution were perfused through the column at 0.3 ml/min. Five fractions were collected at 2.0 ml
increments, then diluted 1 to 3 and heat inactivated as above. The fraction with the highest protein concentration
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was selected, and further dilutions were made to the maximum of expected lysate sensitivity.
Endotoxin was reduced below 0.1 EU/ml while Factor VIII recovery, determined by a chromogenic assay, was
found to be greater than 95%.

Endotoxin Removal from Purified
Factor VIII Using Acticlean Etox
• En.-.toxin (EUIIDI)
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4. A sterile. affinity-purified Factor IX solution (Alpha Therapeutic Corp., Los Angeles, CA) containing 100 units
Factor IXlml was spiked with E. coli endotoxin to 40 EU/ml and adjusted to pH 7.0. Ten ml of the Factor IX
solution were perfused through the column at 0.3 ml/min. Five fractions were collected at 2.0 ml increments, then
diluted 1 to 3 and heat inactivated. The fraction with the highest protein concentration was selected, and further
dilutions were made to the maximum of expected lysate sensitivity.
Endotoxin was reduced to 0.5 EU/ml while Factor IX recovery, determined by a chromogenic assay, was found to
be greater than 98%.
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Endotoxin removal from Purified Factor IX
Using Acticiean Etox
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5. Sterile fetal calf serum (Biocell Laboratories, Rancho Dominguez, CA) was spiked with E. coli endotoxin to 10
EUlml final concentration and adjusted to pH 7.0. Ten ml of the serum were perfused through the Acticlean Etox
column at 0.3mllmin. Five fractions were collected at 2.0 ml increments, and then diluted 1 to 3 and heat
inactivated. The fraction with the highest protein concentration was selected, and further dilutions made to the
maximum of expected lysate sensitivity.
The treatment reduced the endotoxin level in the serum down to 0.12 EUlml.

Endotoxin Removal from Serum (FBS)
Using Acticlean Etox
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Ordering Information
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500ml

L_

i~iclean Etox

:L

IL

2705-04

II

2705-PP

1L
9 ml (Prepacked column)

Acticlean Etox media is available in bulk pack sizes for industrial applications. Please inquire for pricing
information.
Sterogene Bioseparations provides a wide range of resins and services for industrial chromatography. For more
information, please contact our Client Services Group at:

1-800-535-0735
Visit our website at www.sterogene.comfor new product information and applications as they become available.

to place an order or for technical assistance call:

1-800-535-2284
Sterogene Bioseparations Inc. 5922 Farnsworth CI Carlsbad, CA 92008 USA Tel: 760·929·0455 Fax: 760-929-8720 email:
info@sterogene.com.website:www.sterogene.com
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TELEFAX
TO:

amersham pharmacia biotech

Chris Metallo

COMPANY: University of Pennsylvania
DEPT:
PHONE:

FAX:

215-573-7601

FROM:

Nancy Elser

DEPT:

Technical Support

PHONE:

800-526-3593

FAX:

415-695-1189

DATE:

February 22, 2000

TAKE A LOOK AT OUR NEW PRODUCTS

Purify GST fusion proteins in one step
High binding capacity
• GSTrapn.t
1 ml and 5 ml prepacked HiTrapn.t columns
• Glutathione Sepharosen.t 4 Fast Flow 25 ml
For more information and to place your order. call
Amersham Pharmacia Biotech today.

Dear Chris,
Please find enclosed the information you requested on BPG columns. I am still trying
to find you more information on the BPSS columns. As soon as I find something
appropriate, I will fax it to you.
Regards,
Nancy Elser
Tech Support

Amenlham Pharmacia Biotech USA tel

8Q0.526-3593

800 Centannild Aw fax 415-695-1169
P.O. Sol( 1327 www.apbiotClch.com

PiI.c:ataway, NJ 06855-1327
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Data File

BPG™ Columns 100, 140, 200,
and 300 series

Columns

BPG T " columns are glass chromatography columns
designed for industrial applications which demand
high standards of hygiene. The columns are
constructed from component materials of the
highest quality and withstand the harsh conditions
used for cleaning in place of packed separation
media. They are characterized by:
• Hygienic design and operation. Microbial
attachment and growth is hindered through the
use of calibrated precision glass, high grade
electropolished stainless steel and an absence of
dead pockets.
• Easy, efficient packing and running with the
single-screw adaptor.
• Operating pressures matching most BioProcess
Media.
• Materials that conform to the requirements
described in the US Pharmacopoeia (USP XXII).
• Comprehensive documentarion.

General description
BPG columns are designed to meet [he needs of
process development and biopharmaceutical
manufacrure:
- Inner diameters of 100, 140,200 and 300 mm.
. Pressure specifications of 8, 6 and 4 bar.
- Low flow resistance.
- Single screw ada ptor.
- Suitability for use in ion exchange, gel filtration,
affinity and hydrophobic interaction chromato
graphy and comparability with BioProcess
Media.
- Tubing connectjons made with hygienic sanitary
clamp firtings.
- All gaskets recognized as suitable for use in
biopharmaceutical production.
- Capacity to offer a wide range of bed heights
and volumes.
An instruction manual containing full details of
componems, packing, resting, procedures for
cleaning and sanitizing, trouble-shooting, and
spare parts lists.

i

18-1115-231

Fig. 1. BPG .:alumn family, including BPG 450.

Design features
Column tube
The coJumns are designed to very high standards
and use high quality materials:
• Manufactured from calibrated precision
borosilicate glass.
- Exact internal diameter tolerance of the glass
tube.
- Thin O-ring between the column rube and the
adaptor/end-piece forms a very tight seaL
- Minimum dead volume.
- Liquid distribution over a great surface area.

Pharmacia
Biotech

Liquid distribution

- Columns are easily sanitized. A packed BPG
column was subjected to microbial challenge
tesring using five micro-organisms recommended
by the United States Pharmacopoeia (USP XXI).
Sodium hydroxide (NaOH) was the anti
microbial agent. The study showed that 0.5 M
NaOH applied for 30-60 minutes is a good
basis for developing an effective sanitization
procedure. The study is presented in Technical
Note 211.

Efficient liquid distribution is crucial for optimal
column performance. In BPG columns this is
assured through:
- Adaprors and end-pieces based on the well
proven design of a single channel inlet/outlet.
- Support nets with a coarse, open structure to
distribute liquid from the central inlet rapidly
and uniformly over the entire surface area.
- Thin ners to maintain even pressure distribution
over the bed surface and permit liquid to pass
through quickly and evenly Onto the bed,
without creating extra back-pressure.
- Polypropylene distribution plates in the adapror,
and in the bottom plate in BPG 300 columns,
which give uniform distriburion/collection of
liquid at the interface between the net and the
packed bed. These plates are not necessary in
narrower diameter columns.

Easy to pack
The design of adapror with a single-screw makes
light work of all adaptor movement. It is easily
adjQsted during packing and operation, even on the
largest of columns.

Scalable
BPG columns are ideal for scaling up from smaller
lab scale or method development columns. As the
example shows here, Fig. 3, the chromatogram
obtained with an XK 16/20 column, i.d. 16 mm, is
consistent with the chromatogram obtained from
the scaled up run on BPG 300/500 column, i.d.
300 mm. The scale up factor is 350 and no
evidence of dilution or loss of recovery was
detectable.

Materials
.........,..,

-

All the materials selected for the manufacture of
BPG columns are of high quality, often with
special properties, or specially treated, Table 1 .
All materials used in BPG columns meet the
requirements described in the USP XXII;

/

Fig. 2. Adapror end.piece and net. Flat surfaces
give even spread of sample.

- Materials are compatible with the liquids
commonly used in process scale chromarography
(including sanitizarion and cleaning agenrs such
as NaOH and ethanol), see Table 2.
- Parrs in contact with sample and process liquids
are made of marerials of very high quality and .
chemical resistance.
- All stainless steel r.omponents are e1ectro
polished. This improves resistance to corrosion
and reduces friction and contamination.
- Polymeric materials have been tested for their
biologica1 reactiyiry according to USP XXII.
- Documentation of all material testing is
compiled in the Validation Support File.

Operation
Hygiene
BPG column are intended for use iil environments
with some of the toughest regulatory controls:
- Design and materials of construction ensure
hygienic operation.
- Little maintenance is required in routine use.
The columns a re easy to keep clean and free
from microbial contaminations.
- Autoclavable when disassembled.
- All tubing connections are made with sanitary
clamp fittings.

2
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Table 1. Column component materials. Componenrs may be considered to contain "wet" pam, parts coming into contact with
process liquids, and dry partS. The table identifies the materials from which the "wet" and dey parts are manufactured.

.

Borosilicate glass
Ethylene Propylene rubber (EPDM}
Stainless steel: ASTM 316L
ASTM 304 1
Polypropylene (PP)
.
Polycetrafluocoethene (PTFE) (Teflon)
Polyamide (PA) nylon (lO)lm net)
Polyerheretherketone (PEEK) with
30 % carbon fibre
Acetal plastic (POM)
FJ uoroethenepropene (FEP)l
Polyurethane
Polyvinylchloride (PVC»
, The d:lmps are made of s[~inless sTeel.

.

...

Medium:
Sample:
Loading;

3.00

.

...

100

0.00

o

50

Option ro EPDM.

1

The tubing is made of PVC.

Chemical resistance

XK16120 (Lei. 16 mm),
10 em bed height.
20ml
Phenyl SepharoS8 6
Fasl Flow (high sub)
Yeast supemanlant,
(NH4)ZSO", added 10
0.5M
450 ml sample:

Table 2 is a guide to the resiscance of materials to
chemical solvents. The information has been
complied from published material from several
sources. Please note that the effects of a solvent
will be more severe at htgher temperatures and
[hac combined effects have not been taken into
consideration.

0.41 nlIJ'ml medium
Starting buffer: 0.5 M ammomium
sulphate, 20 mM
sodium phosphate
pH 7.0
Sution buffer: 20 mM sodium
phosphate pH 7.0
Flow rate:
Loading:
300 cnvb, 600 mIIh
Eluiton:
60 cmlh. 120 mllh
Purification
limB:
1.5 h
Time (min) System:
BioPilot

Individual testing
As evidence of good manufacturing practice, all
BPG columns are individually pressure tested and
inspected. A test certificate accompanies each
column delivery.

Separation at process scale
eolumn:
BPG 3001500 (La. 300 mm), 10 em bed heighl, 7.1 L
Medium:
Phenyl Sepharose 6 Fast Flow (high sub)
Sample:
• Yeast aupemanlant. (NH~12S04 added to 0.5 M
Loading:
SO l aample: 2.56 9 EGF: 0.36 mg/ml medium
Starting buffer:
0.5 M ammomium sulphate.
20 mM sodium phoSphate pH 7.0
20 mM sodkJm phosphate pH 7.0
Elulion bUffer.
Flow rate:

I.oading:
Eluiron:
Purification
System:

300 cmIh. 2100 IJh
60 cmIh. 42 LIh

time: 1.5 h
8ioProcess conlroBed by UNICORN

%8

AU

100

3.0
2.0
50

1.0

o

0.0

o

50

100

.
..

8.1 mgEGF;

2.00

..

...

Separation at lab scale
Column:

..

Time (min)

Fig. J. Developmenr :lnu 5cal< up of a chromarogn1phi..: do",nstream
process for the purih.:.uion of re.:ombinam EGf expre5sed as 3n extra·
cellular procein imrn S. cerel'isi.l(!, Tile starring mareri,,1 was dnrified
supernnranr, (Dollit'k A.1.. PN<"·SSOJl. N. T .. Se<1l1ddl,l, C. Puster
presl!l/t,ltiol1. Crysu! Cit)'. L'S.-i. 1992.)
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Table 2. Chemical resistance of materials of construction.

see note 6
see note 2
see note 3
see note 2
see note 3
see note 2
see note 4

1.7 M
5%
50%
10%
100%
100%
100%
·50%
100%
100%

Acetic acid
Acetonitrile
Acetonitrile
Acetone
Cyclohexane
Ethanol
Ethyl acetate
Ethylene glycol
Glycerol
Hexane

Hydrochloric acid
Isopropyl alcohol
Methanol
Nitric acid
n-Propanol
Sodium chloride
Sodium hydroxide
Trifluoroaceric acid
Triton X-100
Urea

OK
OK

see note 2,7

0.1 M
100%
100%
O.IM
100%
2M
2M
0.1%
100%

see noll: 6,7
see note 2
see note 2
see note7

OK

see note 2,5

OK

see note 7,8

OK
OK

8M

Note 1:

The res, does nor include PVC whinS.

NOie 2:
Nore 3:
Nure 4:
Nore 5:

EPD~1 rubber changes d'ar·Jcrerisrics. Fur repetitive :lnd long term us{:. use FEP O-rings.
Change ro FE? O·rings. polypropylene plastic resim:nce is f:lir.
Poiyproylene pl:l5tic resist.1nce is gc>od/f:)ir.
Can be used under norm::!! running conditions. Do nor use NaCI in storage snluliuns. Please nme thar NaCI c:ln .;"use .:orrosion on
st:linless steel in acid soluI;uns {pH bdow 4.0).
Nor long.:r [h~n 4 hours.
Nor reO;:Ol11mended rl} he usc:J wirh PA nets.
FEP .;h;]llges ch(lracrerisrio;:s. Usc EPDM ruhll~r.

Nore 6:
Nme 7;

Nore 8:

Overview of BPG columns

Column

Bed,....
. height';"
Bed
Bcd with· ." 'Bed' '. Bed
Tube Tube Surface height height packing volume volume
diam. height area
min.
max. device min.
max..
(mm) (mm) (em 2 )
(em)
(em)
(em) '(l)
(l)

a6()(SO(l1

100
100
100
140
140
200

200/750
200/950

100

1001500
1001750
100/950
140/500
140/950

ZOO

q~~~~296

,

300/950

296
296

500
750
950
500
950
500
750
950

79
79
79
154

0
15
45
0

500
750
950

688
688
688·

0
15
45

26
41
54
26
54
26
41
54

48
66
83
48
83
48
66
83

0
2.0
3.5
0
6.9
0
7.3
14.1

154

45

314
314
314

0
25
45

26
41
54

48
66
83

0
17.2
31.0

2.0
3.2
4.2
4.0

Bed
volume .

Overall
dimensions
packing Max.
Total Adaptor mc. stand
device pressure weight weight &: adaptor
(l)
(bar)
(kg)
(kg)
hxdxd (c;m 3 )

with

8.2
12.9
16.9

3.8
5.2
6.6
7.4
12.8
15.1
10.7
26.]

17.9
28.2
37.2

33.0
45.4
57.1

8.3

8
8
8
6
6
6
6

15
16
17
25
27
34
36
39

7
7
7
11
11
13
13
13

172><59x59

4
4
4

68
73
78

29
29
29

133x69x69
158><69x69
178x69x69

6

127><48x48

152x48x48
172x48x48
127:o:59x59
172x59x59
127><59x59
152><59x59

Ordering information
Column

Tube height SOO mm

Tube beight 750 mm

Tube beight 950 mm

Stand

BPG 100
BPG 140
BPG200
BPG300

18-1103-01
18-1113-08
18-]]03-11
18-1103-21

18-1103-01

18-1103-03
18-1113-09
18-1103-13
18-1103-23

18-1031-10
18-1031-20
18-1031-20
included

18-1103-12
18-1103-22

Each column ;ndllde5 :15 sr.lIlJ:Hd: 23 ~tIl1 pnlypropCI1f' tilrer ners and polypropene coarse ners, 2 damps, 1 EPD.\\ gaskets. 2 blank caps and
O-rings in EPD\I. All srands must he ordered separarely ('..;..:epr for BrG 300. BPG 100 nand h:ls feer. while BPG 140,200 and 300 stand has
wheels.

"~p~re parts

BPG 100

BPG 140.·

BPG200

BPG 300

Qty/pk

Flange O-ring
Adaptor O-ring
Support net, adapror
Suppon net, end-piece
Nct, 10 Ilffi, adapror
Net, 10 .um, end'plece
Net, 12 pm, adapror
Net, 12 IJm, end-piece
Nee, 23 pm, adapror
Net, 23 pm, end-piece

18-8494-01
18-8475-01
18-1103-04
18·0251-55
18·1103·05
18-0251-77
18-1103·06

18-1113-06
18-1113-10
IS-1112-99
18-1112-98
18-1] 13-03
18-1113-02
18-1113-05
18-1113-04
1 s- L113-01
18-1113-00

18-8489-01
18-0275-01
18-0252-56
18-0252-55

18-1012-26
18-1012-51
]8-1012-53
18-1012-36
18-1012-55
18-1012-35
18-1104-44
18-11 04·45
18-1012-54
18-1012-34

2

18-1104-41

18-1103-ml
'18-9252-01

18-0252-76

18-0252·77
18-1104-42
18·1104·43
18-9253-01
18-9254-01

4
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2

2
2
2
1
2
2
2

·'1

Note:

Preparing the gel

"<lJ:

Do not exceed 75% of the packing flow rate in subsequent
chromatographic procedures.

Protein G Sepharose 4 Fast Flow is supplied preswollen in 20% ethanol. Prepare
a slurry by decanting the 20% ethanol solution and replace it with binding
buffer in a ratio of 75% settled gel to 25% buffer. The binding buffer should
not contain agents which significantly increase the viscosity. The column may be
equilibrated with viscous buffers at reduced flow rate after packing is"
completed.

7.

For batch procedures remove the ethanol by washing the gel on a medium
porbsitY sintered glass funnel.
'.'1·

1.

After the gel has been packed as described above, elme the column outlet
and remove the top piece from the column. Carefully fill rhe rcst of rhe
column with binding buffer to form an upward menisclls :If rhe top.

to

Packing Sepharose Fast Flow gels

2.

Insert the adaptor at an angle into the column, cnsurilli:! that no air is
trapped under the net.

<t

1.

1.

Make nil tubing connecti!)n~ ill this ,t,lgC. There 11111li111l.! II huhhlc·Free
liquid connection between the colulllll alld the IHlml' ;"nl colulI1n l\IHI the
sample application systelll (LV·3 or LV·4 v;llvesl.

4.

Slide the plunger slowly down the en/limn sn tbar the iIi .. 'lhove rhe net and
in the capillary tubings is disl>\;'u:eJ hy clm:llI. V,IIvcs lin the inler side of the
column should be tUrned in all directions during this procedure to ensure
that air is removed.

S.

Lock the adaptor in position, open the column outlet and start the eluent
flow. Pass eluent through the column at the packillg flow rate until the gel
bed is stable. Re.position the adaptor on rhe gel surface as ltecess:HY.

II.

<t .'
N

o

Using an adaptor
Adaptors should be fitted as follows:

N

01

~

.

2.

De-gas the gel slurry.

3.

Eliminate air from the column dead spaces by flushing the end pieces with
binding buffer. Make sure: no air ha~ been trapped under the column net.
Close the column outlet with a few centimeters of hinding buffer remaining
in the column.
.

4.

Pour the slurry inro the column in one continuous motion. Pouring the
slurry down a glass rod held against the wall of the column will minimize
the introduction of air bubbles.
.

S.

Immediately fiJI the remainder of rhe column with binding buffer, mount
the column tOP piece onto the column and connect the column to a pump.

~

\)J

6,

0\
Ill'

4:

-

U
4:
:i

a:

Equilibrate all material to the temperature at which the chromatography
will be performed.

Open the: bottom outlet of [he column and set the pump to run at the
desired flow rate. Ideally, Fast Flow gels are packed at a constant pressure
not exceeding 1 bar (0.1 MPa) in XK columns. If the packing equipment
does not include a pressure gauge, use a packing flow rate of at least 400
cmlh (15 em bed height, HOC, low viscosity buffer).
If the recommended pressure or flow rate cannot be obtained, use the
lIiaximum flow rare the pump can deliver. This should also give a
reasonably well-packed gel.

4:

I
0.

Maintain the packing flow rate for 3 bed volumes aFter a constallt bed
height is reached.

.'

Binding
IgG from most spedes binds Protein G Sepharose Fast Flow at neurr1l1 pH and
physiological ionic strength.
As a'general method we recommend 20 I1lM sodium phosphate, pH 7.0 as
binding buffer.
The binding capacity of Protein G Sepharuse 4 F:m Flow depends on the source
of the particular immunoglobulin, see Tab/I: 3. However, the total cilpacity
drpends upon several factors, such ilS the flow nHl' during s.lmplc application,
the: sample concentration and billdin!; huffer. T.1hlt: J sllllws rhe tot,,1 C<lllacity
under defined conditions for IgG from snmc spc(ics.

~

Q
Q

I

('II

N
I
N
Q
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~

•

Table 1. The relative binding strength of ROlycIOnall~G.from various species
to Protein G and Protein A, as measured in a compe ilive ELISA test.
Protein G
Protein A
Species

Human

r
l.

,

IgG,
IgG2 '
IgG3
IgG 4

Rabbit
Cow
Horse
Goal
Guinea pig
Sheep

Dog

Pig
RatMouse··
Chicken

++
++
++
++
++
++
++
++
+
++
+
++

+

++
++
++
++
+
+
++
++
++
+

strQng binding ,
+ = medium binding
= weak or no binding
Nole that IgO from rat binds to Prolein G copuled 10 Sepharose 4 Fast Flow.
.. IgOl from mouse binds more strongly 10 PrOIein G than to Proleln A.
++,.

Table 2. Gel characteristics

ligand densily:

-2 mg Protein G/ml drained gel

Dynamic binding
capacity·:
Bead structure:'

4% highly cross-linked agarose

Bead size range:

45-165

Mean bead size:
Max linear flow i-ate:

approx. gO ~m
>1 300 cmlh al 0.05 MPs (0.5 bar) in a
XK 16/20 column, bed height 5 cm

( yolum8lrlc now rale (cm'lhl
)
column cross-sectional area (em')

Max operating
backpressure:
pH working range:
pH stability
Long term:
Cleaning-In-place:
Chemical stability:

\)J Ph3rm3cia LKB rccombin:un Protein G, MW 17000 d:llton, is produced in

;:: E coli. and contains two IgG binding regions. The albumin binding region of
native Protein G has been genetically deleted, thereby avoiding undesirable
cross-reactions with albumin.

..r;.:

0.1 MPa (1 bar, 14 psi)

2-9"
3-9'"
3-9'"
The IgG binding capacity and recovery was
maintained aller storage for:
(a) 7 days at 37°C in:
1 M acetic acid pH 2.0,
20 mM sodium phosphate, 1% SOS. pH 7.0,
6 M guandine-HC1. 70% athanol.
.
(b) 2 hours at room temperature in:
0.1 M Hel, pH 1.0,
B M Urea, pH 10.5,
0.1 M Glycine-NaOH, pH 11
Negligible volume vanation due to
changes in pH or ionic strength.

Sanitization:

Sanitize the column with 70% ethanol.

The dynamiC capacity was calculated as the amount of human IgG adsorbed
to the gel before the flow through exceeded 1"10 of the absorbance of the in
going solution. The capacity was determined at a linear flow rate of 30 cm/h
and with a sample concentration of 0.92
Protein G may hydrolyse at low pH.
Estimates to the best of our knowledge and our experience.
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PhYSical stability:
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-1 B mg hUman IgG/ml drained gel
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BTIS Specifications
I

FEATURING

CONTAINER DIAMETER

112" (13mm) 10 2·1/2- (63.5mm)
diametar Glass vials

• NO TRAY/NO LOADING

I

CONWNeR HEIGHT

1-'14" (31.8mm) 11:1 4" (101.6mm)

i

TRAYlYPE

Three-sided

TIU.VSIZE

10'" (254mm) to 20'" (508mm) wide
up to 36· (914mm) long

MACHINE SPEED

Up to 20 rows per mirwte

CONTAINERS PER MINUTE

AIMS per minute xnumber Df vial$
per raN

FEED

Laft to right

CONYE'tOR HEIGHT

32-1/2" (826mm) to 37" (940mm)

ELECTRICALS

120 V: 60 Hz; 1Ph

• AUlOMATIC ADVANCE OF EMPTY TRAY
WHEN WORKING TRAY IS FULL

'

• NO SPLASHING OR TIPPING OF
CONTAINERS

"

• VARIABLE MACHINE SPEED TO MAlCH
PRODUCTION RATES OF UPSTREAM
EQUIPMENT

. OPTIONS

NET WEIGHT

• AUTOMATIC MAKE-UP SYSTEM
ENSURES AOEQUJUE VIA,L SUPPLY

..

'"

,

I

625 b$ (284 kg)

• LAMINAR FLOW HOOD ENCLOSURE
• FEED-THROUGH CONVEYOR FOR
PROCESSING NON-L'IOPHILIZEO VIALS

.

AutomatIc 'Ray Loader
ModeI8T15 _._ - - 
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Bench..ark SO S.ri.s
Iyophlllz.r conllgur.
flons include St....
In Place (S.I.P.),
CI••n In Plac. (C.I.P.),
Aulo..at.d locking
Door, as well as a wide
variety of optlon.1
r.frigeratlon and
condenser types to
..atch any processing
r.quir....nts.

• For lyophilization equipment that
meets your production expectations
and volume requirements every time ...
for greater flexibility and more shelf
size configurations... for lyophilizers
that are designed to meet your own
special needs, turn to VirTis.
The VirTis Company understands
your needs and your frustrations. We
recognize that your requirements
aren't like those of the guy down the
street. And we have some answers.
Every VirTis BenchmarklM
lyophilizer is configured to match
your processing and production envi
ronment and requirements. For more
than 42 years, VirTis has applied
advanced lyophilization techniques
to solve difficult product preservation
problems. This gives us the knowl- '
edge and experience to meet your
needsforecquipment, technology and
post-sale valiga~on support... today,
tomorrow, an:clfuto the next century.
We're proud to support VirTis
freeze dryers with a worldwide sales
and service network extending to
seventy countries and covering
the world's largest installed base.
Whether you're producing antibiotics,
blood fractions, diagnostic, veterinary
or biophannaceutical products, we
make a lyophilization plant that
can be configured, delivered and
commissioned in less time and
withfewer headaches than you
ever thought possible.

The VirTis industrial series
extends from our Genesis"" SQ Series
for pilot runs or small scale produc
tion at 6.94 ft2 IQ,65m2} to oUI largest
standard Benchmark Plus lyophiliza- .
tion plant with 416 ft2 [38,6m2)
of usable shelf area, all built with
the same level of quality and fine
attention to detail.
l~h~,:,

WORLD~STANDARD
CONTROLlERS~JMKE

VALIDATION SIMPLE
,f ,:;,' ,

Benchmark Plus
top-down hydraulic
stoppering permits
complete shelf stock
closure for routine
cleaning. Quick-change
shelf spacing links
make it easy to change
the amount of useable
shelf area and shelf
Interdistance to
accommodate any size
produd ,container.

Window.~ j. a trod. mark 01
MJcrosoit CorporDtion.

FIX DMACS- is a trademark 01
lnt.llution,

80TH PRODUCTION
AN~ PHYSIW
If yopr facility was designed
for s1p3ller batch production, we
help you maximize the space you
have, by creating a unit with higher
capacity that will fit right in. If extra
large or small containers or variable
production runs are part of your
picture, our unique shelving system
can be easily adjusted to fit. Only
yirTis offers you a choice of economi
calround-c~bered lyophilizers, as
well as our unique square chambered
jSQj configurations for maximum
capacity. Utilizing an SQ model can
accommodate larger runs in less
space, or do with one machine what
might have required two. We'll even
build a lyophilizer designed for your
most demanding clean area size con
straints while being able to handle
your process requirements.

,~

•• ~:~~;J!!/t';f::'(

y ~~ dpn't need,~~!je'a computer: .
genius, to take advantage of VirTis's
advanCid contrcilsystems. We deliver
complettf lyophiliZation control and
documentation in a ,user-friendly envi
ronment.
:
Our VirTuoso"" ~d Maestro""
lyop~jJf~tion control systems can
handie:ev'
' ..
. 'HT'-;"'~ery detail of your complex
.c~tOd~ Cycle with complete accuracy
ah~ (!pll complement of safeguards.
A Wm.~ows~~basedoperati.ng system
coupled with the powerful Intellution
FIX DMACS'" supervisory package
guarantees the system is extremely
easy to use, simplifying the process
of meeting validation requirements.
An Allen Bradley PLC- based system
provides you with proven performance
hardware for unparalleled reliability.
An IBM PC- compatible computer,
SVGA color monitor and color printer
furnish clear, vibrant display, graphi
cal trending and solid documentation,
backed by worldwide support.
VirTuoso and Maestro let you safely
implement complex drying cycles
with all the benefits of thermal treat
ment, pressure rise and validation
testing. Sophisticated VirTuoso cou
pled to one of our Benchmark SQ
or plus Series lyophilizers, easily
automates your lyophilization and

sterilization cycles, vacuum control,
barometric end Point-'detewon, auto- .
maticcfdfro~t:in& el:ltt;cticeontrol and
monitoring and aU:t~~ti~'validation
",.
"l',<rZ""'"
testing of all systems
subsystems,
as well ~ccomn:iOdating steam .....
sterilization andc6Z;troI'of product· :
profile <;Y21es.
.'
,f/~Both systems include multi-level
"~;p~~sword protection to safeguard .
,~sensitive information and prodll:cts; .
report generatbr for hard copyd~tail- .'
ing all aspects of your lyophilization
cycle,~d an easy-to-use historical
trending package with zoom control.
An extensive defense system provides
total product and equipment safety.
And an inexpensive optional remote
View package allows complete net
work or off-site monitoring and
control with guarded password
protection.
"~;

as

and

PURITY AND INTEGRITY
THAT GO BnOND
FDA STANDARDS
To ensure performance that will pass
the scrutiny of any regulatory agency,
we build each VirTis lyophilizer to
meet stringent 150-9001 certification
and current good manufacturing
practices icGMPI. Every VirTis system
is extensively factory-tested to verify
critical design and performance para
meters, and we not only invite but
encourage you to visit during manu
facturing and final qualification testing.

"3SY

.Left: VirTuoso and
M..stro PLC·based
- systems oRer
.Itimate In product
.syste.. protection.
validation
testing·
provide
tloc.mentedperfor~ '.
all malorIYs~'
..bsystellis.
..U..,.!rr.....lyWindows·
·;:bas.ahitellution FIX
~",,;{\~; DMACS lIIakes·the IIIOSt
'. ';ji~colliplex and demanding

'~'~f'pharmaceutlcalsj9-_

proCe.sin! '-

Below:
Plus Series In one
of lIIany possible
(onfigurations.

,..

Abov.: Call1••tlz.d
mid-rag. a••chmark
I,ophillz.rs are the
most ft• .:"" pilot
plant and produdion
l,ophUizers ev.r
produced, with the
shortest delivery ti....
In 'h. indus.ry_ Bulk
and vial processing
..odels are available
wi'. usabl. shelf areas
up to 48ft' (4.5.. 2),
and sh.lf processing
t...peratures INti0w
-70"C. Ov.r 100
available options
suit all processing
, r...uir....nts aad
space constraints..
Right: Sa..pl. J'hief
si..plifi.s the
opIi..lz~tion process
b, allo~ing ....pl.
remova'.wit.oa'
" .breaking' ,~~,cI

•.

\:;::2";c,

, " oUr trained field engineers assist

WE WON'T ABANDON
YOU AFTER DELIVERY
What is your most problematic stage'·
of installing a new system? If it's
getting your new equipment up and ">
running, be assured that our Start Up
Assistance Programs are designed
to provide operator training after
verification of your critical perfor
mance parameters. By working
with your engineers, operators and
maintenance staff, we can guarantee
a timely and efficient start-up of your
system, and support for the long life
of your equipment.

355

YOui~alidation staff with the system

.

testing and documentation required
.during the installation qualification
and operational qualification stages.
., And; we'll train your staff to make
· . m:~house routine maintenance easier
throughout the long life of your capi
·.' tal investment. Validation Assistance
Workbooks consist of an extensive
· series of documented tests designed
to audit system performance and
clearly define product processing
parameters.

Max. Number of Shelves

6

6

6

6

Max. Shelf Area: ftl (m2)

16.0(1.48)

16.0(1.48)

25.0(2.32)

1.891481

1.89(481

Min. Number of Shelves

3

Min. Shelf Area: ft2 1m2)
Shelf Interdistance at
Min.: in (mml

I

8

8

15

25.0(2.321

4S.014·46)

4S.0(4.46)

90.0(S.4}

78.0(

2.5(63)

2.5(63)

2.16(54}

2.16{541

1.(8142)

2.40i

2

3

2

3

3

6

8.010.74)

5.3(0.491

12.511.16)

8.310·m

18.0(1.6n

18.0{1.6n

36.0(3.341

24.012

4.28(108)

6.68(169}

5.5{1391

8.512151

6.59i16n

6.59116n

4.67(1181

8.8{2:

Shelf Size: Width in from)
Length in (mml

16(411
24161)

16(41)
241611

20(51)
30(76)

20(51)
30(76)

24(61)
36(911

·24(61}
36(91)

241(10)
36(915)

24(61
36(91

Refrigeration System Data

SL

SL

SL

SL

SL

SL

Standard System
Shelf Temp °C

-55

·55

·55

·55

·55

Condenser Temp °C

·70

-70

·70

-70

Standard Condenser Capacity
in 24 hours: liters (type)

20.0\Ext.)

20.0(Ext.)

34.0\Ext.}

34.0IExt.'

Optional Condenser Capacities
in 24 hours: liters (type)

14.0IExt.J

14.01Ext.J

20.0flnt.)

20.0flnt.)

Shelf Interdistance at
Max.: in (mml

I

I

I

1<

4

SL

SL

·55

-55

·55

·70

·70

·70

-70

42.0(Ext·I

42.0\Ext.)

100.0IExt.,

65.01Ex

34.0IInt.1

34.0flnt.)

50.O(Int.)

50.01In

64.O{Ext.J

64.0\Ext.]

65.0(Ext.)

100.0(E~

150.0(Ext.)

1S0.01b

D

o

THE BENCHMARK PLUS SERIES
WITH LOADING AND UNLOADING CART

3 S \..o

26

:W

336.0(31.2)

168.0(15.7)

416.0{38.6)

240.0(22.42)

2.40(60)

1.80(46)

2.5(63)

1.80(46)

2.5(63)

6

4

9

4

12

6

72.016.72)

36.0(3.34)

24.0(2.23)

144(13.4/

48.0(4.48)

192.0(17.81

72.016.721

4.351110)

10.0(255)

4.67(1181

8.8{2251

0(1171

10.6(2701

4.35(1101

10.0(255)

36(914)
4811220)

2x,24(6101
2x,48{l220)

36{9141
4811220)

24(610)
361915)

24(610)
36(915)

2x,24(610)
2x,48(1220)

361914)
48(1220)

2x,241610
2x,48(122D)

36(9141
48112201

LL

LL

LL

LL

SL

SL

LL

LL

LL

u..

·55

-55

-55

-55

-55

·55

-55

-55

·55

·55

-70

-70

·70

-70

-70

·70

-70

·70

-70

·70

I.OlExt.)

120.0[Ext.1

3OD.0IExt.,

220.0[Ext.l

lOD.O(Ext.)

65.0(Ext.)

220.0(Ext.,

120.0(Ext.j

i.OlInt.)

100.0(Int.)

220.0(Int.)

2OD.O(Int.)

50.0IInt.)

50.0(Int.)

100.0IInt.)

lOD.O(Int.)

220.0lInt.,

200.0lInt.'

I.O(En.,

220.0(Ext.)

3OD.0IExt.)

300.0(Ext.)

65.0IExt.)

lOO.O(Ext.,

120.0(Ext.)

220.0(Ext.)

3OD.O(Ext.)

3OD.OIExt.)

1.0IExt.)

3OD.0(Ext.)

450.0lExt.,

450.0(Ext.)

150.0(Ext.)

150.0(Ext.)

300.0(Ext.,

300.0lExt.,

450.0IExt.,

450.0(Ext.,

600.0lExt.)

600.alExt.,

600.0lExt.,

6OD.O(Ext.)

.0(22.3)

416.0(38.61

240.0(22.42)

90.0{8.4)

2.5(63)

1.80(46)

2.51631

1.68(421

4

12

6

2(10.41

48.0(4.48)

192.0(17.8)

011091

10.6(2701

24{610)
8(1220)

30(461
7

220.O(Ext.'

.,

THE. BENCHMARK SO SERIES
CONSTRUCTED ON AMONOBLOCK FRAME

3S1

VirTil B.nchmark
S.rl.1 L,ophDiz-.rs
can be conllrucl•• on
vlrtuall, any lingl. or
.ultipl. frame cOIlfigu·
ralion r.qulred b, Ih.
eusto••r, alld all are
availabl. In .Ith.r
square cha.....r or
round cha.....r .0d.ll.

'j

Once a unit has been
validated and brought
up to a full production
schedule, VirTis
continues to back
up its customers. A
worldwide network
of sales and senice
support provide a
full range of post-sale
assistance.
Lyophilization and
service support
seminars, maintenance
and performance audit
contract programs,
and a 24-hour hot-line
are designed to keep
production on schedule.

>.~-,}

Finishes.

... ' ,

.}j·j~'Heat1JransferSistems·

Benchl:naIk lyop~r
product"
'p'
Benchmark
incorporates an~extreme.',-.
"·',;;·A:;,<
,"
(
"C:;,,;:-x
chambers; condensers .and,product
.
Iy efficient.. silicone heat traIiSfer
, ,'...'
shelves 3ie'engmeered of pliiiIriia: ;,
system that can provide Unlform
'~tica1'grade #4, IRA V~ue l~s f;:~
temperatures from;7.,O"C to +65"C.
';>;~~~~J1~.;han~5'IDi~o in~h~~i~~t~~sli", . . • 7;jyvitI:.ei*~r th~:;t;'ridard manual
::·'·'~1.~;~\l"ith welds giqun~ smpoth ~<i.fJ:ush<"'ik;t~·· cOI!tr()l ,!&stem or ()Ur optional
YfrTh6s6or Maestro systems, you
, --';Mirror finish ~ielectropoli;hfug'?
is optional.
",:,,;,
,
cifu.
easily ~hieve shelf temperature
.... ,';.
'r"
'~"
cbntrol
of +1-l"C. .
.,'¢':
-:'~~".--"2.',

~c

_:-,,-~

;,,,.~~,*j.-.-

~-+~'4",;,"-"'~'~~~"~"~';i!'f

}d~

.

('~,

~M-~'

-,~

,~\3,'~_:;~.

".:2~:":--'
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Automated Controls
For the "hands-off" operation that can
save you time and money, Benchmark
Plus and Benchmark SQ Series
lyophilizers can be equipped with
our optional VirTuoso or Maestro
PLC-based control system. Use
them to control every detail of
your lyophili.zation cycle, including
thermal treatment, precise vacuum
control, primary and secondary
drying, pressure rise barometric end
point detection and validation testing
of systems and subsystems.

Durable Vacuum Components
All vacuum componen~ are selected
for long life and leak~fr~eoperation,
with vacuum
.dqwri times that
meet the most presJirii processing ..
or product schedule. All connections
and piping are resistant to metal azide
formation. The optional Maestro or
VirTuoso automated control system
tests leak rates automatically. We can
also equip Bencmna.rk systems with
optional'standby vacuum pumps,
chemidifrJsistarlt pumps, oil filtra
tion ~androots blower packages.

punip:

Sterili~~gn Systems

Benc~:U:k!s optional steam steriliza
tion system incorporates an efficient
multi-evacuation heat-up cycle and
sterilization system rated and docu
mented to meet ASME vessel code
at 25 PSIG. Higher coded pressure
vessel ratings are available upon
request. A rapid cool-down option
improves turn-around time. A variety
of optional gas sterilization systems
are available.

R.dundant ..anHI
b.ckup controls
or sop.isticat.d
'Le-based ••to..at.d
conlrols deliv.r
consist.nt produd
•••llty d.ring
lyopbOmalloa,
provldin•••I....llon
of re..'d"!~,~.ppor.
'. cycles. SpeCi.r.··
p.ssw.~~jlrotecl.d

r...o•• ·•.••llorln.
syst. .s updato
operators on sys....
status constanlly, at
t••ir conv.nienc••

""'--

.BENCHMARK SQANDPLUS'SERIES .BULK

DRYINGLYOPHILIZERS~?~;t.

.Series/Bulk .,. ' . , 14000 SQc"lu~;~~'SOOo Plus" ·.·;'''r:~j;;"'~~#~·5000 SQ~'\6000SQ; Plui~;
24x36/(610x915)
Shelf Stack: 2 - 24x48 (610 x 1220]
Shelf Size in Imml
I
6 Shelf: ft2 \ro2) I dearance: in (mml

36 (3.31/4.6711181

7 Shelf: ft2 (m2) I dearance: in (mml

42 (3.91/3.96 (100)

8 Shelf: ft2 (m 2) I Clearance: in (mml
9 Shelf:

ft2(m 2J /

dearance: in (mml

-

li2 (10.4114.30 1109)

-

48 (4.5113.43 (87)

128 (1 L9J13. 70 1941

-

i

-

-

54 (5.0)/3.01 (761

144 (13.41/3.25 (831

144113.4j/4.60 (1171

10 Shelf: ftl \ro211 Clearance: in (mm)

60 (5.6}l2.68 (68)

160 {14.9JI2.90 (731

160 (14.9)/4.11 (104)

11 Shelf: ftl \ro2) I Clearance: in \rom)

66 (6.1}12.41 (611

176(16.4/12.60 (66)

176 (16.4)/3.711941

12 Shelf: ft2(m 211 Clearance: in Imml
13 Shelf: ft2 \ro2) I Clearance: in lroml

72 (6.7)/2.18 (551

192117.8]12.35 (601

192 (17.8)/3.38 (85)

192 (17.8)14.35 (1101

78 {7.3)/1.99 {SOl

208 {19.3]12.15 (541

208 (19.3j/3.09(78)

208 (193)/4.00 (1011

14 Shelf: ft21m 2) I Clearance: in lroml

84 (7.8)/1.82146)

224(20.8)11.95(50)

224 (20.8)/2.85 (72)

224 (20.8)/3.65 (93)

15 Shelf: ft2 (m2) I Clearance: in lrom)

90 (8.41/1.68 (42)

240 (22.3)/1.80 (46)

240 122.3)12.64 (671

240 122.3j/3.40 186;

16 Shelf: ft2(m 211 Clearance: in lroml
17 Shelf: ftl/m21I Clearance: in (mm)
18 Shelf: ft2(m 2) I Clearance: in \roml
19 Shelf: ft2 (m 2) I Clearance: in lroml
20 Shelf: ft2 (m211 Clearance: in {roml
21 Shelf: ft2 (ro211 Clearance: in (mm)

-

-

256 (23.8)/2.45(62)

256123.8)/3.15 (80)

272 {25.31/2.29 (58)

272 (25.3)/2.95 (751

-

-

288 (26.8)/2.151541

288 {26.8)/2.80 (701

23 Shelf: ftZ(m2) I Clearance: in (roml
24 Shelf: ft21m211 Clearance: in (rom)

-

25 Shelf: ftl(m211 Clearance: in \rom)
26 Shelf: ft21m21I Clearance: in lmm)

-

Model
Shelf Size in (=1
4000 SQ, 4000 Plus
24 x 36 (610 x 9151

-

-

22 Shelf: ft2[m2) I Clearance: in froml

-

304 (28.2)12,02151)

304 (28,2j12.60 (661

-

320129.7111.901481

320 (29.7)/2.45 (621

-

336(31.21/1,80 {461

336 (31.2)/2.30 (59)

-

-

352(32.7)12.2.0 (561

-

-

368134,2}12.10 [531

-

416(38.6)/1.80 (46)

-

384(35.7112.0 (50)
400 (37,21/1.90 (481

IOmm Bulk Depth
[Litersl

12rom Bulk Depth
ILiters)

15rom Bulk Depth
(Liters'

20mm Bulk Depth
[Liters)

5.34

6.36

7.98

10.62

14.24

16.96

21.28

28.32

14.24

16.96

21.28

28.32

5000SQ,

Benchmark 4000 SQ
And
Benchmark 4000 Plus Models

Benchmark 5000 SQ
And
Benchmark 5000 Plus Models

Condenser Configurations

I

Liters in 24 Hours
(Compressor Sizing)
[Condenser Area]

Liters in 24 HoUl'S
(Compressor Sizing)
[Condenser Area)

Standard Internal

I

50 Liters
(One20Hp)
[21 Square Feet]

100 Liters
(One 30 HpJ
[50 Square Feet]

65 Liter
IOne20Hpl
[35 Square Feet]

120 Liters
(One30Hp)
[60 Square Feet]

100 Liters
(One 20 Hpj
[60 Square Feet]

220 Liters
trwo20 Hp)
[120 Square Feet]

Standard Stoppering
External
Standard Bulk External

I
I

I

Benchmark 6000 SQ
And
Ilenchmark 6000 Plus Models
Liters in 24 Hours
(Compressor Sizing)
[Condenser Area)
200 Liters
trwo20HPI
[100

I

(Two 30 Hpl
[160 Square Feet]

Heavy Duty External

I

150 Liters
(One30Hp)
[80 Square Feet]

300 Liters
trwo30Hp)
[160 Square Feet]

450 Liters
trwo30Hpi
[250 Square Feet]

Extra Heavy Duty External

I

Consult Factory

Consult Factory

600 Liters
(Three 30 Hpl
[320 Square Feet]

?,I.,;)C

I
!

,;,;j;1;'XVIRTlS,BEHCHMARKSQAND PLUS SERIES STOPPERING LYOPHILIZERS .'

"~if~:S.r~.sIS,~ppering::I:i:ikj~ %;.itt.~;; ":~~~~ooo,~;~'~~:~';>~~?~';>'r"
Shelf Size in Imml
4 Shelf: ft2 (m2)
Clearance: in Imml
5 Shelf: ft2 1m2)
Clearance: in !mml
6 Shelf: ftllm 2)
Clearance: in (mm)
7 Shelf: ft2 (m2)
Clearance: in (mm!
8 Shelf: ft2jm2)
Clearance: in Imm)
9 Shelf: ft2 (012)
Clearance: in Imml
10 Shelf: ftllml )
Clearance: in (mm)
11 Shelf: ft2 (m2)
Clearance: in Imm)
12 Shelf: ft2(m2)
Clearance: in (mml
13 Shelf: ft2(m2)
Clearance: in Imml

36x48 (915xI220)
48.0 (4.481
10.61270)
60.0 (5.61)
8.4 1210)
72.0(6,72)
6.8(170)
84.0 (7.851
5.8(145)
96.0 (8.971
4.9(125)

54.015.051

108.0110.09J
4.1(110)
120.0 (11.211
3.8 [951
132.0 (12.34J
3.4 (851
144.0113.451
3.0(75)
156(14.58)

3.61921
60.0 [5.61)
3.3(82)
66.0 (6.171
2.9(72)
72.0 (6.72)
2.6(65)
78.017.28)
2.4(60)

,

;

'.

'

~~:

6000

-

-

-

-

-

(

108.0 110.~~
6.41163)
120.0 (11.21)
5.71145)
132.0 (12.34)
5.1(130)
144.0 (13.45)
4.6 (llS)
156.0114.58)
4.2 (lOS)
168.0115.70)
3.9(100)
180.0 116.821
3.6[901
192 (17.941
3.3 (851
204(19.06)
3.01751
216120.18)
2.8(72)
228.0 (2.1.3)
2.6(651
240.0 (22.42)

-

2.51631

15mm
Dia

23=
Dia

25mm

Dia

Dia

"Dia

43=

52mm
Dia

2598

1050

858

540

294

198

5000 Plus
x 1220)

5196

2100

1716

1080

588

396

6000 SQ, 6000 Plus
36 x 48 (914 x 1220)

5196

2100

1716

1080

588

396

5000
36x

,

72.0(6.72)
10.0 (255)
84.017.85)
8.51215)
96.018.97)
7.31185)

-

-

"

-

2.8 (701
168(15.70)
2.5(631

-

.

36x481915x12201

-

Clearance: in lmm)
17 Shelf: ftl 1m2)
Clearance: in Imml
18 Shelf: ft2(m~
Clearance: in Imml
19 Shelf: ft2 {m 21
Clearance: in (mml
20 Shelf: ftl (m2)
Clearance: in (mm)

4000SQ,
24x36

~;~,,~~~

""".,~,,,"

24x36 (610x9151
24.012.23)
8.8 (225)
30.0 (2.79)
7,0 (1751
36.0(3.34)
5.7(145)
42.0 (3.90)
4.81120)
48.014.461
4.2(105)

Clearance: in (mml
15 Shelf: ft2(m21
Clearance: in (mm)
16 Shelf: ft2(m2)

Stoppering Model
Shelf Size in !mml

.. ."".";....

Generic tPA

Appendix D

Equipment Design for pumps in Separation Section
UF1 Pump
Pressure required at inlet of UF1
F:= 1825.47·

Ib

Flow through Pump

FT

P :=63.72'~
ft
~

:= 0.80

= 40 psi

dP :=40'psi- 14.7·psi

Density of Water

dP

25.3 "Psi

Pump efficiency

Sizing the Pump:
Size:= F. dP
P

Power := Size

Hours per year:

:=~
P'g

:= 7920·hr

Power = 49.135 W

~

Head

t

Size = 0.053 ohp

Electricity := Power·t
Head::= 57.175oft

3l92.

Electricity

= 389.149 okW·hr

Generic tPA

Appendix D

UF2 Pump
Pressure required at inlet of UF2
F:=

1325.~

Flow through Pump

Ib
p := 63.72·-;:]
ft
11 :=0.80

Density of Water

=40 psi
Pressure Drop over filter

M> :=40·psi- 14.7·psi
M> = 25.3 "Psi

Pump efficiency

Sizing the Pump:

.
M>
SIze:=F·
p

Hours per batch:

t := 7920·hr

Size::: 0.084 ohp

Size
Power:=
11

Power::: 78.626 W

M>
Head :=
p.g

Head::: 57,1 750ft

Electricity := Power·t
Electricity", 622.718okW·hr

AppendixD

Generic tPA

MF Pump
Assume an average pressure drop over the microfilter of 20 psi
F :=

1135.6.~

P :=63.72'~
ft
11 :=0.80

Max flow through filter
Pressure Drop over filter

Density of Water

M> := 20'psi

Pump efficiency

Sizing the Pump:
Hours per batch:

Size:= F.M>
P

Size

Power:= Size
11

Power = 53.27 W

Head

:=~

t := 7920·hr

0.057 ohp

Electricity := Power·t
Head = 45.198oft

P'g

'3 lJ>'-\

Electricity

=421.901 okW·hr

.....
Generic tPA

Appendix D

Impeller Power Calculations for Separation section:
Assuming all impellers run for 7920 hrs/yr
7920 is about 400 hrs more than the most used tank (FD Tank)
t :=7920·hr

Power requirements fo large tanks (4000-5000 L): 10 hp
P large:= IO·hp
UFlTank := P large·t

Holduptank := P large·t
Holduptank

= 5.906·10 4O\CW·hr

UFlTank

= 5.906·\04okW·hr

Power requirements for smaller tanks (300-500 L): 5 hp
UF2Tank := P smalrt

P small := 5 ·hp

UF2Tank = 2.953·I0 4okW·hr

Process incll!des two of each of these tanks:
AffinityTanks := 2·P smaWt
AffinityTanks

= 5.906·I04O\CW·hr

FDTanks := 2·P small· t
FDTanks

= 5.906·I04okW·hr

ERTanks :=2·P smaIl·t

MFTanks :=2·P smalrt

ERTanks = 5.906·I04okW·hr

MFTanks = 5.906·\04okW·hr

Total := Holduptank + UFI Tank + UF2Tank + AffinityTanks + FDTanks + ERTanks + MFTanks
Total = 3.839·10 5okW·hr

383900 kW"hr/yr required for Separation Impellers

_
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Equipment Design for water purification Section
Powerfor Pump #1 P-1 (10 Micron Filter Pump)
Pressure Drop over the first ultrafilter: 10 psi

=

Water flow through pump 9.17 gal/min = 73.55 ft"3/hr. We can calculate F by multiply flow
rate in ft"3/hr with water density in Ib/ft"3
F :=4688'

lb

Pressure Drop over filter

Flow through Pump

m

Pin := 14.7 ·psi

Ib

p := 63.72':3
ft

Density of Water

Pout :=(10+ 14.7)·psi

Pump efficiency

11 :=0.80

AP :=P out- Pin

AP::: lOopsi

Sizing the Pump:
Size :=F.

liP

Size

0.054ohp

p

Size
Power:=

Power::: 49.875 kg·m 2 ·sec 3

Power = 49.875 W

11

Hours per batch:

t

:= 8000·hr # of batches:

Electricity := Power·t

Electricity = 399 o kW·hr

Power for Pump #2 P-2 (Carbon Filter Pump)
Pressure Drop over the carbon filter: 12 psi

=

=

Water flow through pump 5 gal/min
40.1 ft"3/hr. We can calculate F by multiply flow
rate in ft"3/hr with water density in Iblft"3

F := 2555'

Ib

m
lb

p := 63.72':3
ft
1]

:= 0.80

Flow through Pump

Pressure Drop over filter
PI := 14.7·psi

Density of Water

P2 :=14.7·psi+ 12'psi

Pump efficiency
liP

120psi

Generic tPA
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Sizing the Pump:

Size := F. LlP

Hours per batch:

Size;. 0.035ohp

p
Power := Size

Power;. 32.619 kg.m 2 .sec 3

11
Head

t := 8000·hr

Electricity := Power·t

:=~

Head:: 27.1 190ft

p.g

Electricity :: 260.95 okW·hr

Power Pump #3 P-3 (Water Softener Pump)
Pressure Drop over water softener: 10 psi

=

=

Water flow through pump 20 gal/min
160.42 ftA3/hr, We can calculate F by multiply flow
rate in ftA3/hr with water density in Ib/ftl\3

F:= 10222'

Ib

PI := 14.7·psi

p :=63.72'~
ft
1]

:= 0.80

Pressure Drop over filter

Flow through Pump

hr

Density of Water

P2 :=14.7·psi+ 10'psi

Pump efficiency

LlP := P 2 - P 1
LlP:: lOops;

Sizing the Pump:

.
LlP
S lze :=F·

p

Power := Size
TJ

Head

:=~
p.g

Hours per batch:

Size

t := 8000-hr

=0.117 ohp

Power:: 108.751 kg.m 2 ·sec- 3
Electricity := Power-t
Electricity :: 870.004 okW ·hr

Head = 22.599oft

2

3-. 0
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Reverse Osmosis System
The manufacturer give the power requirement for the Reverse Osmosis Pump

Power := 1.5·hp

Power = 1.119.103 kg·m2 ·sec- 3

Hours per batch:

t :=8000·hr

Electricity := Power·t
Electricity = 8.948.103 okW ·br

Power for the UV Light System
From the Manufacturer, the power required for the UV lamb

Power := 0.021

kW

if running the light

t

:= 8000

hr

Electricity := Power·t
Electricity

168

kW*hr

3

31

\

Generic tPA
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Power for pump #4 P-4 (UV system pump)
Pressure drop across the UV system : 5 psi
Water flow through pump = 6 gal/min = 48.125 fti\3/hr, We can calculate F by multiply flow
rate in ft"3/hr with water density in Ib/ft"3
F :=3066.5·

Ib

Flow through Pump

nr

Pressure Drop over filter
Pin:= 14.7·psi

p :=63.72'~

Density of Water

Pout :=(5 + 14.7)·psi

ft

11 :=0.80

Pump efficiency

,u> :=P out- Pin

,u> = 50psi

Sizing the Pump:
Size :=F.,u>
p

Size = O.017 ohp

Power := Size
11

Power = 16.312 kg.m 2 ·sec- 3

Hours per year:

Power = 16.312 W

t := 8000·hr

Electricity := Power·t

Electricity

= !30.496okW·hr

Power for pump #5 P-5 (0.2 micron filter pump)
Pressure drop across the filter: 10 psi
Water flow through pump = 8 gal/min = 64.17 ft"3/hr, We can calculate F by multiply flow
rate in ft"3/hr with water density in Ib/ft"3
F :=4088.7·

Ib

nr

p :=63.72.1~
ft
11 :=0.80

Flow through Pump

Pressure Drop over filter
Pin:= 14.7·psi

Density of Water

Pout :=( 10+ 14.7)·psi

Pump efficiency

,u> :=P out- Pin

4

312

~~~~----~~-~~~~~
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Sizing the Pump:

Size = 0.047ohp

Size:= F. M>
p

Size
Power:=

Power

11
time running

t := 8000·hr

=43.499 W

per year

Electricity := Power·t
Electricity = 347.993 okW· hr

Power for pump #6 P-6
Pressure drop : 20 psi

=

Water flow through pump = 5 gal/min
40.1 ftA3/hr, We can calculate F by multiply flow
rate in ft A 3/hr with water density in Ib/ft A 3

F :=2555.4·

Ib

Flow through Pump

lIT

Pin := 14.7·psi

Ib
p := 63.72·-:::J
ft
11 :=0.80

Pressure Drop over filter

Density of Water

Pout :=(20+ 14.7)·psi

Pump efficiency

LlP :=P out- Pin

Sizing the Pump:

Size:= F. M>
P

Size

0.058 ohp

Size

Power:=

Power

11
time running

t :=8000·hr

per year

Electricity := Power·t
Electricity

=

434.985 okW ·hr

5

313

= 54.373 W
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COMPLETE WATER TREATMENT SYSTEM
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AmeriWate~s complete wate'r treatment system is designed to be simple to install, 1'\11 components
are equipped with hosing a.,d quick connects so that r.he system c<'.n be easily joined tov.ther. ()1l11
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REVERSE OSMOSIS SYSTEM*
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tf,v11
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r

4000 polyethylene, horizontal holding rank, 95" dia. x 140 high. Includes
inlet/outlet mercury float switch with plug in cord and ca.1i locks for easy ~on
nection.
11

REPRESSURlZATION SYSTEM
ModeJ LB·5 stainless steel pump, 115 volt. Provides flow tip to 30 GPl\L

-

DelO"Ylizvz...

vI'

Fr If''~ ,7 INVESTMENT

$ 55;.00

price does

To prevent bacteria grO'\'N'th in the holding t2nk, we recommend that you keep the water
recirculating through 211 ultra violet light system. The price fer this option is as follows:
$850.00

Relief Valve
Interconnecting Piping
Spray Ball A~sembly

$ 82.00
$225.00
$260.00

TOTAL
,

$1417.00

'\' -

.../

~

$ 3,554.00"
Plus freight

RECIRCULATION OPTION

UV System - 7 GPM
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*Product flow rate varies with temperature. All m.odels are rated at 77 degrees!
with feed water of 1500 mg/l NaCl @ 200 PSI and pH of 7.5
OUf

f

0J
f~
$ 7,434.00
dl...!.

$1',595.00

;'*Holding tank \'rill be drop shipped from the manufacturer.
not include freigbt.

I V

$ 1,515.00

Model IR02. 220 volt system is capable of producing up to 4,600 gallon3 per
day. Includes two rnode14" 40 high output memDr'MleS and p9l'ticulate tiltt:r.
( \ bOO c> L).
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HOLDINGTANKA7~1
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$ 4,537,00

,;"

;;.

,-'

("'J::'"

0

"",:..'"

,..

!

~

~

[ill]

~~

i

~

§...
:3

~

""'"'

:h ~~
-+

~
""I
,-.,f)

i!;

Si

........,
,

ai

3"1'5

it
!!i

-_._""

.--.

.

Technical Question - Your E-mail, 28 Feb 00

Subject:
Date:
From:
To:

Technical Question - Your E-mail, 28 Feb 00
Wed, 1 Mar 2000 09:01:35 -0600
"Lewis, James" <JLewis@osmonics.com>
'"kasidit@seas.upenn.edu''' <kasidit@seas.upenn.edu>

Dear Mr. Nootong,
Thank you for
regarding Osmonics' Pleated Filter Cartridges.
For
any of our cartridges, we recommend a maximum flow rate of 5 gpm/Ten Inch
Equivalent (TIE) length.
Thus, a 20" long cartridge would have a maximum
flow ra~e of 10 gpm.
The maximum can be reduced by other factors such as
the micron rating of the cart
, the solution viscosity and available
pressure drop.
When we size a housing for a given filtration, typically we would include
enough TIEs to keep the initial differential pressure at 2 psid or less.
For the 'Flotrex-AP021 cartridge this rate would be 5 gpm.
For the
Memtrex-FE921, this rate would be about 3.5 gpm.
In each case, a fluid with
a viscosity of water was assumed.
The data necessary for these calculations
is available on ou website, osmonics.com.
Please let us know if you have further questions.
project.

Good luck on your

Best regards,
Jim Lewis
Application Engineer

3lLP
10fl

4/19/00 10:50 PM

Ameriwater: Water Treater Senes

Am eri\\:'atcr"

.........If''',,'

Industrial

Water
Treaters
Series
• Softeners
• Dealkalizers
• Filters

Softening
Water softening cation sodium form resin
Ultra high exchange capacity, better than 8% cross linked gelular,
strongly acidic. cation exchange resin. Very good kinetics, excellent
stability at elevated temperatures and good chemical resistance over a
wide pH range.

Model

WTTS 16
WTMS 16
WTTD 16
WTTS24
WT MS 24
WTTD24

Mode

Timer
Meter
MeterlAlternating
IIIIUW.II
Timer
"l~iUII
Meter
MeterlAlternating~!2f~lff!~
RmmiLi-~'~;-i,j&!t

••
40
40
40

80
80
80

Dealkalization
Water Dealkalization Anion Chloride Form Resin
Very effective for the reduction of bicarbonate alkalinity. Type II gelular,
strongly basic resin in the chloride form gives high capacity and good
leakage characteristics.

3"
10f4
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Amenwater: Water !reater :Senes

WySIWyg:l! lL.OfHllp.Ji W

Model

WT TS 16D
WTMS 16D
WTMD 16D
WTTS 24D
WTMS24D
WTMD24D

Meter
Timer
Meter
Meter

i~ll:¥?Jlj~~!ki
~!~:I~~1!1~li1W~!~

'+""""'!l!1I'I'lJHIIWY"'''''p'

lil!~1fi~:l:)1~1i~'~'(iF"tiH
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50

~1!l.T~~1:r~

100
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7' __ , __ _
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20
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40

~.~I~u~~~~I~
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~;fh~~~l~$j

~"'n':::B'tlIi"'''i\g"

:~1ij~!~~~,~~lii~
l;'ij;lfl~Kg~~i~;

Ci:gG'iff'lOO;)l:
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ni:il~QIiI~ilm

Filtration
Activated Carbon
Made from select grades of bituminous coal to produce a high density.
durable granular product capable of withstanding hydraulic loading, back
washing, and mechanical handling. Abrasion #80, Iodine #950,
Backwash 8-10 GPM/sq.ft.

Sediment filter Ag
Ag granuals have irregular surface characteristics for maximum removal
with less pressure loss. Requires less backwash water. Backwash 8-10
GPM/sq.ft. Removal down to 15 microns.

Manganese Greensand
Capable of removing iron, manganese and hydrogen sulfide from water
through oxidation and filtration. Feed of chlorine or potassium
permanganate will continue the oxidation process. Backwash 10-12
GPM/sq.ft. Iron limit is 15 PPM.

MultiwMedia
High quality quartz sand and gravel in layers provides for excellent
particulate filtration. Backwash 10-12 GPM/sq.ft. Removal down to 20
microns.

Model

WTTS 16A
WTTS24A
WTTS 16 C
WTTS 24 C

Timer
Timer

WTTS 16M

Timer

WTTS24M

Timer

WTTS 16G

Timer

WTTS 24 G

Timer

318
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Ameriwater: Water Treater Senes

One versatile system for softening, dealkalizing, and filtering applications
The AmeriWater Water Treaters Series of equipment is designed specifically for the
water treatment professional. We offer a variety of sizes and media to meet the needs
of your industry. Whether you need a softener, dealkalizer, or filter, you~1I find our
pricing to be very competitive, without sacrificing quality and durability.
Modular Cartridge design
means anything you need to
change, clean or service is 1--11d6i
right up front.
Light",eig~ corrosion resistant

Noryl construction allo\>ls
for easy I nstallation and 10l'lg
service life,

1-----1

Versatile controls avai lable
............- - -... in meter I nitiated electronic
ti mer ,or mechanical 7-day
timer .

........- - 1 full size porti ng on all

Tank inner shell constructed
of polyethylene. Outer shell 1 - - - 
\>Iound \>lith conti nuous
fl berglass to provide
superior strength under
pressures of up to 150 psi.

mal n flo\>l paths permits
high service flo\>l and
back\>lash rates,

Ultra High CapaCity Water
Softener Resins; provide
superior service runs and
longer life.

Heavy-Duty polyethylene
Brine Tank Illcludes brine
\>lei I , ai r check and
ove rfl 0\>1 safety shut off.

All systems can be moved
easi lyon a hand truck.

Options include bypass or no bypass water during restoration
and PVC or threaded brass installation adapters

2" Control with
meter initiated
electronic timer

1 112" Control
with
mechanical
7-day timer

Water treaters series configurations

Water Softener or Dealkalizer Single Tank System

30f4

411910011:32 PM

SYBRON CHEMICALS INC.
SYBRON CHEMICALS INC.
BIRMINGHAM ROAD, P,O. BOX 66, BIRMINGHAM, NEW JERSEY 08011 (609) 893-1100

IONAC C-249 is a premium quality cation exchange resin capable of meeting the most exacting requirements of both
household and commercial water softeners and suitable for treating even potable water. Extremely low fines content, high
operating capacity and excellent physical quality make IONAC C·249 • A PREMIUM PRODUCT AT STANDARD COST.

IONAC C·249 is a bead·form. standard crosslinked.
polystyrene sulfonate cation exchange resin, posses·
sing high cation exchange capacity, combined with
excellent stability and operating characteristics. It con
tains a minimal amount of "fines" (-50 mesh) thus
showing low pressure loss effects.

u. S,
Standard Mesh

Size mm

Typical
Distribution

+16
-16+20
-20+30
-30+40
-40+50
-50

1.19
1.19-0.84
0.84-0,59
0.59-0.42
0.42-0.30
0.30

4.0
29.0
49.0
16.0
1.5
0.5

%
%

%
%
%
%

IONAC C-249 is specially manufactured to eliminate
color throw and to assure compliance with F.D.A.
Regulations, Para. 173;25. It has also been approved by
the Meat Inspection Division of the U.S, Department of
Agriculture for use in the treatment of water for meat
packaging plants,
IONAC C-249 also meets the
stringent specifications for extractable limits set by
the French Ministry of Health for cation exchange
resins used in potable water supplies and for food
industry uses.
IONAC C·249 is supplied in the fully swollen moist
sodium form, and its primary application (detailed in
this bulletin) is in the softening of water, for household,
municipal, and industrial use.

NOTE: Similar cation exchange resins with different
crosslinkage, ionic form, particle size distribution, or
degrees of purity are available.

The data included herein are based on test information obtained by Sybron Chemicals Inc. These data are believed to be reliable but do not imply
any warranty of performance guarantee. We recommend that the user determine performance by testing on his own processing equipment. We
assume no liability or responsibility for patent infringement resulting from the use of this product.
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KEY FACTORS AFFECTING CAPACITY OF IONAC C-249
Regenerant quantity, contact time with resin, and brine concentration
Water flow rate during service run.
Bed depth
Figure 1
(Parameter: Total Disolved Solids, ppm)

CAPACITY
Figures 1, 2, 5 and 6 illustrate the effect of
total dissolved solids (T.D.S.) and various
hardness levels on operating (softening)
capacities at different salt (NaCI) dosages.

IONAC C-249 - CAPACITY
.. 5 lb•• N. CI/cu. ft.

24-1--

~
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:::J

u

...

&

..:

Ql
~

Figures 3 and 4 illustrate the effect of
Sodium vs. Total Hardness on expected
leakage.
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For clarity the Total Dissolved Solids
(Sodium plus Total Hardness as ppm
C a C OJ) is given as a parameter, vs. In
fluent Hardness. To obtain TOTAL DIS
SOLVED SOLIDS (T.D.S.):

z

a::
w

a...

o
. Add Sodium to Total Hardness (all
expressed as CaCO,)

17+---+
16+----+---------~

Capacity ratings and related data are based
upon capacity break-through, i.e. end-point
of 10% rise from the average residual
hardness.
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INFLUENT WATER HARDNESS

15

20

30

(grains/gal. as CaCo.)

Figure 2
(Parameter: Total Dissolved Solids, ppm)
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FOR METRIC CONVERSIONS:
Multiply
Muiliply
Multiply
Muillply
Multiply
Multiply

gpm sq. ft. • 2,44
gpm cu. fl. • 8
PSllft.'bed • . 22
Bed depth. II. • 30.48
Ib.leu. It. x 16
Kgr.leu. fl. • 2.29
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•
•
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CAPACITY CALCULATION:
U.S. gal. I regon. x Total Hardn ... (in ppm)
R..ln volumo leu. It.) • 17.1 • lOGO

• kllogralno/eu. It.
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IONAC C·249  Capacity
@ 10 Ibs. Na Cl/cu. ft.

18

Motrle convorslon 1 Kg,/cu. ft.• 2.29 gm (CaCO,) pe, Iller 01 ''''n
(1 cu. It. a 28.3 lito,.)
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INFLUENT WATER HARDNESS (grains/gal. as CaCo,)
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Figure 5
Figure 3

36 •

(Parameter, Total Dissolved Solids, ppm)

(Parameter: Total Dissolved Solids, ppm)
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INFLUENT HARDNESS (grains/gal. as CaCoJ
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IONAC C·249 .. Capacity
@ 15 tbs. Na Cl/eu. ft.

15

5

20

30

INFLUENT HARDNESS (grains/gal. as CaCo,)

Figure 4
( Par am e t e r: Total Dissolved Solids, ppm)
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IONAC C·249  LEAKAGE
@ 10 Ibs. Nli elley. ft.

Figure 6
(Parameter : Total Dissolved Solids~ ppml
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IONAC C·249 .. C8J)acity
(Ij) 20 Ibs. Na Cl/eu. ft.
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INFLUENT HARDNESS (grains/gal. as CaCo,)

INFLUENT HARDNESS (grains/gal, as CaCo,)

For 15 and 20 lb. Salt (NaCI) regeneration, per cu. ft., no
leakage curves are presented_ The reason for omitting
these is that at the Total Solids and Total Hardness levels
shown the leakage at 15 lb. of Salt is below 1.5 ppm; and
at 20 lb. of Salt the leakage is below 0.5 ppm.
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Figure 7 (Parameter: Total Dissolved Solids ppm)

Figure 9
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BACKWASH FLOW RATE, U.S. gpm/sq.
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When lonac C-249 ion exchange resin is to be used on
the sodium cycle for softening potable water or for
treating water for food processing, it should be
contracted with a minimum of 60 gallons of potable
water per cu. ft. of resin over a period of at least 15
minutes before being placed in service. This total

/ ~1f'}1

l- v:I
2

ft.

~

~

3

IONAC C·249 Form) PI'lItaj,.

I
4 5

I

(Na.1

Drop

I 11
8 10

20

30

FLOW RATE, U.S. gpmisq. ft.
volume of water can be used in either the
backwashing, brining or rinse portions of a normal
regeneration cycle. When so contacted, lonac C-249
will meet the extractive requirements of the Food
Additives Regulations, Para. 173;25.

SYBRON CHEMICALS INC.
SYBRON CHEMICALS INC.
BIRMINGHAM ROAD. P.O. BOX 66, BIRMINGHAM. NEW JERSEY 08011 (609) 893·]]00
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ULTRAVIOLET WATER PURIFIERS

Principles of Operation
;I
S:ta-l-n-k:~-:.; Stce~

£1""",,"""

.3

1. Water enters the purifier and
flows into the annular space
between the quartz sleeve and
the outside chamber wall.
2. Within the chamber, water is
exposed to intense germicidal
ultraviolet radiation.

(d /" ,/

I.:~~' ~«

'G

«,-,<--".,.......

Optic""j

3. Transformer with LED indicator light provides visual indication of
germicidal lamp operation.
4. Water leaving the purifier is instantly ready for use.
MinipureTM Water Purifiers are manufactured under one or more patents
owned by Atlantic Ultraviolet Corporation.
MinipureTM, Ster-L-RayTM and Easy-Off™ Retainer Cap are
trademarks of the Atlantic Ultraviolet Corporation.
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ULTRAVIOLET WATER PURIFIERS

I MIN-9 I

I

I

9
540 3/4" MPT 29-3/8" 14-1/4,1 . 5-9/16"
• Maximum recommended operating pressure for all purifiers is 100 PSI.
• Pressure drop at maximum recommended flow rate is 5 PSI or less.
o All data shown above is for 118 volt 60 Hz. Units are also available for 220 volt 50 Hz and 12
volt DC operation.
Minip'ureTM Water Purifiers are manufactured under one or more patents
owned by Atlantic Ultraviolet Corporation.
Minipure TM. Sterol-Ray TM and Easy-OffTM Retainer Cap are
trademarks of the Atlantic Ultraviolet Corporation.
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ULTRAVIOLET WATER PURIFIERS
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Ster-L-Ray Lamp Data for Minipure™ Water Purifiers

_iii;

e·iiiil

-~

05-1119
OS 1366

.: (iiiii

05-13i'D
\)5-0097 A

L' •

,iii

'Wattage is lamp watts only and does not include ballast loss.
"Maximum rated output at 254 nanometers.
All MinipureTM Water Purifiers employ genuine Sterol-RayTM germicidal lamps that afford the
maximum efficiency and longevity in producing the required germicidal rays. In addition to the
obvious advantages of high efficiency and low power requirements, there is no possibility of
the purifier overheating, as is the case with some other types. Consequently the need for
additional equipment to combat overheating is eliminated.

™Water Purifiers are manufactured under one or more patents

Minipure

owned by Atlantic Ultraviolet Corporation.
MinipureTM, Sterol-RayTM and Easy-Off™ Retainer Cap are
trademarks of the Atlantic Ultraviolet Corporation.
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Large Volume Models

Large Volume Models
Technical Data
Cat. No. 880-110,880-120
Cat. No. 880-110 Shown

Standard Model - Fixed Speed

RANDOLPH
AUSTIN CO.

The Series 880 is offered with choice of two fixed
speed motors. Motors offered include a 100 rpm and
190 rpm 3/4 hp - 115/230 volt - 60 hz - single phase
gearhead open type. Units are mounted on a durable
cast metal base. Available in explosion proof model
also. Refer to chart below for flow rates,
specifications and shipping weight.
Dimensions: L 29" x W 17" x H 21" Cat No. 880-300

Variflow Model 
DC Control
The Series 880-300 (not shown) is offered with a 220 volt single phase control to a
geared 190 rpm DC motor. The Vari-Flow control permits accurate adjustment with
forward and reverse capabilities.
Dimensions: L 29" x W 17" x H 21"

Technical Data - Series 880 - Models

Cat.#.

Pump
Speed
rpm.

Mode

Motor
hp.

Output gpm
Flow Rate
3/4" 10
1" 10
Tubing
Tubing

880-PHO Pumphead only
880-110 Std. model -

Ship.
wt.
115 lb.

100

3/4

6

12

240 lb.

880-120 Std. model fixed speed

190

3/4

11

21

240 lb.

880-300 Vari-:low

190

1

1/2-11

1-21

250 lb.

225

.7

3-14

5-23.5

210 lb .

fixed speed

speed control
880-400 Air-motor

RANDOLPH AUSTIN
COMPANY
10f2
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Series 750 - Models

Cat.#.

Model

Pump
Speed
rpm.

Motor
hp.

Output gph
Flow Rate
5/8" ID
3/4" ID
Tubing
Tubing

Ship.
wt.

750-PHO Pumphead only

20 lb.

750-000 Pumphead and pulley

20 lb.

750-100 Std. model
single phase
motor

430

1/3

390

570

65 lb.

750-101 Zero-max
0-400
speed control
model

1/2

360

00

120 lb.

750-200 Explosion
proof model

430

1/3

390

570

120 lb.

750-201 Expl. proof 0-400
model/speed
control

1/2

360

470 140 lb.

750-332 Vari-flow
3-125
speed control
model

1/4

8.2-113

12-166

66 lb.

750-342 Vari-flow
4-165
speed control
model

1/4

10-150

14.6-219

66lb.

750-352 Vari flow
6-250
speed control
model

1/4

:4-227

20-332

66 lb.

750-362 Vari-flow 12 500
speed control
model

1/4

24 454

36-662

66 lb.

750-400 Air drive
model - ARO

10-90 psi

102-390

:26-570

42 lb.

750-450 Air drive
model
Gast

10 90 psi

92-288

111-544

38 lb.

Back to Intermediate Volume Page
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FLOTREXm-AP FILTERS

POLYPROPYLENE MICROFIBER
(0.65, " 2, 3, 5, '0. 20. AND 40~m ABSOLUTE RATINGS)

Constructed of thermally-bonded polypropylene
fiber media, absolute-rated Flotrex-AP (FAP) filters combine
exceptional solids holding capacities with precise micron retention
ratings. The FAP filters are constructed of high-purity polypropylene and are made
with all FDA-acceptable materials.

FAP ADVANTAGES

FAP filters are absolute-rated for air. gas and liquid filtra
tion with low pressure drop across the wide range of 0.65
to 40 micron. The graded sheets of melt-blown media are
layered to provide absolute particle retention, high solids
loading and long service life.

• Broad chemical compatibility
• Dependable protection for
final filters
• Efficient removal of
Cryptosporidium and
Giardia cysts

The FAP filter is just one example of our strong commit
ment to liquid, gas and air treatment. Our complete port
folio includes filters for every stage of processing, and we
offer custom solutions for your unique applications.
Osmonics is your complete source for filters, housings and
other filtration equipment.

• High throughput
• High efficiency
• Long service life

Whether you require an integrated solution or a single
component for a specific application, look to Osmonics
first. From one end of the filtration spectrum to the other,
Osmonics has a total commitment to fluid purity.

• Absolute rating (99.9%)
• Fast rinse up to
18 megohm
• Thermally-bonded
polypropylene fiber media
• All FDA-acceptable materials
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SPECIFICATIONS
Effective Filtration Area for
10-inch Equivalent
0.65~m

- 5.0 ftl (0.45 m2)
1~m - 5.0 ft2 (0.45 m2)
2~m - 5.2 ft2 (0,48 m2)
3~m - 5.2 ftl (0.48 m2)
5~m - 6.1 ftl (0.57 m2)
1O~m - 6.7 ft2 (0.62 ml)
20~m - 6.9 ftl (0.64 ml)
40~m - 7.2 ft2 (0.67 m2)

Polypropylene Microfibers

APPLICATIONS
Flotrex-AP filters are specifically designed for pharmaceutical
prefiltration. Typical applications include:

Operational Data
Maximum Rated Differential Pressure 
Forward now - 60 psi (4.14 bar)
Reverse flow - 30 psi (2.07 bar)
Maximum Rated Operating Temperature 
180°F (82°C) at 10 psid
(0.69 bar) in water

Prefiltration and Final
Chemical Filtration

Bottled Water Final
Filtration

• Broad chemical
compatibility

• Efficient removal of
Giardia and
Cryptosporidium

cysts

Cartridge Dimensions
(Nominal)

Prefiltration of
Pharmaceuticals and
Biol~ical Fluids

Outside diameter 
2.75 inches (70 mm)
Inside diameter 
1.25 inch (31 mm)

• Dependable
protection for
final filters

High Throughput for
Beer Filtration

Integrity test and particle
retention data available on request.

ORDERING INFORMATION
Type

Absoulte
Micron
Rating

FAP

96 = 0.651Jm
01 = 1.0IJm
02 = 2.D!Jm
03 = 10IJm
05 = 5.01Jm
10 10.01Jrn
20 20.0jJm
40 = 40.0jJm

Cartridge
length
1 = 10
2 = 20
3 = 30
4 = 40

Inch
Inch
Inch
Inch

• Viton and Teflon are registered trademarks of
E.I. DuPont de Nemours and Company. Inc.

End #1
Adapter
A = Open End
Gasket
B = 120 O-Ring
C = 213 O-Ring
E = 222 O-Ring
F 226 O-Ring
J = 020 O-Ring
Q = 222 O-Ring
Stainless Steel
Support Ring
Z = 226 Q·Ring
Stainless Steel
Support Ring

End #2
Adapter
A = Open End
Gasket
B = 120 O-Ring
C = 213 D-Ring
G = Closed End

Cap

H = Fin Adapter

Elastomer
Material
B=
E=
S=
T=

Buna-N
EPOM
Silicone
Tenon*
Encapsulated
(Only in 222 and 226 Sizes)
V = Viton"

For more information call toll free in the USA (800) 848-1750
Manufactured in the USA

~.

OSMONICS
5951 Clearwater Drive. Minnetonka, MN 55343-8995 USA
Phone (612) 933-2277. Fax (612) 933-0141
http://w w w. 0 S m 0 n i c S . com

() Copyr>ght 1999. 1997. 1996 Q,monics. Inc.
Printed in USA, PIN 1161965 Rev. D
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MEMTRExm-FE-S FILTERS
PTFE MEMBRANE
(0.2 pm ABSOLUTE RATING)

Memtrex-FE-S (MFE-S) validatable sterilizing
grade filter cartridges are designed for sterile
venting and final filtration of pharmaceutical fluids.
MFE-S is the sterilization (S) grade MFE
for valication uses. This commitment to validation
by Osmonics is based upon the FDA Guidelines that we
"establish documented evidence of assurance that a specif
ic process will consistently produce a product meeting its
predetermined specification and quality attributes" (FDA
1987). MFE-S is designed for final sterile filtration of phar
maceutical products.

MFE-S ADVANTAGES
• Sterilization (S) grade MFE
for validation uses
• High-purity Gore'
membrane
• High throughput

MFE-S is designed for vent and process fluid filtration in val
idated systems where critical fluids need absolute, aseptic
and sterile hydrophobic or chemically resistant protection.

• Meets HIMA guidelines
• 100% integrity tested

A detailed Validation Guide is available from Osmonics to
document our rigorous testing for your records and
reviews.

• Steam sterilizable
• Meets USP 23 Class VI
Plastic Test

The MFE-S filter is just one example of our strong
commitment to the pharmaceutical industry.
Our
complete portfolio includes filters for every stage of pro
cessing, and we offer custom solutions for your unique
applications. Osmonics is your complete source for filters,
housings and other filtration equipment.

• Passes MEM Elution
Cytotoxicity tested

• Gore is a registered trademark of w,L. Gore & Associates, Inc.
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SPECIFICATIONS
Effective Filtration Area for
10-inch Equivalent
0.21..1m - 9.0 fe (0.9 m2)
Operational Data
Maximum Rated Differential Pressure 
Forward flow - 60 psi (4.14 bar)
Reverse flow- 30 psi (2.07 bar)
PTFE Membrane
Maximum Rated Operating Temperature 180°F (82°C) at 10 pisd
Memtrex-FE-S filters are specifically designed for chemical,
(0.69 bar) in water
air, gas and vent filtration. Typical applications include:
Integrity Test
Vent Filtration in
Pharmaceutical
Diffusional Flow 60% IPA per
Pharmaceutical
Vailidation
10-inch Element
•
Ultra
high
purity
Vailidated
Process
0.21..1m - 10 cclmin at 13 psig (0.90 bar)
• Broad chemical
compatibility
Sterilization
Autoclave at 250°F (121°C) 
Acid, Base, and Oxidant
Maximum 10 hours
Filtration
Steam-in-Place at 257°F (125°C) 
Maximum 10 hours

•

APPLICATIONS

•

Biosafety
Passes USP 23 Class VI 250°F (121°C)
Plastics test passes MEM Elution
Cytotoxicity Test
Gravimetric Extractables
7.7 mg per 10 inch cartridge
Bacterial Endotoxin
Leachate is below 0.25 EUlmL which meets
the USP 23 limit for Water For Injection (WFI)

ORDERING INFORMATION
Type

MFE

Absolute
Micron
Rating
92 =

0.2~m

Cartridge
length
1 = 10
2 ;; 20
3 = 30
4 = 40

Inch
Inch
Inch
Inch

End #1
Adapter
Q

l

=

222 O-Rin~
Stainless teel
Su~port Ring
22 O-Rin~
Stainless teel
Support Ring

End #2
Adapter
A;;; Open End
Gasket
B = 120 O-Ring
C = 213 O-Ring
G Closed End
Cap
H;;; Fin Adapter

Elastomer
Material
Silicone

Grade
S

Sterilizing
Pharmaceutical

For more information call toll free in the USA (800) 848-1750
Manufactured in the USA

~

OSMONICS
5951 Clearwater Drive, Minnetonka, MN 55343-8995 USA
Phone (612) 933·2277, Fax (612) 933·0141
hrtp:llwww.osmonics.com

I) Copyright 1999 0"""";0,, lOG.
Printed in USA, PIN 1204170 Rev. B
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RO Systems &om Anrerm'ater deliver versatility and value

IR0 open skid style RO system
Sizes l~a[]ge from .2,000-1'5,000 GPU
Pump pressure gauge stai nles3
steel liquid filled for accuracy

Del uxe control panel i ncJ udes
temperature compensated digi
tal conductivity monitor, hour
meter, tank level controller
alarm 'With silencer designed
for three phase 208/220/460
volts 'With transformer.
Disconnect, motor protection
and motor starter
J

Filter housi ng for
particulate filtration

Standard control panel.
Same features as Del uxe less
three- phase motor starter pro
tection. Operates. on 208/230
SI ngle- phase that can be pI ugged
into standard 208/230 'Wall
receptacle

4

t--;::=====

Flo'W meters measure product
'Water and reject 'Water

Skid mounted on 'Wheels for easy
maneuveri ng and mai ntenance

Thin film composite membrane
4"x 40" provides superior salt
rejection and flo'W

I--~

IRO Model Specifications
-.umu" an .'!4 t]" a'H.'!4 0 ' , tn»'!J P" a':.'4 0" a.r..'!J t].' ;I1II.'!J••
er ormance:
Projected
Rejection
Initial
Production

>96%

>96%

2300

11500

1.5

7.5

(GPD)~

Product Flow
(GPM)~

Recovery Rate
50-75 %
ectnca - NOTE: The only difference between models 5 and 0 is the control panel and
Electrical specs

All "S" models
Single Phase**
Pump Horse
Power
All "D" models
Three Phase**
Pump Horse
Power

220Yt3;S:M.aximuIIl Amp~
1.5
. 2~OV7_5 MaximUlll Amps
1.5

em ranes:
Size (inches)
Quantity

4x40
1

~j[~1!~~I~~'0B

4 x40

~n!litttjli~g~!

4 x40

riZ:l~~~,gllulliHilll

l'i~~t,\~I~i~;;~l~fi!ffi

3

:~~~:r\~',~l~(flil~~i.~-

5

f~~~;~ll}~_glll~!f~

Type

l,illima-G-rl.II~\"lmIl·1l<911••''''Wl!!IlI'IlIIIJI...
1 of3

Thin Film
Composite..

Thin Film
Composite

.(!i• •IIII"
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, Ameriwater: IRO Systems
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Requirements
Max Free
Chlorine
Temperature
Range
Operating pH
4-11
Range
Cleaning pH
2.0 - 11.5
Range
Prefiltration
5 micron
Pressure Feed
20-80
Range (PSIG)
Max Fouling
<3
Index (SDI)
Langelier
<0
Saturation Index
ImenSlons
Connections
HxWxD
(inches)
Approx Shipping
492
Weight (lbs)

.

.

'33·113 degrees F (1.,45. degrees. C)
4-11
2.0 - 11.5

5 micron

.

20-80

20-80

<3

<3

<0

<0

InletlOntlet/Jl')taiI1,l
!':FPT.:
".
-: '/
'-"',"

,

·-:;72
x.·24;~3S).
'.' <,' "., '",. '-'

,«

>;;;",;,

542

.. Product flow rate varies with temperature. All model capacities are rated at 77 degrees F (25
C) with feed water of 1500 mg/L NaCI @ 200 PSI and pH of 7.5
... 208V and 440V are also available

Here are other AmeriWater RO systems:

Custom designed systems
15,000 GPD

for applications larger than

AMERIWATER REl'ERSE OSMOSIS SYS1D1S ARE EASY TO IIAINTAIN
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Kasadill\ootanq
3900 Chestnut Street
Apt. 409
Philadelphia, PA 19104

12b': F;;\\

RE: Research Waste\vater
Dcar Kasadit:

As per your prdirninary specifications, EarthCarc is pleased to submit this preliminary quotation for the
transportation and disposal of the wastewater at LJniver!:>ily ofPennsylvaJ'ia. Material will bl:! transported to
Gloucester County WWTP for treatment and disposal.
Transportation and Disposal
PH 5.5 lo 9

TSS less than 1%.

Budget

$0.16 to SO.21/gallon
600\) gal. min imum
BOD less than }0,000 ppm

One hour loading and 112 hour unloading is free: .523.15 per quaJ1er hour dCmUlTa.l:;\~ \vill be charged thereafter.
It will be the responsibility of the Customer to pay for any tank clean·outs (if nt:cessary). If a tank cleiU1:-out is
required, then the cost plus demurrage will be charged.

All pricing based OD facmty acceptance. Ifth~s preliminary proposal is .{cceptable, we would require a
sample and analysis of the waste (lrnot already provided). l:pon revie\v of the ::.ample, a tinal proposal will he
issued provided the material is acceptable, Shuuld the material arrive at the tLsposal facility not meeting lhe
above specifications. the waste 'v\ill face possible rejection or surcharges.
This preliminary pricing is in efft!ct for thirty (30) Uays from the date of '(his correspondence. RateS do not
include any state, federal, or local taxes or fees. \vhich may be imposed.

We appreciate this opportunity w assist in yow' environmental conc.erns. l.:pon agreeing to these terms and
conditions. \ve ask for your acknowledgement in the below area provided. Should you have any questions
regarding this transportation and disposal package. please feel free to caB 111": c.t (610) 458~9333. I look f01"\Vurd
to servicing Jour needs in the near future.
Very t ly yours,

~13K~

athleen B. Roegner.

